000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|NED|0|0|0|100|XEU|7115|11291|lyfalmen|V0457|8760|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||7115||7115|11291||2|0|E|0|||0
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|NED|0|0|0|100|XEU|21846|30904|lyfalmen|V0475|9452|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21846||21846|30904||2|0|E|0|||0
000193|N05AH0302|Zyprexa Velotab|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|28217|38962|lyfalmen|V0540|20624|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||28217||28217|38962||2|0||0|||0
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|FER|0|0|0|100|DKK|4461|7638|lyfalmen|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4461||4461|7638||1|H|0|0|||0
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|BOI|0|0|0|100|DKK|4263|8258|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||4263||4263|8258||1|0||0|||0
000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|FER|0|0|0|100|DKK|11862|17825|lyfalmen|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||11862||11862|17825||1|H|0|0|||0
000546|G03DA0406|Crinone|sk-hlaup|8|%|6|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|1|G|0|MEC|0|0|0|100|SEK|2784|5330|lyfalmen|V0942|4841|1|6|0|6,0000|Icepharma hf|Merck AB|Prógesterón||2784||2784|5330||2|0|G|0|||0
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3838|6781|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3838||3838|6781||1|0||0|||0
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|G|0|JAS|0|0|0|100|SEK|2845|5414|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2845||2845|5414||1|0|G|0|||0
000613|G03DA0406|Crinone|sk-hlaup|8|%|15|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|1|G|0|MEC|0|0|0|100|SEK|7705|12103|lyfalmen|V0942|12103|1|15|0|15,0000|Icepharma hf|Merck AB|Prógesterón||7705||7705|12103||2|0|G|0|||0
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3139|5818|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3139||3139|5818||1|0||0|||0
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0||0|||0
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0||0|||0
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|1|G|0|MRP|0|0|0|100|SEK|87218|113587|lyfalmen|||1|6|0|122,7907|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||87218||87218|113587||2|0|G|0|||0
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|14768|21825|lyfalmen|V0115|7967|1|100|0|400,0000|Icepharma hf|Upjohn EESV|Atorvastatín||14768||14768|21825||1|0|E|0|||0
001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|G|0|RDT|0|0|0|100|DKK|1705|3845|lyfalmen|V0050|2494|1|100|0|15,8333|Vistor hf|Recordati Ireland Limited|Metóprólól||1705||1705|3845||1|0|G|0|||0
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5237|8706|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5237||5237|8706||1|0|G|0|||0
001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2617|5100|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||2617||2617|5100||1|0|G|0|||0
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|FKA|0|0|0|100|DKK|17899|26134|lyfalmen|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||17899||17899|26134||1|0|0|0|||0
001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|G|0|VIF|0|0|1|100|CHF|12396|18560|lyfalmen|V0637|18557|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||12396||12396|18560||1|0|G|0|||0
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|FKA|0|0|0|100|DKK|24400|34135|lyfalmen|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||24400||24400|34135||1|0|0|0|||0
001870|QP54AA0601|Slice vet.|forbl|0,2|% w/w|2,5|kg|1|þpakki|duft|QP54AA06|01.02.2019||R|0|0|0|0|0|IBV|0|0|0|100|DKK|128915|207811|veteldis|||0|2,5|0||Vistor hf|Intervet International BV|emamektín||128915||128915|207811||1|0||0|||0
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|HES|0|0|0|100|DKK|2303|4668|lyfalmen|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2303||2303|4668||1|H|0|0|||0
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|G|0|NEL|0|0|0|100|DKK|4300|7416|lyfalmen|||1|15|0|75,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||4300||4300|7416||1|0|G|0|||0
001905|N03AX0901|Lamictal|dreifit.|2|mg|30|stk|1|glas||N03AX09|01.08.2020||R|0|0|0|G|0|GPH|0|0|0|100|DKK|483|2163|lyfalmen|||1|30|0|0,2000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||483||483|2163||1|0|G|0|||0
001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1648|2538|lyfalmen|V0291|2273|2|60|0|12,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||756||756|2538||1|0|G|0|||0
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|BIG|0|0|1|100|SEK|3221|5931|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3221||3221|5931||2|0|E|0|||0
001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2878|3576|lyfalmen|V0292|3494|2|60|0|24,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||1510||1510|3576||1|0|G|0|||0
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|GRH|0|0|1|100|DKK|1532|3607|lyfalmen|V0004|2839|1|28|0|18,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||1532||1532|3607||1|0|E|0|||0
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|GRH|0|0|1|100|DKK|3120|5792|lyfalmen|V0005|2874|1|28|0|37,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||3120||3120|5792||1|0|E|0|||0
002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|FKA|0|0|0|100|DKK|20783|29560|lyfalmen|||1|5760|0||Vistor hf|Fresenius Kabi AB|Blöndur||20783||20783|29560||2|0|0|0|||0
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2746|5278|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2746||2746|5278||1|0|G|0|||0
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|G|0|MSD|0|0|0|100|DKK|11754|17676|lyfalmen|V0492|16040|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||11754||11754|17676||1|0|G|0|||0
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||||1|0||0|||0
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||||1|0||0|||0
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|G|0|ATE|0|0|1|100|IKR|||lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||2728||1|0|G|0|||0
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|1|0|0|LPT|0|0|0|100|XEU|28788|33001|lyfalmen|||1|1|0||Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||23504||23504|33001||1|0|0|0|||0
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|G|0|MSD|0|0|0|100|DKK|11186|14877|lyfalmen|V0089|3631|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||9720||9720|14877||1|0|G|0|||0
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|7623|11990|lyfalmen|V0515|5198|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||7623||7623|11990||1|0|G|0|||0
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|10583|16064|lyfalmen|V0253|4878|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||10583||10583|16064||1|0|G|0|||0
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|20539|29251|lyfalmen|V0516|12509|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||20539||20539|29251||1|0|G|0|||0
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|1|G|0|PFP|0|0|0|100|DKK|8058|12589|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||8058||8058|12589||1|0|G|0|||0
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|1|G|0|PFP|0|0|0|100|DKK|11899|17876|lyfalmen|V0992|15322|1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||11899||11899|17876||1|0|G|0|||0
003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|G|0|AZD|0|0|0|100|SEK|5700|9343|lyfalmen|V0971|9342|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5700||5700|9343||1|0|G|0|||0
003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|innö.t|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|G|0|AZD|0|0|0|100|SEK|6786|10838|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6786||6786|10838||1|0|G|0|||0
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|G|0|PLS|0|0|1|100|DKK|2880|5462|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2880||2880|5462||1|0|G|0|||0
003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|0|0|SGB|0|0|0|100|XEU|31560|43191|lyfalmen|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||31560||31560|43191||1|H|0|0|||0
003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|1900|3191|lyfalmen|||2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||1230||1230|3191||1|0|G|0|||0
003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|G|0|ATE|0|0|0|100|XEU|23506|25815|lyfalmen|||2|500|0|166,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||17667||17667|25815||1|0|G|0|||0
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1004|2649|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||836||836|2649||1|0|E|0|||0
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2129|3294|lyfalmen|V0322|2912|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||1305||1305|3294||1|0|G|0|||0
004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|HES|0|0|0|100|DKK|17594|25714|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||17594||17594|25714||1|H|0|0|||0
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|G|0|HES|0|0|0|100|DKK|7356|11623|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7356||7356|11623||1|0|G|0|||0
004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4007|7013|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4007||4007|7013||1|0|G|0|||0
004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5386|8911|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5386||5386|8911||1|0|G|0|||0
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|0|PEU|0|0|0|100|DKK|16129|23698|lyfalmen|||1|1|0|0,5000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||16129||16129|23698||1|H|0|0|||0
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|BOI|0|0|0|100|DKK|6767|13009|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Fenetamathýdrójoðíð í blöndum með öðrum sýklalyfjum||6767||6767|13009||1|0||0|||0
004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2333|4709|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir  mótefnavakar||2333||2333|4709||1|0||0|||0
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2652|2717|lyfalmen|V0494|2717|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||886||886|2717||1|0|G|0|||0
004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2837|5403|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir  mótefnavakar||2837||2837|5403||1|0||0|||0
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3853|4295|lyfalmen|V0320|4295|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cítalópram||2032||2032|4295||1|0|G|0|||0
004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|G|0|SDH|0|0|0|100|XEU|7646|12022|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||7646||7646|12022||1|0|G|0|||0
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|781|2573|lyfalmen|||2|24|0|3,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||781||781|2573||1|0||0|||0
004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|PLS|0|0|1|100|DKK|3914|6885|lyfalmen|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||3914||3914|6885||1|0|0|0|||0
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|ATE|0|0|1|100|DKK|335|1959|lyfalmen|||2|8|0|2,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||335||335|1959||1|0||0|||0
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|ATE|0|0|1|100|DKK|858|2679|lyfalmen|||2|14|0|3,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||858||858|2679||1|0||0|||0
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|ATE|0|0|1|100|DKK|1469|3520|lyfalmen|||2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||1469||1469|3520||1|0||0|||0
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2394|4793|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||2394||2394|4793||1|0||0|||0
005108|G04CA0201|Omnic|hylki|0,4|mg|90|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|G|0|ASP|0|0|0|100|XEU|8141|7204|lyfalmen|V0148|4253|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4146||4146|7204||1|0|G|0|||0
005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2431|4186|lyfalmen|V0337|3971|2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díkloxacillín||1953||1953|4186||1|0|E|0|||0
005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|G|0|AZD|0|0|0|100|SEK|17101|25036|lyfalmen|V0356|25034|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||17101||17101|25036||1|0|G|0|||0
005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|G|0|BOI|0|0|0|100|DKK|1663|3787|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1663||1663|3787||1|0|G|0|||0
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|G|0|BII|0|0|0|100|DKK|4529|7732|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4529||4529|7732||1|0|G|0|||0
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|G|0|BII|0|0|0|100|DKK|4569|7787|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4569||4569|7787||1|0|G|0|||0
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|1740|3893|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1740||1740|3893||2|0|G|0|||0
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|5465|9020|lyfalmen|V0020|7004|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||5465||5465|9020||2|0|G|0|||0
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|3992|6993|lyfalmen|V0020|3502|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3992||3992|6993||2|0|G|0|||0
005766|H01CC0201|Cetrotide|sts|0,25|mg|1|hgl|1|pakki||H01CC02|01.12.2016||R|0|0|1|G|0|MRP|0|0|0|100|SEK|4337|7467|lyfalmen|||1|1|0|1,0000|Icepharma hf|Merck Europe B.V.|Cetrorelix||4337||4337|7467||2|0|G|0|||0
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|5058|8460|lyfalmen|V0324|3838|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5058||5058|8460||1|0|G|0|||0
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|8119|12673|lyfalmen|V0325|4526|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||8119||8119|12673||1|0|E|0|||0
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|G|0|NED|0|0|0|100|XEU|2549|5006|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2549||2549|5006||2|0|G|0|||0
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|13638|20166|lyfalmen|V0326|5352|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13563||13563|20166||1|0|E|0|||0
005963|J01CR0204|Amoxin comp|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|RHA|0|0|1|100|IKR|1834|2668|lyfalmen|V0169|2599|2|14|0|8,1667|Alvogen|ratiopharm Oy|Amoxicillín og beta-laktamasa hemill ||850||850|2668||2|0|E|0|||0
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5121|8546|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5121||5121|8546||1|0|G|0|||0
006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|MSD|0|0|0|100|DKK|93213|121169|lyfalmen|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||93213||93213|121169||1|H|0|0|||0
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|G|0|NAS|0|0|0|100|DKK|4890|8229|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4890||4890|8229||1|0|G|0|||0
006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|MSD|0|0|0|100|DKK|71213|93344|lyfalmen|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||71213||71213|93344||1|H|0|0|||0
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|BOI|1|0|0|100|DKK|3312|6454|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|Meloxícam||||3312|6454||1|0||0|||0
006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|G|0|LEP|0|0|0|100|DKK|12588|18824|lyfalmen|V1030|16227|1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12588||12588|18824||1|0|G|0|||0
006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|GEB|0|1|0|100|XEU|415510|523289|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||415510||415510|523289||1|H|L|0|||0
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|G|0|MSD|0|0|0|100|DKK|12658|18920|lyfalmen|V0099|14463|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||12658||12658|18920||1|0|G|0|||0
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|11033|16684|lyfalmen|V0117|4773|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||11033||11033|16684||1|0|E|0|||0
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|15800|23245|lyfalmen|V0118|7714|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15800||15800|23245||1|0|E|0|||0
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|18786|27355|lyfalmen|V0195|9966|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||18786||18786|27355||1|0|E|0|||0
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|1|0|0|PLS|0|1|0|100|DKK|78122|102082|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||78122||78122|102082||1|0|L|0|||0
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|1|0|0|PLS|0|1|0|100|DKK|199732|254922|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||199732||199732|254922||1|0|L|0|||0
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|G|0|UPJ|0|0|0|100|DKK|2123|4420|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Upjohn EESV|Tímólól í blöndum||2123||2123|4420||1|0|G|0|||0
007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|BAM|0|0|0|100|SEK|6936|11045|lyfalmen|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||6936||6936|11045||2|0|0|0|||0
007449|V03AB3402|Fomepizol EUSA Pharma|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|SER|0|0|0|100|XEU|90379|117585|lyfalmen|||1|100|0||SERB SA|SERB SA|Fómepízól||90379||90379|117585||3|H|0|0|||0
007462|N01AB0801|Sevorane|innö.guf|100|%|250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|ABV|0|0|0|100|DKK|21446|30399|lyfalmen|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||21446||21446|30399||1|H|0|0|||0
007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|5627|9243|lyfalmen|||1|30|0|15,0000|Icepharma hf|Upjohn EESV|Tólteródín||5627||5627|9243||1|0|G|0|||0
007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|0|0|SHG|0|1|0|100|DKK|229705|292200|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||229705|292200||1|H|L|0|||0
007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|4570|7788|lyfalmen|||1|30|0|30,0000|Icepharma hf|Upjohn EESV|Tólteródín||4570||4570|7788||1|0|G|0|||0
007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|14424|21351|lyfalmen|||1|100|0|100,0000|Icepharma hf|Upjohn EESV|Tólteródín||14424||14424|21351||1|0|G|0|||0
007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1576|2700|lyfalmen|V0290|2700|2|60|0|6,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||873||873|2700||1|0|G|0|||0
007852|G02BB0101|NuvaRing|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst.|G02BB01|01.11.2002||R|0|0|0|0|0|DSM|0|0|0|100|DKK|3718|5922|lyfalm11|V0983|5232|1|3|0|84,0000|Vistor hf|Merck Sharp & Dohme|Skeiðarinnleg með progestógeni og östrógeni||3718||3718|5922||1|0||0|||1
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|NEL|0|0|0|100|DKK|1280|3260|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Ólópatadín||1280||1280|3260||1|0||0|||0
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|G|0|MCK|0|0|0|100|SEK|321|1940|lyfalmen|V0502|1037|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||321||321|1940||2|0|G|0|||0
008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|1|100|XEU|831|2254|lyfalmen|V0226|2248|2|20|0|6,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||549||549|2254||1|0|G|1|30|dagar|0
008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|G|0|GPH|0|0|1|100|DKK|976|2841|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||976||976|2841||1|0|G|0|||0
008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2650|4519|lyfalmen|V0227|4388|2|100|0|33,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||2195||2195|4519||1|0|G|1|30|dagar|0
008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3770|5344|lyfalmen|V0228|5214|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||2794||2794|5344||1|0|G|1|30|dagar|0
008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4418|6717|lyfalmen|V0224|6591|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||3792||3792|6717||1|0|G|1|30|dagar|0
008370|H01AB0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|H01AB01|01.01.2006||R|0|0|0|0|0|GEB|0|0|0|100|XEU|117481|152625|lyfalmen|||1|2|0||Vistor hf|Genzyme Europe B.V.|Thyrotropin alfa||117481||117481|152625||1|H|0|0|||0
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|CHP|0|0|0|100|IKR|8120|13996|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |Fenbendazolum||8120||8120|13996||2|0||0|||0
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|CHP|1|0|0|100|XEU|11017|21072|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||11017||11017|21072||2|0||0|||0
008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|G|0|RTH|0|0|1|100|XEU|||lyfalmen|V0575|1677|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||2661||2|0|G|0|||0
008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2603|5081|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2603||2603|5081||1|0|G|0|||0
008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012|31.07.2021|L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0||0|||0
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|1|G|0|RRG|0|0|0|100|DKK|91988|119620|lyfalmen|||1|2|0|20,7700|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||91988||91988|119620||2|0|G|0|||0
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|1|G|0|RRG|0|0|0|100|DKK|107688|140445|lyfalmen|||1|2|0|27,6900|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||107688||107688|140445||2|0|G|0|||0
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|6556|10522|lyfalmen|V0145|3584|1|4|0|8,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||6556|10522||2|0|E|0|||0
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|13001|19392|lyfalmen|V0145|7167|1|8|0|16,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||13001|19392||2|0|E|0|||0
008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0||0|||0
009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4383|7531|lyfalmen|||2|60|0|60,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4383||4383|7531||2|0|G|0|||0
009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|FMC|0|0|0|100|XEU|8082|12622|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8082||8082|12622||2|0|0|0|||0
009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4944|8303|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4944||4944|8303||2|0|G|0|||0
009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|FMC|0|0|0|100|XEU|8082|12622|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8082||8082|12622||2|0|0|0|||0
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|PEU|0|0|1|100|DKK|10212|15554|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Europe MA EEIG|Parekoxíb||10212||10212|15554||1|0||0|||0
009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|FMC|0|0|0|100|XEU|5953|9692|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5953||5953|9692||2|0|0|0|||0
009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0||0|||0
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|G|0|PEU|0|0|1|100|DKK|20314|28967|lyfalmen|V1033|16129|1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||20314||20314|28967||1|0|G|0|||0
009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1060|2957|lyfalmen|||1|8|0|21,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1060||1060|2957||1|0|G|0|||0
009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1169|3107|lyfalmen|||1|8|0|28,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1169||1169|3107||1|0|G|0|||0
009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1352|3359|lyfalmen|||1|8|0|42,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1352||1352|3359||1|0|G|0|||0
009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1693|3828|lyfalmen|||1|8|0|56,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1693||1693|3828||1|0|G|0|||0
009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|NOK|6058|9836|lyfalmen|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6058||6058|9836||2|0|0|0|||0
009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|8082|12622|lyfalmen|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8082||8082|12622||2|0|0|0|||0
009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|NOK|6058|9836|lyfalmen|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6058||6058|9836||2|0|0|0|||0
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|1|0|0|GII|0|1|0|100|DKK|52511|69690|lyfsjukr|||1|30|0|30,0000|Gilead Sciences International Ltd|Gilead Sciences Ireland UC|Tenófóvír dísóproxíl||52511||52511|69690||2|0|L|0|||0
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|DPL|0|0|1|100|XEU|8714|13492|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8714||8714|13492||1|0||0|||0
009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9960|15207|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9960||9960|15207||1|0||0|||0
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9211|14176|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||9211||9211|14176||1|0||0|||0
009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9960|15207|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9960||9960|15207||1|0||0|||0
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9211|14176|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||9211||9211|14176||1|0||0|||0
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|8714|13492|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8714||8714|13492||1|0||0|||0
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|0|0|MSD|0|0|0|100|DKK|5515|9089|lyfalmen|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||5515||5515|9089||1|H|0|0|||0
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|G|0|LUN|0|0|0|100|DKK|14834|21915|lyfalmen|V0605|2874|1|100|0|50,0000|Vistor hf|H. Lundbeck A/S|Memantín||14834||14834|21915||1|0|G|0|||0
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|7478|11791|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||7478||7478|11791||1|0|E|0|||0
010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|FKA|0|0|0|100|DKK|9160|14106|lyfalmen|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||9160||9160|14106||1|H|0|0|||0
010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|SAO|0|0|1|100|XEU|1291|3275|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1291||1291|3275||2|0||0|||0
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|0|1|0|0|JCI|0|1|0|100|SEK|245428|311755|lyfsjukr|||1|56|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||245428||245428|311755||3|0|L|0|||0
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|0|1|0|0|JCI|0|1|0|100|SEK|246063|312545|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||246063||246063|312545||3|0|L|0|||0
010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|1|0|0|PEU|0|1|0|100|DKK|658265|825209|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||658265||658265|825209||1|0|L|0|||0
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|0|0|BAM|0|0|0|100|SEK|39409|53118|lyfalmen|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||39409||39409|53118||2|H|0|0|||0
010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|2572|2690|lyfalmen|V0058|2690|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Felódipín||866||866|2690||2|0|G|0|||0
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|18797|27370|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||18797||18797|27370||1|0|E|0|||0
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|12664|18929|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||12664||12664|18929||1|0||0|||0
010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|3535|3106|lyfalmen|V0059|3106|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Felódipín||1168||1168|3106||2|0|G|0|||0
010989|R06AE0707|Cetirizin STADA|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.05.2018||L|1|0|0|G|0|ASR|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cetirizín|||||1677||2|0|G|0|||0
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|28875|39795|lyfalmen|V0683|3393|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||28875||28875|39795||1|0|E|0|||0
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|G|0|OPC|0|0|0|100|DKK|23331|32783|lyfalmen|V0684|3393|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||23331||23331|32783||1|0|G|0|||0
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3356|6117|lyfalmen|V0825|2811|1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3356||3356|6117||1|0|G|0|||0
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3474|6280|lyfalmen|V0826|3647|1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||3474||3474|6280||1|0|G|0|||0
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|14883|21983|lyfalmen|V0327|6315|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14883||14883|21983||1|0|E|0|||0
011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|G|0|MSD|0|0|1|100|DKK|1093|3002|lyfalmen|V0827|2186|1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1093||1093|3002||1|0|G|0|||0
011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|G|0|GPA|0|0|0|100|XEU|2087|2921|lyfalmen|V0069|2884|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1034||1034|2921||1|0|G|0|||0
011397|J01CA0102|Doktacillin|stl/irs|||1|g|10|hgl||J01CA01|01.03.2020||R|0|0|0|0|0|MEA|0|0|1|100|SEK|13779|20463|lyfalmen|||1|10|0|1,6667|Icepharma hf|Meda AB|Ampicillín||13779||13779|20463||2|0|0|0|||0
011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|G|0|AZD|0|0|0|100|SEK|5624|9239|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5624||5624|9239||1|0|G|0|||0
011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|0|0|0|JAS|0|0|0|100|SEK|5067|8472|lyfalmen|V0691|5611|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5067||5067|8472||1|0|E|1|30|dagar|0
011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|0|0|0|JAS|0|0|0|100|SEK|6481|7946|lyfalmen|V0624|5393|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4685||4685|7946||1|0|E|1|30|dagar|0
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|CHP|1|0|0|100|XEU|1794|3526|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||1794||1794|3526||2|0||0|||0
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3538|6368|lyfalmen|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||3538||3538|6368||1|H|0|1|30|dagar|0
011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|OCO|0|0|0|100|DKK|4162|8067|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||4162||4162|8067||2|0||0|||0
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3390|4938|lyfalmen|V0323|4166|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||2499||2499|4938||1|0|G|0|||0
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|MAR|0|0|0|100|DKK|3598|6450|lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||3598||3598|6450||2|H|0|0|||0
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|MAR|0|0|0|100|DKK|1896|4108|lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||1896||1896|4108||2|H|0|0|||0
012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|1|0|0|MSD|0|1|0|100|DKK|26267|36496|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||26267||26267|36496||1|0|L|0|||0
012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|G|0|GPH|0|0|0|100|DKK|3458|6258|lyfalmen|V0909|2783|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||3458||3458|6258||1|0|G|0|||0
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|6309|10182|lyfalmen|V0924|6005|1|4|0|4,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||6309||6309|10182||2|0|E|0|||0
012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|0|0|0|JAS|0|0|0|100|SEK|8482|10176|lyfalmen|V0622|6175|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6305||6305|10176||1|0|E|1|30|dagar|0
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|GPH|0|0|1|100|DKK|887|2719|lyfalmen|||1|80|0|2,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||887||887|2719||1|0|E|0|||0
012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|JCI|0|0|0|100|SEK|4127|6426|lyfalm11|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||4127||4127|6426||1|0||0|||1
012953|G03BA0306|Testogel|hlaup|50|mg|30|skpokar|1|pakki|hlaup til notkunar um húð|G03BA03|01.12.2003||R|0|0|0|G|0|LBI|0|0|0|100|DKK|5562|9153|lyfalmen|||1|30|0|30,0000|Vistor hf|Laboratoires Besins International|Testósterón||5562||5562|9153||1|0|G|0|||0
012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1974|2806|lyfalmen|V0250|2453|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Gabapentín||950||950|2806||2|0|G|0|||0
012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2941|3425|lyfalmen|V0251|3150|2|100|0|22,2200|Alvogen|ratiopharm GmbH|Gabapentín||1400||1400|3425||2|0|G|0|||0
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|6163|8464|lyfalmen|V0959|4558|1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5061||5061|8464||1|0|E|1|30|dagar|0
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|8878|12461|lyfalmen|V0996|7001|1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||7965||7965|12461||1|0|E|1|30|dagar|0
013172|J06BB0101|Rhophylac|stl|300|mcg|2|ml|1|áfspr||J06BB01|01.02.2004||R|0|0|0|0|0|CSB|0|0|0|100|SEK|7207|11418|lyfalmen|||1|2|0||Icepharma hf|CSL Behring GmbH|And-D(rh) immúnóglóbúlín||7207||7207|11418||2|H|0|0|||0
013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2793|4837|lyfalmen|V0042|4116|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxazósín||2426||2426|4837||1|0|G|0|||0
013347|L01EB0101|Iressa|töflur|250|mg|30|stk|1|þpakki||L01EB01|01.03.2010||R|0|0|1|0|0|AZE|0|1|0|100|SEK|292207|369935|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Gefitinib||292207||292207|369935||1|0|L|0|||0
013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|0|0|0|MUP|0|0|0|100|DKK|1186|3130|lyfalmen|||1|5|0|1,6700|Icepharma hf|Mundipharma A/S|Oxýcódon||1186||1186|3130||2|0|E|1|30|dagar|0
013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|771|2410|lyfalmen|V0562|2410|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Íbúprófen||663||663|2410||2|0|G|0|||0
013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|0|0|0|MUP|0|0|0|100|DKK|2279|4635|lyfalmen|||1|10|0|3,3300|Icepharma hf|Mundipharma A/S|Oxýcódon||2279||2279|4635||2|0|E|1|30|dagar|0
013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5739|9397|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||5739||5739|9397||1|0|G|0|||0
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2117|4412|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2117||2117|4412||1|0|G|0|||0
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|G|0|NAS|0|0|0|100|DKK|4417|7577|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4417||4417|7577||1|0|G|0|||0
013971|L01EA0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01EA01|01.06.2012||R|0|0|1|0|0|NEL|0|1|0|100|DKK|94270|122506|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatinib||94270||94270|122506||1|0|L|0|||0
013982|L01EA0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01EA01|01.05.2004||R|0|0|1|0|0|NEL|0|1|0|100|DKK|187679|239931|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatinib||187679||187679|239931||1|0|L|0|||0
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2285|4643|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2285||2285|4643||1|0|G|0|||0
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|GRH|0|0|1|100|DKK|6053|9829|lyfalmen|||1|50|0|13,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||6053||6053|9829||1|0|0|0|||0
014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|G|0|UCB|0|0|0|100|DKK|15139|22335|lyfalmen|V1000|16638|1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||15139||15139|22335||1|0|G|0|||0
014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|48142|64164|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||48142||48142|64164||2|0|E|0|||0
014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|SHS|0|0|1|100|DKK|1265|3239|lyfalmen|V0479|2950|2|60|0|4,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1265||1265|3239||1|0|E|0|||0
014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|SHS|0|0|1|100|DKK|1640|3755|lyfalmen|||2|100|0|6,6667|Artasan ehf|Sandoz A/S|Amoxicillín||1640||1640|3755||1|0|E|0|||0
014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|G|0|AZD|0|0|0|100|SEK|16875|24725|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||16875||16875|24725||1|0|G|0|||0
014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|370|1826|lyfalmen|V0563|1826|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Íbúprófen||238||238|1826||2|0|G|0|||0
014435|QM01AE0303|Dolovet vet.|duft|160|mg/g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|VET|0|0|0|100|XEU|2356|4630|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|Ketóprófen||2356||2356|4630||2|0||0|||0
014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|1|0|0|GEI|0|1|0|100|DKK|71705|93966|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Adefovír||||71705|93966||2|0|L|0|||0
014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1003|2271|lyfalmen|V0564|2271|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Íbúprófen||562||562|2271||2|0|G|0|||0
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|22246|31410|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||22246||22246|31410||1|0|G|0|||0
014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0||0|||0
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|61635|81230|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||61635||61635|81230||1|0|G|0|||0
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|41087|55240|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||41087||41087|55240||1|0|G|0|||0
014889|A16AA0501|Carbaglu|dreifit.|200|mg|60|stk|1|glas||A16AA05|01.12.2016||R|0|0|1|0|0|OUS|0|0|0|100|XEU|673186|843766|lyfalmen|||1|60|0|60,0000|Recordati AB|Orphan Europe SARL|Carglumicsýra||673186||673186|843766||3|0|E|0|||0
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2449|4211|lyfalmen|V0673|3975|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1971||1971|4211||1|0|G|0|||0
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|G|0|NAS|0|0|0|100|DKK|7084|11248|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7084||7084|11248||1|0|G|0|||0
015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1016|2896|lyfalmen|||1|8|0|14,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1016||1016|2896||1|0|G|0|||0
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1694|2818|lyfalmen|V0234|1705|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||959||959|2818||1|0|G|0|||0
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2419|2818|lyfalmen|V0233|2206|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||959||959|2818||1|0|G|0|||0
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|G|0|NAS|0|0|0|100|DKK|8241|12841|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8241||8241|12841||1|0|G|0|||0
015460|H01AC0114|Norditropin NordiFlex|stl|5|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|13872|20591|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||13872||13872|20591||1|0|L|0|||0
015591|H01AC0114|Norditropin NordiFlex|stl|10|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|27743|38363|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||27743||27743|38363||1|0|L|0|||0
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|11232|16958|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11232||11232|16958||1|0|G|0|||0
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|11168|16870|lyfalmen|V0900|16865|1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11168||11168|16870||1|0|G|0|||0
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|9757|14927|lyfalmen|V0829|14925|1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9757||9757|14927||1|0|G|0|||0
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|1|G|0|HES|0|0|0|100|DKK|17090|17116|lyfalmen|V0470|17116|1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||11347||11347|17116||1|0|G|0|||0
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|1|G|0|HES|0|0|0|100|DKK|34140|31942|lyfalmen|V1008|31942|1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||22666||22666|31942||1|0|G|0|||0
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3684|6350|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3684||3684|6350||2|0||0|||0
015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5663|9761|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||5663||5663|9761||2|0||0|||0
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3063|5279|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3063||3063|5279||2|0||0|||0
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3109|5359|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3109||3109|5359||2|0||0|||0
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5437|9371|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||5437||5437|9371||2|0||0|||0
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|0|0|0|ETH|0|0|1|100|GBP|1423|3457|lyfalmen|||2|10|0|3,3300|Icepharma hf|Ethypharm|Morfín||1423||1423|3457||2|0|E|1|30|dagar|0
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|2989|5152|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||2989||2989|5152||2|0||0|||0
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|GPH|0|0|0|100|DKK|1513|3580|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1513||1513|3580||1|0|E|0|||0
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|2320|4691|lyfalmen|||1|14|0|7,0000|Icepharma hf|Upjohn EESV|Pregabalín||2320||2320|4691||1|0|E|0|||0
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|4927|8279|lyfalmen|V0686|1935|1|56|0|14,0000|Icepharma hf|Upjohn EESV|Pregabalín||4927||4927|8279||1|0|E|0|||0
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|8688|13456|lyfalmen|V0687|2612|1|56|0|28,0000|Icepharma hf|Upjohn EESV|Pregabalín||8688||8688|13456||1|0|E|0|||0
016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|G|0|ATE|0|0|0|100|XEU|4773|8067|lyfalmen|||2|1000|0|1000,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||4773||4773|8067||1|0|G|0|||0
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|1525|3597|lyfalmen|||1|14|0|3,5000|Icepharma hf|Upjohn EESV|Pregabalín||1525||1525|3597||1|0|E|0|||0
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|10944|16561|lyfalmen|V0689|3390|1|56|0|56,0000|Icepharma hf|Upjohn EESV|Pregabalín||10944||10944|16561||1|0|E|0|||0
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|0|PEU|0|0|1|100|DKK|87466|113901|lyfalmen|||1|70|0|7,0000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||87466||87466|113901||1|0|0|0|||0
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3050|5696|lyfalmen|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3050||3050|5696||1|H|0|0|||0
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|2233|4571|lyfalmen|V0685|2141|1|56|0|4,6667|Icepharma hf|Upjohn EESV|Pregabalín||2233||2233|4571||1|0|E|0|||0
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|OPC|0|0|0|100|DKK|15407|22704|lyfalmen|V0690|6125|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||15407||15407|22704||1|0|E|0|||0
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7897||1|0|E|0|||0
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|OPC|0|0|0|100|DKK|25442|35453|lyfalmen|V0682|3393|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||25442||25442|35453||1|0|E|0|||0
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|7338|10019|lyfalmen|V0960|5406|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6191||6191|10019||1|0|E|1|30|dagar|0
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|G|0|LVR|0|0|0|100|DKK|2778|5322|lyfalmen|V0240|5322|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2778||2778|5322||3|0|G|0|||0
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|48014|64002|lyfalmen|V0721|11614|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||48014||48014|64002||1|0||0|||0
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|70737|92742|lyfalmen|V0722|43747|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||70737||70737|92742||1|0||0|||0
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|26298|36535|lyfalmen|V0720|8242|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||26298||26298|36535||1|0||0|||0
016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|GEB|0|1|0|100|XEU|60519|79818|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||60519||60519|79818||1|H|L|0|||0
016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1464|3513|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1464|3513||1|0|E|0|||0
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|1|0|0|GEI|0|1|0|100|DKK|29963|41171|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín||29963||29963|41171||2|0|L|0|||0
016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|1930|4154|lyfalmen|V0943|3907|1|4|0|2,8000|Icepharma hf|Mundipharma A/S|Búprenorfín||1930||1930|4154||2|0|G|1|30|dagar|0
017020|G03AC0601|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03AC06|01.12.1972||R|0|0|0|G|0|PLS|0|0|0|100|DKK|971|2537|lyfalm11|||1|3|0|89,8204|Icepharma hf|Pfizer ApS|Medroxýprógesterón||971||971|2537||1|0|G|0|||1
017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|ATE|0|0|0|100|XEU|6049|9824|lyfalmen|||2|500|0|333,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Zópíklón||6049||6049|9824||1|0||2|225|mg|0
017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|ATE|0|0|0|100|SEK|6700|10720|lyfalmen|||2|500|0|500,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Zópíklón||6700||6700|10720||1|0||2|225|mg|0
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|1|G|0|BNB|0|0|0|100|XEU|84415|110042|lyfalmen|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||84415||84415|110042||2|0|G|0|||0
017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|3459|6259|lyfalmen|V0944|5814|1|4|0|5,6000|Icepharma hf|Mundipharma A/S|Búprenorfín||3459||3459|6259||2|0|G|1|30|dagar|0
017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|6163|9981|lyfalmen|V0945|4189|1|4|0|11,2000|Icepharma hf|Mundipharma A/S|Búprenorfín||6163||6163|9981||2|0|G|1|30|dagar|0
017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|G|0|MSD|0|0|1|100|DKK|7163|11357|lyfalmen|V0986|9375|1|3|0|1,7273|Vistor hf|M.S.D.|Aprepitant||7163||7163|11357||1|0|G|0|||0
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005|31.08.2021|R|1|0|0|G|0|MEA|0|0|1|100|DKK|2513|4957|lyfalmen|||1|30|0|150,0000|Icepharma hf|Meda AB|Prednisón||2513||2513|4957||2|0|G|0|||0
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|BOI|0|0|0|100|DKK|6704|12889|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||6704||6704|12889||1|0||0|||0
017668|J02AC0107|Fluconazol Krka|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1500|2186|lyfalmen|V0556|2186|2|4|0|3,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||500||500|2186||2|0||0|||0
017679|J02AC0107|Fluconazol Krka|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.12.2018||L|1|0|0|0|0|KRK|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól|||||||2|0||0|||0
017701|J02AC0107|Fluconazol Krka|hylki|150|mg|6|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2300|3563|lyfalmen|V0556|3279|2|6|0|4,5000|LYFIS ehf|Krka Sverige AB|Flúkónazól||1500||1500|3563||2|0||0|||0
017712|J02AC0107|Fluconazol Krka|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1271|2117|lyfalmen|V0551|2101|2|7|0|1,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól||450||450|2117||2|0||0|||0
017745|J02AC0107|Fluconazol Krka|hylki|50|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|3500|2599|lyfalmen|V0552|2555|2|28|0|7,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||800||800|2599||2|0||0|||0
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|8311|12937|lyfalmen|V0107|2530|1|30|0|15,0000|Icepharma hf|Upjohn EESV|Eplerenón||8311||8311|12937||1|0|0|0|||0
018420|C07AG0207|Carvedilol STADA|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1544|2599|lyfalmen|V0946|2599|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||800||800|2599||2|0|G|0|||0
018431|C07AG0207|Carvedilol STADA|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2107|3356|lyfalmen|V0947|3356|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1350||1350|3356||2|0|G|0|||0
018442|C07AG0207|Carvedilol STADA|töflur|25|mg|100|stk|1|pakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2975|3631|lyfalmen|V0948|3631|2|100|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1550||1550|3631||2|0|G|0|||0
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|G|0|GPH|0|0|0|100|DKK|816|2280|lyfalmen|V0243|2069|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||568||568|2280||1|0|G|0|||0
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|6181|10005|lyfalmen|V0985|7087|1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6181||6181|10005||1|0|G|0|||0
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|17278|25279|lyfalmen|V0441|11254|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||17278||17278|25279||1|0|G|0|||0
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|G|0|MEC|0|0|1|100|SEK|1072|2973|lyfalmen|V0414|2973|1|100|0|50,0000|Icepharma hf|Merck AB|Prednisólón||1072||1072|2973||2|0|G|0|||0
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|5154|8592|lyfalmen|V0438|4609|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5154||5154|8592||1|0|G|0|||0
018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|COR|0|0|1|100|DKK|4499|7690|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||4499||4499|7690||1|0|E|0|||0
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|13034|19438|lyfalmen|V0440|8958|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||13034||13034|19438||1|0|G|0|||0
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|29969|41178|lyfalmen|V0111|6315|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Eplerenón||29969||29969|41178||1|0|E|0|||0
018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|0|0|WIL|0|0|0|100|XEU|93220|121178|lyfalmen|||1|3|0|21,0000|Williams & Halls efh|medac Gesellschaft|BCG bóluefni||93220||93220|121178||2|H|0|0|||0
018726|J06BA0209|Nanogam|irl|50|mg/ml|20|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|1|SPP|0|1|0|100|XEU|9392|14425|lyfsjukr|||1|20|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||9392||9392|14425||2|H|L|0|||0
018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|COR|0|0|1|100|DKK|724|2494|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||724||724|2494||1|0|E|0|||0
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|1|G|0|TGM|0|0|0|100|NOK|75777|99116|lyfalmen|||1|28|0|28,0000|Teva Pharma Iceland ehf|TEVA GmbH|Glatíramer acetat||75777||75777|99116||1|0|G|0|||0
019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|GEH|0|0|0|100|NOK|5395|8924|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||5395||5395|8924||2|H|0|0|||0
019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|194191|248030|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||194191||194191|248030||2|H|L|0|||0
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|16401|24072|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||16401||16401|24072||2|H|0|0|||0
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|19616|28497|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||19616||19616|28497||2|H|0|0|||0
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|17637|25773|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||17637||17637|25773||2|H|0|0|||0
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|23736|33295|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||23736||23736|33295||2|H|0|0|||0
019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|97078|126058|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||97078||97078|126058||2|H|L|0|||0
019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|48541|64668|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||48541||48541|64668||2|H|L|0|||0
019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|24272|33973|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||24272||24272|33973||2|H|L|0|||0
019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|5917|11396|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||5917||5917|11396||1|0||0|||0
019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|458|2020|lyfalmen|V0633|2020|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||379||379|2020||1|0|G|0|||0
019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|CAR|0|0|0|100|DKK|32357|61558|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||32357||32357|61558||1|0||0|||0
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|NED|0|0|0|100|XEU|6169|9989|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6169||6169|9989||2|0|E|0|||0
019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|RRG|0|1|0|100|DKK|45960|61404|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||45960||45960|61404||2|H|L|0|||0
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|NED|0|0|0|100|XEU|5762|9429|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5762||5762|9429||2|0|E|0|||0
019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|RRG|0|1|0|100|DKK|174019|222942|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||174019||174019|222942||2|H|L|0|||0
019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|MYL|0|0|1|100|SEK|900|2423|lyfalmen|V0159|2310|2|20|0|6,6667|Icepharma hf|Mylan AB|Amoxicillín||672||672|2423||2|0|E|0|||0
019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|0|0|NED|0|1|0|100|XEU|154127|198202|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||154127||154127|198202||2|H|L|0|||0
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|12047|18079|lyfalmen|V0812|3197|1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12047||12047|18079||2|0|E|0|||0
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|12047|18079|lyfalmen|V0813|3197|1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12047||12047|18079||2|0|E|0|||0
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|11379|17160|lyfalmen|V0814|3197|1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11379||11379|17160||2|0|E|0|||0
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|11379|17160|lyfalmen|V0815|3197|1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11379||11379|17160||2|0|E|0|||0
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|11379|17160|lyfalmen|V0816|3325|1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11379||11379|17160||2|0|E|0|||0
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|0|1|0|0|VIC|0|1|0|100|DKK|57389|75859|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín og abacavír||57389||57389|75859||1|0|L|0|||0
019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1118|2819|lyfalmen|V0160|2755|2|30|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||960||960|2819||2|0|E|0|||0
020011|N06AB0405|Citalopram PCD|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|G|0|PDA|0|0|0|100|IKR|4500|7692|lyfalmen|V0320|4295|2|100|0|200,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||4500||4500|7692||2|0|G|0|||0
020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1|0||0|||0
020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|29618|40734|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||29618||29618|40734||1|0||0|||0
020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|LVR|0|0|0|100|NOK|2588|5060|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2588||2588|5060||3|0|E|0|||0
020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|1|0|0|RPR|0|1|0|100|XEU|90838|118166|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|HRA Pharma Rare Diseases|Mitotanum||90838||90838|118166||0|0|L|0|||0
020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|1|G|0|REI|0|0|0|100|DKK|45439|60745|lyfalmen|||1|2|0|155,7500|Vistor hf|Recordati Ireland Limited|Leuprórelín||45439||45439|60745||1|0|G|0|||0
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|1|G|0|REI|0|0|0|100|DKK|21056|29905|lyfalmen|||1|2|0|51,9400|Vistor hf|Recordati Ireland Limited|Leuprórelín||21056||21056|29905||1|0|G|0|||0
020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|G|0|RTH|0|0|0|100|XEU|6138|9946|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Diltíazem||6138||6138|9946||2|0|G|0|||0
020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|BOA|0|0|0|100|XEU|2074|3575|vetorma|||0|7,74|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum í blöndum||2074||2074|3575||1|0||0|||0
020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|0|0|UCC|0|0|0|100|DKK|46568|62173|lyfalmen|||1|180|0|12,0000|Vistor hf|UCB Pharma S.A.|sodium oxybate||||46568|62173||1|0|E|3|||0
020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|LLS|0|0|0|100|DKK|2430|4843|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2430||2430|4843||2|0||0|||0
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|GAN|0|0|0|100|XEU|1895|4106|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||1895||1895|4106||2|0||0|||0
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|G|0|ATE|0|0|1|100|IKR|633|2357|lyfalmen|V0188|2193|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||624||624|2357||1|0|G|0|||0
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|G|0|ATE|0|0|1|100|XEU|1318|2752|lyfalmen|V0189|2668|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||911||911|2752||1|0|G|0|||0
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|G|0|MSD|0|0|0|100|DKK|11957|17956|lyfalmen|V0490|14893|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||11957||11957|17956||1|0|G|0|||0
021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Bisakódýl|||||||1|0||0|||0
021465|A16AX0501|Wilzin|hylki|25|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|G|0|URE|0|0|0|100|XEU|32929|44922|lyfalmen|||1|250|0|41,6700|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||32929||32929|44922||3|0|G|0|||0
021589|A16AX0501|Wilzin|hylki|50|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|G|0|URE|0|0|0|100|XEU|60323|79570|lyfalmen|||1|250|0|83,3300|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||60323||60323|79570||3|0|G|0|||0
021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|3741|6647|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3741||3741|6647||1|0|G|0|||0
021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|12489|18688|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||12489||12489|18688||1|0|G|0|||0
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|AZD|0|0|0|100|SEK|11699|17600|lyfalmen|V0214|4512|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||11699||11699|17600||1|0|E|0|||0
021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|6236|10081|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6236||6236|10081||1|0|G|0|||0
021625|A07EC0203|Pentasa Sachet|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|G|0|FER|0|0|0|100|DKK|13718|20379|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||13718||13718|20379||1|0|G|0|||0
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|FKA|0|0|0|100|DKK|14767|21823|lyfalmen|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||14767||14767|21823||1|H|0|0|||0
021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|17522|25615|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||17522||17522|25615||1|0|G|0|||0
021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|22731|32024|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||22731||22731|32024||1|0|G|0|||0
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|FKA|0|0|0|100|DKK|8491|13185|lyfalmen|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||8491||8491|13185||1|H|0|0|||0
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|PLS|0|0|1|100|DKK|4064|7092|lyfalmen|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4064||4064|7092||1|0|0|0|||0
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|18198|26546|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18198||18198|26546||1|0|G|0|||0
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|3167|5857|lyfalmen|V0692|2249|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3167||3167|5857||2|0|E|0|||0
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|4451|7624|lyfalmen|V0693|4739|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4451||4451|7624||2|0|E|0|||0
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|11625|17499|lyfalmen|V0694|3884|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||11625||11625|17499||2|0|E|0|||0
021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|1|G|0|SCL|0|0|0|100|DKK|24096|33750|lyfalmen|V1034|33750|1|100|0||Shire Sweden AB |Shire Pharmaceuticals Ireland Limited|Anagrelidum||24096||24096|33750||1|0|G|0|||0
022050|J01CF0204|Cloxacillin Navamedic Nordic|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|0|VIN|0|0|1|100|XEU|2579|5048|lyfalmen|V1053|5048|1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2579||2579|5048||2|0|0|0|||0
022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|AXA|0|0|0|100|DKK|97742|126898|lyfalmen|||1|1200|0||Baxalta Innovations GmbH|Baxalta Innovations GmbH|albumin||97742||97742|126898||1|H|0|0|||0
022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|G|0|SDH|0|0|0|100|XEU|4158|7221|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||4158||4158|7221||1|0|G|0|||0
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|1|0|0|LPT|0|0|0|100|XEU|14577|21562|lyfalmen|||1|1|0||Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||14577||14577|21562||1|0||0|||0
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|VEO|0|0|0|100|DKK|2121|3656|vetorma|||0|2,24|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||2121||2121|3656||2|0||0|||0
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|3552|3130|lyfalmen|V0056|2216|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Amlódipín||1186||1186|3130||1|0|G|0|||0
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|6297|4076|lyfalmen|V0057|2216|1|100|0|200,0000|Icepharma hf|Upjohn EESV|Amlódipín||1873||1873|4076||1|0|G|0|||0
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|VEO|0|0|0|100|DKK|2008|3461|vetorma|||0|1,4|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||2008||2008|3461||2|0||0|||0
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1300|2241|vetorma|||0|0,7|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||1300||1300|2241||2|0||0|||0
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1869|3923|lyfalmen|V0321|3923|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paroxetín||1762||1762|3923||1|0|G|0|||0
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4091||2|0|G|0|||0
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|1|G|0|ATE|0|0|0|30|XEU|2118|4413|lyfalmen|||2|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísótretínóín||2118||2118|4413||1|0|G|0|||0
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|1|G|0|ATE|0|0|0|30|XEU|3148|4866|lyfalmen|V0125|3777|2|30|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísótretínóín||2447||2447|4866||1|0|G|0|||0
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|1|1|0|0|GEI|0|1|0|100|DKK|62459|82272|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír dísóproxíl og emtrícítabín||62459||62459|82272||2|0|L|0|||0
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|1|0|0|SHE|0|0|0|100|DKK|22412|31620|lyfalmen|||1|90|0|20,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||22412||22412|31620||1|0||0|||0
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|1|0|0|SHE|0|0|0|100|DKK|34386|46765|lyfalmen|||1|90|0|30,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||34386||34386|46765||1|0||0|||0
023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|1|G|0|RTH|0|0|0|30|IKR|3000|3907|lyfalmen|V0125|3777|2|30|0|20,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||1750||1750|3907||2|0|G|0|||0
023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|G|0|ZRP|0|0|0|100|DKK|12660|18923|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|zr pharma& GmbH|Darífenacín||12660||12660|18923||1|0|G|0|||0
023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|1|G|0|RTH|0|0|0|30|IKR|5231|7554|lyfalmen|V0125|7554|2|60|0|40,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||4400||4400|7554||2|0|G|0|||0
023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|G|0|ZRP|0|0|0|100|DKK|14992|22133|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|zr pharma& GmbH|Darífenacín||14992||14992|22133||1|0|G|0|||0
023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2202|3041|lyfalmen|V0250|2453|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||1121||1121|3041||2|0|G|0|||0
023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2841|3534|lyfalmen|V0251|3150|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||1479||1479|3534||2|0|G|0|||0
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007|31.08.2021|R|1|0|0|G|0|SGB|0|0|0|100|XEU|15927|23420|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis groupe|Klópídógrel||15927||15927|23420||1|0|G|0|||0
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|G|0|SAO|0|0|0|100|XEU|1915|4134|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||1915||1915|4134||2|0|G|0|||0
023608|N01AB0802|Sevofluran Baxter|innö.guf|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|BAM|0|0|0|100|SEK|116422|151308|lyfalmen|||2|1500|0||Icepharma hf|Baxter Medical AB|Sevóflúran||116422||116422|151308||2|H|0|0|||0
023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|900|2737|lyfalmen|V0066|2673|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2737||2|0|G|0|||0
023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1050|2943|lyfalmen|V0449|2943|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2943||2|0|G|0|||0
023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|750|2530|lyfalmen|V0448|2296|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||750||750|2530||2|0|G|0|||0
023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|0|KRK|0|0|0|100|IKR|6144|9955|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6144||6144|9955||2|0|G|0|||0
023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2327|3975|lyfalmen|V0673|3975|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1800||1800|3975||2|0|G|0|||0
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|1|G|0|UPJ|0|0|0|100|DKK|25694|35771|lyfalmen|V0984|27989|1|90|0|36,0000|Icepharma hf|Upjohn EESV|Síldenafíl||25694||25694|35771||1|0|G|0|||0
023993|A02BC0308|Lansoprazol Krka|sþ-hylki|30|mg|98|stk|1|ílát||A02BC03|01.08.2018||R|1|0|0|G|0|KRK|0|0|1|100|IKR|3500|4939|lyfalmen|V0007|4939|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól||2500||2500|4939||2|0|G|0|||0
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|G|0|MSD|0|0|0|100|DKK|2499|4938|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2499||2499|4938||1|0|G|0|||0
024040|A04AA0109|Ondansetron STADA|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|6000|9756|lyfalmen|V0384|9756|2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||6000||6000|9756||2|0|G|0|||0
024053|A04AA0109|Ondansetron STADA|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|2992|4526|lyfalmen|V0381|4526|2|10|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||2200||2200|4526||2|0|G|0|||0
024112|A16AA0501|Carbaglu|dreifit.|200|mg|5|stk|1|glas||A16AA05|01.12.2016||R|0|0|1|0|0|OUS|0|0|0|100|XEU|58149|76820|lyfalmen|||1|5|0|5,0000|Recordati AB|Orphan Europe SARL|Carglumicsýra||58149||58149|76820||3|0|E|0|||0
024276|N06AB0607|Sertralin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3264|4251|lyfalmen|V0323|4251|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Sertralín||2000||2000|4251||2|0|G|0|||0
024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|65588|86229|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||65588||65588|86229||1|0|G|0|||0
024366|N06AB0607|Sertralin Krka|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1926|3012|lyfalmen|V0322|2971|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Sertralín||1100||1100|3012||2|0|G|0|||0
024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|11726|17638|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11726||11726|17638||1|0||0|||0
024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|11538|17379|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11538||11538|17379||1|0||0|||0
024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|9206|14169|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9206||9206|14169||1|0||0|||0
024603|V04CL0001|Soluprick  Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|2288|4647|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||2288||2288|4647||1|0||0|||0
024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|9206|14169|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9206||9206|14169||1|0||0|||0
024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|9344|14359|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9344||9344|14359||1|0||0|||0
024681|V04CL0002|Soluprick  Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|2288|4647|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||2288||2288|4647||1|0||0|||0
024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1820|4003|lyfalmen|||2|100|0|66,6667|Alvogen|ratiopharm GmbH|Metóprólól||1820||1820|4003||2|0|G|0|||0
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|51118|67928|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||51118||51118|67928||1|0|G|0|||0
025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1547|3627|lyfalmen|||2|100|0|33,3333|Alvogen|ratiopharm GmbH|Metóprólól||1547||1547|3627||2|0|G|0|||0
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|1|0|0|BSP|0|1|0|100|DKK|53169|70522|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||53169||53169|70522||1|0|L|0|||0
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|BOI|1|0|0|100|DKK|9018|17279|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|Meloxícam||9018||9018|17279||1|0||0|||0
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|1|0|0|ALK|0|0|0|100|DKK|14138|20957|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||14138||14138|20957||1|0|E|0|||0
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|ATP|0|0|0|100|DKK|4938|8295|lyfalmen|V0205|1279|1|1|0|30,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||4938||4938|8295||2|0|E|0|||0
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|ATP|0|0|0|100|DKK|13233|19712|lyfalmen|V0205|3838|1|3|0|90,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||13233||13233|19712||2|0|E|0|||0
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|1|0|0|ALK|0|0|0|100|DKK|41017|55152|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||41017||41017|55152||1|0|E|0|||0
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|MAR|0|0|0|100|DKK|5838|9533|lyfalmen|||1|25|0|0,1667|Icepharma hf|Aspen Pharma|Lídókaín||5838||5838|9533||2|H|0|0|||0
025814|H01AC0114|Norditropin NordiFlex|stl|15|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|41627|55923|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||41627||41627|55923||1|0|L|0|||0
025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|65921|86650|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||65921||65921|86650||1|0|G|0|||0
025911|QD11AH9102|Cytopoint|stl|10|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|11138|21302|vetalmen|||1|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||11138||11138|21302||2|0||0|||0
025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|1|0|0|CPV|0|1|0|100|DKK|48501|64618|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Thalidómíde||||48501|64618||2|0|L|0|||0
025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|26838|37218|lyfalmen|||1|98|0|196,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||26838||26838|37218||1|0||0|||0
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|BOA|0|0|0|100|XEU|3651|6293|vetorma|||0|1|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||3651||3651|6293||1|0||0|||0
025978|L03AX1302|Remurel|stl|20|mg/ml|28|áf.spr|1|pakki||L03AX13|01.07.2017||R|0|0|1|G|0|ZET|0|0|0|100|XEU|86441|85799|lyfalmen|||2|28|0|28,0000|Alvogen|Zentiva, k.s.|Glatíramer acetat||65248||65248|85799||2|0|G|0|||0
025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||2|0||0|||0
026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|VIR|0|0|0|100|XEU|2056|4041|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2056||2056|4041||1|0||0|||0
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|BOA|0|0|0|100|XEU|8711|15014|vetorma|||0|2,5|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||8711||8711|15014||1|0||0|||0
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|51450|68348|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||51450||51450|68348||1|0|G|0|||0
026490|L04AD0204|Dailiport|forðahlk|2|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|15688|23091|lyfalmen|||2|50|0|20,0000|Artasan ehf|Sandoz A/S|Tacrolimus||15688||15688|23091||1|0|G|0|||0
026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|1710|3852|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1710|3852||1|0|G|0|||0
026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|6751|10790|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||6751|10790||1|0|G|0|||0
026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|3378|6147|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3378|6147||1|0|G|0|||0
026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|13184|19644|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||13184|19644||1|0|G|0|||0
026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|19681|28587|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||19681|28587||1|0|G|0|||0
026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|26124|36315|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||26124|36315||1|0|G|0|||0
026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|MEA|0|0|1|100|DKK|1235|3198|lyfalmen|||2|100|0|25,0000|Icepharma hf|Meda AB|Nítrófúrantóín||1235||1235|3198||2|0|0|0|||0
026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0||0|||0
026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|DKK|9634|14758|lyfalmen|V0099|14758|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Lósartan||9634||9634|14758||2|0|G|0|||0
027017|N06BA0202|Attentin|töflur|5|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|4622|7860|lyfalmen|||1|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||4622|7860||2|0|E|1|30|dagar|0
027051|A10BK0301|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|16723|24515|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||16723||16723|24515||1|0|G|0|||0
027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2043|3700|lyfalmen|V0823|3700|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1600||1600|3700||2|0|G|0|||0
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|MEA|0|0|1|100|DKK|867|2691|lyfalmen|||2|50|0|1,2500|Icepharma hf|Meda AB|Nítrófúrantóín||867||867|2691||2|0||0|||0
027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2021|4280|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||2021||2021|4280||1|0|G|0|||0
027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|12418|10901|lyfalmen|||2|100|0|66,6600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||6832||6832|10901||1|0|G|0|||0
027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|11957|10901|lyfalmen|V0342|10901|2|100|0|133,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||6832||6832|10901||1|0|G|0|||0
027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|BAM|0|0|1|100|SEK|2317|4687|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2317||2317|4687||2|0|0|0|||0
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|G|0|EIG|0|0|0|100|SEK|5956|9696|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai GmbH|Zonisamíð||5956||5956|9696||1|0|G|0|||0
027627|N02AE0101|Bupremyl|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|0|G|0|MYL|0|0|0|100|SEK|3915|4189|lyfalmen|V0945|4189|2|4|0|11,2000|Icepharma hf|Mylan AB|Búprenorfín||1955||1955|4189||2|0|G|1|30|dagar|0
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|G|0|OHS|0|0|0|100|DKK|568|2280|lyfalmen|||2|100|0|33,3300|Vistor hf|Orifarm Healthcare A/S|Levótýroxínnatríum||568||568|2280||1|0|G|0|||0
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|G|0|OHS|0|0|0|100|DKK|654|2398|lyfalmen|||2|100|0|66,6667|Vistor hf|Orifarm Healthcare A/S|Levótýroxínnatríum||654||654|2398||1|0|G|0|||0
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|OPC|0|0|0|100|DKK|19299|28061|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||19299||19299|28061||1|0|E|0|||0
027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|NED|0|0|0|100|XEU|28707|39582|lyfalmen|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||28707||28707|39582||2|H|0|0|||0
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|OPC|0|0|0|100|DKK|21885|30954|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||21885||21885|30954||1|0|E|0|||0
027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|NED|0|0|0|100|XEU|34335|46701|lyfalmen|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||34335||34335|46701||2|H|0|0|||0
027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|NED|0|0|0|100|XEU|46261|61785|lyfalmen|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||46261||46261|61785||2|H|0|0|||0
028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|BAB|0|0|0|100|DKK|4042|6321|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Kaflaskipt lyf, prógestógen og östrógen||4042||4042|6321||2|0||0|||1
028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|16680|24456|lyfalmen|V0387|24456|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||16680||16680|24456||1|0|G|0|||0
028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Fexófenadín|||||2943||2|0||0|||0
028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|G|0|MBV|0|0|0|100|DKK|16221|23825|lyfalmen|V0386|23825|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||16221||16221|23825||1|0|G|0|||0
028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|1|0|0|NEL|0|1|0|100|DKK|46440|62011|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||46440||46440|62011||1|0|L|0|||0
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|SSS|0|0|0|100|XEU|2894|5481|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Taugaveiki, hreinsaðir  mótefnavakar||2894||2894|5481||1|0||0|||0
028342|J07BL0101|Stamaril|sts|||0,5|ml|1|hgl|+1 áf.spr.með leysi+2 nálar|J07BL01|01.04.2020||R|0|0|0|0|0|SPU|0|0|0|100|XEU|3972|6965|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Gulusótt, veikluð veira||3972||3972|6965||1|0||0|||0
028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|SSS|0|0|0|100|XEU|39715|53505|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Gulusótt, veikluð veira||||39715|53505||1|0||0|||0
028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|2330|4430|lyfalmen|V0202|4182|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||2130||2130|4430||2|0|G|0|||0
028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1725|3872|lyfalmen|V0428|3101|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1725||1725|3872||2|0|G|0|||0
028497|N04BC0505|Oprymea|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|800|2530|lyfalmen|V0266|2512|2|30|0|1,5000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||750||750|2530||2|0|G|0|||0
028519|N04BC0505|Oprymea|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|2582|4388|lyfalmen|V0267|4303|2|100|0|10,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||2100||2100|4388||2|0|G|0|||0
028531|N04BC0505|Oprymea|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|14853|21942|lyfalmen|||2|100|0|40,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||14853||14853|21942||2|0|G|0|||0
028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|G|0|GPH|0|0|0|100|DKK|5728|4966|lyfalmen|V0245|4629|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2520||2520|4966||1|0|G|0|||0
028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|G|0|GPH|0|0|0|100|DKK|10791|10950|lyfalmen|V0232|9632|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||6867||6867|10950||1|0|G|0|||0
028599|N04BC0508|Pramipexole Alvogen|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|G|0|POF|0|0|0|100|XEU|749|2512|lyfalmen|V0266|2512|2|30|0|1,5000|Alvogen|Alvogen|Pramipexól||737||737|2512||2|0|G|0|||0
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|OCO|1|0|0|100|DKK|7484|14369|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||7484||7484|14369||2|0||0|||0
028610|N04BC0508|Pramipexole Alvogen|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|G|0|POF|0|0|0|100|XEU|2805|4303|lyfalmen|V0267|4303|2|100|0|10,0000|Alvogen|Alvogen|Pramipexól||2038||2038|4303||2|0|G|0|||0
029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|G|0|GCA|0|0|1|100|DKK|1137|2943|lyfalmen|V0625|2190|1|120|0|30,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Flútíkasón||1050||1050|2943||1|0|G|0|||0
029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|LLS|0|0|0|100|DKK|5848|9547|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||5848||5848|9547||2|0||0|||0
029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|LLS|0|0|0|100|DKK|16087|23640|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||16087||16087|23640||2|0||0|||0
029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1|0|0|0|||0
029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|33196|45260|lyfalmen|||1|30|0|20,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||33196||33196|45260||2|0|E|1|30|dagar|0
029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|33196|45260|lyfalmen|||1|30|0|40,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||33196||33196|45260||2|0|E|1|30|dagar|0
029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|11047|16703|lyfalmen|V0801|15063|1|10|0|1,6700|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||11047||11047|16703||2|0|E|1|30|dagar|0
029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|CAM|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|CampusPharma AB|CampusPharma AB|Meklózín|||||||1|0||0|||0
029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|33141|45190|lyfalmen|V0801|45190|1|30|0|5,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||33141||33141|45190||2|0|E|1|30|dagar|0
029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|10963|16587|lyfalmen|||1|10|0|3,3300|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||10963||10963|16587|31.8.2021|2|0|E|1|30|dagar|0
029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|33196|45260|lyfalmen|||1|30|0|15,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||33196||33196|45260||2|0|E|1|30|dagar|0
029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|33196|45260|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||33196||33196|45260||2|0|E|1|30|dagar|0
029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|0|0|EIG|0|1|0|100|SEK|47601|63479|lyfsjukr|||1|2|0||Vistor hf|Eisai GmbH|Eribulin||47601||47601|63479||1|H|L|0|||0
029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|GAN|0|0|1|100|XEU|5456|9008|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||5456||5456|9008||2|0|E|0|||0
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029867|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.09.2017||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
030136|J01CR0205|Spectracillin|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|WEH|0|0|1|100|IKR|1096|2874|lyfalmen|V0168|2851|2|20|0|6,6667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||1000||1000|2874||2|0|E|0|||0
030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|PEU|0|0|0|100|DKK|7729|12136|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||7729||7729|12136||1|0||0|||0
030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|15474|26671|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||15474||15474|26671||2|0||0|||0
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|G|0|NED|0|0|0|100|XEU|2578|5046|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2578||2578|5046||2|0|G|0|||0
031140|N06AX2701|Spravato|nefúði|28|mg|28|mg|2|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|63179|83182|lyfsjukr|||1|56|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||63179||63179|83182||1|H|L|1|30|dagar|0
031201|L04AX0307|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2392|4790|lyfalmen|||1|0,25|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2392||2392|4790||2|0|G|0|||0
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5402|8933|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5402||5402|8933||1|0|G|0|||0
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|FEL|0|0|0|100|DKK|18059|26354|lyfalmen|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||18059||18059|26354||1|H|0|0|||0
032257|C01CA1703|Hypotron|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.10.2018|30.06.2021|R|1|0|0|G|0|RET|0|0|0|100|IKR|8875|13713|lyfalmen|||2|50|0|8,3333|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||8875||8875|13713||1|0|G|0|||0
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|G|0|OPC|0|0|0|100|DKK|19898|28886|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||19898||19898|28886||1|0|G|0|||0
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|BOA|1|0|0|100|DKK|14481|24959|vetorma|||0|200|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||14481||14481|24959||1|0||0|||0
032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2100|3170|lyfalmen|V0069|2943|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1215||1215|3170||2|0|G|0|||0
033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|1|G|0|FER|0|0|0|100|DKK|21008|29845|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||21008||21008|29845||1|0|G|0|||0
033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|1|G|0|FER|0|0|0|100|DKK|38355|51785|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||38355|51785||1|0|G|0|||0
033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|IKR|1274|2196|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||1274||1274|2196||2|0||0|||0
033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|2906|5498|lyfalmen|V1004|4567|1|28|0|3,7400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||2906||2906|5498||2|0|E|1|30|dagar|0
033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|8634|16551|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||8634|16551||2|0||0|||0
033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|9968|15218|lyfalmen|V1005|13223|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||9968||9968|15218||2|0|E|1|30|dagar|0
033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|5816|9503|lyfalmen|V1006|7969|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||5816||5816|9503||2|0|E|1|30|dagar|0
033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|19051|27720|lyfalmen|||1|98|0|26,1400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||19051||19051|27720||2|0|E|1|30|dagar|0
033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|G|0|HES|0|0|1|100|DKK|1446|3488|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||1446||1446|3488||1|0|G|0|||0
033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|G|0|GOV|0|0|1|100|XEU|1404|2779|lyfalmen|V0189|2668|2|100|0|50,0000|Alvogen|Alvogen ehf|Díklófenak||931||931|2779||2|0|G|0|||0
033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|G|0|GOV|0|0|1|100|XEU|624|2357|lyfalmen|V0188|2193|2|30|0|15,0000|Alvogen|Alvogen ehf|Díklófenak||624||624|2357||2|0|G|0|||0
033644|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|8446|13123|lyfalmen|||1|100|0|80,0000|Icepharma hf|Abcur AB|Metadón||8446||8446|13123||2|0|G|1|30|dagar|0
033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|G|0|WEH|0|0|0|100|XEU|15450|22763|lyfalmen|V0185|21702|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||15450||15450|22763||2|0|G|0|||0
033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|1|0|0|JCI|0|1|0|100|SEK|76151|99589|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||76151||76151|99589||1|0|L|0|||0
034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|2340|4599|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2340|4599||2|0||0|||0
034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|XEU|1986|2569|lyfalmen|V0098|2566|2|100|0|100,0000|Alvogen|ratiopharm Oy|Enalapríl og þvagræsilyf||778||778|2569||2|0|G|0|||0
034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|22119|31250|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||22119||22119|31250||2|H|L|0|||0
034613|N02AB0310|Fentanyl Alvogen|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|XEU|3391|6010|lyfalmen|V0220|6010|2|5|0|15,0000|Alvogen|Alvogen|Fentanýl||3278||3278|6010||2|0|G|1|30|dagar|0
034796|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.10.2017||R|1|0|0|G|0|BLS|0|0|0|100|XEU|3919|4405|lyfalmen|V0323|4251|2|100|0|200,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Sertralín||2112||2112|4405||1|0|G|0|||0
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|1040|2929|lyfalmen|||1|6|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||1040||1040|2929||1|0|G|0|||0
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|2430|4843|lyfalmen|||1|12|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||2430||2430|4843||1|0|G|0|||0
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|LEP|0|0|1|100|DKK|6673|10683|lyfalmen|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||6673||6673|10683||1|0|0|0|||0
035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|FKA|0|0|0|100|DKK|1914|4132|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||1914||1914|4132||1|H|0|0|||0
035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|2356|4741|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||2356|4741||1|0|G|0|||0
035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|G|0|FER|0|0|0|100|DKK|14715|21752|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14715||14715|21752||1|0|G|0|||0
035495|N02AJ0602|Parkodin forte|filmhtfl|530|mg|20|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|603|2328|lyfalmen|||2|20|0|6,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||603||603|2328||1|0|E|3|||0
035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2334|3012|lyfalmen|V0049|2910|2|100|0|63,3333|Alvogen|ratiopharm GmbH|Metóprólól||1100||1100|3012||2|0|G|0|||0
035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4390|5571|lyfalmen|V0054|4939|2|100|0|126,6667|Alvogen|ratiopharm GmbH|Metóprólól||2959||2959|5571||2|0|G|0|||0
035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2792|3309|lyfalmen|V0233|3309|2|18|0|18,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||1316||1316|3309||1|0|G|0|||0
035926|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
035982|B01AF0102|Rivaroxaban WH|filmhtfl|10|mg|98|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|30651|42041|lyfalmen|V0975|42041|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||30651||30651|42041||2|0|G|0|||0
036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010|31.08.2021|R|0|0|0|0|0|GEB|0|0|0|100|XEU|22797|32107|lyfalmen|||1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||22797||22797|32107||1|0||0|||0
036261|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|G|0|DSA|0|0|0|100|XEU|7830|12275|lyfalmen|||1|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||7830|12275||2|0|G|0|||0
036339|N02BE5107|Paradorm|filmhtfl|525|mg|10|stk|1|þpakki|500+25 mg|N02BE51|01.09.2020||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6666|Acare ehf|Acare ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||2|0|0|0|||0
036353|R06AX2708|Dasergin|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|G|0|KAN|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||2979||2|0|G|0|||0
036431|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.09.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1415|3446|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer Aps|Metýlprednisólón||||1415|3446||1|0|G|0|||0
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|MEA|0|0|1|100|DKK|700|2461|lyfalmen|||1|20|0|8,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||700||700|2461||2|0|E|0|||0
036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014|30.06.2021|R|0|1|0|G|0|NEL|0|0|0|100|DKK|16200|23796|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16200||16200|23796||1|0|G|0|||0
036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|BIV|0|0|0|100|DKK|1449|2497|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||1449||1449|2497||1|0||0|||0
036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1|0||0|||0
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|MEA|0|0|1|100|DKK|2432|4845|lyfalmen|||1|125|0|6,2500|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||2432||2432|4845||2|0|E|0|||0
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|MEA|0|0|1|100|DKK|923|2768|lyfalmen|||1|30|0|12,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||923||923|2768||2|0|E|0|||0
036968|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|60|stk|1|glas|hart|A02BC01|01.03.2017||R|1|0|0|G|0|VAL|0|0|1|100|IKR|342|1969|lyfalmen|V0006|1312|2|60|0|60,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||342||342|1969||2|0|G|0|||0
037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|6346|7352|lyfalmen|V0532|6767|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||4253||4253|7352||1|0|G|0|||0
037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|11867|10267|lyfalmen|V0533|9392|1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||6371||6371|10267||1|0|G|0|||0
037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|16405|19143|lyfalmen|V0534|17343|1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||12820||12820|19143||1|0|G|0|||0
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2341|4720|lyfalmen|V0434|4626|1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2341||2341|4720||2|0|G|0|||0
037471|C07AB0214|Bloxazoc|forðatfl|200|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|3533|4939|lyfalmen|V0054|4939|2|100|0|133,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||2500||2500|4939||2|0|G|0|||0
037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|V1047|2708|0|100|0|25,0000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||2708||2|0|G|0|||0
037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|V1048|4697|0|250|0|62,5000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||4697||2|0|G|0|||0
037992|J06BA0210|Octagam 10%|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|340887|430479|lyfsjukr|||1|300|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||340887||340887|430479||1|H|L|0|||0
038386|R06AE0706|Zensitin|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0||0|||0
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|G|0|GPH|0|0|0|100|DKK|3294|4207|lyfalmen|V0321|3923|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1968||1968|4207||1|0|G|0|||0
038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|G|0|BLS|0|0|0|100|XEU|1610|2755|lyfalmen|V0110|2585|2|100|0|133,3333|Artasan ehf|Bluefish Pharmaceuticals AB|Simvastatín||913||913|2755||1|0|G|0|||0
039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|13560|20162|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer AG|Rivaoxaban||||13560|20162||2|0|G|0|||0
039145|L01XC0303|Trazimera|st/irþ|420|mg|420|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|0|PEU|0|1|0|100|DKK|214710|273550|lyfsjukr|||1|420|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||214710||214710|273550||1|H|L|0|||0
039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|1|0|0|PSS|0|0|0|100|SEK|27241|37728|lyfalmen|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||27241||27241|37728||2|0|0|0|||0
039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|11668|16475|lyfalmen|V0388|15262|2|50|0|25,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||10881||10881|16475||1|0|G|0|||0
039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|G|0|ABC|0|0|1|100|SEK|1541|3619|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1541||1541|3619||2|0|G|0|||0
039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|GBI|0|0|0|100|DKK|5403|8935|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||5403||5403|8935||1|0||0|||0
039441|A09AA0217|Creon 10.000 (Lyfjaver)|sþ-hylki|||100|stk|1|tfílát||A09AA02|01.12.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|3525|6350|lyfalmen|V0706|6350|3|100|0|16,6700|Lyfjaver ehf|Lyfjaver ehf|Hvatablöndur (lípasi, próteasi o.s.frv.)||3525||3525|6350||3|0|G|0|||0
039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|1|0|0|SGB|0|0|0|100|XEU|17711|25875|lyfalmen|V1027|17265|1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||17711||17711|25875||1|0|E|0|||0
039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4222|7309|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||4222||4222|7309||2|0|G|0|||0
039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1045|2936|lyfalmen|||2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||1045||1045|2936||2|0|G|0|||0
039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1048|2940|lyfalmen|||2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||1048||1048|2940||2|0|G|0|||0
039776|J01FA1001|Zitromax|mixtduft|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|PLS|0|0|1|100|DKK|692|2450|lyfalmen|V0821|2186|1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||692||692|2450||1|0|E|0|||0
039784|J01FA1001|Zitromax|mixtduft|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1458|3505|lyfalmen|V0822|2874|1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1458||1458|3505||1|0|E|0|||0
039829|L04AX0402|Lenalidomid Alvogen|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|708425|872633|lyfsjukr|||2|21|0|52,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||696396||696396|872633||2|0|L|0|||0
039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0||0|||0
039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1979|2585|lyfalmen|V0110|2533|2|98|0|130,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||790||790|2585||1|0|G|0|||0
039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|G|0|ATE|0|0|1|100|XEU|6248|4214|lyfalmen|V0182|4214|2|42|0|7,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valacíklóvír||1973||1973|4214||1|0|G|0|||0
040092|N02AX0213|Tramadol Krka|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|2200|4388|lyfalmen|V0227|4388|2|100|0|33,3300|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2100||2100|4388||2|0|G|1|30|dagar|0
040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|2670|5173|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Felódipín||2670||2670|5173||2|0|G|0|||0
040771|N06AX2701|Spravato|nefúði|28|mg|28|mg|3|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|94768|123136|lyfsjukr|||1|84|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||94768||94768|123136||1|H|L|1|30|dagar|0
040823|A06AD6503|Movicol Junior Neutral|mixtduft|6,9|g|30|pokar|1|pakki|lausn|A06AD65|01.11.2018||L|0|0|0|0|0|NOG|0|0|0|100|IKR|||lyfalmen|||0|30|0||Vistor hf|Norgine BV|Makrógól 3350|||||3874||1|0|E|0|||0
040977|J01DD0402|Ceftriaxona Normon|sts|1000|mg|100|stk|1|hgl|+ 100 lykjur með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|219655|279701|lyfalmen|||2|100|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||219655||219655|279701||2|0|0|0|||0
041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|LLS|0|0|0|100|DKK|7853|12307|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7853||7853|12307||2|0|E|0|||0
041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|LLS|0|0|0|100|DKK|7853|12307|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7853||7853|12307||2|0|E|0|||0
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|IBV|0|0|0|100|DKK|3816|6577|vetbolu|||0|100|0||Vistor hf|Intervet International BV|Clostridíum bóluefni||3816||3816|6577||1|0||0|||0
041816|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|4774|3393|lyfalmen|V0682|3393|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1377||1377|3393||2|0|G|0|||0
041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1288|3271|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||1288||1288|3271||2|0|G|0|||0
041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|8106|11133|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7000||7000|11133||2|0|G|0|||0
041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|8023|11354|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7161||7161|11354||2|0|G|0|||0
041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1|0||0|||0
042157|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1157|3090|lyfalmen|V0449|2943|2|100|0|200,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||1157||1157|3090||1|0|G|0|||0
042270|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5896|8787|lyfalmen|V0737|8787|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5296||5296|8787||2|0|E|0|||0
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|2263|4613|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2263||2263|4613||1|0|0|0|||0
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3344|6101|lyfalmen|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3344||3344|6101||1|0|0|0|||0
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|2019|4277|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2019||2019|4277||1|0|0|0|||0
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|FKA|0|0|1|100|DKK|1949|4181|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1949||1949|4181||1|0|0|0|||0
042500|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|1 innöndunartæk+3 rörlykjur|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|12510|18483|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||12340||12340|18483||1|0|G|0|||0
042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|SSS|0|0|0|100|XEU|2148|4454|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Mænusótt, dauð veira||2148||2148|4454||1|0||0|||0
042628|N06AX2108|Aritavi|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.07.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6494|5298|lyfalmen|V0811|5298|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||2761||2761|5298||1|0|E|0|||0
042865|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|MYE|0|0|1|100|DKK|1324|3320|lyfalmen|V0560|3320|2|100|0||Icepharma hf|Mylan Ireland Limited|Lídókaín||1324||1324|3320||2|0||0|||0
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|PLS|0|0|1|100|DKK|495|2179|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||495||495|2179||1|0||2|60|töflur|0
043965|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|5037|5393|lyfalmen|V0624|5393|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2830||2830|5393||1|0|E|1|30|dagar|0
044065|H02AB0804|Kenacort-T|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2019||R|0|0|0|0|0|BBB|0|0|1|100|DKK|689|2446|lyfalmen|||0|1|0|5,3330|Vistor hf|Bristol-Myers Squibb AB|Tríamcínólón||689||689|2446||1|0||0|||0
044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|G|0|LVR|0|0|1|100|CHF|12394|18557|lyfalmen|V0637|18557|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||12394||12394|18557||3|0|G|0|||0
044492|G02AD0602|Angusta|töflur|25|mcg|8|stk|1|pakki||G02AD06|01.06.2017||R|0|0|0|0|0|NGV|0|0|0|100|DKK|13151|19599|lyfalmen|||1|8|0|1,0000|Norgine BV|Norgine B.V.|Misóprostól||13151||13151|19599||1|H|0|0|||0
044532|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8866|13701|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||8866||8866|13701||2|0||0|||0
044560|J05AB0105|Zovirax|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|4917|8266|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||4917||4917|8266||1|0|G|0|||0
044580|L01EG0201|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01EG02|01.09.2011||R|0|0|1|0|0|NEL|0|1|0|100|DKK|322504|407616|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolimus||322504||322504|407616||1|0|L|0|||0
044591|L01EG0201|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01EG02|01.09.2011||R|0|0|1|0|0|NEL|0|1|0|100|DKK|451624|568205|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolimus||451624||451624|568205||1|0|L|0|||0
044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|G|0|BAM|0|0|0|100|SEK|5053|8453|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5053||5053|8453||2|0|G|0|||0
045202|B01AF0102|Rivaroxaban WH|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|29747|40898|lyfalmen|V0976|40619|2|98|0|73,5000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||29747||29747|40898||2|0|G|0|||0
045332|V03AN0502|Airapy|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
045475|A10BK0301|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|6930|11036|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6930||6930|11036||1|0|G|0|||0
045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1275|2384|lyfalmen|V0109|2293|2|98|0|65,3400|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||644||644|2384||1|0|G|0|||0
045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1054|2318|lyfalmen|V0108|2157|2|98|0|32,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||596||596|2318||1|0|G|0|||0
045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|G|0|ATE|0|0|0|100|SEK|3694|6582|lyfalmen|||2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||3694||3694|6582||1|0|G|0|||0
046155|L01AD0105|Carmustine Obvius|sts|100|mg|1|hgl|1|pakki|1 lykja m. 3 ml leysi|L01AD01|01.03.2019||R|0|0|0|0|0|OBV|0|1|0|100|NOK|169759|217644|lyfsjukr|||2|1|0||Oresund Pharma ApS|Obvius Investment B.V.|Carmustine ||169759||169759|217644||2|H|L|0|||0
046188|M01AH0108|Celecoxib Medical|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|2075|4354|lyfalmen|V0429|4098|2|100|0|50,0000|LYFIS ehf|Medical ehf|Celekoxíb||2075||2075|4354||2|0|G|0|||0
046214|J02AC0107|Fluconazol Krka|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|14206|10582|lyfalmen|V0419|9924|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||6600||6600|10582||2|0||0|||0
046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|G|0|TEA|0|0|0|100|SEK|1345|3349|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||||1345|3349||1|0|G|0|||0
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|935|2785|lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||935||935|2785||1|0|G|0|||0
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|488|2095|lyfalmen|V0021|1996|2|90|0|45,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||434||434|2095||1|0|G|0|||0
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|752|2398|lyfalmen|V0022|2292|2|90|0|90,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||654||654|2398||1|0|G|0|||0
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|963|2653|lyfalmen|V0023|2527|2|90|0|135,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||839||839|2653||1|0|G|0|||0
046625|N06AB1008|Escitalopram STADA|filmhtfl|5|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1800|3838|lyfalmen|V0324|3838|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||1700||1700|3838||2|0|0|0|||0
046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|G|0|TSA|0|0|1|100|IKR|1563|2737|lyfalmen|V0625|2737|2|150|0|37,5000|Alvogen|Teva Sweden AB|Flútíkasón||900||900|2737||2|0|G|0|||0
046812|M05BA0605|Ibandronic acid Alvogen|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|1|0|G|0|POF|0|0|0|100|IKR|6568|3838|lyfalmen|V0205|3838|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1700||1700|3838||2|0|G|0|||0
047108|QA14AB0101|Myodine vet|stl|25|mg/ml|10|ml|1|hgl|lausn|QA14AB01|01.04.2019||R|0|0|0|0|0|VEB|0|0|0|100|IKR|3385|6593|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Nandrolone||3385||3385|6593||2|0|0|0|||0
047154|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2961|4383|lyfalmen|V1010|2979|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||2096||2096|4383||2|0|G|0|||0
047238|C01BD0703|Dronedarone Teva|filmhtfl|400|mg|100|stk|1|stsk.þ||C01BD07|01.06.2021||R|1|1|1|0|0|TVI|0|0|0|100|XEU|15023|17265|lyfalmen|V1027|17265|2|100|0|50,0000|Teva Pharma Iceland ehf|Teva B.V|Dronedarón||11455||11455|17265||1|0|E|0|||0
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|AGA|0|0|0|100|XEU|34559|46984|lyfalmen|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||34559||34559|46984||5|H|0|0|||0
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|AGA|0|0|0|100|XEU|144989|186837|lyfalmen|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||144989||144989|186837||5|H|0|0|||0
047709|J05AB1403|Valganciclovir Medical Valley|filmhtfl|450|mg|60|stk|1|glas||J05AB14|01.06.2020||R|1|0|0|0|0|VAL|0|1|1|100|XEU|36972|50036|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Valgancíklóvír||36972||36972|50036||2|0|L|0|||0
047840|C02CA0408|Doxazosin Krka|forðatfl|4|mg|120|stk|1|þpakki||C02CA04|01.10.2020||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3622|4939|lyfalmen|V0042|4939|2|120|0|120,0000|Krka Sverige AB|Krka d.d. Novo mesto|Doxazósín||2500||2500|4939||2|0|G|0|||0
048015|B05AA0115|Albumin Baxalta|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|BTP|0|0|0|100|DKK|4117|7165|lyfalmen|||1|250|0||Takeda Pharma A/S|Baxalta Innovations GmbH|albumin||4117||4117|7165||1|H|0|0|||0
048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|FKA|0|0|1|100|DKK|7573|11921|lyfalmen|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||7573||7573|11921||1|0|0|0|||0
048043|B05AA0115|Albumin Baxalta|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|BTP|0|0|0|100|DKK|6677|10688|lyfalmen|||1|100|0||Takeda Pharma A/S|Baxalta Innovations GmbH|albumin||6677||6677|10688||1|H|0|0|||0
048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1807|3985|lyfalmen|V0324|3838|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||1807||1807|3985||1|0|G|0|||0
048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1063|2961|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||1063||1063|2961||1|0|E|0|||0
048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2526|4975|lyfalmen|V0325|4526|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||2526||2526|4975||1|0|G|0|||0
048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3410|6191|lyfalmen|V0326|5352|2|100|0|150,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||3410||3410|6191||1|0|G|0|||0
048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5292|7923|lyfalmen|V0327|6315|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||4668||4668|7923||1|0|G|0|||0
048196|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|5209|7500|lyfalmen|||2|120|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4361||4361|7500||2|0|G|0|||0
048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|G|0|MEA|0|0|0|100|DKK|2002|4253|lyfalmen|||1|100|0||Icepharma hf|Meda AB|Klídín og geðlyf||2002||2002|4253||2|0|G|2|100|töflur|0
048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|0|0|GEB|0|1|0|100|XEU|808715|1012326|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||808715||808715|1012326||1|H|L|0|||0
048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|GCA|0|0|1|100|DKK|386|2029|lyfalmen|V0230|2029|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||386||386|2029||1|0|E|0|||0
048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|0|0|GAA|0|0|0|100|SEK|4942|8300|lyfalmen|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||4942||4942|8300||2|H|0|0|||0
048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|35717|48448|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||35717||35717|48448||3|0|L|0|||0
048797|G04CA0208|Tamsulosin Mylan|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.11.2016||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4345|4253|lyfalmen|V0148|4253|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||2002||2002|4253||2|0|G|0|||0
049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|6765|10809|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||6765||6765|10809||1|0|G|0|||0
049091|S01EE0101|Xalatan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.08.2013||R|0|0|0|G|0|UPJ|0|0|0|100|DKK|4988|8363|lyfalmen|V0376|5004|1|7,5|0|75,0000|Icepharma hf|Upjohn EESV|Latanóprost||||4988|8363||1|0|G|0|||0
049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|ROD|0|1|0|100|DKK|273152|346236|lyfsjukr|||1|1|0|16,6700|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||273152||273152|346236||1|0|L|0|||0
049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|G|0|ARN|0|0|1|100|DKK|860|2682|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||860||860|2682||1|0|G|0|||0
049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|5037|8431|lyfalmen|||1|7|0|1,7500|Eisai AB|Eisai GmbH|Perampanel||5037||5037|8431||1|0|G|0|||0
049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|G|0|GOV|0|0|0|100|XEU|2286|2293|lyfalmen|V0109|2293|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||578||578|2293||2|0|G|0|||0
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1002|2877|lyfalmen|||2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||1002||1002|2877||1|0|G|0|||0
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1711|3853|lyfalmen|||2|100|0|400,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||1711||1711|3853||1|0|G|0|||0
049696|A04AA0109|Ondansetron STADA|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|3600|4388|lyfalmen|V0384|3252|2|10|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||2100||2100|4388||2|0|G|0|||0
049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||1938|30.6.2021|1|0|E|0|||0
049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|0|0|WPA|0|0|0|100|DKK|70872|92913|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma (International) B.V|Cannabinoids||70872||70872|92913||1|0|E|1|30|dagar|0
049906|N02CC0106|Sumatriptan Apofri|filmhtfl|50|mg|2|stk|1|þpakki||N02CC01|01.06.2020||L|1|0|0|0|0|APO|0|0|0|100|IKR|||lyflausa|||0|2|0||LYFIS ehf|Apofri AB|Súmatriptan|||||||2|0||0|||0
049964|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
050068|J05AP5401|Zepatier|filmhtfl|150|mg|28|stk|1|þpakki|100mg/50mg|J05AP54|01.05.2017||R|0|0|1|0|0|MBV|0|1|0|100|DKK|1056974|1321091|lyfsjukr|||1|28|0||Vistor hf|Merck Sharp & Dohme B.V.|Elbasvir og grazoprevir||1056974||1056974|1321091||1|0|L|0|||0
050117|G04BE0309|Vizarsin|munndr.t|100|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10000|8380|lyfalmen|||2|24|0|48,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||5000||5000|8380||2|0|E|0|||0
050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||4018||1|0|G|0|||0
050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|G|0|RTH|0|0|0|100|XEU|7043|11192|lyfalmen|||2|90|0|120,0000|Alvogen|ratiopharm GmbH|Alfúzósín||7043||7043|11192||2|0|G|0|||0
050323|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|KNM|0|0|0|100|IKR|9201|14162|lyfalmen|V0925|14162|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||||9201|14162||2|0|E|0|||0
050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|1|0|0|NEL|0|1|0|100|DKK|62274|82038|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||62274|82038||1|0|L|0|||0
050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól|||||||1|0||0|||0
050577|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2750|5283|lyfalmen|||2|100|0|37,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||2750||2750|5283||2|0|G|0|||0
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|10670|16184|lyfalmen|V0688|12655|1|56|0|42,0000|Icepharma hf|Upjohn EESV|Pregabalín||10670||10670|16184||1|0|E|0|||0
050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|5179|5455|lyfalmen|V0042|4116|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Doxazósín||2875||2875|5455|||0|G|0|||0
050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|0|ATE|0|0|1|100|IKR|4615|7082|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||4057||4057|7082||1|0|0|0|||0
050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|G|0|ATE|0|0|1|100|IKR|4360|2324|lyfalmen|V0006|2186|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||600||600|2324||1|0|G|0|||0
050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|G|0|ATE|0|0|1|100|IKR|6304|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||1000||1000|2874||1|0|G|0|||0
051109|V03AN0502|Airapy|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1031|2705|lyfalmen|V0363|2705|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||877||877|2705||2|0|G|0|||0
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|3172|5167|lyfalmen|V0365|5167|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2666||2666|5167||2|0|G|0|||0
051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|UCB|0|0|0|100|DKK|16162|23743|lyfalmen|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||16162||16162|23743||1|H|0|0|||0
052210|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.11.2020||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5032|3907|lyfalmen|V0144|3907|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1750||1750|3907||2|0|E|0|||0
052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|1|100|SEK|176|1740|lyfalmen|||2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||176||176|1740|31.7.2021|2|0||2|120|töflur|0
052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|676|2307|lyfalmen|V0305|1247|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||588||588|2307||2|0||2|120|töflur|0
052317|R02AX0101|Strefen|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0
052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|602|2327|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||602||602|2327||2|0||2|60|töflur|0
052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|832|2494|lyfalmen|V0305|2494|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||724||724|2494||2|0||2|120|töflur|0
052360|L01EA0201|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01EA02|01.09.2007||R|0|0|1|0|0|BMS|0|1|0|100|DKK|545861|685409|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatinib||545861||545861|685409||1|0|L|0|||0
052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|G|0|AGC|0|0|0|100|XEU|3174|5867|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Tímólól í blöndum||3174||3174|5867||1|0|G|0|||0
052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.04.2018||R|0|0|0|G|0|TIC|0|0|0|100|XEU|7645|12020|lyfalmen|||1|9|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||7645||7645|12020||1|0|G|0|||0
052467|N06AX1615|Venlafaxine Alvogen|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2018||R|1|0|0|G|0|POF|0|0|0|100|IKR|7035|2874|lyfalmen|V0335|2579|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G|0|||0
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|28896|39821|lyfalmen|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||28896||28896|39821||1|0|0|0|||0
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|23491|32985|lyfalmen|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||23491||23491|32985||1|0|0|0|||0
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|24152|33821|lyfalmen|||1|7680|0||Vistor hf|Fresenius Kabi AB|Blöndur||24152||24152|33821||2|0|0|0|||0
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|21176|30057|lyfalmen|||1|7200|0||Vistor hf|Fresenius Kabi AB|Blöndur||21176||21176|30057||2|0|0|0|||0
052677|N02AB0310|Fentanyl Alvogen|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.09.2020||R|0|0|0|G|0|POF|0|0|0|100|XEU|2241|4582|lyfalmen|||2|5|0|3,6000|Alvogen|Alvogen|Fentanýl||2241||2241|4582||2|0|G|1|30|dagar|0
052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4448|3934|lyfalmen|V0682|3393|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0
052838|A10BJ0201|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.01.2012||R|0|0|0|0|0|NAS|0|0|0|100|DKK|14116|20927|lyfalmen|||1|6|0|24,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||14116||14116|20927||1|0|E|0|||0
053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|39490|53221|lyfalmen|V1007|45389|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||39490||39490|53221||2|0|E|1|30|dagar|0
053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|5697|9339|lyfalmen|V1003|8226|1|98|0|6,5400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||5697||5697|9339||2|0|E|1|30|dagar|0
053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|1670|3787|lyfalmen|V1002|2760|1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||1663||1663|3787||2|0|E|1|30|dagar|0
053304|C10AA0508|Lipistad|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|0|ASR|0|0|0|100|IKR|6489|7967|lyfalmen|V0115|7967|2|100|0|400,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||4700||4700|7967||2|0|E|0|||0
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|1|G|0|SDH|0|0|0|100|XEU|24933|34809|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||24933||24933|34809||1|0|G|0|||0
053846|M05BA0602|Bonviva|stl|3|mg|3|ml|1|áfspr||M05BA06|01.11.2019||R|0|1|0|0|0|ATP|0|0|0|100|DKK|13346|19867|lyfalmen|V0957|16820|1|3|0|0,5000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||13346||13346|19867||2|0|E|0|||0
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|0|0|0|ETH|0|0|0|100|GBP|10671|16185|lyfalmen|||2|10|0|50,0000|Icepharma hf|Ethypharm|Hýdrómorphón||10671||10671|16185||2|0||1|30|dagar|0
053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|OPC|0|0|0|100|DKK|1408|3436|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||1408||1408|3436||1|0|E|0|||0
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|KPA|0|0|1|100|DKK|1890|4099|lyfalmen|||1|15|0|10,0000|Alvogen|Karo Pharma AB|Pívmecillínam||1890||1890|4099||2|0|E|0|||0
054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|KPA|0|0|1|100|DKK|2664|5165|lyfalmen|||1|20|0|13,3300|Alvogen|Karo Pharma AB|Pívmecillínam||2664||2664|5165||2|0|E|0|||0
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|UCN|0|0|1|100|SEK|1083|2989|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1083||1083|2989||1|0||0|||0
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|UCN|0|0|0|100|SEK|1163|3099|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1163||1163|3099||1|0||0|||0
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1462|3510|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúoxetín||1462||1462|3510|30.6.2021|1|0|E|0|||0
054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|0|0|0|CES|1|0|0|100|DKK|5315|10254|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||5315||5315|10254||2|0||1|30|dagar|0
055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|1|G|0|TAB|0|0|0|100|XEU|10529|15990|lyfalmen|||2|100|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||10529||10529|15990||2|0|G|0|||0
055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|1|G|0|TAB|0|0|0|100|XEU|6533|10490|lyfalmen|||2|50|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||6533||6533|10490||2|0|G|0|||0
055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|HES|0|0|1|100|DKK|1949|4181|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Moxífloxacín||||1949|4181||1|0||0|||0
055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|0|G|0|MDI|0|0|0|100|DKK|8790|13596|lyfalmen|||1|100|0|60,0000|Icepharma hf|Mundipharma A/S|Morfín||8790||8790|13596||2|0|G|1|30|dagar|0
055372|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|G|0|VAL|0|0|0|100|XEU|2752|2837|lyfalmen|V0334|2837|2|110|0|82,5000|Acare ehf|Medical Valley Invest AB|Venlafaxín||973||973|2837||2|0|G|0|||0
055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|ATE|0|0|1|100|XEU|1784|3569|lyfalmen|V0467|2772|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1505||1505|3569||1|0|E|0|||0
055825|J02AC0402|Posaconazol Alvogen|sþ-tfl|100|mg|24|stk|1|stsk.þ||J02AC04|01.01.2021||R|0|0|1|0|0|ALE|0|1|0|100|DKK|91080|118472|lyfsjukr|||1|24|0|8,0000|Alvogen|Alvogen Pharma Trading Europe EOOD|Posacónazól||91080||91080|118472||2|0|L|0|||0
055873|N05AX1304|Paliperidon Krka|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|G|0|KNM|0|0|0|100|IKR|10082|15375|lyfalmen|V0965|15375|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||10082||10082|15375||2|0|G|0|||0
055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|G|0|AZD|0|0|1|100|SEK|2995|5620|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2995||2995|5620||1|0|G|0|||0
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2485|2929|lyfalmen|V0112|2733|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1040||1040|2929||1|0|G|0|||0
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3779|3184|lyfalmen|V0113|2735|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1225||1225|3184||1|0|G|0|||0
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5489|3184|lyfalmen|V0114|2736|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1225||1225|3184||1|0|G|0|||0
056196|L01XC0501|Mylotarg|st/irþ|5|mg|1|hgl|1|pakki|lausn|L01XC05|01.06.2019||R|0|0|0|0|0|PEU|0|1|0|100|DKK|1036152|1295194|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Gemtuzumab ozogamicin||1036152||1036152|1295194||2|H|L|0|||0
056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|1|0|0|BNB|0|0|0|100|XEU|22553|31799|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||22553||22553|31799||2|0|E|0|||0
056339|C09BA0203|Enalapril-Hydrochlorthiazid Krka|töflur|32,5|mg|110|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2943|lyfalmen|V0098|2823|2|110|0|110,0000|LYFIS ehf|Krka Sverige AB|Enalapríl og þvagræsilyf||1050||1050|2943||2|0|G|0|||0
056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|CES|1|0|0|100|XEU|25688|44276|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||25688||25688|44276||2|0||0|||0
056500|B01AF0301|Lixiana|filmhtfl|15|mg|10|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|3212|5919|lyfalmen|||1|10|0|2,5000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||3212||3212|5919||1|0|G|0|||0
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986|31.07.2021|R|1|0|0|0|0|MEA|0|0|1|100|DKK|1884|4091|lyfalmen|||1|40|0|10,0000|Icepharma hf|Meda AB|Erýtrómýcín||1884||1884|4091||2|0|E|0|||0
056858|L04AD0204|Dailiport|forðahlk|5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|45072|60281|lyfalmen|||2|50|0|50,0000|Artasan ehf|Sandoz A/S|Tacrolimus||45072||45072|60281||1|0|G|0|||0
056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|0|0|BNB|0|1|0|100|XEU|204813|261241|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Netherlands B.V.|Natalizumab||204813||204813|261241||2|H|L|0|||0
057304|V03AN0502|Airapy|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|3264|5990|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3264||3264|5990||2|0|0|0|||0
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|HES|0|1|0|100|DKK|3379|6149|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3379||3379|6149||1|0|L|0|||0
057365|N06AX1614|Venlafaxin Krka|forðahlk|75|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2859|2874|lyfalmen|V0334|2579|2|100|0|75,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G|0|||0
057376|N06AX1614|Venlafaxin Krka|forðahlk|150|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|3700|2874|lyfalmen|V0335|2579|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G|0|||0
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|HES|0|1|0|100|DKK|2354|4738|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2354||2354|4738||1|0|L|0|||0
057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|G|0|WEH|0|0|0|100|XEU|9971|15222|lyfalmen|V0607|3019|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||9971||9971|15222||2|0|G|0|||0
057979|L01BC5901|Lonsurf|filmhtfl|21,14|mg|20|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|88247|114888|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||88247|114888||2|0|L|0|||0
058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|PEU|0|0|1|100|DKK|19229|27965|lyfalmen|V1050|27965|1|112|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||19229|27965||1|0||0|||0
058199|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|100|stk|1|tfílát||N02AA05|01.10.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4635|7809|lyfalmen|V0585|7809|2|100|0|26,6666|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||4585||4585|7809||1|0|G|1|30|dagar|0
058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|ROD|0|1|0|100|DKK|349024|440599|lyfsjukr|||1|1|0|33,3300|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||349024||349024|440599||1|0|L|0|||0
058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|LOH|0|0|0|100|XEU|154333|266008|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||154333|266008||2|0||0|||0
058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|LOH|0|0|0|100|XEU|234446|404091|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||234446|404091||2|0||0|||0
058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|MEA|0|0|1|100|DKK|2041|4307|lyfalmen|||1|100|0|2,5000|Icepharma hf|Meda AB|Trímetóprím||2041||2041|4307||2|0|E|0|||0
058609|N05AX1302|Xeplion|stl|50|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|35522|48202|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||35522||35522|48202||1|0|E|0|||0
058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|4797|8101|lyfalmen|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||4797||4797|8101||2|0|0|0|||0
058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1139|3066|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1139||1139|3066||1|0|G|0|||0
058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1640|3755|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1640||1640|3755||1|0|G|0|||0
059012|A06AH0301|Moventig|filmhtfl|25|mg|30|stk|1|þpakki|stakskammtaþynna|A06AH03|01.10.2018||R|1|0|0|0|0|KWA|0|0|0|100|XEU|11496|17321|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Naloxegol||11496||11496|17321||2|0|0|0|||0
059059|N06DA0405|Galantamin STADA|forðahlk|16|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|14895|21999|lyfalmen|||2|84|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||14895||14895|21999||2|0|G|0|||0
059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|G|0|ATE|0|0|1|100|IKR|2374|2737|lyfalmen|V0006|1224|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||900||900|2737||1|0|G|0|||0
059211|L01XC2801|Imfinzi|irþ|50|mg/ml|10|ml|1|hgl|500 mg/10 ml|L01XC28|01.06.2019||R|0|0|0|0|0|AZE|0|1|0|100|SEK|433554|545731|lyfsjukr|||1|10|0||Vistor hf|AstraZeneca AB|Durvalumab||||433554|545731||1|H|L|0|||0
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|1|G|0|REI|0|0|0|100|DKK|89604|116605|lyfalmen|||1|2|0|311,1900|Vistor hf|Recordati Ireland Limited|Leuprórelín||89604||89604|116605||1|0|G|0|||0
059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|0|0|PEU|0|0|0|100|DKK|56253|74422|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer Europe MA EEIG|Anidulafungin||56253||56253|74422||1|H|0|0|||0
059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|G|0|BPC|0|0|0|100|SEK|23871|33466|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||23871||23871|33466||1|0|G|0|||0
059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|G|0|BAB|0|0|0|100|DKK|4403|7558|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AB|Nífedipín||||4403|7558||2|0|G|0|||0
059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|1|0|0|ASP|0|0|0|100|XEU|8510|13211|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||8510||8510|13211||1|0|E|0|||0
059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|1|0|0|ASP|0|0|0|100|XEU|42551|57092|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||42551||42551|57092||1|0|E|0|||0
059976|J01DD0402|Ceftriaxona Normon|irs|2000|mg|1|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|3090|5751|lyfalmen|||2|1|0|1,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||3090||3090|5751||2|0|0|0|||0
060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|20761|29532|lyfalmen|V0713|29532|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||20761||20761|29532||1|0|G|0|||0
060930|J01AA0212|Doxycyklin EQL Pharma|töflur|100|mg|100|stk|1|þpakki||J01AA02|01.07.2018||R|1|0|0|0|0|EQL|0|0|1|100|IKR|5000|8380|lyfalmen|||2|100|0|100,0000|LYFIS ehf|EQL Pharma AB|Doxýcýklín||5000||5000|8380||2|0|E|0|||0
061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|1|0|0|SGB|0|1|0|100|XEU|97365|126421|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||97365||97365|126421||1|0|L|0|||0
061147|N05CF0201|Stilnoct|filmhtfl|10|mg|28|stk|1|þpakki||N05CF02|01.04.2021||R|1|0|0|0|0|SNP|0|0|1|100|XEU|300|1911|lyfalmen|V0060|1826|1|28|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||300||300|1911||1|0||2|30|töflur|0
061388|C10AA0508|Lipistad|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1994|2806|lyfalmen|V0112|2733|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0||0|||0
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|G|0|MBV|0|0|0|100|DKK|4858|8184|lyfalmen|||1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Tíbólón||4858||4858|8184||1|0|G|0|||0
061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|HES|0|0|0|100|DKK|3655|6529|lyfalmen|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3655||3655|6529||1|H|0|0|||0
061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|1|0|0|MLD|0|0|0|100|DKK|13734|20401|lyfalmen|||1|1|0|1,2500|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||13734||13734|20401||1|0|0|0|||0
061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|1|0|0|MLD|0|0|0|100|DKK|18430|26865|lyfalmen|||1|1|0|1,7900|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||18430||18430|26865||1|0|0|0|||0
062347|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|15000|18015|lyfalmen|V0924|18015|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||12000||12000|18015||2|0|E|0|||0
062544|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.11.2019||R|1|0|0|G|0|PIX|0|0|1|100|NOK|5536|9118|lyfalmen|||1|10|0|1,6667|Phoenix Labs|Phoenix Labs|Famcíclóvír||5536||5536|9118||2|0|G|0|||0
062575|J05AP0801|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AP08|01.09.2015||R|0|0|1|0|0|GSE|0|1|0|100|XEU|1956938|2440394|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir||||1956938|2440394||1|0|L|0|||0
062662|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|úðaílá|HFA 134a|R03AC12|01.09.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|3602|6456|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3602||3602|6456||1|0|G|0|||0
062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|882|2712|lyfalmen|V0308|2689|1|60|0|30,0000|Icepharma hf|Upjohn EESV|Alprazólam||882||882|2712||1|0||2|60|mg|0
062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|BAN|0|0|0|100|DKK|17156|29570|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Phoximum||17156||17156|29570||2|0||0|||0
062793|J05AE1002|Darunavir Alvogen|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.07.2017||R|1|0|1|0|0|ALO|0|1|0|100|XEU|74174|63048|lyfsjukr|||2|60|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||47260||47260|63048||2|0|L|0|||0
062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|GBI|0|0|0|100|DKK|11237|15113|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||9892||9892|15113||1|0||0|||0
062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|GBI|0|0|0|100|DKK|113376|147519|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||113376||113376|147519||1|0||0|||0
063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1741|3191|lyfalmen|V0276|3191|2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||1230||1230|3191||1|0|G|0|||0
063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5373|6233|lyfalmen|V0277|6233|2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||3440||3440|6233||1|0|G|0|||0
063426|L02BB0601|Nubeqa|filmhtfl|300|mg|112|stk|1|þpakki||L02BB06|01.01.2021||R|1|0|0|0|0|BAB|0|1|0|100|DKK|424308|534232|lyfsjukr|||1|112|0||Icepharma hf|Bayer AB|Darolutamide||424308||424308|534232||2|0|L|0|||0
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Icepharma hf|Meda AB|Laktúlósa|||||3385||2|0|E|0|||0
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|ATE|0|0|0|100|XEU|2069|3564|lyfalmen|V0123|3564|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín||1501||1501|3564||1|0|E|0|||0
063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|1|0|0|RRG|0|1|0|100|DKK|137250|177212|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||137250||137250|177212||2|0|L|0|||0
063940|N05CD0806|Buccolam|munnh.l|2,5|mg|0,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12505|18710|lyfalmen|||2|2|0|1,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12505||12505|18710||3|H|E|2|450|mg|0
063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|920|2764|lyfalmen|V0310|2764|1|60|0|60,0000|Icepharma hf|Upjohn EESV|Alprazólam||920||920|2764||1|0||2|60|mg|0
064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|891695|1115530|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||891695|1115530||2|H|L|0|||0
064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|353560|446241|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||353560|446241||2|H|L|0|||0
064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|3056520|3807966|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||3056520|3807966||2|H|L|0|||0
064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|1583931|1976478|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||1583931|1976478||2|H|L|0|||0
064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|1947|4178|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1947||1947|4178||2|0|G|0|||0
064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|6211|5693|lyfalmen|V0029|5693|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3048||3048|5693||2|0|G|0|||0
064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|IBV|0|0|0|100|DKK|1127|2215|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Oxytetracyclinum||1127||1127|2215||1|0||0|||0
064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|6434|11090|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||6434|11090||1|0||0|||0
064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|0|0|OCT|0|1|0|100|DKK|30940|42407|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||30940||30940|42407||1|H|L|0|||0
064809|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.03.2020||R|1|0|0|G|0|ATE|0|0|0|100|IKR|4118|3904|lyfalmen|V0679|3904|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan||1748||1748|3904||1|0|G|0|||0
064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|G|0|ASS|0|0|1|100|DKK|791|2587|lyfalmen|||2|50|0|16,6667|Vistor hf|Takeda AS|Metóklópramíð||791||791|2587||1|0|G|0|||0
064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|G|0|ASS|0|0|1|100|DKK|1063|2961|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||1063||1063|2961||1|0|G|0|||0
064963|L01ED0401|Alunbrig|filmhtfl|90|mg|28|stk|1|þpakki||L01ED04|01.02.2021||R|1|1|1|0|0|ASS|0|1|0|100|DKK|498883|626982|lyfsjukr|||1|28|0||Vistor hf|Takeda AS|Brigatinib||498883||498883|626982||1|0|L|0|||0
065012|C07AB0215|Metoprolol Alvogen|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.02.2021||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2334|2910|lyfalmen|V0049|2910|2|100|0|63,3333|Alvogen|Alvogen ehf|Metóprólól||1026||1026|2910||2|0|G|0|||0
065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|4742|9167|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketóprófen||4742||4742|9167||2|0||0|||0
065093|R03AK0605|Salmex|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.07.2021||R|0|0|0|G|0|GPN|0|0|0|100|DKK|3858|6391|lyfalmen|V0437|5304|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||3555||3555|6391||2|0|G|0|||0
065200|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|529|2226|lyfalmen|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||529||529|2226||2|0|0|0|||0
065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
065339|A07EA0604|Cortiment|forðatfl|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|G|0|FEL|0|0|0|100|DKK|14966|22097|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||14966||14966|22097||1|0|G|0|||0
065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|GEH|0|0|0|100|NOK|9494|14565|lyfalmen|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||9494||9494|14565||2|H|0|0|||0
065468|M01AH0503|Coxerit|filmhtfl|60|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|5183|7140|lyfalmen|V0830|6864|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4099||4099|7140||2|0|G|0|||0
065583|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|112|stk|1|þpakki||C10AX09|01.07.2019||R|0|0|0|0|0|VAL|0|0|0|100|DKK|8777|6866|lyfalmen|V0954|6866|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||3900||3900|6866||2|0|0|0|||0
065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|1|G|0|LVR|0|0|0|100|SEK|47950|62602|lyfalmen|V0451|53065|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||46907||46907|62602||3|0|G|0|||0
065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065751|J01CR0204|Amoxin comp|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|RTH|0|0|1|100|DKK|1941|4170|lyfalmen|||2|70|0|3,7333|Alvogen|ratiopharm GmbH|Amoxicillín og beta-laktamasa hemill ||1941||1941|4170||2|0|E|0|||0
065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065827|N02AJ0601|Parkodin|filmhtfl|510|mg|200|stk|1|ílát|10+500 mg|N02AJ06|01.02.2018||R|2|0|0|0|0|ATE|0|0|1|100|XEU|2695|5207|lyfalmen|||2|200|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||2695||2695|5207||1|0|E|1|||0
065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|GEH|0|0|0|100|NOK|2999|5626|lyfalmen|||1|100|0||Icepharma hf|GE Healthcare AS|Iohexol||2999||2999|5626||2|H|0|0|||0
065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|1517|3586|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||1517||1517|3586||1|0|G|0|||0
065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|2775|5317|lyfalmen|||2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||2775||2775|5317||1|0|G|0|||0
065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|4770|7660|lyfalmen|||2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||4477||4477|7660||1|0|G|0|||0
066013|A11HA0801|Vedrop|mixtúra|50|mg/ml|20|ml|1|glas||A11HA08|01.07.2017||R|0|0|1|0|0|OUS|0|0|0|100|XEU|11502|17329|lyfalmen|||1|20|0|5,0000|Recordati AB|Orphan Europe SARL|Tocofersolanum||11502||11502|17329||3|0|E|0|||0
066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|DOR|1|0|0|100|DKK|4280|8291|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Meloxícam||4280||4280|8291||2|0||0|||0
066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|GOG|0|0|1|100|DKK|835|2647|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||835||835|2647||2|0||0|||0
066497|N05AH0415|Quetiapin Krka|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|7500|8930|lyfalmen|V0272|8917|2|100|0|75,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||5400||5400|8930||2|0|G|0|||0
066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól|||||||1|0||0|||0
066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|0|0|ATE|0|0|0|100|XEU|12055|18090|lyfalmen|||2|50|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paklítaxel||||12055|18090||1|H|0|0|||0
067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|7802|12237|lyfalmen|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||7802||7802|12237||1|0|0|0|||0
067229|J05AR1901|Odefsey|filmhtfl|250|mg|30|stk|1|glas|200+25+25 mg|J05AR19|01.09.2016||R|0|0|1|0|0|GSU|0|1|0|100|DKK|103530|135274|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland UC|Emtricitabine, tenofovir alafenamide og rilpivirine||||103530|135274||2|0|L|0|||0
067394|A02BC0512|Nexium (Lyfjaver)|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.05.2019||R|1|0|0|0|0|LVR|0|0|1|100|DKK|10895|15595|lyfalmen|V0012|5765|3|100|0|133,3300|Lyfjaver ehf|Lyfjaver ehf|Esómeprazól||10242||10242|15595||3|0|0|0|||0
067829|QA04AD9002|Prevomax|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.06.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|8116|15568|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|maropitant||||8116|15568||2|0||0|||0
067848|QN02BG9102|Librela|stl|30|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|16883|32201|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||16883||16883|32201||2|0||2|||0
067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|2294|4655|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||2294|4655||2|0|0|0|||0
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|1|G|0|MEA|0|0|0|100|DKK|4396|7549|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Flekaíníð||4396||4396|7549||2|0|G|0|||0
068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|G|0|IPC|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón|||||3123||2|0|G|0|||0
068629|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.02.2017||R|1|0|0|G|0|GRP|0|0|0|100|XEU|8610|13349|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||8610||8610|13349||1|0|G|0|||0
068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014|31.07.2021|L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2|0||0|||0
068811|L04AX0307|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2964|5578|lyfalmen|||1|0,55|0|11,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2964||2964|5578||2|0|G|0|||0
068860|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||||2|0||0|||0
068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|2576|5044|lyfalmen|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||2576||2576|5044||2|H|0|0|||0
068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|3284|6018|lyfalmen|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||3284||3284|6018||2|H|0|0|||0
068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3622||2|0||0|||0
068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3805||2|0||0|||0
068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3576||2|0||0|||0
068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3755||2|0||0|||0
069030|G04BD1202|Betmiga (Lyfjaver)|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.08.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|15009|22156|lyfalmen|V0651|22156|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||15009||15009|22156||3|0|G|0|||0
069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|G|0|FEL|0|0|0|100|DKK|12436|18615|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||12436||12436|18615||1|0|G|0|||0
069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|G|0|FEL|0|0|0|100|DKK|35987|48790|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||35987||35987|48790||1|0|G|0|||0
069177|C10AA0704|Rosuvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|9540|10169|lyfalmen|V0195|10169|2|100|0|400,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||6300||6300|10169||2|0|E|0|||0
069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|369276|465787|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer AG|Riociguatum||369276||369276|465787||1|0|L|0|||0
069423|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
069536|L04AA0607|Mycofenolsýra Accord|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|1|G|0|AEE|0|0|0|100|XEU|14555|17526|lyfalmen|V0470|17116|2|120|0|10,8000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||11645||11645|17526||1|0|G|0|||0
069596|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|G|0|KRK|0|0|0|100|IKR|||lyfalmen|||2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||3284||2|0|G|0|||0
069912|J05AF1301|Vemlidy|filmhtfl|25|mg|30|stk|1|þpakki||J05AF13|01.08.2017||R|0|0|1|0|0|GEI|0|1|0|100|DKK|63742|83894|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír alafenamíð||||63742|83894||2|0|L|0|||0
070203|N05CF0107|Imomed|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.05.2020||R|1|0|0|0|0|DIC|0|0|0|100|IKR|450|2117|lyfalmen|V0312|2117|2|30|0|30,0000|LYFIS ehf|Medical ehf|Zópíklón||450||450|2117||2|0||2|30|töflur|0
070512|L01EB0401|Tagrisso|filmhtfl|40|mg|30|stk|1|stsk.þ||L01EB04|01.07.2020||R|0|0|1|0|0|AZE|0|1|0|100|SEK|870214|1088814|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||870214||870214|1088814||1|0|L|0|||0
070563|B02BD0208|Afstyla|sts|250|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|20679|29428|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||20679||20679|29428||2|0|L|0|||0
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|G|0|JAS|0|0|0|100|SEK|9394|14428|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||9394||9394|14428||1|0|G|0|||0
070921|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2016||R|0|0|0|0|0|CZV|1|0|0|100|XEU|7205|12419|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||7205||7205|12419||1|0||0|||0
071450|J01FA1008|Azitromicina Normon|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.03.2019||R|1|0|0|0|0|WEH|0|0|1|100|IKR|1100|3012|lyfalmen|V0174|2599|2|3|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Azitrómýcín||1100||1100|3012||2|0||0|||0
071784|A10BD2401|Steglujan|filmhtfl|105|mg|98|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|34853|47156|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||34695||34695|47156||1|0|G|0|||0
071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|1|0|0|GEB|0|0|0|100|XEU|72266|94676|lyfalmen|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||72266|94676||1|0|0|0|||0
072103|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|0|0|ATE|0|0|0|100|XEU|13319|11352|lyfalmen|||2|56|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||7159||7159|11352||1|0|E|0|||0
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|ORF|1|0|0|100|DKK|6687|12857|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|Detomidinum||6687||6687|12857||1|0||0|||0
072374|N06AX1203|Wellbutrin Retard (Lyfjaver)|töflur|300|mg|30|stk|1|askja|m/br. losunarhraða|N06AX12|01.10.2020||R|0|0|0|0|0|LVR|0|0|0|100|DKK|5224|8688|lyfalmen|V1029|8688|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Bupropionum||5224||5224|8688||3|0|E|0|||0
072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|G|0|PSA|0|0|0|100|XEU|6211|5693|lyfalmen|V0029|5693|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3048||3048|5693||2|0|G|0|||0
072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|AGA|0|0|0|100|XEU|204448|260787|lyfalmen|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||204448||204448|260787||5|H|0|0|||0
072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|AGA|0|0|0|100|XEU|217473|276987|lyfalmen|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||217473||217473|276987||5|H|0|0|||0
072701|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|200|stk|1|glas|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|23000|11133|lyfalmen|||2|200|0|200,0000|Medical ehf|Medical ehf|Tamsúlósín||7000||7000|11133||2|0|G|0|||0
072735|L04AX0306|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2886|5470|lyfalmen|||1|1|0|8,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2886||2886|5470||2|0|G|0|||0
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|0|0|0|PBV|0|0|0|100|SEK|504|2192|lyfalmen|||1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Súfentaníl||504||504|2192||1|0|0|1|30|dagar|0
073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|1|0|0|JCI|0|1|0|100|SEK|53122|70462|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||53122||53122|70462||1|0|L|0|||0
073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8431|5649|lyfalmen|V0286|5627|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||3016||3016|5649||1|0|G|0|||0
073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|G|0|SHS|0|0|0|100|DKK|441|2105|lyfalmen|V0500|2054|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||441||441|2105||1|0|G|0|||0
073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|1|0|0|JCI|0|1|0|100|SEK|333608|421426|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Macitentan||||333608|421426||1|0|L|0|||0
073313|L01ED0101|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01ED01|01.05.2013||R|1|1|1|0|0|PEU|0|1|0|100|DKK|491547|617858|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotinib||491547||491547|617858||1|0|L|0|||0
073495|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|38 mg/8 mg|QP54AB51|01.04.2018|31.08.2021|R|0|0|0|0|0|BIV|0|0|0|100|XEU|2688|4633|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2688||2688|4633||1|0||0|||0
073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2975|5593|lyfalmen|V1010|2979|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||2975||2975|5593||1|0|G|0|||0
073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|15450|21702|lyfalmen|V0185|21702|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Letrózól||14679||14679|21702||1|0|G|0|||0
073728|L01CB0105|Etópósíð Accord|irþ|20|mg/ml|25|ml|1|hgl||L01CB01|01.06.2020||R|0|0|0|0|0|AEE|0|0|0|100|XEU|8797|13606|lyfalmen|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Etoposíð||8797||8797|13606||1|H|0|0|||0
073803|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|KNM|0|0|0|100|IKR|4700|7967|lyfalmen|V0924|6005|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4700||4700|7967||2|0|E|0|||0
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|912|2753|lyfalmen|V0305|2494|1|100|0|25,0000|Icepharma hf|Upjohn EESV|Alprazólam||912||912|2753||1|0||2|120|töflur|0
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|UPJ|0|0|1|100|DKK|491|2174|lyfalmen|||1|20|0|10,0000|Icepharma hf|Upjohn EESV|Alprazólam||491||491|2174||1|0||2|60|töflur|0
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|1334|3334|lyfalmen|||1|100|0|50,0000|Icepharma hf|Upjohn EESV|Alprazólam||1334||1334|3334||1|0||2|60|töflur|0
073885|N05CF0201|Stilnoct|filmhtfl|10|mg|150|stk|1|þpakki||N05CF02|01.05.2021||R|1|0|0|0|0|SNP|0|0|0|100|XEU|1810|3989|lyfalmen|||1|150|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1810||1810|3989||1|0||2|30|töflur|0
073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1342|3345|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1342||1342|3345||2|0|G|0|||0
073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|IKR|3687|6355|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||3687||3687|6355||2|0||0|||0
073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|G|0|AEP|0|0|0|100|DKK|878|2706|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||878||878|2706||2|0|G|0|||0
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|NEL|0|0|0|100|DKK|2836|5401|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||2836||2836|5401||1|0|E|0|||0
074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20148|28757|lyfalmen|||1|28|0|28,0000|Eisai AB|Eisai GmbH|Perampanel||20148||20148|28757||1|0|G|0|||0
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|1023|2906|lyfalmen|||2|25|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1023||1023|2906||1|0||2|50|töflur|0
074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Alvogen|ratiopharm GmbH|Paracetamól|||||||2|0||0|||0
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|ATE|0|0|0|100|DKK|871|2697|lyfalmen|||2|50|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||871||871|2697||1|0||2|50|töflur|0
074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|ATE|0|0|0|100|DKK|1391|3412|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1391||1391|3412||1|0||2|50|töflur|0
074664|N06AB1008|Escitalopram STADA|filmhtfl|15|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2800|5352|lyfalmen|V0326|5352|2|100|0|150,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||2800||2800|5352||2|0|0|0|||0
074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|G|0|AEP|0|0|0|100|DKK|650|2393|lyfalmen|||1|60|0|12,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||650||650|2393||2|0|G|0|||0
074927|C02AC0201|Intuniv|forðatfl|2|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|10222|15567|lyfalmen|||1|28|0|18,6666|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||10222||10222|15567||1|0|E|0|||0
075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|G|0|AEP|0|0|0|100|DKK|2124|4421|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||2124||2124|4421||2|0|G|0|||0
075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|4999|8379|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4999||4999|8379||1|0|G|0|||0
075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|14653|21666|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14653||14653|21666||1|0|G|0|||0
075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|5269|8750|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5269||5269|8750||1|0|G|0|||0
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1088|2995|lyfalmen|V0363|2705|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1088||1088|2995||1|0|G|0|||0
075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|15425|22729|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15425||15425|22729||1|0|G|0|||0
075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||L|0|0|0|0|0|NIE|0|0|0|100|DKK|||lyfalmen|||1|4|0||Artasan ehf|Norgine B.V.|Hægðalyf með osmótíska verkun|||||4738||1|0|E|0|||0
075451|G04CB0106|Finasteride Alvogen|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|G|0|POF|0|0|0|100|IKR|5987|3563|lyfalmen|V0445|2884|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||1500||1500|3563||2|0|G|0|||0
075865|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|12143|10491|lyfalmen|V0440|8958|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||6534||6534|10491||2|0|G|0|||0
075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|5470|9027|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5470||5470|9027||2|0|0|0|||0
075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|5470|9027|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5470||5470|9027||2|0|0|0|||0
075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|6290|10155|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6290||6290|10155||2|0|0|0|||0
075921|N02AA0507|OxyContin Depot|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|3904|6871|lyfalmen|V0598|5282|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxýcódon||3904||3904|6871||2|0|G|1|30|dagar|0
076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|G|0|MBV|0|0|0|100|DKK|4692|7956|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||4692||4692|7956||1|0|G|0|||0
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|G|0|MBV|0|0|0|100|DKK|16310|23947|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||||16310|23947||1|0|G|0|||0
076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|14491|21443|lyfalmen|||1|98|0|24,5000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||14491||14491|21443||1|0|G|0|||0
076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|G|0|MBV|0|0|0|100|DKK|14630|21635|lyfalmen|V0982|21633|1|98|0|49,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||14630||14630|21635||1|0|G|0|||0
076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1605|2461|lyfalmen|V0143|1132|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||700||700|2461||2|0|E|0|||0
076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2971|3571|lyfalmen|V0143|2264|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3571||2|0|E|0|||0
076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3742|3604|lyfalmen|V0143|3396|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1530||1530|3604||2|0|E|0|||0
076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1667|2613|lyfalmen|V0144|1302|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||810||810|2613||2|0|E|0|||0
076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3208|3897|lyfalmen|V0144|2605|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3897||2|0|E|0|||0
076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|7023|4182|lyfalmen|V0144|3907|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1950||1950|4182||2|0|E|0|||0
076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|G|0|GOV|0|0|0|100|IKR|1944|2273|lyfalmen|V0291|2273|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||563||563|2273||2|0|G|0|||0
076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|dropaí||S01GX08|01.06.2013||L|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen|||||3410||1|0|G|0|||0
076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2737|lyfalmen|V0290|2700|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2737||2|0|G|0|||0
076657|N05AH0416|Quetiapin Medical Valley|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|6400|5008|lyfalmen|V0273|5008|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||2550||2550|5008||2|0|0|0|||0
076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|229995|292561|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||229995||229995|292561||1|0|L|0|||0
076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|133331|172338|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||133331||133331|172338||1|0|L|0|||0
076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|66666|87593|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||66666||66666|87593||1|0|L|0|||0
076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|38333|51757|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||38333||38333|51757||1|0|L|0|||0
076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2750|5283|lyfalmen|V0598|5282|2|98|0|13,0700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||2750||2750|5283||1|0|G|1|30|dagar|0
076792|B02BD0208|Afstyla|sts|1000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|79977|104429|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||79977||79977|104429||2|0|L|0|||0
077085|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|105|stk|1|glas||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|7330|11587|lyfalmen|||2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||7330||7330|11587||2|0|E|0|||0
077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|0|0|SPP|0|1|0|100|XEU|50696|67394|lyfsjukr|||1|1|0||Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||50696||50696|67394||2|H|L|0|||0
077555|N07BC0102|Buvidal|stl|8|mg|0,16|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13183|19643|lyfsjukr|||1|0,16|0|3,8095|Vistor hf|Camurus AB|Búprenorfín||13183||13183|19643||1|H|L|1|30|dagar|0
077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2625|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2625||2|0|E|1|30|dagar|0
077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2701|lyfalmen|V0671|2701|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||874||874|2701||2|0|E|1|30|dagar|0
077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4697|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4697||2|0|E|1|30|dagar|0
077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|6040|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0
077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8380|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8380||2|0|E|1|30|dagar|0
077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|10169|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0
077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12674|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12674||2|0|E|1|30|dagar|0
077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|1|0|G|0|TVA|0|0|0|100|IKR|5017|5352|lyfalmen|V0275|4788|2|100|0|12,5000|Alvogen|Teva B.V.|Quetíapín||2800||2800|5352||2|0|G|0|||0
078145|B01AF0301|Lixiana|filmhtfl|30|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|9635|14760|lyfalmen|||1|30|0|15,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||9635||9635|14760||1|0|G|0|||0
078205|B05AA0116|Alburex|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.09.2021||R|0|0|0|0|0|CSB|0|0|0|100|SEK|5636|9255|lyfalmen|||1|250|0||Icepharma hf|CSL Behring GmbH|albumin||5636||5636|9255||2|H|0|0|||0
078216|B05AA0116|Alburex|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.09.2021||R|0|0|0|0|0|CSB|0|0|0|100|SEK|8990|13872|lyfalmen|||1|100|0||Icepharma hf|CSL Behring GmbH|albumin||8990||8990|13872||2|H|0|0|||0
078457|QD11AH9001|Apoquel|töflur|16|mg|100|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|37500|71316|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||37500||37500|71316||2|0||0|||0
078674|N06BA1201|Elvanse Adult|hylki|50|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|12887|19236|lyfalmen|||1|30|0|50,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||12887||12887|19236||1|0|E|1|30|dagar|0
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|G|0|MSD|0|0|0|100|DKK|8038|6381|lyfalmen|V0069|2884|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3548||3548|6381||1|0|G|0|||0
079195|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5032|3907|lyfalmen|V0144|3907|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1750||1750|3907||2|0|E|0|||0
079272|N06DX0109|Marbodin|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2071|3975|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1800||1800|3975||2|0|G|0|||0
079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3826|6764|lyfalmen|V0315|6764|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúoxetín||3826||3826|6764||1|0|G|0|||0
079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|G|0|TSA|0|0|0|100|XEU|16237|23847|lyfalmen|V0184|13461|2|100|0|100,0000|Alvogen|Teva Sweden AB|Anastrózól||16237||16237|23847||2|0|G|0|||0
079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1|0||0|||0
079885|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.03.2021||R|1|0|0|G|0|NEL|0|0|0|100|DKK|5670|9302|lyfalmen|V0025|9302|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||5670||5670|9302||1|0|G|0|||0
080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|ATE|0|0|1|100|XEU|477|2154|lyfalmen|||2|10|0|2,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||477||477|2154||1|0|E|0|||0
080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|ATE|0|0|1|100|XEU|774|2438|lyfalmen|V0418|2438|2|20|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||683||683|2438||1|0|E|0|||0
080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|785|2450|lyfalmen|V0177|2450|2|10|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||692||692|2450||1|0|E|0|||0
080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1368|3216|lyfalmen|V0411|3216|2|20|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||1248||1248|3216||1|0|E|0|||0
080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Cloprostenolum||4985||4985|9628||2|0||0|||0
080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|ANI|1|0|0|100|XEU|3799|7378|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3799|7378||2|0||2|||0
080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
080431|H02AB0207|Dexamethasone Krka|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|G|0|KNM|0|0|1|100|IKR|3000|3287|lyfalmen|V0422|3287|2|20|0|53,3300|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||1300||1300|3287||2|0|G|0|||0
080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|VEO|0|0|0|100|DKK|12393|21361|vetorma|||0|24|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||12393||12393|21361||2|0||0|||0
080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|G|0|BLS|0|0|0|100|XEU|6590|6896|lyfalmen|||2|30|0|30,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Letrózól||3922||3922|6896||1|0|G|0|||0
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|G|0|LBK|0|0|0|100|DKK|2170|4485|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2170||2170|4485||1|0|G|0|||0
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|5226|8691|lyfalmen|V1029|8688|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||5226||5226|8691||1|0|E|0|||0
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2478|4909|lyfalmen|V1028|4907|1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2478||2478|4909||1|0|E|0|||0
080621|B01AF0301|Lixiana|filmhtfl|30|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|32117|43895|lyfalmen|||1|100|0|50,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||32117||32117|43895||1|0|G|0|||0
080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|0|0|AMR|0|0|0|100|XEU|3780|6701|lyfalmen|||1|1|0|1,0000|Alvogen|Amring|Mifepriston||3780||3780|6701||2|H|0|0|||0
081038|QI01AN0101|Evalon|innúðal|||1000|skammtar|1|hgl|+50ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|IKR|22950|39557|vetorma|||0|1000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||22950||22950|39557||2|0|0|0|||0
081185|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9984|3257|lyfalmen|V0815|3197|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1278||1278|3257||2|0|E|0|||0
081305|L01ED0101|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01ED01|01.05.2013||R|1|1|1|0|0|PEU|0|1|0|100|DKK|614433|770694|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotinib||614433||614433|770694||1|0|L|0|||0
081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0||0|||0
081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0||0|||0
081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081626|N06AX2108|Aritavi|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1859|2410|lyfalmen|V0692|2410|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||663||663|2410||1|0|E|0|||0
081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Bauluventill.|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|4264|7367|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4264||4264|7367||1|0|G|0|||0
081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Kranaventill|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081681|N06DA0304|Nimvastid|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|6070|9853|lyfalmen|||2|28|0|4,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||6070||6070|9853||2|0|G|0|||0
081821|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|lykjur|innr.lyf, fleyti|N01AX10|01.11.2019||R|0|0|0|0|0|FKA|0|0|0|100|DKK|1477|3531|lyfalmen|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1477||1477|3531||1|H|0|0|||0
081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|G|0|SDH|0|0|0|100|XEU|4724|8000|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||4724||4724|8000||1|0|G|0|||0
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|G|0|SDH|0|0|0|100|XEU|6391|10294|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6391||6391|10294||1|0|G|0|||0
082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|26506|36798|lyfalmen|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||26506||26506|36798||2|H|0|0|||0
082334|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|VIR|1|0|0|100|XEU|12981|22374|vetorma|||0|10|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||12981||12981|22374||1|0||0|||0
082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|VIR|1|0|0|100|XEU|54509|93952|vetorma|||0|50|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||54509||54509|93952||1|0||0|||0
082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|629|2364|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||629||629|2364||1|0|G|0|||0
082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2893|5480|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2893||2893|5480||1|0|G|0|||0
082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2604|5082|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2604||2604|5082||1|0|G|0|||0
082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3661|6537|lyfalmen|V0080|6242|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan||3661||3661|6537||1|0|G|0|||0
083019|L01EB0202|Varlota|filmhtfl|150|mg|30|stk|1|þpakki||L01EB02|01.04.2018||R|1|1|1|0|0|ALO|0|1|0|100|XEU|262210|297533|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlotinib||233993||233993|297533||2|0|L|0|||0
083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||L|1|0|0|G|0|MYL|0|0|0|100|DKK|||lyfalmen|V0706|6350|1|100|0|16,6700|Icepharma hf|Mylan AB|Hvatablöndur (lípasi, próteasi o.s.frv.)|||||6350||2|0|G|0|||0
083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|3286|6021|lyfalmen|V0701|5352|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3286||3286|6021||1|0|G|0|||0
083209|QN02BG9102|Librela|stl|5|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|9749|18666|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||9749||9749|18666||2|0||2|||0
083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|4870|3455|lyfalmen|V0686|3455|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||1422||1422|3455||1|0|E|0|||0
083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|5835|11241|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||5835||5835|11241||2|0||0|||0
083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|GCA|0|0|1|100|DKK|843|2565|lyfalmen|V0231|2565|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||775||775|2565||1|0|E|0|||0
083875|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|4863|5393|lyfalmen|V0624|5393|2|30|0|36,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||2830||2830|5393||1|0|E|1|30|dagar|0
083966|R03AK1401|Atectura Breezhaler|innönddu|252,5|mcg/sk|30|stk|1|stsk.þ|125 mcg/127,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|4434|7601|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||4434||4434|7601||1|0|G|0|||0
084182|V03AC0301|Exjade|filmhtfl|180|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|160308|205890|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||160308||160308|205890||1|0||0|||0
084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2430|4843|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||2430||2430|4843||2|0||2|60|mg|0
084252|C03EA0115|Amiloride/HCT Alvogen|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.03.2020||R|1|0|0|G|0|POF|0|0|0|100|IKR|1345|3349|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||1345||1345|3349||2|0|G|0|||0
084454|G04CA5203|Dutasteride/Tamsulosin Teva|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.05.2020||R|0|0|0|G|0|TVI|0|0|0|100|XEU|2796|4383|lyfalmen|V1010|2979|2|30|0|30,0000|Teva Pharma Iceland ehf|Teva B.V|Dútasteríð og tamsúlósínhýdroklóríð||2096||2096|4383||1|0|G|0|||0
084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|58449|77200|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||58449||58449|77200||1|0|L|0|||0
084744|C09CA0604|Kairasec|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|5622|9236|lyfalmen|||2|98|0|392,0000|Acare ehf|Medical Valley Invest AB|Candesartan||5622||5622|9236||2|0|G|0|||0
084866|N02AJ0602|Parkodin forte|filmhtfl|530|mg|40|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1192|3139|lyfalmen|||2|40|0|13,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1192||1192|3139||1|0|E|3|||0
084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|1|0|0|MSD|0|1|0|100|DKK|35832|48594|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||35832||35832|48594||1|0|L|0|||0
085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|0|G|0|MDI|0|0|0|100|DKK|12021|18044|lyfalmen|||1|100|0|100,0000|Icepharma hf|Mundipharma A/S|Morfín||12021||12021|18044||2|0|G|1|30|dagar|0
085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|1|G|0|GAN|0|0|0|100|XEU|34496|46904|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||34496||34496|46904||2|0|G|0|||0
085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,3|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|SAO|0|0|1|100|XEU|2460|4884|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Levófloxacín||2460||2460|4884||2|0||0|||0
085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|G|0|GPH|0|0|1|100|DKK|775|2565|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||775||775|2565||1|0|G|0|||0
085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl||B01AB04|01.05.2018||R|0|0|0|0|0|PLS|0|0|0|100|DKK|11624|17497|lyfalmen|||1|4|0|40,0000|Icepharma hf|Pfizer Aps|Dalteparín||11624||11624|17497||1|H|0|0|||0
085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|4140|7196|lyfalmen|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4140||4140|7196||2|0|0|0|||0
085515|G04CB0105|Finasterid STADA|filmhtfl|5|mg|100|stk|1|þpakki||G04CB01|01.05.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4051|3563|lyfalmen|V0445|2943|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||1500||1500|3563||2|0|G|0|||0
085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ 5x1ml lykja m.leysi|G03GA02|01.03.2001||R|0|0|1|G|0|FEL|0|0|0|100|DKK|19515|28358|lyfalmen|||1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||19515||19515|28358||1|0|G|0|||0
085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|16416|22882|lyfalmen|V0652|22712|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||15536||15536|22882||1|0|G|0|||0
085584|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|75|pokar|lausn|B05BB01|01.01.2019||R|0|0|0|0|0|BAM|0|0|1|100|SEK|8470|13156|lyfalmen|||1|3750|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||8470||8470|13156||2|0|0|0|||0
085627|G03AA0708|Melleva|filmhtfl|||63|stk|1|þpakki|150mcg/30mcg|G03AA07|01.04.2020||R|0|0|0|0|0|EXH|0|0|0|100|XEU|866|1872|lyfalm11|V0545|1872|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Levónorgestrel og ethinylestradíól||431||431|1872||2|0||0|||1
085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|1|G|0|NED|0|0|0|100|XEU|80115|104603|lyfalmen|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||80115||80115|104603||2|0|G|0|||0
085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|1|G|0|ATE|0|0|0|100|SEK|20550|29265|lyfalmen|V0579|29265|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rílúzól||20550||20550|29265||1|0|G|0|||0
085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|AEB|0|0|0|100|DKK|29322|40360|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||29322||29322|40360||1|0|E|0|||0
085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|0|0|ATE|0|0|0|100|XEU|8027|12546|lyfalmen|||2|60|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Karbóplatín||8027||8027|12546||1|H|0|0|||0
085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|G|0|TIC|0|0|0|100|XEU|2533|4984|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||2533||2533|4984||1|0|G|0|||0
085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|G|0|TIC|0|0|0|100|XEU|6157|9972|lyfalmen|||1|9|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||6157||6157|9972||1|0|G|0|||0
085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|SNP|0|0|1|100|XEU|359|1992|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||359||359|1992||1|0||2|45|töflur|0
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1821|4004|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1821||1821|4004||1|0|G|0|||0
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|2968|5583|lyfalmen|V0365|5167|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||2968||2968|5583||1|0|G|0|||0
086118|L04AA3301|Entyvio|stl|108|mg|1|áf-penni|1|pakki||L04AA33|01.03.2021||R|0|1|0|0|0|TPA|0|1|0|100|DKK|74795|97874|lyfsjukr|||1|1|0|20,0000|Vistor hf|Takeda Pharma A/S|Vedolizumab||74795||74795|97874||1|0|L|0|||0
086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|1|0|0|BNB|0|0|0|100|XEU|39159|52802|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||39159||39159|52802||2|0|E|0|||0
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|GPH|0|0|1|100|DKK|7943|12431|lyfalmen|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||7943||7943|12431||1|0|0|0|||0
086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|GRH|0|0|1|100|DKK|10241|15594|lyfalmen|V0012|5765|1|100|0|133,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||10241||10241|15594||1|0|E|0|||0
086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|26898|37294|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||26898|37294||1|0|G|0|||0
086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|47016|62739|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||47016|62739||1|0|G|0|||0
086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|0|0|BSP|0|1|0|100|DKK|48533|64658|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||48533||48533|64658||1|H|L|0|||0
086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|15890|20919|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||||15890|20919||2|0|E|0|||1
086649|L01XG0301|Ninlaro|hylki|3|mg|1|stk|3|þpakki|Hver hylki sérpakkað í þynnu|L01XG03|01.01.2019||R|0|0|1|0|0|TPA|0|1|0|100|DKK|791891|991402|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||791891||791891|991402||1|0|L|0|||0
086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|ROA|0|1|1|100|DKK|42569|57115|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||42569||42569|57115||2|0|L|0|||0
087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1|0||0|||0
087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1|0||0|||0
087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|SNP|0|0|1|100|XEU|333|1956|lyfalmen|V0060|1956|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||333||333|1956||1|0||2|30|töflur|0
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|225|1808|lyfalmen|V0312|706|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||225||225|1808||1|0||2|30|töflur|0
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|0|100|XEU|594|2316|lyfalmen|V0312|2117|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||594||594|2316||1|0||2|30|töflur|0
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|0|100|XEU|1671|3798|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1671||1671|3798||1|0||2|30|töflur|0
087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|14741|21787|lyfalmen|||2|250|0|166,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||14741||14741|21787||1|0|G|0|||0
087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|14741|21787|lyfalmen|||2|250|0|333,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||14741||14741|21787||1|0|G|0|||0
087572|G04BD0801|Vesicare|mixtúra|1|mg/ml|150|ml|1|glas||G04BD08|01.08.2019||R|0|0|0|G|0|ASP|0|0|0|100|XEU|5391|8918|lyfalmen|||1|150|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5391||5391|8918||1|0|G|0|||0
087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1428|3463|lyfalmen|V0952|3251|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1428||1428|3463||1|0|G|0|||0
087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|CHP|0|0|0|100|XEU|32635|56250|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||32635||32635|56250||2|0||0|||0
087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1|0||0|||0
087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|VIR|0|0|0|100|XEU|4652|8996|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4652||4652|8996||1|0||0|||0
088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|CES|1|0|0|100|SEK|22894|39460|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||22894||22894|39460||2|0||0|||0
088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|2950|4976|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||2950||2950|4976||2|0||0|||1
088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|G|0|RGP|0|0|1|100|DKK|1006|2883|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Flútíkasón fúróat||1006||1006|2883||1|0|G|0|||0
088300|L04AX0306|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3040|5682|lyfalmen|||1|1|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3040||3040|5682||2|0|G|0|||0
088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|7196|3934|lyfalmen|V0684|3393|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0
088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|7738|12149|lyfalmen|||1|28|0|42,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||7738||7738|12149||1|0||0|||0
088677|N07BC0102|Buvidal|stl|24|mg|0,48|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13183|19643|lyfsjukr|||1|0,48|0|11,4286|Vistor hf|Camurus AB|Búprenorfín||13183||13183|19643||1|H|L|1|30|dagar|0
088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|G|0|LEP|0|0|0|100|DKK|4462|7639|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4462||4462|7639||1|0|G|0|||0
088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|G|0|LEP|0|0|0|100|DKK|7710|12110|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7710||7710|12110||1|0|G|0|||0
088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|G|0|LEP|0|0|0|100|DKK|12646|18904|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12646||12646|18904||1|0|G|0|||0
088817|A10BD2301|Segluromet|filmhtfl|1002,5|mg|56|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|5781|9455|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||5781||5781|9455||1|0|G|0|||0
088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|413971|521375|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||413971||413971|521375||1|H|L|0|||0
088961|N02AA0507|OxyContin Depot|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|20752|29521|lyfalmen|V0588|27665|1|98|0|104,5300|Icepharma hf|Mundipharma A/S|Oxýcódon||20752||20752|29521||2|0|G|1|30|dagar|0
088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|PLS|0|0|0|100|DKK|1392|3056|lyfalm11|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||||1392|3056||1|0||0|||1
089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|MPS|0|0|0|100|DKK|22034|31142|lyfalmen|||1|10|0||Vistor hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||22034||22034|31142||1|0|0|0|||0
089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|0|1|0|0|NEL|0|1|0|100|DKK|129111|167089|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||129111||129111|167089||1|0|L|0|||0
089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||6222||1|0||0|||0
089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|1|0|0|PLS|0|1|0|100|DKK|18386|26804|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||18386||18386|26804||1|0|L|0|||0
089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|1|0|0|PLS|0|1|0|100|DKK|39990|53853|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||39990||39990|53853||1|0|L|0|||0
089692|C07AB0214|Bloxazoc|forðatfl|50|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|1419|3287|lyfalmen|V0048|3006|2|100|0|33,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1300||1300|3287||2|0|G|0|||0
089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|G|0|PAC|0|0|1|100|DKK|22389|31591|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||22389||22389|31591||1|0|G|0|||0
089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|G|0|PAC|0|0|1|100|DKK|89558|116547|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||89558||89558|116547||1|0|G|0|||0
090153|N05AH0414|Quetiapin Hexal|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2017|31.07.2021|R|1|1|0|G|0|SSA|0|0|0|100|DKK|15006|17485|lyfalmen|||2|100|0|100,0000|Artasan ehf|Hexal A/S|Quetíapín||11615||11615|17485||1|0|G|0|||0
090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|2329|4704|lyfalmen|||1|20|0|5,0000|Icepharma hf|STADA Nordic ApS.|Cefalexín||2329||2329|4704||2|0|E|0|||0
090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|4660|7912|lyfalmen|||1|40|0|10,0000|Icepharma hf|STADA Nordic ApS.|Cefalexín||4660||4660|7912||2|0|E|0|||0
090257|R03AK0606|Salmeterol/Fluticasone Neutec|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2021||R|0|0|0|G|0|NET|0|0|0|100|DKK|3364|4537|lyfalmen|||2|60|0|30,0000|Lyfjaver ehf|Neutec Inhaler Ireland Limited|Salmeteról og fluticason||2208||2208|4537||3|0|G|0|||0
090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|STA|0|0|1|100|DKK|705|2468|lyfalmen|||1|100|0|2,5000|Icepharma hf|STADA Nordic ApS.|Cefalexín||705||705|2468||2|0|E|0|||0
090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|4164|7229|lyfalmen|||1|10|0|3,3333|Icepharma hf|STADA Nordic ApS.|Cefazólín||4164||4164|7229||2|0|0|0|||0
090607|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|G|0|SNP|0|0|1|100|XEU|1781|3949|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1781||1781|3949||1|0|G|0|||0
090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|769|2556|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai GmbH|Rúfínamíð||769||769|2556||1|0|G|0|||0
090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|0|0|AAS|0|0|0|100|XEU|19740|28668|lyfalmen|||1|60|0||Alcon Danmark A/S|Alcon Nordic A/S|Flúorescein||19740||19740|28668||1|H|0|0|||0
091015|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|28|stk|1|þpakki|hart|N06AX16|01.02.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1084|2990|lyfalmen|V0333|2990|2|28|0|10,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1084||1084|2990||2|0|E|0|||0
091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|PLS|0|0|0|100|DKK|2460|4884|lyfalmen|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2460||2460|4884||1|H|0|0|||0
091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|PLS|0|0|0|100|DKK|4257|7357|lyfalmen|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4257||4257|7357||1|H|0|0|||0
091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|PLS|0|0|0|100|DKK|12495|18696|lyfalmen|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||12495||12495|18696||1|H|0|0|||0
091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.03.2011||R|1|1|0|0|0|HES|0|0|0|100|DKK|3342|5907|lyfalmen|V0958|5736|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3203||3203|5907||1|0|E|1|30|dagar|0
091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|G|0|BII|0|0|0|100|DKK|5864|9569|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||5864||5864|9569||1|0|G|0|||0
091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|sk-ílá|lausn|S01BA01|01.05.2011||R|0|0|0|G|0|TAE|0|0|1|100|SEK|3479|6286|lyfalmen|||1|30|0||Alvogen|Trimb Healthcare AB|Dexametasón||3479||3479|6286||2|0|G|0|||0
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|974|1996|lyfalmen|V0021|1996|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||362||362|1996||1|0|G|0|||0
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1683|2292|lyfalmen|V0022|2292|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||577||577|2292||1|0|G|0|||0
091804|L01EM0301|Piqray|filmhtfl|150|mg|28|stk|1|þpakki||L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|244306|310359|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Limited|Alpelisib||244306||244306|310359||1|0|L|0|||0
091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1094|3004|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||1094||1094|3004||1|0|G|0|||0
092097|QD11AH9001|Apoquel|töflur|16|mg|20|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|8617|16519|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||8617||8617|16519||2|0||0|||0
092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2|0||0|||0
092188|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2017||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyfalmen|V0004|2839|2|28|0|18,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||2839||2|0|E|0|||0
092199|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2060|4251|lyfalmen|V0011|2703|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E|0|||0
092210|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|G|0|KRK|0|0|1|100|IKR|3453|4939|lyfalmen|V0011|4730|2|98|0|65,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2500||2500|4939||2|0|G|0|||0
092234|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1510|2874|lyfalmen|V0005|2874|2|28|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||1000||1000|2874||2|0|E|0|||0
092245|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2400|4251|lyfalmen|V0012|3228|2|56|0|74,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E|0|||0
092256|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|G|0|KRK|0|0|1|100|IKR|4794|5765|lyfalmen|V0012|5650|2|98|0|130,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||3100||3100|5765||2|0|G|0|||0
092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
092620|H01AC0113|Norditropin FlexPro|stl|5|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|29935|41135|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||29935||29935|41135||1|0|L|0|||0
092631|H01AC0113|Norditropin FlexPro|stl|10|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|60088|79273|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||60088||60088|79273||1|0|L|0|||0
092644|H01AC0113|Norditropin FlexPro|stl|15|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|90134|117275|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||90134||90134|117275||1|0|L|0|||0
092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2134|4435|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2134||2134|4435||1|0|G|0|||0
092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|G|0|WEH|0|0|0|100|IKR|1863|4026|lyfalmen|V0203|4026|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1837||1837|4026||2|0|G|0|||0
093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|1077|2980|lyfalmen|||1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxýcódon||1077||1077|2980||2|0|E|1|30|dagar|0
093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|2149|4456|lyfalmen|||1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||2149||2149|4456||2|0|E|1|30|dagar|0
093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|4179|7250|lyfalmen|||1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||4179||4179|7250||2|0|E|1|30|dagar|0
093072|L01EX0301|Votrient|filmhtfl|200|mg|90|stk|1|glas||L01EX03|01.01.2017||R|1|0|1|0|0|NEL|0|1|0|100|DKK|317393|401259|lyfsjukr|||1|90|0||Vistor hf|Novartis Europharm Ltd|Pazopanib||317393||317393|401259||1|0|L|0|||0
093083|L01EX0301|Votrient|filmhtfl|400|mg|60|stk|1|glas||L01EX03|01.01.2017||R|1|0|1|0|0|NEL|0|1|0|100|DKK|423390|533090|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Pazopanib||423390||423390|533090||1|0|L|0|||0
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4626|7865|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||4626||4626|7865||1|0|G|0|||0
093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|5121|8546|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5121||5121|8546||1|0|G|0|||0
093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|0|1|0|0|ERZ|0|0|0|100|XEU|23118|30391|lyfalmen|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||21440||21440|30391||2|0|0|0|||0
093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|G|0|HES|0|0|0|100|DKK|1814|3995|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1814||1814|3995||1|0|G|0|||0
093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|G|0|TIL|0|0|0|100|DKK|5148|8584|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5148||5148|8584||2|0|G|0|||0
093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|G|0|TIL|0|0|0|100|DKK|3812|6745|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3812||3812|6745||2|0|G|0|||0
093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2295|4657|lyfalmen|||1|50|0||Icepharma hf|Aspen Pharma|Lídókaín||2295||2295|4657||2|0||0|||0
093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|G|0|ABC|0|0|0|100|SEK|31937|43668|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||31937||31937|43668||2|0|G|0|||0
093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|0|1|0|0|JCI|0|1|0|100|SEK|393457|495862|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||393457||393457|495862||1|0|L|0|||0
093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|0|1|0|0|JCI|0|1|0|100|SEK|393457|495862|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||393457||393457|495862||1|0|L|0|||0
094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|G|0|AAC|0|0|0|100|DKK|5193|8646|lyfalmen|||1|9|0|9,0000|Icepharma hf|Almirall S.A.|Almótriptan||5193||5193|8646||2|0|G|0|||0
094132|QM01AC0604|Metacam handa köttum og naggrísum|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|BOI|0|0|0|100|DKK|1673|3288|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|Meloxícam||1673||1673|3288||1|0||0|||0
094146|L04AA2901|Xeljanz|forðatfl|11|mg|28|stk|1|þpakki||L04AA29|01.06.2020||R|0|1|1|0|0|PEU|0|1|0|100|DKK|114058|148367|lyfsjukr|||1|28|0|30,8000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||114058||114058|148367||1|0|L|0|||0
094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1718|3863|lyfalmen|||2|25|0|1,2500|Alvogen|ratiopharm GmbH|Acíklóvír||1718||1718|3863||2|0|G|0|||0
094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|G|0|BLS|0|0|0|100|IKR|1955|4189|lyfalmen|V0324|3761|2|98|0|49,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Escítalópram||1955||1955|4189||1|0|0|0|||0
094757|N04BC0408|Ropinirole Alvogen|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|XEU|12508|17343|lyfalmen|V0534|17343|2|84|0|112,0000|Alvogen|Alvogen|Rópíníról||11512||11512|17343||2|0|G|0|||0
094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|1|0|0|VIC|0|1|0|100|DKK|71340|93504|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín, lamívúdín og abacavír||71340||71340|93504||1|0|L|0|||0
094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|HAL|0|0|1|100|DKK|42823|57436|lyfalmen|||1|1|0||Vistor hf|Grunenthal GmbH|Capsaicin||||42823|57436||1|0|E|0|||0
094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|6057|10440|vetbolu|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6057||6057|10440||2|0||0|||0
094843|D02AX0001|Oviderm|krem|250|mg/g|100|g|1|túpa||D02AX|01.03.2018||L|0|0|0|0|0|GAB|0|0|0|100|IKR|||lyflausa|||0|100|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||||1|0||0|||0
094971|R06AX2709|Desloratadine Alvogen|munndr.t|5|mg|100|stk|1|þpakki||R06AX27|01.05.2021||L|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|100|0|100,0000|Alvogen|Alvogen|Deslóratadín|||||||2|0||0|||0
095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|0|0|TAG|0|0|0|100|DKK|40559|54573|lyfalmen|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||40559||40559|54573||1|H|0|0|||0
095314|N04BA0211|Duodopa|hlaup|||100|ml|7|askja||N04BA02|01.10.2018||R|0|1|0|0|0|AIS|0|1|0|100|DKK|95280|123784|lyfsjukr|||1|700|0||Vistor hf|AbbVie A/S|Levódópa og dópadekarboxýl­asa­hemill||95280||95280|123784||1|0|L|0|||0
095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|G|0|ATE|0|0|0|100|DKK|8211|12800|lyfalmen|||1|50|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dísúlfíram||8211||8211|12800||1|0|G|0|||0
095621|L04AX0306|Metojectpen|stl|20|mg|0,4|ml|6|áfpen||L04AX03|01.11.2019||R|0|0|0|G|0|WIL|0|0|0|100|XEU|14404|21324|lyfalmen|||1|2,4|0|48,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||14404||14404|21324||2|0|G|0|||0
095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|14824|21902|lyfalmen|V0963|14969|1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||14824||14824|21902||1|0|E|0|||0
095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|15046|22207|lyfalmen|V0964|16808|1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15046||15046|22207||1|0|E|0|||0
095682|N06BA0408|Methylphenidate Teva|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|4923|4558|lyfalmen|V0959|4558|2|30|0|20,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||2223||2223|4558||1|0|E|1|30|dagar|0
095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|G|0|JCI|0|0|0|100|SEK|17516|25607|lyfalmen|V0965|15375|1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17516||17516|25607||1|0|G|0|||0
095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|GOV|0|0|0|100|XEU|1810|3989|lyfalmen|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1810|3989||2|H|0|0|||0
095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|GOV|0|0|0|100|XEU|3147|5829|lyfalmen|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||3147|5829||2|H|0|0|||0
095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|G|0|TAB|0|0|0|100|IKR|3740|5352|lyfalmen|V0701|5352|2|40|0|13,3400|Alvogen|Teva Pharma B.V.|Búdesóníð||2800||2800|5352||2|0|G|0|||0
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|IKR|4999|9655|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||4999||4999|9655||2|0|0|0|||0
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|XEU|6242|10776|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||5590||5590|10776||2|0|0|0|||0
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|IKR|11467|21926|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||11467||11467|21926||2|0|0|0|||0
096201|L01XC3201|Tecentriq|irþ|1200|mg|20|ml|1|hgl|lausn|L01XC32|01.01.2018||R|0|1|0|0|0|RRG|0|1|0|100|DKK|687784|861922|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||687784||687784|861922||2|H|L|0|||0
096223|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|830|2599|lyfalmen|V0685|2141|2|56|0|4,6667|Acare ehf|Medical Valley Invest AB|Pregabalín||800||800|2599||2|0|E|0|||0
096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008|30.06.2021|R|0|1|0|G|0|NEL|0|0|0|100|DKK|9019|13912|lyfalmen|||1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||9019||9019|13912||1|0|G|0|||0
096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|655204|821402|lyfsjukr|||1|21|0|10,5000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||655204||655204|821402||2|0|L|0|||0
096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|601398|754482|lyfsjukr|||1|21|0|21,0000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||601398||601398|754482||2|0|L|0|||0
096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|633039|793835|lyfsjukr|||1|21|0|31,5000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||633039||633039|793835||2|0|L|0|||0
096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|696322|872541|lyfsjukr|||1|21|0|52,5000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||696322||696322|872541||2|0|L|0|||0
096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008|30.06.2021|R|0|1|0|G|0|NEL|0|0|0|100|DKK|8443|13119|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||8443||8443|13119||1|0|G|0|||0
096703|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.02.2019||R|0|0|0|0|0|ATE|0|0|0|100|GBP|9519|14600|lyfalmen|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Epírúbicín||||9519|14600||1|H|0|0|||0
097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|ELC|0|0|0|100|DKK|68793|118572|vetorma|||1|1000|0||Elanco Denmark ApS|Elanco GmbH|Óvirkar bakteríur í bóluefnum||68793||68793|118572||2|0||0|||0
097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|VMD|1|0|0|100|XEU|7568|14529|vetalmen|||0|10|0||Icepharma hf|V.M.D. n.v.|Bútorfanóltartrat||||7568|14529||2|0||2|||0
097152|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|10404|15818|lyfalmen|V0334|2528|1|98|0|73,5000|Icepharma hf|Upjohn EESV|Venlafaxín||10404||10404|15818||1|0|E|0|||0
097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|19355|28138|lyfalmen|V0335|2528|1|98|0|147,0000|Icepharma hf|Upjohn EESV|Venlafaxín||||19355|28138||1|0|E|0|||0
097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|32722|44660|lyfalmen|||1|1|0|14,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||32722||32722|44660||1|0|E|0|||0
097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|5799|11172|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5799||5799|11172||2|0||0|||0
097847|G03AC0803|Nexplanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.12.2016||R|0|0|0|0|0|DSM|0|0|0|100|DKK|16582|21772|lyfalm11|||1|1|0|1000,0000|Vistor hf|Merck Sharp & Dohme|Etónógestrel||16582||16582|21772||1|0||0|||1
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2417|2527|lyfalmen|V0023|2527|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||748||748|2527||1|0|G|0|||0
097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|VIN|0|0|1|100|DKK|2883|5466|lyfalmen|||2|2000|0|5,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2883|5466|30.6.2021|2|0|0|0|||0
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1501|3564|lyfalmen|||2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1501||1501|3564||1|0|E|0|||0
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|G|0|ATE|0|0|0|100|IKR|2976|3563|lyfalmen|V0678|3563|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan||1500||1500|3563||1|0|G|0|||0
098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|G|0|BIG|0|0|1|100|SEK|556|2263|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||556||556|2263||2|0|G|0|||0
098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|G|0|BIG|0|0|1|100|SEK|556|2263|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||556||556|2263||2|0|G|0|||0
098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2|0||0|||0
098363|L04AA4201|Mayzent|filmhtfl|0,25|mg|120|stk|1|þpakki||L04AA42|01.11.2020||R|1|1|1|0|0|NEP|0|1|0|100|DKK|239621|304533|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Limited|Siponimod||239621||239621|304533||1|0|L|0|||0
098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|906|2463|lyfalmen|V0243|2463|2|50|0|4,1600|Alvogen|ratiopharm GmbH|Lamótrigín||701||701|2463||2|0|G|0|||0
098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|1571|2910|lyfalmen|V0244|2698|2|50|0|8,3300|Alvogen|ratiopharm GmbH|Lamótrigín||1026||1026|2910||2|0|G|0|||0
098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|4185|4723|lyfalmen|V0245|4723|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Lamótrigín||2343||2343|4723||2|0|G|0|||0
098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|7289|9829|lyfalmen|V0232|9829|2|100|0|66,6600|Alvogen|ratiopharm GmbH|Lamótrigín||6053||6053|9829||2|0|G|0|||0
098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|2525|4771|lyfalmen|V0381|4526|2|10|0|2,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||2378||2378|4771||1|0|G|0|||0
099100|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2991|2530|lyfalmen|V0107|2530|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||750||750|2530||2|0||0|||0
099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|0|AZA|0|0|0|100|SEK|80558|105163|lyfalmen|||1|10|0|60,2400|Vistor hf|AstraZeneca AB|Fulvestrant||80558||80558|105163||1|0|0|0|||0
099327|B02BB0102|Fibryga|sts/irs|1|g|1|g|1|glas|leysir,lausn|B02BB01|01.04.2021||R|0|0|0|0|0|OCT|0|1|0|100|DKK|65952|86690|lyfsjukr|||1|1|0|0,2000|Vistor hf|Octapharma AB|Manna Fíbrínógen||65952||65952|86690||1|H|L|0|||0
099436|L01EM0301|Piqray|filmhtfl|||56|stk|1|þpakki|28x50 mg + 28x200 mg|L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|488714|614335|lyfsjukr|||1|56|0|23,3333|Vistor hf|Novartis Europharm Limited|Alpelisib||488714||488714|614335||1|0|L|0|||0
099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2306|2329|lyfalmen|V0284|2329|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||604||604|2329||2|0|G|0|||0
099482|N05AH0414|Quetiapin Hexal|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2017|31.07.2021|R|1|1|0|G|0|SSA|0|0|0|100|DKK|10529|12908|lyfalmen|||2|100|0|75,0000|Artasan ehf|Hexal A/S|Quetíapín||8290||8290|12908||1|0|G|0|||0
099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4309|4176|lyfalmen|V0285|3278|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||1946||1946|4176||2|0|G|0|||0
099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|7712|7160|lyfalmen|V0286|5627|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||4114||4114|7160||2|0|G|0|||0
099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|2733|3823|lyfalmen|V0685|3823|2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||1689||1689|3823||1|0|E|0|||0
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1559|3644|lyfalmen|V0247|3644|2|60|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||1559||1559|3644||1|0|G|0|||0
099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2581|5050|lyfalmen|V0248|5050|2|60|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||2581||2581|5050||1|0|G|0|||0
099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5374|4274|lyfalmen|V0249|4274|2|60|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||2017||2017|4274||1|0|G|0|||0
099863|L01EX0101|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01EX01|01.12.2012||R|1|0|1|0|0|PEU|0|1|0|100|DKK|158185|203249|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitinib||158185||158185|203249||1|0|L|0|||0
099872|L01EX0101|Sutent|hylki|25|mg|28|stk|1|þpakki||L01EX01|01.03.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|315665|399110|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitinib||315665||315665|399110||1|0|L|0|||0
099881|L01EX0101|Sutent|hylki|50|mg|28|stk|1|þpakki||L01EX01|01.03.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|631308|791682|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitinib||631308||631308|791682||1|0|L|0|||0
099959|L01BA0403|Pemetrexed Accord|irþ|500|mg|500|mg|1|hgl|stofn f. innr.þykkni lausn|L01BA04|01.04.2018||R|0|0|0|0|0|CLU|0|1|0|100|XEU|138771|179104|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare S.L.U.|Pemetrexed||138771||138771|179104||1|H|L|0|||0
100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|NED|0|0|0|100|XEU|10851|16433|lyfalmen|V0925|14162|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||10851|16433||2|0|E|0|||0
100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2102|3763|lyfalmen|V0823|3700|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1646||1646|3763||1|0|G|0|||0
100441|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|322|1842|lyfalmen|V0563|1826|2|30|0|15,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||250||250|1842||2|0|G|0|||0
100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1000|2874|lyfalmen|V0685|2141|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1000||1000|2874||2|0|E|0|||0
100830|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|15|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|ASR|0|0|1|100|IKR|700|2186|lyfalmen|V0821|2186|2|15|0|2,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||500||500|2186||2|0|E|0|||0
100843|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|22,5|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|ASR|0|0|1|100|IKR|1000|2874|lyfalmen|V0822|2874|2|22,5|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||1000||1000|2874||2|0|E|0|||0
100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|ATE|0|0|1|100|XEU|3476|6282|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lymecycline||3476||3476|6282||1|0|E|0|||0
101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|9374|13106|lyfalmen|V0254|11588|1|100|0|33,3300|Icepharma hf|Upjohn EESV|Gabapentín||8434||8434|13106||1|0|G|0|||0
101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|13381|19916|lyfalmen|V0256|18988|1|100|0|44,4400|Icepharma hf|Upjohn EESV|Gabapentín||13381||13381|19916||1|0|G|0|||0
101148|QI10AB0301|Alpha Ject  5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|PHA|0|0|0|100|NOK|55973|82992|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||51484||51484|82992||1|0||0|||0
101367|QM01AE9104|Canicaral vet|töflur|40|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|5189|10015|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5189||5189|10015||2|0||0|||0
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1794|3967|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||||1794|3967||1|0||0|||0
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|G|0|ATE|0|0|0|100|XEU|3094|5757|lyfalmen|||2|96|0|96,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||||3094|5757||1|0|G|0|||0
101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|BOI|0|0|0|100|DKK|12117|23159|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|Meloxícam||12117||12117|23159||1|0||0|||0
101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|5777|9449|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||5777||5777|9449||2|0|E|0|||0
101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|17137|25085|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||17137||17137|25085||2|0|E|0|||0
102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1005|2881|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1005||1005|2881||1|0|G|0|||0
102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1515|3583|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1515||1515|3583||1|0|G|0|||0
102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|BAM|0|0|0|100|SEK|5453|9003|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5453||5453|9003||2|H|0|0|||0
102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|ATE|0|0|1|100|XEU|391|2036|lyfalmen|V0230|2029|2|100|0|16,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól||391||391|2036||1|0|E|0|||0
102249|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|2|glas|2 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|400|0|13,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|0|0|G|0|WEH|0|0|0|100|XEU|7854|3393|lyfalmen|V0684|3393|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1377||1377|3393||2|0|G|0|||0
102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|G|0|TOG|0|0|0|100|SEK|3016|5649|lyfalmen|||1|98|0|147,0000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||3016||3016|5649|31.8.2021|1|0|G|0|||0
102952|G04BD0805|Solifenacin Alvogen|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|14924|13574|lyfalmen|V0441|11254|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||8774||8774|13574||2|0|G|0|||0
103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|WEH|0|0|1|100|IKR|321|1940|lyfalmen|||2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||321||321|1940|30.6.2021|2|0||2|30|töflur|0
103114|L04AX0306|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2467|4893|lyfalmen|||1|1|0|3,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2467||2467|4893||2|0|G|0|||0
103197|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.01.2017||R|1|0|1|0|0|PMA|0|0|0|100|DKK|7002|9229|lyfalmen|V0657|8655|1|30|0|10,0000|Actavis hf|Teva Pharma B.V.|Modafinil||5617||5617|9229||1|0|E|2|||0
103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|1|0|0|TBB|0|1|0|100|NOK|90654|117933|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Teva B.V.|Lipegfilgrastim||90654||90654|117933||1|0|L|0|||0
103444|L04AB0404|IDACIO|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.08.2020||R|0|1|1|0|0|FKA|0|1|0|100|DKK|33888|46135|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||33888||33888|46135||1|0|L|0|||0
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2030|3161|lyfalmen|V0088|3108|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|3161||2|0|G|0|||0
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2590|3747|lyfalmen|V0089|3631|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3747||2|0|G|0|||0
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|1845|3934|lyfalmen|V0069|2884|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3934||2|0|G|0|||0
103678|N06AX1615|Venlafaxine Alvogen|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|G|0|POF|0|0|0|100|IKR|5678|2874|lyfalmen|V0334|2579|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G|0|||0
103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|280036|354798|lyfalmen|||1|40|0||Icepharma hf|Baxter Medical AB|Blöndur||280036||280036|354798||2|H|0|0|||0
103854|L01EK0101|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01EK01|01.05.2013||R|1|0|1|0|0|PEU|0|1|0|100|DKK|99168|128701|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||99168||99168|128701||1|0|L|0|||0
103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|DEC|0|0|0|100|DKK|3725|7238|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||3725||3725|7238||1|0||0|||0
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||2375||1|0|E|0|||0
104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|GEH|0|0|0|100|NOK|8113|12665|lyfalmen|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||8113||8113|12665||2|H|0|0|||0
104401|N06AB0607|Sertralin Krka|filmhtfl|50|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5696|7004|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Sertralín||4000||4000|7004||2|0|G|0|||0
104482|L01CA0403|Vinorelbine Alvogen|hylki|30|mg|1|stk|1|þpakki|mjúkt|L01CA04|01.10.2019||R|0|0|1|G|0|ALE|0|0|0|100|SEK|11251|15322|lyfalmen|V0992|15322|2|1|0||Alvogen|Alvogen Pharma Trading Europe EOOD|Vínorelbín||10044||10044|15322||2|0|G|0|||0
104503|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|9953|15197|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||9953||9953|15197||1|0|E|0|||0
104688|N05AH0415|Quetiapin Krka|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|4500|4801|lyfalmen|V0275|4788|2|100|0|12,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||2400||2400|4801||2|0|G|0|||0
104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|G|0|FER|0|0|0|100|DKK|6717|10743|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6717||6717|10743||1|0|G|0|||0
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|G|0|FER|0|0|0|100|DKK|3507|6325|lyfalmen|V0017|5597|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3507||3507|6325||1|0|G|0|||0
104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|G|0|FER|0|0|0|100|DKK|5605|9213|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5605||5605|9213||1|0|G|0|||0
104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|4264|7367|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||4264||4264|7367||2|0|G|0|||0
104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|96543|125381|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||96543|125381||1|0|L|0|||0
105331|N02AE0105|Buprenorphine Alvogen|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|DKK|3136|5814|lyfalmen|V0944|5814|2|4|0|5,6000|Alvogen|Alvogen|Búprenorfín||3136||3136|5814||2|0|G|1|30|dagar|0
105363|C03DA0403|Eplerenon  Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|BLS|0|0|0|100|XEU|3134|3143|lyfalmen|V0107|2530|2|30|0|15,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Eplerenón||1195||1195|3143||1|0|E|0|||0
105621|N02BE0127|Dolorin Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.04.2021||L|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
105669|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|1969|4208|lyfalmen|||1|20|0|16,0000|Icepharma hf|Abcur AB|Metadón||1969||1969|4208||2|0|G|1|30|dagar|0
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2796|5346|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||2796||2796|5346||2|0||0|||0
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3354|6114|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||3354||3354|6114||2|0||0|||0
105827|L01XK0401|Talzenna|hylki|1|mg|30|stk|1|glas||L01XK04|01.09.2021||R|0|0|1|0|0|PEU|0|1|0|100|DKK|632027|792576|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Europe MA EEIG|Talazoparib||632027||632027|792576||2|0|L|0|||0
106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|RRG|0|0|0|100|DKK|1840|4030|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1840||1840|4030||2|0||0|||0
106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|RRG|0|0|0|100|DKK|2999|4032|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1841||1841|4032||2|0||0|||0
106390|L01EJ0101|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01EJ01|01.03.2016||R|1|0|1|0|0|NEL|0|1|0|100|DKK|428330|539234|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||428330||428330|539234||1|0|L|0|||0
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|GPH|0|0|0|100|DKK|16488|24192|lyfalmen|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||16488||16488|24192||1|H|0|0|||0
106602|J01MA0207|Ciprofloxacin Navamedic|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.05.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|6417|10330|lyfalmen|||2|1000|0|2,5000|Icepharma hf|Navamedic ASA|Cíprófloxacín||6417||6417|10330||2|0|0|0|||0
106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|WEH|0|0|0|100|XEU|3391|2551|lyfalmen|V0107|2530|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||765||765|2551||2|0|E|0|||0
107002|R07AA0201|Curosurf|innönddr|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|CHI|0|0|0|100|XEU|117534|152691|lyfalmen|||1|3|0|1,5000|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||117534||117534|152691||1|H|0|0|||0
107194|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|75 mg/15 mg|QP54AB51|01.04.2018|31.08.2021|R|0|0|0|0|0|BIV|0|0|0|100|XEU|3003|5176|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3003||3003|5176||1|0||0|||0
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1473|3525|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1473||1473|3525||1|0|G|0|||0
107322|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.02.2021||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5896|8787|lyfalmen|V0737|8787|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5296||5296|8787||2|0|E|0|||0
107464|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|4360|4609|lyfalmen|V0438|4609|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||2260||2260|4609||2|0|G|0|||0
107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|PBV|0|0|0|100|XEU|18780|25819|lyfalmen|||1|250|0||Williams & Halls efh|Piramal Critical Care B.V.|Sevóflúran||17670||17670|25819||2|H|0|0|||0
107643|N06BA0902|Atomoxetin Actavis|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|12030|3257|lyfalmen|V0814|3197|2|28|0|8,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1278||1278|3257||1|0|E|0|||0
107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5625|3934|lyfalmen|V0683|3393|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0
107785|L01EF0201|Kisqali|filmhtfl|200|mg|42|stk|1|þpakki||L01EF02|01.11.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|280800|355748|lyfsjukr|||1|42|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||280800||280800|355748||1|0|L|0|||0
107918|N06BA0409|Methylphenidate STADA|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|4000|6040|lyfalmen|||2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||3300||3300|6040|30.6.2021|2|0|E|1|30|dagar|0
107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|0|0|0|VEB|1|0|0|100|IKR|7285|13992|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||7285|13992||2|0||1|30|dagar|0
108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2|0||1|30|dagar|0
108413|C10AX1401|Praluent|stl|75|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|68630|90077|lyfalmen|||1|2|0|27,7778|Vistor hf|Sanofi-aventis groupe|Alirocumab||68630||68630|90077||1|0|E|0|||0
108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|G|0|NEL|0|0|0|100|DKK|8691|13460|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||8691||8691|13460||1|0|G|0|||0
108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|1|0|0|OUS|0|0|0|100|XEU|78844|102995|lyfalmen|||1|180|0|30,0000|Recordati AB|Orphan Europe SARL|Betain anhydrous||78844||78844|102995||3|0|E|0|||0
109338|M01AH0502|Coxient|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2186|2|7|0|14,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||500||500|2186||2|0|G|0|||0
109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|5390|7679|lyfalmen|V0585|7653|2|98|0|26,1300|Alvogen|ratiopharm GmbH|Oxýcódon||4491||4491|7679||2|0|G|1|30|dagar|0
109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|XEU|3869|6823|lyfalmen|||2|28|0|14,9300|Alvogen|ratiopharm GmbH|Oxýcódon||3869||3869|6823||2|0|G|1|30|dagar|0
109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|9846|13596|lyfalmen|V0587|13596|2|98|0|52,2700|Alvogen|ratiopharm GmbH|Oxýcódon||8790||8790|13596||2|0|G|1|30|dagar|0
109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|XEU|18909|25153|lyfalmen|||2|98|0|104,5300|Alvogen|ratiopharm GmbH|Oxýcódon||17186||17186|25153||2|0|G|1|30|dagar|0
110001|N03AX1602|Lyrica (Lyfjaver)|hylki|75|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|8797|13606|lyfalmen|V0686|3455|3|100|0|25,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||8797||8797|13606||3|0|E|0|||0
110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0||0|||0
110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|G|0|LTH|0|0|0|100|SEK|1754|3912|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1754||1754|3912||1|0|G|0|||0
110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2461|lyfalmen|V0291|2273|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||700||700|2461||2|0|G|0|||0
110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2608|3494|lyfalmen|V0292|3494|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1450||1450|3494||2|0|G|0|||0
110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4870|8201|lyfalmen|||2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4870||4870|8201||2|0|G|0|||0
110341|A10BJ0601|Ozempic|stl|0,25|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|18409|26836|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||18409||18409|26836||1|0|E|0|||0
110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5000|8380|lyfalmen|||2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||5000||5000|8380||2|0|G|0|||0
110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|MBV|0|0|0|100|DKK|1442|3118|lyfalm11|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1442||1442|3118||1|0||0|||1
110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|G|0|COR|0|0|0|100|DKK|5213|8673|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||5213||5213|8673||1|0|G|0|||0
110750|J05AJ0101|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AJ01|01.04.2012||R|1|0|1|0|0|MBV|0|1|0|100|DKK|86362|112504|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Raltegravír||86362||86362|112504||1|0|L|0|||0
110958|L01AX0304|Temozolomide Accord|hylki|100|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|1|0|0|CLU|0|1|0|100|XEU|8173|12747|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||8173||8173|12747||1|0|L|0|||0
111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|1|0|0|0|GED|0|0|0|100|XEU|13633|16958|lyfalm11|||2|1|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Plast lyfjalykkja (IUD) með prógestógen||12675||12675|16958||1|0|E|0|||1
111479|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|G|0|POF|0|0|0|100|XEU|4506|4834|lyfalmen|V0373|4834|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2424||2424|4834||2|0|G|0|||0
111775|G03AA1209|Asubtela|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.11.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|2492|4411|lyfalm11|V0993|4411|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Dróspírenón og ethinylestradíól||2492||2492|4411||2|0||0|||1
111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|GCA|0|0|1|100|DKK|657|2402|lyfalmen|||1|100|0|33,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||657||657|2402||1|0|E|0|||0
112073|V03AB3301|Cyanokit|irs|5|g|1|hgl|1|pakki|lausn|V03AB33|01.05.2019||R|0|0|0|0|0|SEB|0|0|0|100|XEU|127253|164778|lyfalmen|||2|1|0||Swedish Orphan Biovitrum A/S|SERB S.A.|Hydroxocobalamin||127253||127253|164778||3|H|0|0|||0
112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|184638|236149|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer AG|Riociguatum||184638||184638|236149||1|0|L|0|||0
112345|J01FF0104|Clindamycin EQL Pharma|hylki|150|mg|32|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|1500|3563|lyfalmen|||2|32|0|4,0000|LYFIS ehf|EQL Pharma AB|Klindamýcín||1500||1500|3563||2|0|E|0|||0
112704|N05AH0415|Quetiapin Krka|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|1800|2599|lyfalmen|V0284|2329|2|100|0|6,2500|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||800||800|2599||2|0|G|0|||0
112713|N05AH0415|Quetiapin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3800|3287|lyfalmen|V0285|3278|2|100|0|25,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||1300||1300|3287||2|0|G|0|||0
112732|N05AH0415|Quetiapin Krka|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|5000|5627|lyfalmen|V0286|5627|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||3000||3000|5627||2|0|G|0|||0
112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|RTH|0|0|1|100|IKR|1627|3737|lyfalmen|||2|100|0|3,3333|Alvogen|ratiopharm GmbH|Amoxicillín||1627||1627|3737||2|0|E|0|||0
113088|M05BA0802|Aclasta|irl|5|mg|100|ml|1|glas|lausn|M05BA08|01.04.2019||R|0|1|0|0|0|NEL|0|0|0|100|DKK|50783|67504|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||50783||50783|67504||1|0|E|0|||0
113179|S01LA0601|Beovu|stl|120|mg/ml|0,165|ml|1|áfspr|lausn|S01LA06|01.06.2020||R|0|1|0|0|0|NEP|0|1|0|100|DKK|111558|145258|lyfsjukr|||1|0,165|0||Vistor hf|Novartis Europharm Limited|Brolucizumab||111558||111558|145258||1|H|L|0|||0
113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014|31.07.2021|L|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyfalmen|||2|5|0||Alvogen|ratiopharm Oy|Amorolfín|||||5077||2|0|E|0|||0
113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|1|0|0|G|0|NEL|0|0|0|100|DKK|6468|10400|lyfalmen|V0024|10400|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6468||6468|10400||1|0|G|0|||0
113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|1|0|0|G|0|NEL|0|0|0|100|DKK|5670|9302|lyfalmen|V0025|9302|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||5670||5670|9302||1|0|G|0|||0
113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|2816|5374|lyfalmen|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||2816||2816|5374||2|H|0|0|||0
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|G|0|SNP|0|0|1|100|XEU|3344|6101|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3344||3344|6101||1|0|G|0|||0
113566|C07AB0215|Metoprolol Alvogen|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.01.2021||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1257|3006|lyfalmen|V0048|3006|2|100|0|31,6667|Alvogen|Alvogen ehf|Metóprólól||1096||1096|3006||2|0|G|0|||0
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|G|0|SNP|0|0|1|100|XEU|4652|7901|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4652||4652|7901||1|0|G|0|||0
113818|L01EA0301|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01EA03|01.06.2008||R|0|1|1|0|0|NEL|0|1|0|100|DKK|478175|601227|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotinib||478175||478175|601227||1|0|L|0|||0
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|568|2280|lyfalmen|||1|20|0|10,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||568||568|2280||2|0|E|0|||0
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|826|2635|lyfalmen|||1|30|0|15,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||826||826|2635||2|0|E|0|||0
114063|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|5000|8380|lyfalmen|V0145|3584|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||5000||5000|8380||2|0|E|0|||0
114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1|0||0|||0
114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|1|0|0|WIL|0|1|0|100|XEU|33056|45083|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||33056|45083||2|0|L|0|||0
114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3561|6399|lyfalmen|V0824|3968|1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3561||3561|6399||1|0|G|0|||0
114505|C07AB0215|Metoprolol Alvogen|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|4390|4939|lyfalmen|V0054|4939|2|100|0|126,6667|Alvogen|Alvogen|Metóprólól||2500||2500|4939||2|0|G|0|||0
114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|G|0|AEP|0|0|0|100|IKR|6061|9840|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Chlorambucíl||6061||6061|9840||2|0|G|0|||0
114605|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|DKK|8340|11902|lyfalmen|V0973|11902|2|100|0|60,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||7559||7559|11902||2|0|G|0|||0
114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|G|0|MED|0|0|0|100|IKR|14000|16638|lyfalmen|V0420|16638|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||11000||11000|16638||2|0|G|0|||0
114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|5673|9778|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5673||5673|9778||2|0||0|||0
114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|1967|3747|lyfalmen|V0278|3747|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1634||1634|3747||2|0|G|0|||0
114950|L01BC0702|Azacitidine Accord|sts|25|mg/ml|100|mg|1|hgl||L01BC07|01.05.2020||R|0|0|0|0|0|CLU|0|1|0|100|XEU|48811|65010|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Azasitidín||48811||48811|65010||1|H|L|0|||0
114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2651|3684|lyfalmen|V0279|3684|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1588||1588|3684||2|0|G|0|||0
114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|7888|6775|lyfalmen|V0280|6775|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||3834||3834|6775||2|0|G|0|||0
114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|10901|6775|lyfalmen|V0282|6775|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||3834||3834|6775||2|0|G|0|||0
114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|0|KNM|0|0|0|100|IKR|5276|8760|lyfalmen|V0457|8760|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5276||5276|8760||2|0|G|0|||0
115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|12539|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8022||8022|12539||2|0|G|0|||0
115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|5779|9452|lyfalmen|V0475|9452|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5779||5779|9452||2|0|G|0|||0
115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20624|lyfalmen|V0540|20624|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13896||13896|20624||2|0|G|0|||0
115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|82794|107991|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||82794||82794|107991||1|H|L|0|||0
115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|RAU|0|0|1|100|XEU|7294|11537|lyfalmen|||2|10|0||Actavis Group hf|B.Braun Melsungen AG|Naloxón||7294||7294|11537||2|0|0|0|||0
115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1085|2991|lyfalmen|V0158|2991|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||1085||1085|2991||2|0|E|0|||0
115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|G|0|MED|0|0|0|100|IKR|1741|3287|lyfalmen|V0276|3191|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1300||1300|3287||2|0|G|0|||0
115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|G|0|BII|0|0|0|100|DKK|10665|16177|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10665||10665|16177||1|0|G|0|||0
115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|G|0|BII|0|0|0|100|DKK|9183|14137|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||9183||9183|14137||1|0|G|0|||0
115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|G|0|PAC|0|0|1|100|DKK|42640|57205|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||42640||42640|57205||1|0|G|0|||0
115613|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
115770|D10AF5101|Duac|hlaup|||30|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.03.2018||R|0|0|0|0|0|STE|0|0|0|100|DKK|3404|6183|lyfalmen|||1|30|0||Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Klindamýcín í blöndum||3404||3404|6183||1|0|0|0|||0
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|GPH|0|0|1|100|DKK|3289|6025|lyfalmen|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||3289||3289|6025||1|0|0|0|||0
116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1720|3865|lyfalmen|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1720||1720|3865||1|0|0|0|||0
116551|M01AE0102|Ibufen|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0
116573|M01AE0102|Ibufen|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0
116584|M01AE0102|Ibufen|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|798|2478|lyfalmen|V0562|2410|2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||712||712|2478||1|0|G|0|||0
116595|M01AE0102|Ibufen|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|406|1982|lyfalmen|V0563|1826|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||352||352|1982||1|0|G|0|||0
116606|M01AE0102|Ibufen|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|849|2647|lyfalmen|V0564|2271|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||835||835|2647||1|0|G|0|||0
116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|13935|20678|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||13935||13935|20678||1|0|G|0|||0
116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4182|6680|lyfalmen|V0081|6437|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan||3765||3765|6680||1|0|G|0|||0
116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|5431|8973|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||5431||5431|8973||1|0|G|0|||0
116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|5914|9638|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||5914||5914|9638||1|0|G|0|||0
116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|15178|22389|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||15178||15178|22389||1|0|G|0|||0
117103|QN01AX0305|Ketabel vet.|stl|100|mg/ml|25|ml|1|hgl|lausn|QN01AX03|01.04.2021||R|0|0|0|0|0|Bel|1|0|0|100|XEU|3025|5910|vetalmen|||0|25|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Ketaminum||3025||3025|5910||2|0|0|1|30|dagar|0
117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|KEL|1|0|0|100|XEU|9145|17520|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||9145||9145|17520||2|0||0|||0
117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1465|3514|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1465||1465|3514||1|0|G|0|||0
117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|ASZ|0|0|0|100|SEK|10980|15890|lyfalmen|V0275|4788|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||10456||10456|15890||1|0|E|0|||0
117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|G|0|ASZ|0|0|0|100|SEK|20226|26941|lyfalmen|V0273|5008|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||18485||18485|26941||1|0|G|0|||0
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|G|0|ROA|0|0|0|100|DKK|1386|3406|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||1386||1386|3406||2|0|G|0|||0
117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|G|0|ASZ|0|0|0|100|SEK|29029|39989|lyfalmen|V0272|8917|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||29029||29029|39989||1|0|G|0|||0
117676|L01DB0107|Caelyx pegylated liposomal|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|0|0|JCI|0|1|0|100|SEK|53612|71082|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||53612||53612|71082||1|H|L|0|||0
117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|KEL|0|0|0|100|NOK|5050|9751|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||5050||5050|9751||2|0||0|||0
117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|KEL|0|0|0|100|XEU|13266|25339|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||13266||13266|25339||2|0||0|||0
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1710|3852|lyfalmen|V0278|3747|2|28|0|7,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1710||1710|3852||1|0|G|0|||0
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2573|3814|lyfalmen|V0279|3684|2|28|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1683||1683|3814||1|0|G|0|||0
118046|N07BC0102|Buvidal|stl|96|mg|0,27|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|56379|74582|lyfsjukr|||1|0,27|0|45,7143|Vistor hf|Camurus AB|Búprenorfín||56379||56379|74582||1|H|L|1|30|dagar|0
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|7720|7564|lyfalmen|V0282|6775|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||4407||4407|7564||1|0|G|0|||0
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1636|3750|lyfalmen|V0283|3750|2|28|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1636||1636|3750||1|0|G|0|||0
118153|L02BB0401|Xtandi|filmhtfl|40|mg|112|stk|1|þpakki||L02BB04|01.10.2019||R|1|0|0|0|0|APE|0|1|0|100|XEU|406025|511493|lyfsjukr|||1|112|0|28,0000|Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||406025||406025|511493||1|0|L|0|||0
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|AGA|0|0|0|100|XEU|15122|22312|lyfalmen|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||15122||15122|22312||5|H|0|0|||0
118421|C02AC0201|Intuniv|forðatfl|3|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|11252|16985|lyfalmen|||1|28|0|28,0000|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||11252||11252|16985||1|0|E|0|||0
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|7888|8180|lyfalmen|V0280|6775|2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||4855||4855|8180||1|0|G|0|||0
118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|5043|9738|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5043||5043|9738||2|0||0|||0
118612|A07EC0203|Pentasa Sachet|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|G|0|FER|0|0|0|100|DKK|19593|28466|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||19593||19593|28466||1|0|G|0|||0
118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|BAM|0|0|0|100|SEK|1192|3139|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1192||1192|3139||2|H|0|0|||0
118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|G|0|AEP|0|0|0|100|DKK|457|2127|lyfalmen|||1|120|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||457||457|2127||2|0|G|0|||0
119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|G|0|AEP|0|0|0|100|DKK|1349|3355|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||1349||1349|3355||2|0|G|0|||0
119520|M01AH0503|Coxerit|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2326|4457|lyfalmen|V0824|3968|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||2150||2150|4457||2|0|G|0|||0
119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|1|0|0|GAN|0|0|0|100|XEU|2907|5499|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||2907||2907|5499||2|0|E|0|||0
119710|N03AX1603|Pregabalin Krka|hylki|100|mg|84|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|5500|9068|lyfalmen|||2|84|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||5500||5500|9068||2|0|E|0|||0
119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1297|3283|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1297||1297|3283||2|0||2|60|mg|0
119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|1|0|0|RGP|0|1|0|100|DKK|316950|400708|lyfsjukr|||1|30|0|20,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||316950||316950|400708||1|0|L|0|||0
120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|1|0|0|RGP|0|1|0|100|DKK|294253|372480|lyfsjukr|||1|30|0|40,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||294253||294253|372480||1|0|L|0|||0
120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|G|0|CLA|0|0|0|100|XEU|1693|3828|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Cýklópentólat||1693||1693|3828||1|0|G|0|||0
120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|0|0|NED|0|1|0|100|XEU|36549|49501|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||36549||36549|49501||2|H|L|0|||0
120278|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|51710|68676|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||51710||51710|68676||1|H|L|0|||0
120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|KRK|0|0|0|100|IKR|7679|7898|lyfalmen|V0118|7871|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||4650||4650|7898||2|0|E|0|||0
121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|RRG|0|1|0|100|DKK|395762|498728|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||395762||395762|498728||2|H|L|0|||0
121133|C10AA0704|Rosuvastatin Xiromed|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|7410|8242|lyfalmen|V0118|7871|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||4900||4900|8242||2|0|E|0|||0
121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|skpokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|GRH|0|0|1|100|DKK|3672|6552|lyfalmen|||1|28|0|9,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||3672||3672|6552||1|0|E|0|||0
121274|H02AB0901|Solu-Cortef|sts|100|mg|5|hgl|1|pakki|Act-O-Vial|H02AB09|01.02.2021||R|0|0|0|G|0|PLS|0|0|1|100|DKK|2377|4770|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer Aps|Hýdrókortisón||2377||2377|4770||1|0|G|0|||0
121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|60|0|10,0000|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
121792|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|0|0|0|PBV|0|0|0|100|XEU|793|2589|lyfalmen|V1051|2589|1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||793||793|2589||1|0|0|1|30|dagar|0
121912|L04AX0306|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3023|5659|lyfalmen|||1|1|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3023||3023|5659||2|0|G|0|||0
122129|B06AC0501|Takhzyro|stl|300|mg|2|ml|1|áfspr|27Gx13mm áföst nál með hlíf|B06AC05|01.04.2021||R|0|0|1|0|0|HPI|0|1|0|100|DKK|1841349|2296634|lyfsjukr|||1|2|0|14,0187|Vistor hf|Shire Pharmaceuticals Ireland Limited|Lanadelumab||1841349||1841349|2296634||1|0|L|0|||0
122231|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.12.2020||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2190|4512|lyfalmen|V0214|4512|2|98|0|49,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2190||2190|4512||2|0|E|0|||0
122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|TSA|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Alvogen|Teva Sweden AB|Flútíkasón|||||||2|0||0|||0
122326|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|G|0|VAL|0|0|1|100|IKR|2500|2861|lyfalmen|V0010|2193|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||990||990|2861||2|0|G|0|||0
122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|BIV|0|0|0|100|DKK|8920|15375|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||8920||8920|15375||1|0||0|||0
123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|CHP|0|0|0|100|XEU|30799|53085|vetorma|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||30799||30799|53085||2|0||0|||0
123487|L01BC0603|Ecansya|filmhtfl|500|mg|120|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|1|0|0|KAN|0|0|0|100|IKR|18000|26273|lyfalmen|||2|120|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||18000||18000|26273||2|0|0|0|||0
123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|618|2349|lyfalmen|||2|100|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||618||618|2349||1|0|G|0|||0
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|1|G|0|SMA|0|0|0|100|XEU|30502|41853|lyfalmen|V0579|29265|1|56|0|28,0000|Vistor hf|Sanofi Mature IP|Rílúzól||30502||30502|41853||1|0|G|0|||0
124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|CHP|0|0|0|100|XEU|1704|3349|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||1704|3349||2|0||0|||0
124141|A11HA0801|Vedrop|mixtúra|50|mg/ml|60|ml|1|glas||A11HA08|01.07.2017||R|0|0|1|0|0|OUS|0|0|0|100|XEU|34224|46560|lyfalmen|||1|60|0|15,0000|Recordati AB|Orphan Europe SARL|Tocofersolanum||34224||34224|46560||3|0|E|0|||0
124225|B01AF0102|Rivaroxaban WH|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|8560|13280|lyfalmen|V1035|13280|2|28|0|21,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||8560||8560|13280||2|0|G|0|||0
124347|R03AC0206|Ventoline|innönddu|200|mcg/sk|60|skammtar|1|stk||R03AC02|01.03.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|683|2438|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||683||683|2438||1|0|G|0|||0
124356|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|7762|12182|lyfalmen|V0995|5283|1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||7762||7762|12182||1|0|G|0|||0
124908|D02AX0001|Oviderm|krem|250|mg/g|500|g|1|túpa|fjölskammtaílát m.dælu|D02AX|01.03.2018||L|0|0|0|G|0|GAB|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||4529||1|0|G|0|||0
125038|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|1|G|0|AEP|0|0|0|100|IKR|3254|5977|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Melphalan||3254||3254|5977||2|0|G|0|||0
125246|N03AX1214|Gabapentin Alvogen|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|DKK|12707|18988|lyfalmen|V0256|18988|2|100|0|44,4400|Alvogen|Alvogen|Gabapentín||12707||12707|18988||2|0|G|0|||0
125376|B03BA0105|Optovite B12|stl|1000|mcg|2|ml|5|lykjur||B03BA01|01.05.2020||R|0|0|0|G|0|LNA|0|0|1|100|XEU|5760|9426|lyfalmen|||2|10|0|250,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Cyanocobalamin||5760||5760|9426||2|0|G|0|||0
125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|5524|3356|lyfalmen|V0285|3278|2|100|0|25,0000|Alvogen|Teva Sweden AB|Quetíapín||1350||1350|3356||2|0|G|0|||0
125613|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|1583931|1976478|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||1583931||1583931|1976478||2|H|L|0|||0
125713|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.04.2021||R|0|1|0|G|0|NEL|0|0|0|100|DKK|8873|13711|lyfalmen|V0347|13709|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||8873||8873|13711||1|0|G|0|||0
126390|A10BK0101|Forxiga|filmhtfl|5|mg|28|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|G|0|AZE|0|0|0|100|SEK|6510|10458|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||6510||6510|10458||1|0|G|0|||0
126496|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|G|0|BLS|0|0|0|100|XEU|2183|2587|lyfalmen|V0057|2216|2|100|0|200,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Amlódipín||791||791|2587||1|0|G|0|||0
126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|44238|59226|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||44238||44238|59226||2|H|L|0|||0
126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|88477|115179|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||88477||88477|115179||2|H|L|0|||0
126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|176953|226591|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||176953||176953|226591||2|H|L|0|||0
126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|0|0|FIN|0|1|0|100|DKK|119655|155329|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||119655||119655|155329||2|H|L|0|||0
126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|30182|41448|lyfalmen|V0976|41448|1|100|0|75,0000|Icepharma hf|Bayer AG|Rivaoxaban||||30182|41448||2|0|G|0|||0
126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|G|0|NEL|0|0|1|100|DKK|3313|6058|lyfalmen|||1|3|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||3313|6058||1|0|G|0|||0
126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|G|0|ABC|0|0|1|100|SEK|7122|11301|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||7122||7122|11301||2|0|G|0|||0
127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|G|0|ATE|0|0|1|100|XEU|3120|4827|lyfalmen|V0011|4827|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||2419||2419|4827||1|0|G|0|||0
127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
127403|G04B00001|Lyngonia|filmhtfl|||60|stk|1|þpakki|425,25-519,75 mg|G04B000|01.11.2017||L|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|60|0||Florealis ehf|Florealis ehf|Dry Bearberry leaf extract|||||||2|0||0|||0
128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|0|NED|0|0|0|100|XEU|5882|9594|lyfalmen|V0279|3684|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||5882||5882|9594||2|0|E|0|||0
128348|C03AB0102|Centyl mite med kaliumklorid|filmhtfl|||100|stk|1|glas|1,5 mg / 573 mg|C03AB01|01.05.1999||R|1|0|0|G|0|KPA|0|0|0|100|DKK|1461|3509|lyfalmen|||1|100|0|50,0000|Alvogen|Karo Pharma AB|Bendróflúmetíazíð og kalíum||1461||1461|3509||2|0|G|0|||0
128750|L04AA2901|Xeljanz|filmhtfl|10|mg|56|stk|1|þpakki||L04AA29|01.01.2019||R|0|1|1|0|0|PEU|0|1|0|100|DKK|228116|290224|lyfsjukr|||1|56|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||228116||228116|290224||1|0|L|0|||0
129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|G|0|NED|0|0|0|100|XEU|22604|31863|lyfalmen|V0282|6775|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22604||22604|31863||2|0|G|0|||0
129152|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|1 innöndunartæki og 1 rörlykja|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|4198|7276|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4198||4198|7276||1|0|G|0|||0
129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|17658|15042|lyfalmen|V0680|14780|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||9840||9840|15042||2|0||0|||0
129289|N06BA0409|Methylphenidate STADA|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|7500|10169|lyfalmen|V0997|9364|2|30|0|60,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0
129668|A02AH0003|Natriumbikarbonat Meda|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|100|0||Icepharma hf|Meda AB|Natríumhýdrógenkarbonat|||||3404||2|0||0|||0
129817|R03BB0101|Atrovent|lausn|0,25|mg/ml|60|sk-ílát|1|pakki|fyrir eimgjafa|R03BB01|01.04.1989||R|0|0|0|G|0|BOI|0|0|0|100|DKK|3519|6341|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||3519||3519|6341||1|0|G|0|||0
129860|B01AF0102|Rivaroxaban WH|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|29747|40898|lyfalmen|V0977|40619|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||29747||29747|40898||2|0|G|0|||0
129923|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9984|3257|lyfalmen|V0812|3197|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1278||1278|3257||2|0|E|0|||0
129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|15164|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|15164||2|0|E|1|30|dagar|0
130001|N06AB0608|Sertralin WH|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|G|0|WEH|0|0|0|100|IKR|3423|4251|lyfalmen|V0323|4251|2|100|0|200,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||2000||2000|4251||2|0|G|0|||0
130242|L04AA4001|Mavenclad|töflur|10|mg|1|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|0|MRP|0|1|0|100|SEK|306624|387866|lyfsjukr|||1|1|0|29,4118|Icepharma hf|Merck Europe B.V.|Cladribine||306624||306624|387866||2|0|L|0|||0
130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|MYL|0|0|1|100|DKK|5198|4907|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2477||2477|4907||2|0||0|||0
130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|0|0|PFM|0|1|0|100|DKK|354431|447324|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||354431||354431|447324||1|H|L|0|||0
130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|19295|36777|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||19295||19295|36777||1|0||0|||0
130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1478|3532|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1478||1478|3532||2|0||0|||0
130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|PEU|0|0|1|100|DKK|9640|14766|lyfalmen|V1049|14766|1|53|0|23,7500|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||9640|14766||1|0||0|||0
130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|PHA|0|0|0|100|NOK|39847|64233|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||39847|64233||1|0||0|||0
131010|QN01BB0301|Mepidor vet.|stl|20|mg/ml|10|ml|6|hgl|lausn|QN01BB03|01.06.2017||R|0|0|0|0|0|RPG|1|0|0|100|XEU|6616|12722|vetalmen|||0|60|0||Icepharma hf|Richter Pharma AG|Mepivacaine||6616||6616|12722||2|0||0|||0
131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|MYL|0|0|0|100|SEK|4621|7312|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||4224||4224|7312||2|0||0|||0
131620|C08CA0107|Amlodipine Vitabalans|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|G|0|VIB|0|0|0|100|IKR|2050|2461|lyfalmen|V0057|2216|2|100|0|200,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G|0|||0
132106|H05BX0107|Cinacalcet STADA|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|15128|8242|lyfalmen|V0720|8242|2|28|0|14,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||4900||4900|8242||2|0||0|||0
132322|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|0|VAL|0|0|1|100|XEU|1122|2167|lyfalmen|V0003|2167|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||486||486|2167||2|0||0|||0
132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|G|0|ATE|0|0|0|100|IKR|5076|5765|lyfalmen|V0581|5765|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3100||3100|5765|||0|G|0|||0
132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|G|0|ATE|0|0|0|100|IKR|3156|5159|lyfalmen|V0580|5159|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||2660||2660|5159|||0|G|0|||0
132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|0|0|TPA|0|1|0|100|DKK|390900|492681|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||390900||390900|492681||1|H|L|0|||0
132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|G|0|AGC|0|0|0|100|XEU|8687|13455|lyfalmen|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||8687||8687|13455||1|0|G|0|||0
132554|L04AD0205|Advagraf (Lyfjaver)|forðahlk|1|mg|50|stk|1|stsk.þ||L04AD02|01.06.2021||R|0|0|1|G|0|LVR|0|0|0|100|XEU|14864|21957|lyfalmen|V1044|21957|3|50|0|10,0000|Lyfjaver ehf|Lyfjaver ehf|Tacrolimus||14864||14864|21957||3|0|G|0|||0
132633|D11AH0501|Dupixent|stl|300|mg|2|áf.spr|1|pakki|með nálarhlíf|D11AH05|01.08.2019||R|0|0|1|0|0|SGB|0|1|0|100|XEU|176115|225549|lyfsjukr|||1|2|0|28,0374|Vistor hf|Sanofi-aventis groupe|Dupilumab||176115||176115|225549||1|0|L|0|||0
132635|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|125|mg|98|stk|1|þpakki|100 + 25 mg|C09DA01|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2364|3631|lyfalmen|V0089|3631|2|98|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1550||1550|3631||2|0|G|0|||0
132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|0|0|0|JAS|0|0|0|100|SEK|4733|8012|lyfalmen|V0681|7377|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4733||4733|8012||1|0|E|1|30|dagar|0
132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|6169|11874|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||||6169|11874||2|0||0|||0
132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|G|0|BLS|0|0|0|100|XEU|4424|3970|lyfalmen|V0335|2579|2|100|0|150,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1796||1796|3970||1|0|G|0|||0
132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|CLA|0|0|0|100|XEU|422|2079|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Proxýmetakaín||422||422|2079||1|0||0|||0
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1|0||0|||0
133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009|30.06.2021|R|0|0|0|0|0|SLP|0|0|0|100|SEK|22473|31697|lyfalmen|||1|0,5|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||22473||22473|31697||1|H|0|0|||0
133101|M01AH0108|Celecoxib Medical|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|1323|3319|lyfalmen|V0037|3150|2|20|0|20,0000|LYFIS ehf|Medical ehf|Celekoxíb||1323||1323|3319||2|0|G|0|||0
133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009|30.06.2021|R|0|0|0|0|0|SLP|0|0|0|100|SEK|29882|41068|lyfalmen|||1|1|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||29882||29882|41068||1|H|0|0|||0
133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009|30.06.2021|R|0|0|0|0|0|SLP|0|0|0|100|SEK|40632|54665|lyfalmen|||1|2|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||||40632|54665||1|H|0|0|||0
133384|B05ZB0002|Phoxilium|blóð.sk|1,2|mmól/l|5000|ml|2|pokar|Blóðsk.- blóðsíunarlausn|B05ZB|01.10.2017||R|0|0|0|0|0|GAA|0|0|0|100|SEK|5436|8980|lyfalmen|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||5436||5436|8980||2|H|0|0|||0
133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|BLS|0|0|0|100|XEU|1296|3282|lyfalmen|V0333|3204|2|30|0|11,2500|Artasan ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1296||1296|3282||1|0|E|0|||0
134067|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2019||R|0|0|1|G|0|AZA|0|0|0|100|SEK|47988|62602|lyfalmen|V0451|53065|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||46907||46907|62602||1|0|G|0|||0
134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|G|0|SAO|0|0|0|100|XEU|2790|5338|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2790||2790|5338||2|0|G|0|||0
134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|G|0|SAO|0|0|0|100|XEU|7091|11258|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7091||7091|11258||2|0|G|0|||0
134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|1|0|0|BRS|0|1|0|100|DKK|56142|74282|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||56142||56142|74282||1|0|L|0|||0
134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|1|0|0|GAD|0|1|0|100|DKK|102540|134042|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland UC|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||102540||102540|134042||2|0|L|0|||0
135062|C09CA0306|Valsartan Krka|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3912|3838|lyfalmen|V0678|3563|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan||1700||1700|3838||2|0|G|0|||0
135084|C09CA0306|Valsartan Krka|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5538|4251|lyfalmen|V0679|3904|2|98|0|196,0000|LYFIS ehf|Krka Sverige AB|Valsartan||2000||2000|4251||2|0|G|0|||0
135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|G|0|SDH|0|0|0|100|XEU|9517|14597|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9517||9517|14597||1|0|G|0|||0
135253|A10BB0906|Gliclazíð Krka|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3500|5008|lyfalmen|V0020|3502|2|90|0|45,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||2550||2550|5008||2|0|G|0|||0
135264|A10BB0906|Gliclazíð Krka|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4800|7004|lyfalmen|V0020|7004|2|180|0|90,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||4000||4000|7004||2|0|G|0|||0
135384|R03BA0501|Flixotide|innönddu|500|mcg/sk|60|skammtar|1|sk-ílá|Fjölskammtaílát|R03BA05|01.09.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4211|7294|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4211||4211|7294||1|0|G|0|||0
135434|R03BA0501|Flixotide|innönddu|100|mcg/sk|60|skammtar|1|pakki|fjölskammtaílát|R03BA05|01.07.1995||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1195|3143|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1195||1195|3143||1|0|G|0|||0
135498|G04CB0202|Dutasteride Medical Valley|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.09.2017||R|1|0|0|G|0|VAL|0|0|0|100|DKK|2211|2783|lyfalmen|V0909|2783|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð||934||934|2783||2|0|G|0|||0
135533|R03AC1201|Serevent|innönddu|50|mcg/sk|60|skammtar|1|innö.t||R03AC12|01.10.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|2733|5260|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2733||2733|5260||1|0|G|0|||0
136121|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|2 hgl m 5 ml leysi + 2 millist|B06AC01|01.03.2019||R|0|1|1|0|0|SSE|0|1|0|100|DKK|194909|248923|lyfsjukr|||1|2|0|0,7143|Shire Services BVBA|Shire Services BVBA|C1 hemill||194909||194909|248923||1|0|L|0|||0
136180|M05BA0306|Pamidronatdinatrium Pfizer|irþ|3|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|PLS|0|0|0|100|DKK|5871|9579|lyfalmen|||2|10|0|0,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5871||5871|9579||1|H|0|0|||0
136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|1|G|0|PEU|0|0|0|100|DKK|35089|47654|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||35089||35089|47654||1|0|G|0|||0
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|MEA|0|0|0|100|DKK|8475|13163|lyfalmen|||1|100|0|100,0000|Icepharma hf|Meda AB|Ísóníazíð||8475||8475|13163||2|0||0|||0
136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|58449|77200|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||58449||58449|77200||1|0|L|0|||0
136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|2740|5269|lyfalmen|||1|28|0|14,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||2740||2740|5269||1|0||0|||0
136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|804|2605|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||804||804|2605||2|0||2|60|mg|0
136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól|||||||1|0||0|||0
137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|16195|14574|lyfalmen|V0261|11408|2|100|0|100,0000|Alvogen|Teva Pharma B.V.|Quetíapín||9500||9500|14574||2|0|G|0|||0
137665|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|30|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|1627|2957|lyfalmen|V1002|2957|2|30|0|2,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||1060||1060|2957||2|0|E|1|30|dagar|0
137690|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|G|0|MEC|0|0|0|100|SEK|623|2355|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck AB|Levótýroxínnatríum||623||623|2355||2|0|G|0|||0
137721|L04AA4001|Mavenclad|töflur|10|mg|6|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|0|MRP|0|1|0|100|SEK|1839746|2294640|lyfsjukr|||1|6|0|176,4706|Icepharma hf|Merck Europe B.V.|Cladribine||1839746||1839746|2294640||2|0|L|0|||0
137883|N05AH0415|Quetiapin Krka|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|6500|7004|lyfalmen|V0273|5008|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||4000||4000|7004||2|0|G|0|||0
138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|4824|5613|lyfalmen|V0689|3390|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2990||2990|5613||2|0|E|0|||0
138318|L04AX0307|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2627|5114|lyfalmen|||1|0,35|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2627||2627|5114||2|0|G|0|||0
138505|J05AP5601|Vosevi|filmhtfl|600|mg|28|stk|1|glas|400/100/100 mg|J05AP56|01.11.2017||R|0|0|1|0|0|GSE|0|1|0|100|DKK|2315723|2886622|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|sofosbuvir,velpatasvir,voxilaprevir||||2315723|2886622||2|0|L|0|||0
138567|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2500|2806|lyfalmen|V0114|2736|2|100|0|200,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||950||950|2806||2|0|G|0|||0
138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|LBK|0|0|0|100|DKK|16038|23573|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||16038||16038|23573||1|0||0|||0
138619|L04AX0306|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3397|6174|lyfalmen|||1|1|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3397||3397|6174||2|0|G|0|||0
138687|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|4809|5611|lyfalmen|V0691|5611|2|30|0|18,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||2988||2988|5611||1|0|E|1|30|dagar|0
139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|G|0|ATE|0|0|0|100|XEU|2595|4834|lyfalmen|V0373|4834|2|15|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tímólól í blöndum||2424||2424|4834||1|0|G|0|||0
139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|1|0|0|AEB|0|1|0|100|XEU|102055|133439|lyfsjukr|||1|56|0|28,0000|Vistor hf|Amgen Europe B.V.|Apremilast||102055||102055|133439||1|0|L|0|||0
139959|N06DA0304|Nimvastid|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G|0|||0
140013|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.12.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|515|2207|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||515||515|2207||1|0|G|0|||0
140132|C08CA0107|Amlodipine Vitabalans|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|G|0|VIB|0|0|0|100|IKR|1267|2461|lyfalmen|V0056|2216|2|100|0|100,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G|0|||0
140191|R06AX2708|Dasergin|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|0|0|KAN|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||||2|0||0|||0
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|G|0|BII|0|0|0|100|DKK|975|2840|lyfalmen|V0266|2512|1|30|0|1,5000|Vistor hf|Boehringer Ingelheim International |Pramipexól||975||975|2840||1|0|G|0|||0
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|LBK|0|0|0|100|DKK|9020|13913|lyfalmen|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9020||9020|13913||1|0|0|0|||0
140563|A07DA0201|Dropizol|dropar|10|mg/ml|10|ml|1|dropaí||A07DA02|01.06.2018||R|0|0|0|0|0|ARO|0|0|0|100|DKK|6680|10692|lyfalmen|||2|10|0|1,0000|Pharmanovia A/S|Pharmanovia A/S|opium||6680||6680|10692||2|0|E|1|30|dagar|0
140611|N06BA0408|Methylphenidate Teva|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|3079|5736|lyfalmen|V0958|5736|2|30|0|10,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||3079||3079|5736||1|0|E|1|30|dagar|0
140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|SRR|0|0|0|100|NOK|70268|133483|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||70268||70268|133483||1|0||0|||0
140792|L04AD0205|Advagraf (Lyfjaver)|forðahlk|3|mg|50|stk|1|stsk.þ||L04AD02|01.06.2021||R|0|0|1|G|0|LVR|0|0|0|100|XEU|44270|59266|lyfalmen|V1045|59266|3|50|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Tacrolimus||44270||44270|59266||3|0|G|0|||0
140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|1|0|0|JAS|0|1|0|100|SEK|62300|82071|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||62300||62300|82071||1|0|L|0|||0
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1132|3056|lyfalmen|V0413|2825|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1132||1132|3056||1|0|G|0|||0
141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|G|0|NEL|0|0|1|100|DKK|2969|5584|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||2969||2969|5584||1|0|G|0|||0
141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1|0||0|||0
141238|N05CH0104|Melatonin Vitabalans|töflur|3|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|LYF|0|0|1|100|IKR|4000|4113|lyfalmen|||2|50|0|75,0000|LYFIS ehf|LYFIS ehf|Melatonin||1900||1900|4113||2|0|0|0|||0
141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|FKA|0|0|1|100|DKK|3372|6139|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3372||3372|6139||1|0|0|0|||0
141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|14055|20843|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||14055|20843||2|0|G|0|||0
141783|R02AX0103|Strefen Körsbär & Mint|munnhúði|16,2|mg/ml|15|ml|1|glas||R02AX01|01.08.2018||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0
141847|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|100|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|34030|46315|lyfalmen|V1007|46315|2|100|0|53,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||34030||34030|46315||2|0|E|1|30|dagar|0
141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2543||1|0||0|||0
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|G|0|BII|0|0|0|100|DKK|5909|9631|lyfalmen|V0267|4303|1|100|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||5909||5909|9631||1|0|G|0|||0
142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1593|3691|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1593||1593|3691||2|0|G|0|||0
142123|R07AX0101|INOmax|lyfjagas|800|ppm|2|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|0|LIN|0|0|0|100|XEU|21674|30687|lyfalmen|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||21674|30687||5|H|0|0|||0
142177|QP54AA5401|BROADLINE|bl.lausn|||0,3|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2520|4343|vetorma|||0|0,9|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2520||2520|4343||1|0||0|||0
142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|3969|4651|lyfalmen|V0384|3252|2|10|0|5,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||2291||2291|4651||1|0|G|0|||0
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|G|0|SNP|0|0|0|100|XEU|867|2691|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||867||867|2691||1|0|G|0|||0
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|YLA|0|0|1|100|DKK|3120|5792|lyfalmen|||1|100|0|50,0000|Icepharma hf|Mylan ApS|Metenamín||3120||3120|5792||2|0|E|0|||0
142410|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|1|0|0|PEU|0|1|0|100|DKK|425070|535179|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||425070||425070|535179||1|0|L|0|||0
142606|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|985|2854|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||985||985|2854||2|0|G|1|30|dagar|0
142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|1544|2599|lyfalmen|V0946|2599|2|100|0|16,6700|Alvogen|ratiopharm GmbH|Carvedílól||800||800|2599||2|0|G|0|||0
142914|C07AB0214|Bloxazoc|forðatfl|100|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2043|2984|lyfalmen|V0049|2910|2|100|0|66,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1080||1080|2984||2|0|G|0|||0
143139|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16820||1|0||0|||0
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|PLS|0|0|0|100|DKK|2113|4406|lyfalmen|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2113||2113|4406||1|H|0|0|||0
143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|8196|4734|lyfalmen|V0687|4664|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||2351||2351|4734||1|0|E|0|||0
143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|GBI|0|0|0|100|DKK|4552|7763|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4552||4552|7763||1|0||0|||0
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|CLA|0|0|0|100|XEU|1013|2892|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Trópíkamíð||1013||1013|2892|31.8.2021|1|0||0|||0
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1274|3251|lyfalmen|V0173|2676|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1274||1274|3251||1|0|E|0|||0
143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|4710|7981|lyfalmen|V0387|6987|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||4710||4710|7981||1|0|G|0|||0
143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|G|0|MBV|0|0|0|100|DKK|4615|7850|lyfalmen|V0386|6807|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||4615||4615|7850||1|0|G|0|||0
143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|G|0|ATE|0|0|0|100|DKK|2734|5261|lyfalmen|||2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Litíum||2734||2734|5261||1|0|G|0|||0
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1608|3711|lyfalmen|V0174|2599|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1608||1608|3711||1|0|E|0|||0
144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|G|0|AZD|0|0|1|100|SEK|3847|6793|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3847||3847|6793||1|0|G|0|||0
144490|N07XX0801|Vyndaqel|hylki|61|mg|30|stk|1|stsk.þ||N07XX08|01.10.2020||R|0|1|1|0|0|PEU|0|1|0|100|DKK|1364618|1703714|lyfsjukr|||1|30|0|91,5000|Icepharma hf|Pfizer Europe MA EEIG|Tafamidis||1364618||1364618|1703714||1|0|L|0|||0
144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9003|13596|lyfalmen|V0587|13596|2|98|0|52,2700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||8790||8790|13596||1|0|G|1|30|dagar|0
144940|C07AB0706|Bisoprolol Medical Valley|filmhtfl|5|mg|105|stk|1|glas||C07AB07|01.02.2021||R|1|0|0|G|0|VAL|0|0|0|100|XEU|1252|3221|lyfalmen|V1038|3221|2|105|0|52,5000|Acare ehf|Medical Valley Invest AB|bisoprolol||1252||1252|3221||2|0|G|0|||0
144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|tfílát||N05BA02|01.04.2020||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1352|3359|lyfalmen|||2|24|0|8,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1352||1352|3359||1|0||2|50|töflur|0
144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|tfílát||N05BA02|01.04.2021||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1121|3041|lyfalmen|||2|24|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1121||1121|3041||1|0||2|25|töflur|0
145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|0|0|0|0|JAN|0|1|0|100|DKK|75661|98970|lyfsjukr|||1|1|0|26,6700|Vistor hf|Janssen Biologics B.V.|Infliximab||75661||75661|98970||1|H|L|0|||0
145158|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|4452|7626|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||||4452|7626||1|0|G|0|||0
145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|4397|8512|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4397||4397|8512||1|0||0|||0
145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|5945|11449|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5945||5945|11449||1|0||0|||0
145479|L04AX0402|Lenalidomid Alvogen|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|644043|793919|lyfsjukr|||2|21|0|31,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||633107||633107|793919||2|0|L|0|||0
145545|D07AD0101|Dermovat|krem|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|476|2153|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||476||476|2153||1|0|G|0|||0
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0|1,1400|Icepharma hf|Meda AB|Pýrvín|||||||2|0||0|||0
145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|7230|13887|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||7230||7230|13887||1|0||0|||0
145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|8655|16591|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||8655||8655|16591||1|0||0|||0
145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|BAM|0|0|1|100|SEK|6700|10720|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6700||6700|10720||2|0|0|0|||0
145691|L03AA1302|Pelgraz|stl|6|mg/spr|0,6|ml|1|spr|áföst nál með nálavörn|L03AA13|01.03.2019||R|0|0|1|0|0|CLU|0|1|0|100|XEU|107041|139640|lyfsjukr|||2|0,6|0|20,0000|Artasan ehf|Accord Healthcare S.L.U.|Pegfilgrastím||107041||107041|139640||1|0|L|0|||0
145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|G|0|VIF|0|0|1|100|CHF|24795|34634|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||24795||24795|34634||1|0|G|0|||0
146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|RGP|0|1|0|100|DKK|23944|33558|lyfsjukr|||1|1|0|4,8000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||23944||23944|33558||1|H|L|0|||0
146428|L04AD0205|Advagraf (Lyfjaver)|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.06.2021||R|0|0|1|G|0|LVR|0|0|0|100|XEU|69206|90805|lyfalmen|V1046|90805|3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Tacrolimus||69206||69206|90805||3|0|G|0|||0
146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|1|0|0|0|DAN|0|0|0|100|XEU|16619|24372|lyfalmen|V0817|3325|1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||16619||16619|24372||2|0|E|0|||0
146494|G04BD0806|Solifenacin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|13872|11254|lyfalmen|V0441|11254|2|90|0|180,0000|Icepharma hf|Mylan AB|Sólífenacín||7088||7088|11254||2|0|G|0|||0
146529|B06AC0201|Firazyr|stl|30|mg|3|ml|1|áfspr|+ ein nál|B06AC02|01.05.2020||R|0|0|1|0|0|HPI|0|1|0|100|DKK|240821|306025|lyfsjukr|||1|3|0|1,0000|Vistor hf|Shire Pharmaceuticals Ireland Limited|Icatibant ||240821||240821|306025||1|0|L|0|||0
146751|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9984|3257|lyfalmen|V0815|3197|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1278||1278|3257||2|0|E|0|||0
146812|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.08.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|15111|13206|lyfalmen|||2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||8506||8506|13206||1|0|G|0|||0
146827|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2100|2873|lyfalmen|V0114|2873|2|105|0|210,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||999||999|2873||2|0|G|0|||0
147365|G04BD1202|Betmiga (Lyfjaver)|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.01.2021||R|1|0|0|G|0|LVR|0|0|0|100|XEU|15347|22622|lyfalmen|V1031|22622|3|90|0|45,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||15347||15347|22622||3|0|G|0|||0
147481|N06AB0608|Sertralin WH|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|G|0|WEH|0|0|0|100|IKR|1825|2971|lyfalmen|V0322|2971|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||1070||1070|2971||2|0|G|0|||0
147578|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3370||1|0||0|||0
147605|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|BLS|0|0|1|100|XEU|1639|3754|lyfalmen|||2|30|0|3,7500|Artasan ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1639||1639|3754||1|0|E|0|||0
147788|N03AX1603|Pregabalin Krka|hylki|150|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|6431|5311|lyfalmen|V0687|4664|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2770||2770|5311||2|0|E|0|||0
147902|L01EX0801|Lenvima|hylki|10|mg|30|stk|1|þpakki||L01EX08|01.12.2018||R|0|0|1|0|0|SIE|0|1|0|100|SEK|229994|292559|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||229994||229994|292559||1|0|L|0|||0
147931|D11AX1802|Solaraze 3%|hlaup|3|% w/w|100|g|1|túpa||D11AX18|01.01.2020||R|0|0|0|0|0|ALM|0|0|0|100|XEU|15256|22496|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||15256||15256|22496||1|0|E|0|||0
148087|J01DD0402|Ceftriaxona Normon|irs|2000|mg|50|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|149009|191837|lyfalmen|||2|50|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||||149009|191837||2|0|0|0|||0
148170|J05AE1003|Darunavir Medical Valley|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.06.2020||R|1|0|1|0|0|VAL|0|1|0|100|XEU|47806|62108|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Darunavír||46517||46517|62108||2|0|L|0|||0
148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|1|0|0|ROA|0|0|0|100|DKK|93281|121255|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||93281||93281|121255||2|0||0|||0
148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|1126|2775|lyfalmen|V0577|2775|2|20|0|6,6667|Vistor hf|Orion Corporation|Pívmecillínam||928||928|2775||1|0|E|0|||0
148266|QI01AN0101|Evalon|innúðal|||5000|skammtar|1|hgl|+250ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|IKR|104840|180702|vetorma|||0|5000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||104840||104840|180702||2|0|0|0|||0
148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|1676|3805|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Pívmecillínam||1676||1676|3805||1|0|E|0|||0
148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|5761|9046|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Pívmecillínam||5484||5484|9046||1|0|E|0|||0
148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|1|0|0|STG|0|0|0|100|DKK|57718|76275|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||57718||57718|76275||1|0|E|0|||0
148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|1|0|0|STG|0|0|0|100|DKK|57718|76275|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||57718||57718|76275||1|0|E|0|||0
148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|SEK|530|2093|lyfalmen|V0601|2093|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||432||432|2093||1|0|G|0|||0
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|G|0|LFS|0|0|0|100|DKK|928|2775|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||928||928|2775||1|0|G|0|||0
148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|AGA|0|0|0|100|XEU|91094|118489|lyfalmen|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||91094||91094|118489||5|H|0|0|||0
148780|J01DH0205|Meropenem WH|sts/irs|500|mg/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|0|WEH|0|0|1|100|XEU|13148|15156|lyfalmen|||2|10|0|1,6667|Williams & Halls efh|Williams & Halls ehf|Meropenem||9581||9923|15156|31.8.2021|2|0|0|0|||0
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|BAN|1|0|0|100|DKK|3392|6606|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|Xylazinum||3392||3392|6606||2|0||0|||0
149203|R03AC0206|Ventoline|innúðal|0,1|mg/sk|200|skammtar|1|úðaílá|dreifa|R03AC02|01.04.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|438|2101|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||438||438|2101||1|0|G|0|||0
149240|A02BX1301|Gaviscon|mixtúra|||400|ml|1|glas||A02BX13|01.06.2019||L|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||4121||1|0||0|||0
149279|L01XC2401|Darzalex|irþ|20|mg/ml|20|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|JCI|0|1|0|100|SEK|263969|334815|lyfsjukr|||1|20|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||263969||263969|334815||1|H|L|0|||0
149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015|31.07.2021|R|0|0|0|0|0|FKA|0|0|1|100|DKK|2282|4639|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2282||2282|4639||1|0|0|0|||0
149908|J02AC0303|Vortil|irs|200|mg|1|hgl|1|pakki|lausn|J02AC03|01.10.2017||R|0|0|0|0|0|WEH|0|0|0|100|XEU|14298|21178|lyfalmen|||2|1|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Voricónazól||14298||14298|21178||2|H|0|0|||0
150005|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|13067|13852|lyfalmen|||2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||8976||8976|13852||1|0|G|0|||0
150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||L|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen|||||7370||1|0|G|0|||0
150281|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4613|6591|lyfalmen|V0253|4878|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||3700||3700|6591||2|0|G|0|||0
150448|L01XG0201|Kyprolis|irs|60|mg|1|hgl|1|pakki||L01XG02|01.10.2016||R|0|0|0|0|0|AEB|0|1|0|100|DKK|157880|202870|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Carfilzomib||157880||157880|202870||1|H|L|0|||0
150498|B01AC2202|Prasugrel Krka|filmhtfl|5|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|G|0|KAN|0|0|0|100|IKR|6577|10445|lyfalmen|V0805|10445|2|30|0|15,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6500||6500|10445||2|0|G|0|||0
150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|39082|52705|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||39082|52705||1|0|L|0|||0
151037|N06DX0109|Marbodin|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4300|5627|lyfalmen|V0607|3019|2|98|0|98,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||3000||3000|5627||2|0|G|0|||0
151060|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|42795|54274|lyfalmen|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||40323||40323|54274||2|0|0|0|||0
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|G|0|LBK|0|0|0|100|DKK|5653|9279|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||5653||5653|9279||1|0|G|0|||0
151207|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|1|glas|1 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|200|0|6,6667|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|G|0|SNP|0|0|0|100|XEU|1433|3470|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1433||1433|3470||1|0|G|0|||0
151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|G|0|LUN|0|0|0|100|DKK|28576|39417|lyfalmen|V0607|3019|1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Memantín||28576||28576|39417||1|0|G|0|||0
151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|G|0|TPA|0|0|0|100|DKK|396|2043|lyfalmen|V0633|2020|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||396||396|2043||1|0|G|0|||0
151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|4061|7087|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Europe B.V.|Chóríógónadótrópín alfa||||4061|7087||2|0|G|0|||0
151682|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|4900|3393|lyfalmen|V0682|3393|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1377||1377|3393||2|0|G|0|||0
151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|LTH|0|0|1|100|SEK|1058|2954|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||1058||1058|2954|31.8.2021|1|0||0|||0
151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|DIV|0|0|0|100|IKR|1195|2349|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1195|2349||2|0||0|||0
151873|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2018||R|1|0|0|G|0|BFP|0|0|0|100|XEU|1786|2742|lyfalmen|V0234|1705|2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||904||904|2742||1|0|G|0|||0
151905|L03AX1302|Remurel|stl|40|mg/ml|12|áf.spr|1|pakki||L03AX13|01.07.2018||R|0|0|1|G|0|ZET|0|0|0|100|XEU|109316|94764|lyfalmen|||2|12|0|24,0000|Alvogen|Zentiva, k.s.|Glatíramer acetat||72336||72336|94764||2|0|G|0|||0
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|HES|0|0|0|100|DKK|1652|3772|lyfalmen|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1652||1652|3772||1|H|0|0|||0
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0||0|||0
152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2634|5123|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2634||2634|5123||1|0|G|0|||0
152408|R03AK1401|Atectura Breezhaler|innönddu|385|mcg/sk|30|stk|1|stsk.þ|125 mcg/260mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|4897|8238|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||4897||4897|8238||1|0|G|0|||0
152410|N05AH0416|Quetiapin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|7800|8917|lyfalmen|V0272|8917|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||5390||5390|8917||2|0|0|0|||0
152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|G|0|AZD|0|0|0|100|SEK|4228|7317|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4228||4228|7317||1|0|G|0|||0
152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|G|0|ASZ|0|0|0|100|SEK|7730|12137|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||7730||7730|12137||1|0|G|0|||0
152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6074|5158|lyfalmen|V0182|4214|2|42|0|7,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||2659||2659|5158||1|0|G|0|||0
152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6259|9732|lyfalmen|||2|90|0|15,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||5982||5982|9732||1|0|G|0|||0
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||||1|0||0|||0
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1445|3487|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín í blöndum||1445||1445|3487||2|0||0|||0
153145|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.04.2021||R|0|1|0|G|0|NEL|0|0|0|100|DKK|15938|23435|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15938||15938|23435||1|0|G|0|||0
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||||1|0||0|||0
153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|29433|40500|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||29433|40500||1|0|L|0|||0
153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|V0575|1677|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||5052||1|0|G|0|||0
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|GSE|0|1|0|100|DKK|167840|215257|lyfsjukr|||1|10|0|14,2857|Gilead Sience Sweden AB|Gilead Sciences Ireland|Amfóterícín||167840||167840|215257||2|H|L|0|||0
153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|808|2610|lyfalmen|||2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||808||808|2610||1|0|G|0|||0
153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|36692|49682|lyfalmen|V0452|49682|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Exemestan||36692||36692|49682||1|0|G|0|||0
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|JAS|0|0|1|100|SEK|3482|6291|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3482||3482|6291||1|0|E|0|||0
153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012|30.06.2021|R|1|0|0|0|0|ATE|0|0|1|100|XEU|1181|3123|lyfalmen|||2|24|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1181||1181|3123||1|0||2|25|töflur|0
154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|G|0|TVA|0|0|1|100|IKR|726|2131|lyfalmen|V0908|2048|2|30|0|30,0000|Alvogen|Teva B.V.|Deslóratadín||460||460|2131||2|0|G|0|||0
154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|1|G|0|ALE|0|0|0|100|SEK|20816|19375|lyfalmen|V0183|19375|2|1|0|27,9070|Alvogen|Alvogen Pharma Trading Europe EOOD|Góserelín||12988||12988|19375||2|0|G|0|||0
154116|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|6978|5352|lyfalmen|V0995|5283|2|7,5|0|75,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||2800||2800|5352||2|0|G|0|||0
154147|R03AL0801|Trelegy Ellipta|innönddu|||30|skammtar|1|innö.t|92 mcg/55 mcg/22 mcg|R03AL08|01.06.2019||R|0|0|0|G|0|GSD|0|0|0|100|DKK|8237|12835|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Trading Services Ltd.|Vilanterol, umeclidinium bromide, fluticasone furoate||8237||8237|12835||1|0|G|0|||0
154377|G03CA0325|Estrofem 1 mg|filmhtfl|1|mg|84|stk|1|skífup||G03CA03|01.05.2020||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2132|4432|lyfalmen|V0129|2211|1|84|0|42,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2132||2132|4432||1|0|G|0|||0
154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||12499||1|0|G|0|||0
154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20148|28757|lyfalmen|||1|28|0|42,0000|Eisai AB|Eisai GmbH|Perampanel||20148||20148|28757||1|0|G|0|||0
154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|16665|24436|lyfalmen|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||16665||16665|24436||1|0|0|0|||0
154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|19041|27706|lyfalmen|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||19041||19041|27706||1|0|0|0|||0
154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|23820|33401|lyfalmen|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||23820||23820|33401||1|0|0|0|||0
154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|FKA|0|0|0|100|DKK|21732|30760|lyfalmen|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||21732||21732|30760||1|0|0|0|||0
154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|21791|30835|lyfalmen|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||21791||21791|30835||1|0|0|0|||0
154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|26410|36677|lyfalmen|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||26410||26410|36677||1|0|0|0|||0
154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|14207|21052|lyfalmen|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||14207||14207|21052||1|0|0|0|||0
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|G|0|PLS|0|0|1|100|DKK|2845|5414|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2845||2845|5414||1|0|G|0|||0
154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|20996|29829|lyfalmen|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||20996||20996|29829||1|0|0|0|||0
154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3274|2746|lyfalmen|V0334|2528|2|98|0|73,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Venlafaxín||907||907|2746||1|0|G|0|||0
154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5738|2745|lyfalmen|V0335|2528|2|98|0|147,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Venlafaxín||906||906|2745||1|0|G|0|||0
155121|L04AA4001|Mavenclad|töflur|10|mg|4|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|0|MRP|0|1|0|100|SEK|1226497|1531930|lyfsjukr|||1|4|0|117,6471|Icepharma hf|Merck Europe B.V.|Cladribine||1226497||1226497|1531930||2|0|L|0|||0
155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1559|3644|lyfalmen|V0247|3644|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||1559||1559|3644||2|0|G|0|||0
155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|2913|5052|lyfalmen|V0248|5050|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||2582||2582|5052||2|0|G|0|||0
155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|5508|4274|lyfalmen|V0249|4274|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||2017||2017|4274||2|0|G|0|||0
155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|16556|24286|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||16556||16556|24286||1|0||0|||0
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1452|3496|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1452||1452|3496||1|0|G|0|||0
155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|5384|6600|lyfalmen|V0253|4878|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3707||3707|6600||1|0|G|0|||0
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|G|0|LBK|0|0|0|100|DKK|626|2360|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||626||626|2360||1|0|G|0|||0
155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1319|2966|lyfalm11|V0590|2930|2|84|0|84,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Desógestrel||1319||1319|2966||1|0||0|||1
155485|L01XK0101|Lynparza|filmhtfl|150|mg|56|stk|1|þpakki||L01XK01|01.03.2020||R|0|0|1|0|0|AZA|0|1|0|100|SEK|358801|452759|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||358801||358801|452759||1|0|L|0|||0
155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|RHG|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0||0|||0
155579|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|0|SSE|0|0|1|100|DKK|35768|48513|lyfalmen|||1|50|0|8,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||35768||35768|48513||1|0|E|0|||0
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|JAS|0|0|1|100|SEK|5615|9226|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||5615||5615|9226||1|0|E|0|||0
156066|J05AR0603|Efavirenz/Emtricitabine/Tenofovir Krka|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.06.2020||R|0|0|1|0|0|KAN|0|1|0|100|IKR|59860|78985|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||59860||59860|78985||2|0|L|0|||0
156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|19129|27827|lyfalmen|V0383|18962|2|100|0|25,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||19129||19129|27827||1|0|G|0|||0
156427|J02AC0106|Fungyn|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.11.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|4589|2737|lyfalmen|V0552|2737|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||900||900|2737||2|0|E|0|||0
156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|G|0|NED|0|0|0|100|XEU|4861|8189|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||4861||4861|8189||2|0|G|0|||0
156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|G|0|NED|0|0|0|100|XEU|5642|9264|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5642||5642|9264||2|0|G|0|||0
156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|MEA|0|0|1|100|DKK|368|2004|lyfalmen|||2|15|0|3,7500|Icepharma hf|Meda AB|Nítrófúrantóín||368||368|2004||2|0|0|0|||0
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|CNI|0|0|0|100|SEK|606|2332|lyfalmen|||1|6|0|3,0000|Vistor hf|McNeil Sweden AB|Mebendazól||606||606|2332||1|0||0|||0
156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|0|0|0|RPG|1|0|0|100|DKK|7349|13544|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||7049||7049|13544||2|0|0|1|30|dagar|0
157054|N06BA0202|Attentin|töflur|10|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|8684|13451|lyfalmen|||1|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||8684|13451||2|0|E|1|30|dagar|0
157257|QJ01DB0101|Cefabactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2589|5082|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||2589|5082||2|0||0|||0
157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2|0||2|||0
157673|D05AX5205|Calcipotriol/Betamethasone Teva|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2021||R|0|0|0|G|0|TVI|0|0|0|100|XEU|11091|16227|lyfalmen|V1030|16227|2|120|0||Teva Pharma Iceland ehf|Teva B.V|Kalcípótríól í blöndum||10701||10701|16227||1|0|G|0|||0
157745|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|20|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|60953|80367|lyfalmen|||1|200|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||60953||60953|80367||2|H|0|0|||0
157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|1|0|0|SAR|0|1|0|100|DKK|36901|45276|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||33209||33209|45276||1|0|L|0|||0
157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|G|0|HES|0|0|0|100|DKK|1374|3389|lyfalmen|||1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1374||1374|3389||1|0|G|0|||0
157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|ALM|0|0|0|100|DKK|6043|9816|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||6043||6043|9816||1|0||0|||0
157995|J06BA0210|Octagam 10%|irl|100|mg/ml|20|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|22726|32017|lyfsjukr|||1|20|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||22726||22726|32017||1|H|L|0|||0
158007|J06BA0210|Octagam 10%|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|56815|75133|lyfsjukr|||1|50|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||56815||56815|75133||1|H|L|0|||0
158018|J06BA0210|Octagam 10%|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|113629|147834|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||113629||113629|147834||1|H|L|0|||0
158040|J06BA0210|Octagam 10%|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|227257|289155|lyfsjukr|||1|200|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||227257||227257|289155||1|H|L|0|||0
158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|SNP|0|0|0|100|XEU|956|2814|lyfalmen|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||956||956|2814||1|H|0|0|||0
158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|ASA|0|0|0|100|SEK|18815|27395|lyfalmen|V0910|7540|1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||18815|27395||1|0||0|||0
158608|J02AX0501|Mycamine|irþstofn|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|APG|0|0|0|100|XEU|42532|57068|lyfalmen|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||42532|57068||1|H|0|0|||0
158619|J02AX0501|Mycamine|irþstofn|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|APG|0|0|0|100|XEU|65233|85780|lyfalmen|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||65233||65233|85780||1|H|0|0|||0
158639|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.12.2016||R|1|0|0|0|0|GPA|0|0|0|100|XEU|3757|3545|lyfalmen|V0143|3396|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1487||1487|3545||1|0|E|0|||0
158698|L01BC5901|Lonsurf|filmhtfl|21,14|mg|60|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|237290|301634|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||237290||237290|301634||2|0|L|0|||0
158849|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|13593|3392|lyfalmen|V0817|3325|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1376||1376|3392||2|0|E|0|||0
158860|J01FA0904|Clarithromycin Krka|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|1724|3871|lyfalmen|||2|14|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1724||1724|3871||2|0||0|||0
158992|A04AA0501|Aloxi|hylki|500|mcg|5|stk|1|þpakki||A04AA05|01.02.2021||R|0|0|0|0|0|HBL|0|0|1|100|DKK|53783|71298|lyfalmen|||1|5|0|5,0000|Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||53783||53783|71298||3|0|E|0|||0
159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|1891|4101|lyfalmen|V0219|4101|2|5|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||1891||1891|4101||1|0|G|1|30|dagar|0
159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|3360|6010|lyfalmen|V0220|6010|2|5|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||3278||3278|6010||1|0|G|1|30|dagar|0
159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|4851|8175|lyfalmen|||2|5|0|22,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||4851||4851|8175||1|0|G|1|30|dagar|0
159138|A02AA0403|Magnesia medic|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3180||2|0||0|||0
159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|4801|8106|lyfalmen|V0223|8106|2|5|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||4801||4801|8106||1|0|G|1|30|dagar|0
159207|G04CB0204|Dutasteride Sumar Pharma|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.04.2021||R|1|0|0|G|0|POF|0|0|0|100|DKK|2147|2783|lyfalmen|V0909|2783|2|30|0|30,0000|Alvogen|Alvogen|Dútasteríð||934||934|2783||2|0|G|0|||0
159387|N06BA0905|Atomoxetin STADA|hylki|25|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4800|3425|lyfalmen|V0814|3425|2|30|0|9,3750|LYFIS ehf|LYFIS ehf|Atomoxetín||1400||1400|3425||2|0|E|0|||0
159405|A10BD2401|Steglujan|filmhtfl|115|mg|28|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|10023|15082|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||9869||9869|15082||1|0|G|0|||0
159454|L01XG0102|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XG01|01.12.2015||R|0|0|0|0|0|IPC|0|1|0|100|SEK|122999|145533|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomib||111779||111779|145533||2|H|L|0|||0
159458|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.11.2016||L|1|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0||0|||0
159605|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.09.2017||R|0|0|0|0|0|ESS|0|0|0|100|DKK|41575|55858|lyfalmen|||1|5|0|5,0000|Essential Pharma Ltd.|Essential Pharma Ltd.|Samtengt laxakalsítónín||41575||41575|55858||2|H|0|0|||0
159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|G|0|MYL|0|0|1|100|SEK|651|2394|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||651||651|2394||2|0|G|0|||0
159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|G|0|MYL|0|0|1|100|SEK|1599|3699|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1599||1599|3699||2|0|G|0|||0
159711|R03AK0605|Salmex|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.01.2021||R|0|0|0|G|0|GPN|0|0|0|100|DKK|5006|7831|lyfalmen|V0981|6271|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||4601||4601|7831||2|0|G|0|||0
159762|N06DA0304|Nimvastid|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|74,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G|0|||0
159765|N05AX1212|Abilify Maintena (Lyfjaver)|sts|400|mg|1|hgl|1|pakki||N05AX12|01.05.2019||R|0|0|0|0|0|LVR|0|0|0|100|DKK|41073|55223|lyfalmen|V0980|55223|3|1|0|30,0800|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||41073||41073|55223||3|0|E|0|||0
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|GRP|0|0|0|100|DKK|128314|166098|lyfalmen|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||128314||128314|166098||1|H|0|0|||0
159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|NIL|1|0|0|100|XEU|3930|7626|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Flunixinum||3930||3930|7626||2|0||0|||0
160155|L04AB0102|Benepali|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|0|SUG|0|1|0|100|XEU|58592|77381|lyfsjukr|||2|4|0|14,2900|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||58592||58592|77381||2|0|L|0|||0
160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|G|0|ATE|0|0|1|100|XEU|5354|2976|lyfalmen|V0010|2193|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1074||1074|2976||1|0|E|0|||0
160487|N06BA0409|Methylphenidate STADA|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|5600|7898|lyfalmen|V0996|7001|2|30|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||4650||4650|7898||2|0|E|1|30|dagar|0
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981|30.06.2021|R|1|0|0|G|0|SNP|0|0|0|100|XEU|780|2572|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||780||780|2572||1|0|G|0|||0
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.12.1972|31.08.2021|R|0|0|0|0|0|PLS|0|0|0|100|DKK|855|2675|lyfalmen|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||855||855|2675||1|H|0|0|||0
161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1377|3393|lyfalmen|V0169|2599|1|14|0|8,1667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1377||1377|3393||1|0|E|0|||0
161117|H02AB0901|Solu-Cortef|sts|100|mg|5|hgl|1|pakki|Act-O-Vial |H02AB09|01.08.1998|31.08.2021|R|0|0|0|G|0|PLS|0|0|1|100|DKK|2355|4739|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||2355||2355|4739||1|0|G|0|||0
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.12.1972|31.08.2021|R|0|0|0|G|0|PLS|0|0|1|100|DKK|563|2273|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||563||563|2273||1|0|G|0|||0
161180|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|1582|2435|lyfalmen|V0143|1132|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||681||681|2435||1|0|E|0|||0
161424|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10000|7692|lyfalmen|V0145|7167|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4500||4500|7692||2|0|E|0|||0
161488|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.06.2021||R|0|0|0|0|0|PEU|0|0|1|100|DKK|9640|14766|lyfalmen|V1049|14766|1|53|0|23,7500|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||9640|14766||1|0||0|||0
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|G|0|PLS|0|0|0|100|DKK|53679|71167|lyfalmen|V0452|49682|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||53679||53679|71167||1|0|G|0|||0
161592|J01DD0103|Cefotaxim Navamedic|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|0|NAV|0|0|1|100|DKK|6094|9886|lyfalmen|||2|100|0|2,5000|Icepharma hf|Navamedic ASA|Cefotaximum||||6094|9886||2|0|0|0|||0
161596|R03BA0501|Flixotide|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.08.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2516|4961|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2516||2516|4961||1|0|G|0|||0
161824|A06AX0401|Constella|hylki|290|mcg|90|stk|1|glas||A06AX04|01.12.2016||R|0|0|0|G|0|AGC|0|0|0|100|XEU|26277|36509|lyfalmen|||1|90|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||26277||26277|36509||1|0|G|0|||0
162055|QN02BG9102|Librela|stl|10|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|10607|20294|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||10607||10607|20294||2|0||2|||0
162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|ROD|0|0|0|100|DKK|511279|642399|lyfalmen|||1|60|0|30,0000|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||511279||511279|642399||1|0|E|0|||0
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1823|4007|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1823||1823|4007||1|0|G|0|||0
162440|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|13997|20763|lyfalmen|V0145|10751|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||13997||13997|20763||2|0|E|0|||0
162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|LEV|1|0|0|100|XEU|5292|10210|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|Detomidinum||5292||5292|10210||2|0||0|||0
162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2337|3794|lyfalmen|V0041|3794|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1668||1668|3794||2|0|G|0|||0
162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BLS|0|0|0|100|XEU|463|2054|lyfalmen|V0500|2054|2|100|0|25,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Metformín||404||404|2054||1|0|G|0|||0
162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BLS|0|0|0|100|XEU|669|2419|lyfalmen|||2|100|0|42,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Metformín||669||669|2419||1|0|G|0|||0
162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BLS|0|0|0|100|XEU|418|2073|lyfalmen|V0502|2073|2|60|0|30,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Metformín||418||418|2073||1|0|G|0|||0
162872|L01AX0304|Temozolomide Accord|hylki|140|mg|5|stk|1|skpoki||L01AX03|01.10.2019||R|0|0|1|0|0|CLU|0|1|0|100|XEU|24287|33992|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||24287||24287|33992||1|0|L|0|||0
162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1118|3037|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1118||1118|3037||1|0|G|0|||0
163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|9129|14063|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai GmbH|Rúfínamíð||9129||9129|14063||1|0|G|0|||0
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|0|0|0|HES|0|0|0|100|DKK|1149|3079|lyfalmen|V0671|2701|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1149||1149|3079||1|0|E|1|30|dagar|0
163164|QH01CA9002|Busol|stl|0,004|mg/ml|10|ml|5|hgl|lausn|QH01CA90|01.11.2018||R|0|0|0|0|0|TPW|1|0|0|100|IKR|14280|27263|vetalmen|||0|50|0||Dýraheilsa ehf|T.P. Whelehan Son & Co. Ltd.|Buserelin||14280||14280|27263||2|0||0|||0
163239|L04AX0306|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3795|6721|lyfalmen|||1|1|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3795||3795|6721|31.8.2021|2|0|G|0|||0
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|1062|2960|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1062||1062|2960||1|0||0|||0
163324|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3291|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G|0|||0
163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|5918|9643|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||5918||5918|9643||1|0||0|||0
163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|10322|15705|lyfalmen|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||10322||10322|15705||2|H|0|0|||0
163445|A04AA0109|Ondansetron STADA|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|6200|9481|lyfalmen|V0383|9481|2|50|0|12,5000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||5800||5800|9481||2|0|G|0|||0
163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2276|4631|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2276||2276|4631||1|0|G|0|||0
163494|L01EX0201|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01EX02|01.06.2013||R|0|0|1|0|0|FIN|0|1|0|100|DKK|406804|512462|lyfsjukr|||1|112|0||Icepharma hf|Bayer AG|Sorafenib||406804||406804|512462||2|0|L|0|||0
163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1658|3780|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1658||1658|3780||1|0|G|0|||0
163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|G|0|RHG|0|0|1|100|XEU|570|2282|lyfalmen|||2|30|0|20,0000|Alvogen|ratiopharm GmbH|Íbúprófen||570||570|2282||2|0|G|0|||0
163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1710|3852|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm GmbH|Íbúprófen||1710||1710|3852||2|0|G|0|||0
163967|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2186|2|7|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||500||500|2186||2|0|G|0|||0
164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3459|6259|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3459||3459|6259||1|0|0|0|||0
164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|1|0|0|NRO|0|0|0|100|DKK|37022|50099|lyfalmen|||1|100|0||Pharmanovia A/S|Nova Laboratories Ireland Limited|Merkaptópúrín||37022||37022|50099||2|0|0|0|||0
164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|10386|19875|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||10386||10386|19875||1|0||0|||0
164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|361248|455803|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer AG|Riociguatum||361248||361248|455803||1|0|L|0|||0
164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|953|2810|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||953||953|2810||2|0|G|0|||0
164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|G|0|TIL|0|0|0|100|DKK|4963|8329|lyfalmen|||1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4963||4963|8329||2|0|G|0|||0
164944|M01AX0001|Harpatinum|hylki|225|mg|90|stk|1|þpakki||M01AX00|01.01.2018||L|0|0|0|0|0|FLO|0|0|1|100|IKR|||lyflausa|||0|90|0||Florealis ehf|Florealis ehf|Devil´s claw dry extrakt ethanolic 60%|||||||2|0||0|||0
165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1|0||0|||0
165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|ATE|0|0|0|100|GBP|3963|6953|lyfalmen|||2|100|0|33,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||3963||3963|6953||1|0||2|50|töflur|0
165179|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20148|28757|lyfalmen|||1|28|0|35,0000|Eisai AB|Eisai GmbH|Perampanel||20148||20148|28757||1|0|G|0|||0
165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|LAS|1|0|0|100|XEU|6474|12453|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6474||6474|12453||2|0||0|||0
165507|L01CE0201|Irinotecan Actavis|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01CE02|01.04.2018||R|0|0|0|0|0|ATE|0|0|0|100|XEU|8026|12545|lyfalmen|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Irinotecan||8026||8026|12545||1|H|0|0|||0
165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|156885|201632|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|Merck AB|Sómatrópín||156885||156885|201632||2|0|L|0|||0
165689|N06AB0406|Citalopram STADA|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.09.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2600|5077|lyfalmen|V0318|5077|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||2600||2600|5077||2|0|G|0|||0
165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|184638|236149|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer AG|Riociguatum||184638||184638|236149||1|0|L|0|||0
165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3923|6898|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3923||3923|6898||1|0|0|0|||0
165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|RPG|1|0|0|100|XEU|5602|10799|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|butylscopolamine and analgesics||||5602|10799||2|0||0|||0
166029|G04BE0309|Vizarsin|munndr.t|50|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8916|6728|lyfalmen|||2|24|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3800||3800|6728||2|0|E|0|||0
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1432|3469|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1432||1432|3469||1|0|G|0|||0
166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|1|G|0|PLS|0|0|0|100|DKK|13507|20089|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||13507||13507|20089||1|0|G|0|||0
166277|C10AA0508|Lipistad|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2665|2806|lyfalmen|V0113|2735|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0
166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1806|3984|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1806||1806|3984||2|0|G|0|||0
166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|G|0|MYL|0|0|1|100|SEK|3418|6202|lyfalmen|V0428|6202|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||3418||3418|6202||2|0|G|0|||0
166628|L04AB0401|Humira|stl|40|mg/penna|0,4|ml|2|áfpen|áfylltur penni|L04AB04|01.11.2016||R|0|1|1|0|0|ABD|0|1|0|100|DKK|115189|149774|lyfsjukr|||1|0,8|0|27,5900|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Adalimumab||115189||115189|149774||1|0|L|0|||0
167366|C01CA1702|Midodrin Evolan|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|G|0|EVO|0|0|0|100|IKR|8346|12985|lyfalmen|V0968|10556|2|50|0|4,1666|LYFIS ehf|Evolan Pharma AB|midodrine||8346||8346|12985||2|0|G|0|||0
167588|B02BD0208|Afstyla|sts|500|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|40766|54834|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||40766||40766|54834||2|0|L|0|||0
167753|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2548|3907|lyfalmen|||2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1750||1750|3907|31.7.2021|2|0|G|0|||0
167887|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|1220|2668|lyfalmen|V0189|2668|2|100|0|50,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||850||850|2668||2|0|G|0|||0
167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1679|2936|lyfalmen|V0005|2874|2|28|0|37,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||1045||1045|2936||1|0|E|0|||0
168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|1|0|0|GEI|0|1|0|100|DKK|130481|168793|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||130481||130481|168793||2|0|L|0|||0
168079|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.02.2021||R|1|0|0|0|0|VAL|0|0|0|100|XEU|1947|3564|lyfalmen|V0123|3564|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1501||1501|3564||2|0|E|0|||0
168083|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|G|0|GOV|0|0|0|100|IKR|19158|16638|lyfalmen|V0420|16638|2|90|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||11000||11000|16638||2|0|G|0|||0
168119|B06AC0102|Berinert|sts/irs|500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|1|0|0|CSB|0|1|0|100|SEK|96479|125300|lyfsjukr|||1|1|0|0,3571|Icepharma hf|CSL Behring GmbH|C1 hemill||96479||96479|125300||2|0|L|0|||0
168222|B05BA1024|SmofKabiven extra Nitrogen|irl|||1518|ml|4|pokar|fleyti|B05BA10|01.05.2021||R|0|0|0|0|0|FKA|0|0|0|100|DKK|40073|53958|lyfalmen|||1|6072|0||Vistor hf|Fresenius Kabi AB|Blöndur||40073||40073|53958||1|0|0|0|||0
168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|G|0|ATE|0|0|1|100|IKR|5208|5737|lyfalmen|V0007|4939|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lansóprazól||3080||3080|5737||1|0|E|0|||0
168388|L04AC1301|Taltz|stl|80|mg|1|ml|1|áfpen||L04AC13|01.06.2020||R|0|0|1|0|0|NED|0|1|0|100|XEU|140867|181710|lyfsjukr|||1|1|0|27,5862|Icepharma hf|Eli Lilly Nederland B.V.|Ixekizumab||140867||140867|181710||2|0|L|0|||0
168640|L04AX0307|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2367|4756|lyfalmen|||1|0,3|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2367||2367|4756||2|0|G|0|||0
168662|L04AX0307|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2818|5377|lyfalmen|||1|0,5|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2818||2818|5377||2|0|G|0|||0
168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|G|0|HES|0|0|0|100|DKK|3127|5802|lyfalmen|V0240|5322|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||3127||3127|5802||1|0|G|0|||0
168778|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|G|0|HES|0|0|0|100|DKK|5700|9343|lyfalmen|||1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||5700||5700|9343||1|0|G|0|||0
169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8106|12655|lyfalmen|V0688|12655|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||8106||8106|12655||2|0|E|0|||0
169293|L01XX2702|Arsenic Trioxide Accord|irþ|1|mg/ml|10|ml|10|hgl||L01XX27|01.05.2020||R|0|0|0|0|0|CLU|0|1|0|100|XEU|496647|624201|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Arsenic trioxide||496647||496647|624201||1|H|L|0|||0
169402|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|2815|2461|lyfalmen|V0994|2448|2|2,5|0|25,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||700||700|2461||2|0|G|0|||0
169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1522|3216|lyfalmen|V0411|3216|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1248||1248|3216||2|0|E|0|||0
169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1007|2450|lyfalmen|V0177|2450|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||692||692|2450||2|0|E|0|||0
169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|994|2439|lyfalmen|V0418|2438|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||684||684|2439||2|0|E|0|||0
169872|QG03XA9101|Improvac|stl|||100|ml|1|glas||QG03XA91|01.04.2019||R|0|0|0|0|0|ZBE|0|0|0|100|IKR|9550|18289|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||9550||9550|18289||2|0|0|0|||0
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3104|5770|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||3104||3104|5770||2|0||0|||0
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3824|6761|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||3824||3824|6761||2|0||0|||0
169944|L01ED0501|Lorviqua|filmhtfl|100|mg|30|stk|1|þpakki||L01ED05|01.04.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|713029|893320|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Europe MA EEIG|Lorlatinib||713029||713029|893320||1|0|L|0|||0
169998|S01GA0101|Cleye|augndr|0,12|mg/ml|10|ml|1|glas||S01GA01|01.08.2017||L|0|0|0|0|0|EVE|0|0|0|100|IKR|||lyflausa|||1|10|0||LYFIS ehf|Elara Pharmaservices Europe Limited|Nafazólín|||||||2|0||0|||0
170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|RRG|0|1|0|100|DKK|19775|28716|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||19775||19775|28716||2|H|L|0|||0
170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|RRG|0|1|0|100|DKK|49177|65473|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||49177||49177|65473||2|H|L|0|||0
170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|GBI|0|0|0|100|DKK|4952|8314|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4952||4952|8314||1|0||0|||0
170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|RRG|0|1|0|100|DKK|98485|127837|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||98485||98485|127837||2|H|L|0|||0
170237|L04AA2701|Gilenya|hylki|0,25|mg|28|stk|1|þpakki||L04AA27|01.07.2019||R|0|1|1|0|0|NEL|0|1|0|100|DKK|249192|316436|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||249192||249192|316436||1|0|L|0|||0
170309|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.07.2018||R|1|0|0|G|0|BLS|0|0|0|100|XEU|888|2201|lyfalmen|V0108|2201|2|100|0|33,3400|Artasan ehf|Bluefish Pharmaceuticals AB|Simvastatín||511||511|2201||1|0|G|0|||0
170335|N02AX0213|Tramadol Krka|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|1|100|IKR|550|2248|lyfalmen|V0226|2248|2|20|0|6,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||545||545|2248||2|0|G|1|30|dagar|0
170486|C10AX1401|Praluent|stl|75|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|179753|230074|lyfalmen|||1|6|0|83,3333|Vistor hf|Sanofi-aventis groupe|Alirocumab||179753||179753|230074||1|0|E|0|||0
170534|L01ED0401|Alunbrig|filmhtfl|180|mg|28|stk|1|þpakki||L01ED04|01.02.2021||R|1|1|1|0|0|ASS|0|1|0|100|DKK|665177|833805|lyfsjukr|||1|28|0||Vistor hf|Takeda AS|Brigatinib||665177||665177|833805||1|0|L|0|||0
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2278|4633|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín í blöndum||2278||2278|4633||2|0||0|||0
170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|1|0|0|SAR|0|1|0|100|DKK|29144|36448|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||26229||26229|36448||1|0|L|0|||0
170758|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|G|0|AZD|0|0|1|100|SEK|893|2727|lyfalmen|||1|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||893||893|2727||1|0|G|0|||0
170881|QM01AC0607|Meloxoral|mixtúra|0,5|mg/ml|5|ml|1|glas|handa köttum|QM01AC06|01.12.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|1158|2276|vetalmen|||0|5|0||Dýraheilsa ehf|Le Vet B.V.|Meloxícam||1158||1158|2276||2|0||0|||0
170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|0|0|CPV|0|1|0|100|DKK|49084|65355|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe B.V.|Azasitidín||49084||49084|65355||2|H|L|0|||0
171292|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|12809|13886|lyfalmen|V0441|12504|2|100|0|200,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||9000||9000|13886||2|0|G|0|||0
171340|R01AX0302|Lomuspray|nefúði|21|mcg/sk|15|ml|1|úðaílá|180 sk, lausn|R01AX03|01.04.2020||L|0|0|0|G|0|SNP|0|0|1|100|XEU|||lyfalmen|||1|15|0|15,7500|Vistor hf|Sanofi-aventis Norge AS|Ípratrópínbrómíð|||||2934||1|0|G|0|||0
171486|L04AB0202|Remsima|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|0|0|0|0|HUN|0|1|0|100|DKK|44506|59565|lyfsjukr|||2|1|0|26,6700|Vistor hf|Celltrion Healthcare Hunary Kft|Infliximab||44506||44506|59565||1|H|L|0|||0
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3146|5828|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||||3146|5828||2|0||0|||0
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3570|6412|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||3570||3570|6412||2|0||0|||0
171762|A03AA0407|Duspatalin Retard|forðahlk|200|mg|30|stk|1|þpakki||A03AA04|01.11.2016||R|0|0|0|G|0|MYL|0|0|0|100|DKK|1188|3133|lyfalmen|||1|30|0|20,0000|Icepharma hf|Mylan AB|Mebeverín||1188||1188|3133||2|0|G|0|||0
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|2831|5395|lyfalmen|V0247|3644|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2831||2831|5395||1|0|G|0|||0
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|4906|8251|lyfalmen|V0248|5050|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4906||4906|8251||1|0|G|0|||0
172269|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|200|stk|1|þpakki||N03AX14|01.12.2019||R|1|0|0|G|0|ASR|0|0|0|100|IKR|13449|9756|lyfalmen|V0253|9756|2|200|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||6000||6000|9756||2|0|G|0|||0
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|9077|13992|lyfalmen|V0249|4274|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||9077||9077|13992||1|0|G|0|||0
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|16449|24138|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||16449||16449|24138||1|0|G|0|||0
172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|15257|22498|lyfalmen|||1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||15257||15257|22498||1|0||0|||0
172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|G|0|RDT|0|0|0|100|DKK|8625|13369|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||8625||8625|13369||1|0|G|0|||0
172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2549|2377|lyfalmen|V0284|2329|2|100|0|6,2500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||639||639|2377||1|0|G|0|||0
173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|7140|7802|lyfalmen|V0118|7714|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rósuvastatín||4580||4580|7802||1|0|E|0|||0
173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3948||1|0|E|0|||0
173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|1|0|0|RAG|0|1|0|100|DKK|11736|17651|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||11736||11736|17651||1|0|L|0|||0
174063|C03EA0115|Amiloride/HCT Alvogen|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.03.2020||R|1|0|0|G|0|POF|0|0|0|100|IKR|2015|4271|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||2015||2015|4271||2|0|G|0|||0
174267|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|ílát|150+37,5+200 mg|N04BA03|01.05.2021||R|1|0|0|G|0|LVR|0|0|0|100|DKK|11165|16865|lyfalmen|V0900|16865|3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11165||11165|16865||3|0|G|0|||0
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989|31.07.2021|R|0|0|0|0|0|MEA|0|0|1|100|DKK|541|2243|lyfalmen|||1|14|0|7,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||541||541|2243||2|0|E|0|||0
174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|G|0|LPT|0|0|0|100|XEU|1344|3348|lyfalmen|||1|5|0|25,0000|Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1344||1344|3348||1|0|G|0|||0
174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5489|lyfalmen|||2|30|0|4,5000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5489||2|0|G|0|||0
174626|A10AE0601|Tresiba|stl|200|ae/ml|3|ml|3|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|G|0|NAS|0|0|0|100|DKK|9899|15123|lyfalmen|||1|9|0|45,0000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||9899||9899|15123||1|0|G|0|||0
174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|G|0|LPT|0|0|0|100|XEU|3517|6339|lyfalmen|V0368|4497|1|15|0|75,0000|Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Brímónidín||3517||3517|6339||1|0|G|0|||0
174806|J05AE1002|Darunavir Alvogen|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.07.2017||R|1|0|1|0|0|ALO|0|1|0|100|XEU|50206|45083|lyfsjukr|||2|30|0|20,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||33056||33056|45083||2|0|L|0|||0
174825|N02CX0001|Glitinum|hylki|100|mg|30|stk|1|þpakki||N02CX|01.12.2018||L|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|30|0||Florealis ehf|Florealis ehf|Tanacetum parthenium|||||||2|0||0|||0
174903|N06BA1201|Elvanse Adult|hylki|70|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|15416|22717|lyfalmen|||1|30|0|70,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||15416||15416|22717||1|0|E|1|30|dagar|0
175246|B02BD0205|Elocta|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|22265|31434|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||22265|31434||3|0|L|0|||0
175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|G|0|NAA|0|0|1|100|DKK|6725|8749|lyfalmen|||1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||5268||5268|8749||1|0|G|0|||0
175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|CHP|0|0|0|100|XEU|5004|9664|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||5004||5004|9664||2|0||0|||0
175351|L01XC0203|Truxima|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|0|CTH|0|1|0|100|DKK|173832|222710|lyfsjukr|||2|50|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||173832||173832|222710||1|H|L|0|||0
175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|NED|0|0|0|100|XEU|4371|7514|lyfalmen|V0278|3747|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4371||4371|7514||2|0|E|0|||0
176472|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.09.2017||R|0|0|0|G|0|KPA|0|0|1|100|DKK|1292|3276|lyfalmen|||1|100|0||Alvogen|Karo Pharma AB|Hýdrókortisón||1292||1292|3276||2|0|G|0|||0
176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|2486|4431|lyfalmen|V0429|4098|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2131||2131|4431||2|0|G|0|||0
176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|RNE|0|0|1|100|DKK|2582|5052|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||2582||2582|5052||1|0|0|0|||0
176773|R02AA0308|Strepsils Ingefær|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2018||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
176835|C09CA0106|Losatrix|filmhtfl|25|mg|100|stk|1|þpakki||C09CA01|01.01.2018||R|1|0|0|G|0|RTH|0|0|0|100|IKR|3105|5772|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Lósartan||3105||3105|5772||2|0|G|0|||0
176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6188|10666|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||6188||6188|10666||2|0||0|||0
177099|L01XC1901|Blincyto|st/irþ|38,5|mcg/ml|1|hgl|1|pakki|lausn|L01XC19|01.04.2017||R|0|1|0|0|0|AEB|0|1|0|100|DKK|404100|509098|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Blinatumomab||404100||404100|509098||1|H|L|0|||0
177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|7378|11653|lyfalmen|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||7378||7378|11653||2|0|0|0|||0
177199|L01EF0101|Ibrance|hylki|125|mg|21|stk|1|þpakki||L01EF01|01.02.2017||R|1|0|1|0|0|PEU|0|1|0|100|DKK|306824|388114|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||306824||306824|388114||1|0|L|0|||0
177320|A04AA0501|Aloxi|hylki|500|mcg|1|stk|1|þpakki||A04AA05|01.02.2021||R|0|0|0|0|0|HBL|0|0|1|100|DKK|11002|16641|lyfalmen|||1|1|0|1,0000|Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||11002||11002|16641||3|0|E|0|||0
177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|ATE|0|0|1|100|XEU|951|2807|lyfalmen|V0231|2565|2|300|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól||||951|2807||1|0|0|0|||0
177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|DOR|1|0|0|100|XEU|4296|8321|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4296||4296|8321||2|0||0|||0
177723|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.11.2020||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3475|3396|lyfalmen|V0143|3396|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1379||1379|3396||2|0|E|0|||0
177754|N06AX1203|Wellbutrin Retard (Lyfjaver)|töflur|150|mg|30|stk|1|askja|m/br. losunarhraða|N06AX12|01.10.2020||R|0|0|0|0|0|LVR|0|0|0|100|DKK|2477|4907|lyfalmen|V1028|4907|3|30|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Bupropionum||2477||2477|4907||3|0|E|0|||0
177882|L04AX0501|Esbriet|filmhtfl|801|mg|84|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|340226|429657|lyfalmen|||1|84|0|28,0350|Icepharma hf|Roche Registration GmbH|Pírfenidon||||340226|429657||2|0|E|0|||0
177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|G|0|ATE|0|0|0|100|XEU|8738|11719|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kolkisín||7426||7426|11719|31.7.2021|1|0|G|0|||0
178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|31892|43611|lyfalmen|V0975|42899|1|100|0|50,0000|Icepharma hf|Bayer AG|Rivaoxaban||31892||31892|43611||2|0|G|0|||0
178273|L01EE0101|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01EE01|01.01.2016||R|0|0|1|0|0|NEL|0|1|0|100|DKK|775038|970442|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||775038||775038|970442||1|0|L|0|||0
178511|B02BD0205|Elocta|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|89064|115922|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||89064|115922||3|0|L|0|||0
178752|L04AD0204|Dailiport|forðahlk|1|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|9511|14589|lyfalmen|||2|50|0|10,0000|Artasan ehf|Sandoz A/S|Tacrolimus||9511||9511|14589||1|0|G|0|||0
178991|N05AH0416|Quetiapin Medical Valley|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|3000|4788|lyfalmen|V0275|4788|2|100|0|12,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||2390||2390|4788||2|0|0|0|||0
179100|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|0|SDG|0|1|0|100|DKK|129665|151651|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||116698||116698|151651||1|0|L|0|||0
179207|N02BE0122|Dolorin|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|8567|13290|lyfalmen|V1035|13280|1|28|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||||8567|13290||2|0|G|0|||0
179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|16785|24601|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||16785||16785|24601||1|0||0|||0
179733|N02AA0507|OxyContin Depot|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|1301|3289|lyfalmen|V0597|2719|1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||1301||1301|3289||2|0|G|1|30|dagar|0
179790|N06BA0903|Atomoxetin Medical Valley|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2020||R|1|1|0|0|0|VAL|0|0|0|100|XEU|7427|11720|lyfalmen|V0818|11719|2|28|0|35,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||7427||7427|11720||2|0|E|0|||0
180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|1|0|0|WIL|0|1|0|100|XEU|109514|142716|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||109514||109514|142716||2|0|L|0|||0
180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|G|0|MED|0|0|0|100|IKR|5799|4939|lyfalmen|V0148|4726|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||2500||2500|4939||2|0|G|0|||0
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|G|0|PLS|0|0|1|100|DKK|668|2417|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||668||668|2417||1|0|G|0|||0
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
181502|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|60|pokar|lausn|B05BA03|01.07.2021||R|0|0|0|0|0|BAM|0|0|0|100|SEK|9097|14019|lyfalmen|||1|6000|0||Icepharma hf|Baxter Medical AB|Kolvetni||9097||9097|14019||2|0|0|0|||0
181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|0|0|PLS|0|0|0|100|DKK|9179|14132|lyfalmen|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||9179||9179|14132||1|H|0|0|||0
181890|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.11.2016||L|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1|0||0|||1
181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|5745|9405|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||5745||5745|9405||1|0||0|||0
182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||6402||2|0|G|0|||0
182177|J02AC0106|Fungyn|hylki|150|mg|4|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|2031|2186|lyfalmen|V0556|2186|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||500||500|2186||2|0|E|0|||0
182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|9079|13994|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||9079||9079|13994||1|0|G|0|||0
182416|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|glas|47,5 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|1309|3300|lyfalmen|V0048|3006|2|100|0|33,3333|Artasan ehf|Hexal A/S|Metóprólól||1309||1309|3300||1|0|G|0|||0
182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|14213|21061|lyfalmen|||2|50|0|8,3333|Icepharma hf|Abcur AB|Noradrenalín||14213||14213|21061||2|H|0|0|||0
182561|L01EB0201|Erlotinib WH|filmhtfl|150|mg|30|stk|1|þpakki||L01EB02|01.06.2020||R|0|1|1|0|0|WEH|0|1|0|100|XEU|298592|285751|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlotinib||224520||224520|285751||2|0|L|0|||0
182569|N06BA0902|Atomoxetin Actavis|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7765|3392|lyfalmen|V0817|3325|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1376||1376|3392||1|0|E|0|||0
182763|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|16329|31150|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||16329||16329|31150||1|0||0|||0
182805|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.03.2021||R|1|0|0|G|0|NEL|0|0|0|100|DKK|6468|10400|lyfalmen|V0024|10400|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6468||6468|10400||1|0|G|0|||0
182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|0|0|0|RPG|1|0|0|100|XEU|19360|36900|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||19360|36900||2|0||1|30|dagar|0
183133|J01DD5201|Zavicefta|st/irþ|||20|ml|10|hgl|2g/0,5g|J01DD52|01.12.2017||R|0|0|0|0|0|PIP|0|0|1|100|DKK|166903|214092|lyfalmen|||1|200|0|3,3333|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftazidime og beta-laktamasa hemill||166903||166903|214092||1|0|0|0|||0
183175|R03AK1401|Atectura Breezhaler|innönddu|187,5|mcg/sk|90|stk|3|stsk.þ|125 mcg/62,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|11280|17024|lyfalmen|||1|270|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||11280||11280|17024||1|0|G|0|||0
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|IBV|1|0|0|100|DKK|5062|9774|vetalmen|||0|50|0||Vistor hf|Intervet International BV|Flunixinum||5062||5062|9774||1|0||0|||0
183366|L04AD0204|Dailiport|forðahlk|0,5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|5694|9335|lyfalmen|||2|50|0|5,0000|Artasan ehf|Sandoz A/S|Tacrolimus||5694||5694|9335||1|0|G|0|||0
183455|C10AX0903|Ezetimib Krka|töflur|10|mg|30|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3187|5885|lyfalmen|V0612|5885|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||3187||3187|5885||2|0|E|0|||0
183485|L01EF0201|Kisqali|filmhtfl|200|mg|21|stk|1|þpakki||L01EF02|01.11.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|141910|183008|lyfsjukr|||1|21|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||141910||141910|183008||1|0|L|0|||0
183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|G|0|ALK|0|0|1|100|DKK|5435|8979|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5435|8979||1|0|G|0|||0
183794|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|G|0|LVR|0|0|0|100|DKK|27579|38156|lyfalmen|V0652|38156|3|168|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban 	||27579||27579|38156||3|0|G|0|||0
183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6537|11267|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||6537||6537|11267||2|0||0|||0
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|G|0|MDK|0|0|0|100|SEK|1715|3858|lyfalmen|||1|100|0|100,0000|Icepharma hf|Mylan Denmark ApS|Flúdrókortisón||1715||1715|3858||2|0|G|0|||0
183924|N06BA0905|Atomoxetin STADA|hylki|40|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4500|3425|lyfalmen|V0815|3425|2|30|0|15,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||1400||1400|3425||2|0|E|0|||0
184205|L04AC0501|Stelara|irþ|130|mg|26|ml|1|hgl|lausn|L04AC05|01.09.2017||R|0|0|0|0|0|JCI|0|1|0|100|SEK|334222|422190|lyfsjukr|||1|26|0|240,7407|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||334222||334222|422190||1|H|L|0|||0
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|G|0|TIL|0|0|0|100|DKK|2978|5597|lyfalmen|V0017|5597|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||2978||2978|5597||2|0|G|0|||0
184247|V08CA0901|Gadovist|stl|1|mmol/ml|10|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|BAB|0|0|0|100|DKK|41317|55531|lyfalmen|||1|50|0||Icepharma hf|Bayer AB|Gadóbútról||||41317|55531||2|H|0|0|||0
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|G|0|HES|0|0|0|100|DKK|44049|58987|lyfalmen|V0185|21702|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||44049||44049|58987||1|0|G|0|||0
184418|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|5|hgl|lausn|QB03AC|01.07.2017||R|0|0|0|0|0|PHM|0|0|0|100|XEU|11998|22933|vetalmen|||0|500|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||11998||11998|22933||2|0||0|||0
184731|N05AX1205|Aripiprazol Krka|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|0|0|0|0|KRK|0|0|0|100|IKR|3362|6125|lyfalmen|V0690|6125|2|28|0|9,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||3362||3362|6125||2|0|E|0|||0
185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Alvogen|ratiopharm GmbH|Krómóglíkatsýra|||||||2|0||0|||0
185248|G03AA0707|Microstad|húðuðtfl|||63|stk|1|þpakki|150/30 mcg|G03AA07|01.05.2017||R|0|0|0|0|0|ASR|0|0|0|100|IKR|985|2554|lyfalm11|V0545|1872|1|63|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Levónorgestrel og ethinylestradíól||985||985|2554||2|0||0|||1
185822|A02BC0512|Nexium (Lyfjaver)|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.10.2020||R|1|0|0|0|0|LVR|0|0|1|100|DKK|9146|6165|lyfalmen|V0011|4827|3|100|0|66,6667|Lyfjaver ehf|Lyfjaver ehf|Esómeprazól||3391||3391|6165||3|0|E|0|||0
185859|C02AC0201|Intuniv|forðatfl|4|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|12638|18893|lyfalmen|||1|28|0|37,3333|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||12638||12638|18893||1|0|E|0|||0
186026|B02BD0205|Elocta|sts|3000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|267191|338822|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||267191|338822||3|0|L|0|||0
186236|N06BA0409|Methylphenidate STADA|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|4000|6040|lyfalmen|V0960|5406|2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0
186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|ATE|0|0|1|100|XEU|16694|10633|lyfalmen|V0419|10633|2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||6637||6637|10633||1|0|E|0|||0
186615|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|15245|18624|lyfalmen|||2|360|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||12443||12443|18624||2|0|G|0|||0
186638|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.10.2019||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1|0||0|||0
186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|935|2719|lyfalmen|V0597|2719|2|28|0|3,7300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||887||887|2719||1|0|G|1|30|dagar|0
186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|10028|3081|lyfalmen|V0607|3081|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Memantín||1150||1150|3081||2|0|G|0|||0
186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|5849|9548|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||5849||5849|9548||1|0||0|||0
187067|L04AB0205|Flixabi|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|1|0|0|0|SUG|0|1|0|100|XEU|39518|53256|lyfsjukr|||2|1|0|26,6700|Icepharma hf|Samsung Bioepis NL B.V.|Infliximab||39518||39518|53256||2|H|L|0|||0
187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2459|4882|lyfalmen|V0462|4882|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4882||2|0|G|0|||0
187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|5474|9435|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5474||5474|9435||2|0||0|||0
187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|G|0|MEA|0|0|1|100|DKK|3645|6515|lyfalmen|||1|30|0||Icepharma hf|Meda AB|Pímekrólímus||3645||3645|6515||2|0|G|0|||0
187612|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|854|2673|lyfalmen|V0066|2673|2|100|0|100,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||854||854|2673||1|0|G|0|||0
188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||3132||2|0|G|0|||0
188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|PEU|0|0|0|100|DKK|66436|87302|lyfalmen|||1|10|0|5,0000|Icepharma hf|Pfizer Europe MA EEIG|Tigecýklín||66436||66436|87302||1|H|0|0|||0
188405|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|G|0|POF|0|0|0|100|XEU|2002|3747|lyfalmen|V0621|2934|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||1634||1634|3747||2|0|G|0|||0
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|G|0|DEA|0|0|0|100|XEU|5069|8475|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||5069||5069|8475||1|0|G|0|||0
188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|G|0|LTH|0|0|0|100|SEK|5263|8742|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||5263||5263|8742||1|0|G|0|||0
188829|R06AX2707|Dasselta|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|1400|3012|lyfalmen|V0458|2979|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||1100||1100|3012||2|0|G|0|||0
188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|G|0|ABC|0|0|1|100|IKR|2931|3631|lyfalmen|V0422|3287|2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||1550||1550|3631||2|0|G|0|||0
189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|PSA|0|0|0|100|DKK|9062|13270|lyfalmen|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||8553||8553|13270||2|H|0|0|||0
189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|1|0|0|JCI|0|1|0|100|SEK|39270|52942|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||39270||39270|52942||1|0|L|0|||0
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|HES|0|0|0|100|DKK|6393|10297|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||6393||6393|10297||1|H|0|0|||0
189312|N02CD0101|Aimovig|stl|140|mg|1|ml|1|áfpen||N02CD01|01.12.2019||R|0|0|1|0|0|NEL|0|0|0|100|DKK|72491|94960|lyfalmen|||1|1|0|56,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||72491||72491|94960||1|0|E|0|||0
189430|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|5098|8515|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||5098||5098|8515||2|0|G|1|30|dagar|0
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|2522|4969|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2522||2522|4969||1|0|G|0|||0
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|964|2825|lyfalmen|V0413|2825|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||964||964|2825||1|0|G|0|||0
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|467|2141|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||467||467|2141||1|0|G|0|||0
189567|D01BA0203|Terbinafin Actavis|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.2021||R|1|0|0|0|0|ATE|0|0|0|100|XEU|5807|8822|lyfalmen|V0737|8787|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín||5321||5321|8822||1|0|E|0|||0
190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|G|0|AEP|0|0|0|100|DKK|1603|3704|lyfalmen|||1|90|0|45,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1603||1603|3704||2|0|G|0|||0
190696|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|1038|2737|lyfalmen|V0685|2676|2|70|0|5,8333|Acare ehf|Medical Valley Invest AB|Pregabalín||900||900|2737||2|0|E|0|||0
190715|M04AA0106|Allopurinol Alvogen|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.03.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|2615|5097|lyfalmen|||2|100|0|75,0000|Alvogen|Alvogen|Allópúrinol||2615||2615|5097||2|0|G|0|||0
191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||4002||1|0|G|0|||0
191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3330|6081|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3330||3330|6081||1|0|0|0|||0
191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|5089|4932|lyfalmen|V0117|4773|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rósuvastatín||2495||2495|4932||1|0|E|0|||0
191242|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|þpakki||C07AA07|01.08.2020||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1139|3066|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||1139||1139|3066||2|0|G|0|||0
191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3416|6200|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3416||3416|6200||1|0|0|0|||0
191251|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2149|3108|lyfalmen|V0088|3108|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1170||1170|3108||2|0|G|0|||0
191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3616|6475|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3616||3616|6475||1|0|0|0|||0
191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
191724|S01ED5119|Cosopt sine|augndr|25|mg/ml|10|ml|1|glas|20mg/ml+5mg/ml|S01ED51|01.05.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3364|6128|lyfalmen|||1|10|0|50,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3364||3364|6128||2|0|G|0|||0
191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.12.2018||R|1|0|0|0|0|ATE|0|0|0|100|XEU|17525|8474|lyfalmen|V0689|6053|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||5068||5068|8474||1|0|E|0|||0
192030|QD06AA0203|Cyclospray|húðúði|78,6|mg/g|200|ml|1|úðaílá||QD06AA02|01.12.2016||R|0|0|0|0|0|ERO|0|0|0|100|XEU|1072|2107|vetalmen|||0|200|0||Vistor hf|Eurovet Animal Health B.V.|Chlortetracycline||1072||1072|2107||1|0||0|||0
192400|J05AB1106|Valablis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.05.2017||L|1|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír||||||31.8.2021|2|0|0|0|||0
192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|4925|7891|lyfalmen|||2|96|0|48,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||4645||4645|7891||1|0|G|0|||0
192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|2860|4098|lyfalmen|V0429|4098|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||1889||1889|4098||1|0|G|0|||0
192617|C03AB0101|Centyl med kaliumklorid|filmhtfl|||100|stk|1|glas|2,5 mg / 573 mg|C03AB01|01.12.1972||R|1|0|0|G|0|KPA|0|0|0|100|DKK|2392|4790|lyfalmen|||1|100|0|100,0000|Alvogen|Karo Pharma AB|Bendróflúmetíazíð og kalíum||2392||2392|4790||2|0|G|0|||0
192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|6210|10045|lyfalmen|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6210||6210|10045||2|0|0|0|||0
192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|0|0|TIC|0|1|0|100|XEU|139523|180039|lyfsjukr|||2|1|0||Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Dexametasón||139523||139523|180039||1|H|L|0|||0
193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2552|2741|lyfalmen|V0233|2206|2|12|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||903||903|2741||1|0|G|0|||0
193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|G|0|MCS|0|0|0|100|SEK|806|2607|lyfalmen|||1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||806||806|2607||1|0|G|0|||0
193285|N06DX0109|Marbodin|filmhtfl|10|mg|98|stk|1|stsk.þ||N06DX01|01.11.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4000|5627|lyfalmen|V0605|2817|2|98|0|49,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||3000||3000|5627||2|0|G|0|||0
193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|20,0000|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2760||1|0|E|0|||0
193975|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfspr||R03DX10|01.12.2018||R|0|0|1|0|0|ZEN|0|1|0|100|SEK|332676|420267|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||332676||332676|420267||1|0|L|0|||0
194245|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3475|3396|lyfalmen|V0143|3396|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1379||1379|3396||2|0|E|0|||0
194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|2349|2273|lyfalmen|V0556|2186|2|4|0|3,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||563||563|2273||1|0|E|0|||0
194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5127|9897|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||5127||5127|9897||2|0||0|||0
194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|G|0|ATE|0|0|1|100|IKR|5841|5765|lyfalmen|V0012|5765|2|100|0|133,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||3100||3100|5765||1|0|G|0|||0
195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|G|0|MYL|0|0|0|100|SEK|2756|5180|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||2675||2675|5180||2|0|G|0|||0
195104|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0
195449|A02BC0403|Rabeprazol Krka|sh-tfl|10|mg|14|stk|1|þpakki||A02BC04|01.01.2019||L|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|7,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól|||||||2|0||0|||0
195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|BAM|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||13320||2|0||0|||0
195518|N05AH0206|Clozapin Medical|töflur|100|mg|500|stk|1|glas||N05AH02|01.01.2018||R|1|0|0|G|0|MED|0|0|0|100|IKR|23000|28570|lyfalmen|||2|500|0|166,6666|Medical ehf|Medical ehf|Klózapín||20000||20000|28570||2|0|G|0|||0
195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|52295|69416|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|Merck AB|Sómatrópín||52295||52295|69416||2|0|L|0|||0
195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|1|0|0|JAN|0|1|0|100|DKK|142748|184050|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||142748||142748|184050||1|0|L|0|||0
195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|895|2730|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||895||895|2730||1|0|G|0|||0
195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|KPA|0|0|1|100|SEK|632|2368|lyfalmen|||1|15|0||Alvogen|Karo Pharma AB|Blöndur||632||632|2368||2|0|E|0|||0
195999|M05BA0606|Ibandronic acid WH|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|G|0|WEH|0|0|0|100|IKR|3842|3893|lyfalmen|V0205|3838|2|3|0|90,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||1740||1740|3893||2|0|G|0|||0
196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|G|0|MYL|0|0|0|100|SEK|3077|5180|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2675||2675|5180||2|0|G|0|||0
196218|N02AA0508|Oxycodone Alvogen|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1582|3675|lyfalmen|V0584|3536|2|28|0|7,4700|Alvogen|Alvogen ehf|Oxýcódon||1582||1582|3675||2|0|G|1|30|dagar|0
196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|IKR|2615|5097|lyfalmen|||2|100|0|75,0000|Alvogen|ratiopharm GmbH|Allópúrinol||2615||2615|5097||2|0|G|0|||0
196518|L01CE0101|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01CE01|01.04.2019||R|0|0|0|0|0|NEL|0|0|0|100|DKK|52577|69773|lyfalmen|||1|1|0||Vistor hf|Novartis Europharm Ltd|Topotecan||52577||52577|69773||1|H|0|0|||0
196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|||0|100|0|0,8000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||2141||1|0|E|0|||0
196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|G|0|AEP|0|0|0|100|DKK|5797|9477|lyfalmen|||1|100|0|0,8333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||5797||5797|9477||2|0|G|0|||0
196889|D07AB0202|Locoid Crelo|húðfl|0,1|%|30|g|1|glas|á húð|D07AB02|01.03.2018||R|0|0|0|G|0|CPM|0|0|1|100|DKK|580|2296|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||580||580|2296||1|0|G|0|||0
196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|19638|28528|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||19638|28528||1|0|L|0|||0
197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|IKR|842|2657|lyfalmen|||2|100|0|25,0000|Alvogen|ratiopharm GmbH|Allópúrinol||842||842|2657||2|0|G|0|||0
197320|L04AB0204|Inflectra|st/irþ|100|mg|100|mg|1|hgl||L04AB02|01.06.2020||R|0|0|0|0|0|PEU|0|1|0|100|DKK|39772|53577|lyfsjukr|||2|100|0|26,6700|Icepharma hf|Pfizer Europe MA EEIG|Infliximab||39772||39772|53577||1|H|L|0|||0
197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3659|6534|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||3659||3659|6534||2|0||0|||0
197927|L01EX0901|Ofev|hylki|100|mg|60|stk|1|þpakki||L01EX09|01.07.2016||R|0|0|1|0|0|BOE|0|0|0|100|DKK|240316|305397|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||240316||240316|305397||1|0|E|0|||0
198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
198361|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|2872|3563|lyfalmen|||2|14|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1500||1500|3563|31.7.2021|2|0||0|||0
198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|3429|2943|lyfalmen|V0069|2943|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Lósartan||1050||1050|2943||2|0|G|0|||0
198665|H01BA0208|NOCDURNA|frþ.tfl|50|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|G|0|FEL|0|0|0|100|DKK|3773|6691|lyfalmen|||1|30|0|3,7500|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3773||3773|6691||1|0|G|0|||0
199454|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|G|0|DSA|0|0|0|100|XEU|7830|12275|lyfalmen|V0805|9749|1|28|0|14,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||7830|12275||2|0|G|0|||0
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|PLS|0|0|1|100|DKK|590|2310|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||590||590|2310||1|0||2|30|töflur|0
199637|A02AA0403|Magnesia medic|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2299||2|0||0|||0
199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|70351|92254|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||70351|92254||1|0|L|0|||0
199903|A10BK0401|Steglatro|filmhtfl|15|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|5568|9162|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Ertugliflozin||5568||5568|9162||1|0|G|0|||0
199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|BMS|0|1|0|100|DKK|2125442|2649966|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2125442||2125442|2649966||1|H|L|0|||0
370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|36567|69545|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||36567||36567|69545||1|0||0|||0
370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1783|3952|lyfalmen|||2|20|0|5,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1783||1783|3952||2|0|E|0|||0
370901|L01EB0202|Varlota|filmhtfl|100|mg|30|stk|1|þpakki||L01EB02|01.07.2017||R|1|1|1|0|0|ALO|0|1|0|100|XEU|239151|282154|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlotinib||221628||221628|282154||2|0|L|0|||0
371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0||0|||0
371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0||0|||0
371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||9888||1|0|E|0|||0
371826|L01ED0301|Alecensa|hylki|150|mg|224|stk|1|þpakki|4 x 56|L01ED03|01.06.2017||R|0|0|1|0|0|RRG|0|1|0|100|DKK|725308|908591|lyfsjukr|||1|224|0||Icepharma hf|Roche Registration GmbH|Alectinib||725308||725308|908591||2|0|L|0|||0
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|3473|6278|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3473||3473|6278||1|0|G|0|||0
372074|L01XX3502|Anagrelide AOP|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.05.2020||R|0|0|1|G|0|AOP|0|0|0|100|XEU|30377|41694|lyfalmen|V1034|33750|1|100|0||AOP Orphan Pharmaceuticals AG|AOP Orphan Pharmaceuticals AG|Anagrelidum||||30377|41694||2|0|G|0|||0
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|G|0|ROA|0|0|0|100|DKK|3059|5708|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||3059||3059|5708||2|0|G|0|||0
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
372180|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|25|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|WIL|0|1|0|100|XEU|6656|10659|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||6656||6656|10659||2|H|L|0|||0
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
372531|N06BA0408|Methylphenidate Teva|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|7794|7001|lyfalmen|V0996|7001|2|30|0|40,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||3998||3998|7001||1|0|E|1|30|dagar|0
372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2847||2|0|G|0|||0
372780|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.07.2021||L|0|0|0|0|0|KRK|0|0|1|100|IKR|||lyflausa|||2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól|||||||2|0|0|0|||0
373184|P01BB5103|Malastad|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.01.2018||R|1|0|0|0|0|ASR|0|0|0|100|IKR|3105|5772|lyfalmen|V0934|5772|2|12|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Prógúaníl í blöndum||3105||3105|5772||2|0||0|||0
373205|V04CX0005|Hexvix|duft|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.05.2018||R|0|0|0|0|0|CUR|0|0|0|100|XEU|77464|101250|lyfalmen|||1|1|0||PhotoCure ASA|PhotoCure ASA|Önnur sjúkdómsgreiningarefni||||77464|101250||3|H|0|0|||0
373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2770|5311|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|5311||2|0|G|0|||0
373239|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|5098|7500|lyfalmen|||2|60|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4361||4361|7500||2|0|G|0|||0
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|11838|17792|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||11838||11838|17792||1|0|G|0|||0
373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|80072|104549|lyfalmen|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||80072||80072|104549||2|0|G|0|||0
373324|R03AK0601|Seretide|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3566|6406|lyfalmen|V0436|5527|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3566||3566|6406||1|0|G|0|||0
373340|R03AK0601|Seretide|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4354|7491|lyfalmen|V0437|5304|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4354||4354|7491||1|0|G|0|||0
373365|R03AK0601|Seretide|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5516|9090|lyfalmen|V0981|6271|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5516||5516|9090||1|0|G|0|||0
373611|J07AL0103|Pneumovax|stl|25|mcg|0,5|ml|1|áfspr|lausn|J07AL01|01.06.2017||R|0|0|0|0|0|MBV|0|0|0|100|DKK|3958|6946|lyfalmen|||1|0,5|0||Vistor hf|Merck Sharp & Dohme B.V.|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||3958||3958|6946||1|0||0|||0
373887|A05AA0401|Ocaliva|töflur|5|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|0|ILT|0|1|0|100|XEU|389790|491301|lyfsjukr|||1|30|0|15,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||389790||389790|491301||2|0|L|0|||0
374036|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.12.2016||R|0|0|0|0|0|EUS|0|0|0|100|XEU|7904|12377|lyfalmen|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||7904||7904|12377||3|H|0|0|||0
374077|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
374143|L01EX0401|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01EX04|01.07.2012||R|1|1|1|0|0|GEB|0|1|0|100|XEU|338194|417563|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetanib||330502||330502|417563||1|0|L|0|||0
374194|L01EE0101|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01EE01|01.01.2016||R|0|0|1|0|0|NEL|0|1|0|100|DKK|222612|283378|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||222612||222612|283378||1|0|L|0|||0
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|G|0|MCK|0|0|0|100|SEK|459|2130|lyfalmen|V0500|2054|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||459||459|2130||2|0|G|0|||0
374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|5136|8567|lyfalmen|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5136||5136|8567||1|0|0|0|||0
374348|G04CA0201|Omnic|hylki|0,4|mg|30|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|G|0|ASP|0|0|0|100|XEU|3573|6416|lyfalmen|V0926|4386|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3573||3573|6416||1|0|G|0|||0
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|G|0|GPH|0|0|1|100|DKK|10112|15416|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||10112||10112|15416||1|0|G|0|||0
374450|L01EF0101|Ibrance|hylki|100|mg|21|stk|1|þpakki||L01EF01|01.02.2017||R|1|0|1|0|0|PEU|0|1|0|100|DKK|306824|388114|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||306824||306824|388114||1|0|L|0|||0
374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|1 hgl og1 áf spr+ 2 aðsk nálar|J07CA06|01.04.2020||R|0|0|0|0|0|SSS|0|0|0|100|XEU|5019|8406|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||5019||5019|8406|31.7.2021|1|0||0|||0
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|7608|11970|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7608||7608|11970||1|0|G|0|||0
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|10082|15375|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10082||10082|15375||1|0|G|0|||0
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|11967|17969|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11967||11967|17969||1|0|G|0|||0
374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6083|9871|lyfalmen|V0383|9481|2|50|0|12,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||6083||6083|9871||1|0|G|0|||0
374941|QJ01CA0403|Amoxibactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|2720|3774|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||1920||1920|3774||2|0|0|0|||0
375005|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|3056520|3807966|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||3056520||3056520|3807966||2|H|L|0|||0
375153|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3448|5352|lyfalmen|V0580|5159|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||2800||2800|5352||2|0|G|0|||0
375275|J02AC0304|Voriconazole Accord|filmhtfl|50|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|G|0|ACC|0|0|1|100|XEU|10630|16129|lyfalmen|V1033|16129|2|30|0|3,7500|Artasan ehf|Accord Healthcare Limited|Voricónazól||||10630|16129||1|0|G|0|||0
375508|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|1|glas||S01EE05|01.03.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|2415|4822|lyfalmen|||1|3|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2415||2415|4822||2|0|G|0|||0
376235|A04AA5501|Akynzeo|hylki|||1|stk|1|þpakki|300 mg/0,5 mg|A04AA55|01.02.2021||R|1|0|0|0|0|HBI|0|0|1|100|DKK|10336|15724|lyfalmen|||1|1|0||Swedish Orphan Biovitrum A/S|Helsinn Birex Pharmaceuticals Ltd.|Palonosetron,combinations||10336||10336|15724||3|0|E|0|||0
376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|G|0|AZA|0|0|0|100|SEK|30329|41634|lyfalmen|V0459|40443|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||30329||30329|41634||1|0|G|0|||0
376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|5438|8983|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||5438||5438|8983||1|0|G|0|||0
376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|15812|23262|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||15812||15812|23262||1|0|G|0|||0
376510|R06AE0706|Zensitin|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0||0|||0
376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|82791|107988|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||82791||82791|107988||1|0|G|0|||0
377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|BRO|1|0|0|100|IKR|13110|22596|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||13110||13110|22596||2|0||0|||0
377249|C10AX1301|Repatha|stl|140|mg|6|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|200915|256393|lyfalmen|||1|6|0|84,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||200915||200915|256393||1|0|E|0|||0
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|G|0|GPH|0|0|1|100|DKK|8561|7631|lyfalmen|V0182|4214|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||4456||4456|7631||1|0|G|0|||0
377504|G04CB0203|Dutasteride ratiopharm|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.06.2018|31.07.2021|R|1|0|0|G|0|TVA|0|0|0|100|DKK|2135|2777|lyfalmen|||2|30|0|30,0000|Alvogen|Teva B.V.|Dútasteríð||929||929|2777||2|0|G|0|||0
377577|G03DA0408|Cyclogest|sk-stíll|400|mg|15|stk|1|pakki||G03DA04|01.05.2020||R|0|0|1|G|0|GRI|0|0|0|100|SEK|4843|8164|lyfalmen|||1|15|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Prógesterón||4843||4843|8164||3|0|G|0|||0
377640|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|0|SDG|0|1|0|100|DKK|25933|32795|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||23341||23341|32795||1|0|L|0|||0
377966|R03AK0606|Salmeterol/Fluticasone Neutec|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2021||R|0|0|0|G|0|NET|0|0|0|100|DKK|5006|6271|lyfalmen|V0981|6271|2|60|0|30,0000|Lyfjaver ehf|Neutec Inhaler Ireland Limited|Salmeteról og fluticason||3468||3468|6271||3|0|G|0|||0
378432|L01EM0101|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01EM01|01.07.2016||R|1|0|1|0|0|GSE|0|1|0|100|DKK|531886|668028|lyfsjukr|||1|60|0|20,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||531886||531886|668028||2|0|L|0|||0
378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|2048|4317|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2048||2048|4317||1|0|G|0|||0
378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012|30.06.2021|R|0|0|0|0|0|ALM|0|0|0|100|XEU|15505|22839|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||15505||15505|22839||1|0|E|0|||0
378801|A10BH0102|Januvia (Lyfjaver)|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.06.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|14629|21633|lyfalmen|V0982|21633|3|98|0|49,0000|Lyfjaver ehf|Lyfjaver ehf|Sítagliptín||14629||14629|21633||3|0|G|0|||0
378870|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|þpakki|12,5+50 mg|N04BA02|01.02.2018||R|1|0|0|G|0|MSD|0|0|0|100|DKK|1794|3967|lyfalmen|||1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1794||1794|3967||1|0|G|0|||0
379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1298|3284|lyfalmen|V0677|2753|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1298||1298|3284||1|0|G|0|||0
379173|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|5289|7004|lyfalmen|V0830|7004|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4000||4000|7004||2|0|G|0|||0
379419|B02BD0205|Elocta|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|178128|228053|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||178128|228053||3|0|L|0|||0
379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|116029|150819|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||116029||116029|150819||1|0|L|0|||0
379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|HES|0|1|0|100|DKK|109224|91254|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||69561||69561|91254||1|0|L|0|||0
379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|HES|0|1|0|100|DKK|119554|100051|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||76516||76516|100051||1|0|L|0|||0
379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|HES|0|1|0|100|DKK|152533|126745|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||97621||97621|126745||1|0|L|0|||0
379796|N04BC0408|Ropinirole Alvogen|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|G|0|POF|0|0|0|100|XEU|5438|6767|lyfalmen|V0532|6767|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||3828||3828|6767||2|0|G|0|||0
379875|N05BA0105|Stesolid|eþ-lausn|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2962|5575|lyfalmen|||2|12,5|0|2,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||2962||2962|5575||1|0||2|50|túpur|0
379883|N05BA0105|Stesolid|eþ-lausn|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2901|5491|lyfalmen|||2|12,5|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||2901||2901|5491||1|0||2|25|túpur|0
379945|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.09.2017||R|1|0|0|G|0|BLS|0|0|0|100|XEU|2173|3143|lyfalmen|V0322|2971|2|100|0|100,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Sertralín||1195||1195|3143||1|0|G|0|||0
380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2|0||2|||0
380308|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2075|3563|lyfalmen|V0687|2612|2|56|0|28,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E|0|||0
380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|27530|38094|lyfalmen|V0653|38094|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||27530|38094||1|0|G|0|||0
380621|D07AD0101|Dermovat|smyrsli|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|561|2270|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||561||561|2270||1|0|G|0|||0
380658|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|90|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|8271|8937|lyfalmen|V1010|8937|2|90|0|90,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||5405||5405|8937||2|0|G|0|||0
380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|KRK|0|0|0|100|IKR|10426|10169|lyfalmen|V0195|10169|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6300||6300|10169||2|0|E|0|||0
380922|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.09.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|538|2238|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||538||538|2238||1|0|G|0|||0
380973|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.05.2021||R|0|0|0|0|0|TEA|0|0|0|100|SEK|21420|30366|lyfalmen|V1042|30366|1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||21420||21420|30366||1|H|0|0|||0
381120|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|2956|5095|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2956||2956|5095||2|0||0|||0
381510|A10BK0101|Forxiga|filmhtfl|5|mg|98|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|G|0|AZE|0|0|0|100|SEK|21515|30486|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||21515||21515|30486||1|0|G|0|||0
381578|M02AA1506|Diclofenac Teva|hlaup|23,2|mg/g|100|g|1|túpa||M02AA15|01.07.2021||L|0|0|0|0|0|TVI|0|0|1|100|IKR|||lyflausa|||0|100|0||Teva Pharma Iceland ehf|Teva B.V|Díklófenak|||||||1|0||0|||0
381794|V03AC0301|Exjade|filmhtfl|360|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|294851|373223|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||294851||294851|373223||1|0||0|||0
382162|N04BC0408|Ropinirole Alvogen|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|XEU|5958|9392|lyfalmen|V0533|9392|2|84|0|56,0000|Alvogen|Alvogen|Rópíníról||5735||5735|9392||2|0|G|0|||0
382318|S01XA2103|Cystadrops|augndr|3,8|mg/ml|5|ml|1|glas||S01XA21|01.01.2019||R|0|0|1|0|0|OUS|0|0|0|100|XEU|180695|231245|lyfalmen|||1|5|0||Recordati AB|Orphan Europe SARL|mercaptamine ||180695||180695|231245||3|0||0|||0
382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
382474|V03AN0502|Airapy|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
382657|B02BD0205|Elocta|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|133596|172667|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||133596|172667||3|0|L|0|||0
382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|4709|7979|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4709||4709|7979||1|0|G|0|||0
383037|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfspr||N02CD03|01.11.2019||R|0|0|1|0|0|TGH|0|0|0|100|XEU|69871|91646|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||69871||69871|91646||1|0|E|0|||0
383105|J06BA0104|Cutaquig|stl|165|mg/ml|6|ml|1|hgl||J06BA01|01.04.2020||R|0|0|1|0|0|OCT|0|1|0|100|DKK|11394|17181|lyfsjukr|||1|6|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||11394||11394|17181||1|0|L|0|||0
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1201|2037|vetorma|||0|2|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||1182||1182|2037||2|0||0|||0
383238|N02AA0508|Oxycodone Alvogen|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|5390|7679|lyfalmen|V0585|7653|2|98|0|26,1300|Alvogen|Alvogen ehf|Oxýcódon||4491||4491|7679||2|0|G|1|30|dagar|0
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|60|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ketókónazól|||||||1|0||0|||0
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|120|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ketókónazól|||||||1|0||0|||0
383672|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.02.2019||R|1|0|0|G|0|ZRB|0|0|0|100|DKK|1590|3686|lyfalmen|||1|100|0|25,0000|zr pharma& GmbH|zr pharma& GmbH|Klómípramín||1590||1590|3686|31.7.2021|0|0|G|0|||0
383719|L01BA0402|Pemetrexed W&H|irþ|25|mg/hgl|20|ml|1|hgl||L01BA04|01.05.2020||R|0|0|0|0|0|WEH|0|1|0|100|XEU|154406|198549|lyfsjukr|||2|20|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||154406||154406|198549||2|H|L|0|||0
384125|A10BK0301|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|6686|10701|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6686||6686|10701||1|0|G|0|||0
384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|15|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín|||||||1|0||0|||0
384837|N07BC0102|Buvidal|stl|32|mg|0,64|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13183|19643|lyfsjukr|||1|0,64|0|15,2381|Vistor hf|Camurus AB|Búprenorfín||13183||13183|19643||1|H|L|1|30|dagar|0
384858|L01EA0103|Imatinib ratiopharm|filmhtfl|400|mg|30|stk|1|þpakki||L01EA01|01.01.2019||R|1|0|1|0|0|RTH|0|1|0|100|XEU|157883|103737|lyfsjukr|||2|30|0||Alvogen|ratiopharm GmbH|Imatinib||79430||79430|103737||2|0|L|0|||0
385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|7084|11248|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||7084||7084|11248||1|0||0|||0
385343|G04CB0107|Finasteride Medical Valley|filmhtfl|5|mg|100|stk|1|þpakki||G04CB01|01.05.2021||R|1|0|0|G|0|VAL|0|0|0|100|IKR|3900|2943|lyfalmen|V0445|2943|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Fínasteríð||1050||1050|2943||2|0|G|0|||0
386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|ROD|0|1|0|100|DKK|349024|440599|lyfsjukr|||1|1|0|50,0000|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||349024||349024|440599||1|0|L|0|||0
386950|L04AB0404|IDACIO|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.08.2020||R|0|1|1|0|0|FKA|0|1|0|100|DKK|33888|46135|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||33888||33888|46135||1|0|L|0|||0
386959|C03DA0406|Eplerenon Alvogen|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|POF|0|0|0|100|IKR|13329|6701|lyfalmen|V0111|6315|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||3780||3780|6701||2|0|E|0|||0
387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|G|0|NEL|0|0|0|100|DKK|7264|11496|lyfalmen|||1|15|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||7264||7264|11496||1|0|G|0|||0
387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|0|0|WEH|0|1|0|100|XEU|138771|179104|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||138771||138771|179104||2|H|L|0|||0
387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|0|100|XEU|865|2689|lyfalmen|V0308|2689|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||865||865|2689||2|0||2|60|mg|0
387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5375|10368|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5375||5375|10368||2|0||0|||0
387884|C01CA0701|Dobutamin Medical|irþ|12,5|mg/ml|20|ml|5|lykjur||C01CA07|01.10.2016|31.08.2021|R|0|0|0|0|0|DIC|0|0|0|100|IKR|6709|10732|lyfalmen|||2|100|0|2,5000|LYFIS ehf|Medical ehf|Dobutamin||6709||6709|10732||2|H|0|0|||0
387918|QD11AH9102|Cytopoint|stl|30|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|21935|41786|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||21935||21935|41786||2|0||0|||0
388032|A02BC0513|Esomeprazole Jubilant|sþ-tfl|20|mg|30|stk|1|þpakki||A02BC05|01.09.2019||L|1|0|0|0|0|JUB|0|0|0|100|IKR|||lyflausa|||2|30|0|20,0000|Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól|||||||2|0||0|||0
388180|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.2020||L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0
388256|N01BB2001|Emla|krem|50|mg/g|5|g|5|túpa|25mg/g+25mg/g|N01BB20|01.01.1987||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2447|4866|lyfalmen|V1024|4866|1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2447||2447|4866||2|0||0|||0
388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|MAR|0|0|0|100|IKR|||lyflausa|||0|2|0||Icepharma hf|Aspen Pharma|Blöndur|||||||2|0||0|||0
388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|62985|44129|lyfalmen|V0722|43747|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||32302||32302|44129||2|0||0|||0
388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|8520|13225|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||8520||8520|13225||2|0|G|0|||0
389095|A04AA0108|Cinveron|stl|2|mg/ml|4|ml|5|lykjur|lausn|A04AA01|01.07.2018||R|0|0|0|G|0|WEH|0|0|0|100|XEU|6382|10282|lyfalmen|||2|20|0|2,5000|Williams & Halls efh|Williams & Halls ehf|Ondansetrón||6382||6382|10282||2|H|G|0|||0
389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|G|0|MEA|0|0|0|100|DKK|2392|4263|lyfalmen|V0410|4263|1|84|0|84,0000|Icepharma hf|Meda AB|Noretísterón og östrógen||2009||2009|4263||2|0|G|0|||0
389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|G|0|MEA|0|0|0|100|DKK|750|2530|lyfalmen|V0128|2530|1|84|0|84,0000|Icepharma hf|Meda AB|Estradíól||750||750|2530||2|0|G|0|||0
389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|G|0|MEA|0|0|0|100|DKK|518|2211|lyfalmen|V0129|2211|1|84|0|42,0000|Icepharma hf|Meda AB|Estradíól||518||518|2211||2|0|G|0|||0
389330|L01BC5901|Lonsurf|filmhtfl|28,19|mg|60|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|306948|388269|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||306948|388269||2|0|L|0|||0
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|749|2529|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||749||749|2529||1|0|G|0|||0
389404|N06DA0405|Galantamin STADA|forðahlk|24|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|11830|17781|lyfalmen|||2|84|0|126,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||11830||11830|17781||2|0|G|0|||0
389424|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|VAL|0|0|0|100|IKR|7500|11821|lyfalmen|||2|100|0|300,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||7500||7500|11821||2|0|0|0|||0
389603|R06AX2709|Desloratadine Alvogen|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.11.2020||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2|0||0|||0
389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|40446|54430|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||40446|54430||2|0|G|0|||0
389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|14866|21959|lyfalmen|V1044|21957|1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||14866||14866|21959||1|0|G|0|||0
390439|R01AD0905|Mometason Apofri|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.10.2018||L|0|0|0|G|0|APO|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|LYFIS ehf|Apofri AB|Mómetasón|||||2753||2|0|G|0|||0
390541|R03DX0801|Cinqaero|irþ|10|mg/ml|10|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|0|TVB|0|1|0|100|NOK|65630|86282|lyfsjukr|||1|10|0|14,0845|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||65630||65630|86282||1|H|L|0|||0
390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|COR|0|0|0|100|DKK|73430|96148|lyfalmen|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||73430||73430|96148||1|H|0|0|||0
390835|A04AA0101|Zofran|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.07.2019||R|1|0|0|G|0|NAA|0|0|1|100|DKK|3208|5913|lyfalmen|V0381|4526|1|10|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3208||3208|5913||1|0|G|0|||0
390878|N06BA0202|Attentin|töflur|20|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|12127|18190|lyfalmen|||1|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||12127|18190||2|0|E|1|30|dagar|0
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|UPJ|0|0|1|100|DKK|5521|9097|lyfalmen|V0429|4098|1|100|0|50,0000|Icepharma hf|Upjohn EESV|Celekoxíb||5521||5521|9097||1|0|G|0|||0
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|UPJ|0|0|1|100|DKK|2590|5063|lyfalmen|V0037|3150|1|20|0|20,0000|Icepharma hf|Upjohn EESV|Celekoxíb||2590||2590|5063||1|0|G|0|||0
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|UPJ|0|0|1|100|DKK|9473|14537|lyfalmen|V0196|5989|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Celekoxíb||9473||9473|14537||1|0|G|0|||0
391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|0|1|0|0|NEL|0|1|0|100|DKK|258220|327665|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||258220||258220|327665||1|0|L|0|||0
392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|ATE|0|0|0|100|XEU|912|1991|lyfalm11|V0545|1872|2|63|0|84,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||528||528|1991||1|0||0|||1
392024|G04BE0311|Revastad|filmhtfl|20|mg|100|stk|1|þpakki||G04BE03|01.11.2017||R|0|0|1|G|0|ASR|0|0|0|100|IKR|45000|31099|lyfalmen|V0984|31099|2|100|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Síldenafíl||22000||22000|31099||2|0|G|0|||0
392196|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.07.2019||R|0|0|0|G|0|BAB|0|0|0|100|DKK|955|2812|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer AB|Noretísterón||955||955|2812||2|0|G|0|||0
392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|1|0|0|SAO|0|0|0|100|XEU|12397|18561|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||12397||12397|18561||2|0|E|0|||0
392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8790|10195|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||6319||6319|10195||1|0|G|0|||0
392438|L04AX0701|Tecfidera|hylki|120|mg|14|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|1|0|0|BNB|0|1|0|100|XEU|22584|31838|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||22584||22584|31838||2|0|L|0|||0
393642|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3474||1|0||0|||0
393939|S01EE0404|Travoprost Alvogen|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|G|0|POF|0|0|0|100|DKK|2139|3915|lyfalmen|V0669|3915|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1756||1756|3915||2|0|G|0|||0
394026|C10AA0704|Rosuvastatin Xiromed|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.04.2021||R|0|0|0|0|0|VAL|0|0|0|100|XEU|4806|7714|lyfalmen|V0118|7714|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||4516||4516|7714||2|0|E|0|||0
394139|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|VAL|0|0|0|100|XEU|1947|3564|lyfalmen|V0123|3564|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1501||1501|3564||2|0|E|0|||0
394364|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|49220|65527|lyfalmen|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||49220||49220|65527||2|0|0|0|||0
394768|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|4893|7377|lyfalmen|V0681|7377|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4271||4271|7377||1|0|E|1|30|dagar|0
395077|V03AC0301|Exjade|filmhtfl|90|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|79748|104139|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||79748||79748|104139||1|0||0|||0
395175|A10BJ0202|Saxenda|stl|6|mg/ml|3|ml|5|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.09.2017||R|0|0|0|0|0|NAS|0|0|0|100|DKK|33519|45668|lyfalmen|||1|15|0|60,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||33519||33519|45668||1|0|E|0|||0
395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|1|0|0|RAG|0|1|0|100|DKK|134703|174044|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||134703||134703|174044||1|0|L|0|||0
395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|5993|9747|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||5993||5993|9747||1|0||0|||0
395781|A04AA0109|Ondansetron STADA|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|10000|15262|lyfalmen|V0388|15262|2|50|0|25,0000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||10000||10000|15262||2|0|G|0|||0
395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|G|0|LVR|0|0|0|100|SEK|17100|25034|lyfalmen|V0356|25034|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||17100||17100|25034||3|0|G|0|||0
396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|4639|7883|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4639||4639|7883||1|0|G|0|||0
396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||5211||1|0|G|0|||0
396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|RPG|1|0|0|100|DKK|19960|38039|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||19960||19960|38039||2|0||0|||0
396463|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|dreifa,dreifa|J07CA06|01.04.2019||R|0|0|0|0|0|SSS|0|0|0|100|XEU|50456|67090|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||50456||50456|67090||1|0|0|0|||0
396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|2300|2048|lyfalmen|V0006|1224|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|2048||2|0|G|0|||0
396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|5272|10173|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||5272||5272|10173||1|0||0|||0
396873|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|50|stk|1|þpakki||J01CF01|01.07.2019||R|0|0|0|0|0|BLS|0|0|1|100|XEU|3134|5812|lyfalmen|||2|50|0|12,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||3134||3134|5812||1|0|0|0|||0
397353|N03AX1603|Pregabalin Krka|hylki|75|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|4186|3838|lyfalmen|V0686|3455|2|100|0|25,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3838||2|0|E|0|||0
397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|G|0|SHS|0|0|0|100|DKK|2162|2800|lyfalmen|V0250|2453|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||946||946|2800||1|0|G|0|||0
397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|0|0|MRP|0|1|0|100|SEK|30960|42432|lyfsjukr|||1|20|0||Icepharma hf|Merck Europe B.V.|Cetúxímab||30960||30960|42432||2|H|L|0|||0
397659|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|10|lykjur|innr.lyf, fleyti|N01AX10|01.05.2020||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3228|5941|lyfalmen|||2|200|0||Vistor hf|Fresenius Kabi AB|Própófól||3228||3228|5941||1|H|0|0|||0
397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5828||1|0|E|0|||0
397933|L04AA0607|Mycofenolsýra Accord|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|1|G|0|AEE|0|0|0|100|XEU|29443|33065|lyfalmen|V1008|31942|2|120|0|21,6000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||23554||23554|33065||1|0|G|0|||0
397981|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.08.2021||R|0|0|0|0|0|EIS|0|0|1|100|IKR|7518|6501|lyfalmen|V0010|3838|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6501||1|0|E|0|||0
398181|N05CD0804|Midazolam Accord|stl/irl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|0|AEE|0|0|0|100|XEU|1375|3390|lyfalmen|||2|50|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||1375||1375|3390||1|H|0|2|450|mg|0
398265|R03AL1201|Enerzair Breezhaler|innönddu|||90|stk|1|stsk.þ|114 mcg/46 mcg/136mcg|R03AL12|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|23815|33395|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Limited|Indacaterol, glycopyrronium bromide, mometasone||23815||23815|33395||1|0|G|0|||0
398565|N06AA0907|Amitriptylin Abcur|filmhtfl|10|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|627|2361|lyfalmen|||2|100|0|13,3333|Icepharma hf|Abcur AB|Amitriptýlín||627||627|2361||2|0|G|0|||0
398659|L01BB0503|Fludarabin Actavis|stl/irþ|25|mg/ml|2|ml|1|hgl|lausn|L01BB05|01.08.2019||R|0|0|0|0|0|ATE|0|0|0|100|XEU|21786|30829|lyfalmen|||2|2|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúdarabín||21786||21786|30829||1|H|0|0|||0
399039|R03DX0901|Nucala|sts|100|mg|1|hgl|1|pakki||R03DX09|01.06.2016||R|0|0|1|0|0|GSD|0|1|0|100|DKK|164991|211714|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||164991||164991|211714||1|0|L|0|||0
399210|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.07.2019||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
399390|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.06.2021||R|0|0|0|0|0|EIS|0|0|1|100|IKR|1160|1527|lyfalmen|V0003|1084|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1527||1|0|E|0|||0
399482|B02BD0101|Octaplex|irs|1000|ae|1|hgl|1|hgl|+leysir,lausn|B02BD01|01.02.2018||R|0|0|0|0|0|OCT|0|1|0|100|DKK|75283|98492|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||75283||75283|98492||1|H|L|0|||0
399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|0|G|0|GLP|0|0|0|100|DKK|469|2143|lyfalmen|||1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||469||469|2143||1|0|G|1|30|dagar|0
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|G|0|GPH|0|0|0|100|DKK|2531|3022|lyfalmen|V0244|3022|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1107||1107|3022||1|0|G|0|||0
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/sprautu|B01AB04|01.04.1993||R|0|0|0|G|0|PLS|0|0|1|100|DKK|8456|13137|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8456||8456|13137||1|0|G|0|||0
399825|L01EF0101|Ibrance|hylki|75|mg|21|stk|1|þpakki||L01EF01|01.02.2017||R|1|0|1|0|0|PEU|0|1|0|100|DKK|306824|388114|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||306824||306824|388114||1|0|L|0|||0
399904|M01AH0502|Coxient|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|2326|4251|lyfalmen|V0824|3968|2|28|0|14,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||2000||2000|4251||2|0|G|0|||0
399997|C10AA0509|Atorvastatin Xiromed|filmhtfl|20|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2100|2872|lyfalmen|V0113|2872|2|105|0|105,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||998||998|2872||2|0|G|0|||0
400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|G|0|SNP|0|0|1|100|XEU|1151|3082|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1151||1151|3082||1|0|G|0|||0
400134|J05AR2201|Symtuza|filmhtfl|||30|stk|1|glas|800+150+200+10 mg|J05AR22|01.03.2018||R|0|0|1|0|0|JCI|0|1|0|100|SEK|118743|154194|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavir, Kobicistat, Emtricitabin, Tenofoviralafenamid||118743||118743|154194||1|0|L|0|||0
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|PLS|0|0|0|100|DKK|2439|4855|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2439||2439|4855||1|0|E|0|||0
400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|G|0|VIF|0|0|1|100|CHF|56575|74830|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||56575||56575|74830||1|0|G|0|||0
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|466|2139|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||466||466|2139||1|0||2|50|töflur|0
400422|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.09.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|515|2207|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||515||515|2207||1|0|G|0|||0
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|0|100|DKK|1478|3532|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||1478||1478|3532||1|0||2|100|töflur|0
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|413|2066|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||413||413|2066||1|0||2|100|töflur|0
400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|5053|8453|lyfalmen|V0612|5493|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||5053||5053|8453||1|0|E|0|||0
400574|L04AX0701|Tecfidera|hylki|240|mg|56|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|1|0|0|BNB|0|1|0|100|XEU|144179|185830|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||144179||144179|185830||2|0|L|0|||0
401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|2184|3393|lyfalmen|V0037|3150|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1377||1377|3393||2|0|G|0|||0
401139|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.04.2020||R|1|1|0|G|0|PEU|0|0|1|100|DKK|20314|28967|lyfalmen|V1033|16129|1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||20314||20314|28967||1|0|G|0|||0
401403|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|ASR|0|0|1|100|IKR|856|2676|lyfalmen|V0173|2676|2|2|0|3,3300|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||856||856|2676||2|0|E|0|||0
401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|G|0|AZA|0|0|0|100|SEK|8706|13481|lyfalmen|V0459|13481|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||8706||8706|13481||1|0|G|0|||0
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|G|0|LBK|0|0|0|100|DKK|773|2562|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||773||773|2562||1|0|G|0|||0
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1134|3059|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1134||1134|3059||1|0|G|0|||0
402038|N06AB0313|Fluoxetin WH|hylki|20|mg|28|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|0|WEH|0|0|0|100|IKR|1032|2918|lyfalmen|||2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1032||1032|2918||2|0|G|0|||0
402141|J05AE1003|Darunavir Medical Valley|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.06.2020||R|1|0|1|0|0|VAL|0|1|0|100|XEU|33436|44098|lyfsjukr|||2|30|0|20,0000|Acare ehf|Medical Valley Invest AB|Darunavír||32277||32277|44098||2|0|L|0|||0
402203|D07AC1302|Ovixan|húðlausn|1|mg/g|100|ml|1|glas||D07AC13|01.08.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|1274|3251|lyfalmen|V0952|3251|2|100|0||Vistor hf|Galenica AB|Mómetasón||1274||1274|3251||1|0|G|0|||0
402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|1|0|0|SPD|0|1|0|100|DKK|722602|905226|lyfsjukr|||1|180|0|30,0000|Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||722602||722602|905226||1|0|L|0|||0
402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|BID|0|0|0|100|DKK|1978|3888|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Penicillín í blöndum með öðrum sýklalyfjum||1978||1978|3888||1|0||0|||0
402801|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfspr||L04AC16|01.01.2019||R|0|0|1|0|0|JCI|0|1|0|100|SEK|334650|422722|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||334650||334650|422722||1|0|L|0|||0
402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|G|0|LVR|0|0|0|100|DKK|8042|12311|lyfalmen|V0349|12311|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||7856||7856|12311||3|0|G|0|||0
402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|4845|2945|lyfalmen|V0552|2737|2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||1051||1051|2945||1|0|E|0|||0
403163|N02AA0508|Oxycodone Alvogen|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|945|2799|lyfalmen|V0597|2719|2|28|0|3,7300|Alvogen|Alvogen ehf|Oxýcódon||945||945|2799||2|0|G|1|30|dagar|0
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|IBV|1|0|0|100|DKK|6133|11806|vetalmen|||0|20|0||Vistor hf|Intervet International BV|Cloprostenolum||6133||6133|11806||1|0||0|||0
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|dropaí||S01GX01|01.09.2018||R|0|0|0|G|0|SNP|0|0|0|100|XEU|991|2862|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||||991|2862||1|0|G|0|||0
403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|G|0|MYR|0|0|0|100|DKK|17376|25414|lyfalmen|||1|6|0|30,0000|Icepharma hf|Mylan IRE Healthcare Limited|Fondaparinux||17376||17376|25414||2|0|G|0|||0
404136|J01XD0102|Flagyl|irl|5|mg/ml|100|ml|40|pokar||J01XD01|01.04.2020||R|0|0|0|0|0|SNP|0|0|1|100|XEU|20298|28947|lyfalmen|||1|4000|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||20298||20298|28947||1|0|0|0|||0
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2701||2|0|G|0|||0
404491|B01AD0201|Actilyse|sts/irs|20|mg|1|hgl|1|pakki||B01AD02|01.12.2019||R|0|0|0|0|0|BOI|0|0|0|100|DKK|37002|50074|lyfalmen|||1|1|0|0,2000|Vistor hf|Boehringer Ingelheim|Alteplasi||37002||37002|50074||1|H|0|0|||0
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.03.2020||R|0|0|0|0|0|BOI|0|0|0|100|DKK|61877|81536|lyfalmen|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||61877||61877|81536||1|H|0|0|||0
404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|G|0|MEV|0|0|0|100|DKK|963|2823|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||963||963|2823||1|0|G|0|||0
404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|DKK|2965|5110|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2965||2965|5110||2|0||0|||0
405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3586||1|0||0|||0
405200|A05AA0401|Ocaliva|töflur|10|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|0|ILT|0|1|0|100|XEU|389790|491301|lyfsjukr|||1|30|0|30,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||389790||389790|491301||2|0|L|0|||0
405220|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|98|stk|1|þpakki||A02BC04|01.04.2017||R|0|0|0|G|0|KRK|0|0|1|100|IKR|2436|4851|lyfalmen|V0467|4851|2|98|0|49,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||2436||2436|4851||2|0|G|0|||0
405491|V08CA0901|Gadovist|stl|1|mmol/ml|7,5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|BAB|0|0|0|100|DKK|30988|42467|lyfalmen|||1|37,5|0||Icepharma hf|Bayer AB|Gadóbútról||||30988|42467||2|H|0|0|||0
405677|J01DD0401|Rocephalin|irs|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|ROA|0|0|1|100|DKK|4961|8326|lyfalmen|||1|1|0|1,0000|Icepharma hf|Roche A.S.|Ceftríaxón||4961||4961|8326||2|0|0|0|||0
405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|17201|25173|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||17201||17201|25173||1|0||0|||0
405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|416|2071|lyfalmen|||2|60|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metformín||416||416|2071|31.7.2021|1|0|G|0|||0
406106|C10AX1401|Praluent|stl|150|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|179753|230074|lyfalmen|||1|6|0|166,6667|Vistor hf|Sanofi-aventis groupe|Alirocumab||179753||179753|230074||1|0|E|0|||0
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|17223|25204|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||17223||17223|25204||1|0|E|0|||0
406356|L01XK0101|Lynparza|hylki|50|mg|448|stk|1|pakki|4 x 112 hylki|L01XK01|01.07.2016||R|0|0|1|0|0|AZA|0|1|0|100|SEK|707967|887024|lyfsjukr|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||707967||707967|887024||1|0|L|0|||0
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|51961|68994|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||51961||51961|68994||1|0|E|0|||0
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|61488|81044|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||61488||61488|81044|30.6.2021|1|0|E|0|||0
406435|L01ED0501|Lorviqua|filmhtfl|25|mg|90|stk|1|þpakki||L01ED05|01.04.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|713029|893320|lyfsjukr|||1|90|0||Icepharma hf|Pfizer Europe MA EEIG|Lorlatinib||713029||713029|893320||1|0|L|0|||0
407043|B03BA0102|Betolvex|filmhtfl|1|mg|100|stk|1|glas||B03BA01|01.10.2016||L|1|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cyanocobalamin|||||4460||1|0|G|0|||0
407101|N02AA0507|OxyContin Depot|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|7493|11811|lyfalmen|V0585|7653|1|98|0|26,1300|Icepharma hf|Mundipharma A/S|Oxýcódon||7493||7493|11811||2|0|G|1|30|dagar|0
407393|L04AA3701|OLUMIANT|filmhtfl|2|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|1|0|0|NED|0|1|0|100|XEU|117244|152330|lyfsjukr|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||117244||117244|152330||2|0|L|0|||0
407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|17320|33030|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Penetamathýdrójoðíð||||17320|33030||2|0||0|||0
407586|N06BA0905|Atomoxetin STADA|hylki|80|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|7000|3563|lyfalmen|V0817|3563|2|30|0|30,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||1500||1500|3563||2|0|E|0|||0
407933|QP54AA5401|BROADLINE|bl.lausn|||0,9|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|DKK|4181|7206|vetorma|||0|2,7|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||4181||4181|7206||1|0||0|||0
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|344|1971|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||344||344|1971||1|0||2|150|töflur|0
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|0|100|DKK|619|2350|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||619||619|2350||1|0||2|150|töflur|0
408102|B01AF0301|Lixiana|filmhtfl|60|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|29325|40364|lyfalmen|||1|100|0|100,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||29325||29325|40364||1|0|G|0|||0
408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|15949|23450|lyfalmen|V0974|19720|1|100|0|12,5000|Icepharma hf|Bayer AG|Rivaoxaban||15949||15949|23450||2|0|G|0|||0
408166|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|13662|17965|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||11964||11964|17965||1|0|G|0|||0
408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|0|100|XEU|1829|4015|lyfalmen|V0310|2764|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1829||1829|4015||2|0||2|60|mg|0
408561|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0||0|||0
408596|N03AX1214|Gabapentin Alvogen|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.09.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|2941|3425|lyfalmen|V0251|3150|2|100|0|22,2200|Alvogen|Alvogen|Gabapentín||1400||1400|3425||2|0|G|0|||0
408675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.07.2017||R|0|0|0|0|0|GAN|0|0|0|100|XEU|4325|7451|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||4325||4325|7451||2|0||0|||0
408909|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9984|3257|lyfalmen|V0813|3197|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1278||1278|3257||2|0|E|0|||0
408927|N03AX1408|Levetiracetam STADA|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2688|5198|lyfalmen|V0515|5198|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||2688||2688|5198||2|0|G|0|||0
409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|3071|5293|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3071||3071|5293||2|0||0|||0
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|PLS|0|0|1|100|DKK|3609|6465|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3609||3609|6465||1|0|E|0|||0
409115|QJ51CE0902|Procapen vet.|spenalyf|3|g|10|ml|24|dælur|dreifa|QJ51CE09|01.04.2020||R|0|0|0|0|0|ANI|0|0|0|100|IKR|5258|10146|vetalmen|||0|240|0||Dýraheilsa ehf|aniMedica GmbH|Benzylpenicillínprokaín||5258||5258|10146||2|0||0|||0
409210|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|30|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|10501|15951|lyfalmen|||2|30|0|16,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||10501||10501|15951||2|0|E|1|30|dagar|0
409594|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|105|stk|1|glas||H02AB06|01.02.2019||R|1|0|0|G|0|EQL|0|0|1|100|IKR|1330|3329|lyfalmen|V0414|3122|2|105|0|52,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||1330||1330|3329||2|0|G|0|||0
409673|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|2|mg|28|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|2655|5152|lyfalmen|||3|28|0|9,3333|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||2655||2655|5152||3|0|G|0|||0
409720|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.04.2017||R|1|0|0|G|0|GRP|0|0|0|100|XEU|14833|21914|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||14833||14833|21914||1|0|G|0|||0
409745|N05AX1302|Xeplion|stl|100|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|56416|74629|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||56416||56416|74629||1|0|E|0|||0
409748|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.12.2019||R|1|0|0|G|0|TOG|0|0|0|100|SEK|1978|4220|lyfalmen|V1001|4220|1|98|0|73,5000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||1978||1978|4220||1|0|G|0|||0
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|6439|10361|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||6439||6439|10361||1|0|E|0|||0
409850|J07BA0104|TicoVac Junior|stl|1,2|mcg/sk|0,25|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3220|5930|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3220||3220|5930||1|0||0|||0
409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|15010|22158|lyfalmen|V0651|22156|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||15010||15010|22158||1|0|G|0|||0
409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|3633|6498|lyfalmen|V0196|5989|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3633||3633|6498||2|0|G|0|||0
410223|L01EL0101|IMBRUVICA|filmhtfl|280|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|465924|585990|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||465924||465924|585990||1|0|L|0|||0
410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|3473|5615|lyfalmen|||2|100|0|133,3300|Vistor hf|Orion Corporation|Spírónólaktón||2991||2991|5615||1|0|G|0|||0
410465|N03AX1214|Gabapentin Alvogen|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.07.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|1974|2806|lyfalmen|V0250|2453|2|100|0|16,6667|Alvogen|Alvogen|Gabapentín||950||950|2806||2|0|G|0|||0
411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|G|0|MYL|0|0|1|100|SEK|662|2409|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||662||662|2409||2|0|G|0|||0
411034|N06AA0907|Amitriptylin Abcur|filmhtfl|25|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|832|2643|lyfalmen|||2|100|0|33,3333|Icepharma hf|Abcur AB|Amitriptýlín||832||832|2643||2|0|G|0|||0
411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|G|0|MEV|0|0|0|100|DKK|1942|4171|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1942||1942|4171||1|0|G|0|||0
411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|RTH|0|0|1|100|XEU|409|2029|lyfalmen|V0230|2029|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Paracetamól||386||386|2029||2|0|E|0|||0
411409|N03AX1602|Lyrica (Lyfjaver)|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|10943|16560|lyfalmen|V0689|3390|3|56|0|56,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||10943||10943|16560||3|0|E|0|||0
411723|N06BA0703|Aspendos|töflur|100|mg|90|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|1|0|0|MOL|0|0|0|100|IKR|12650|18909|lyfalmen|||2|90|0|30,0000|LYFIS ehf|Medochemie Limited|Modafinil||12650||12650|18909||2|0|E|2|||0
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|1|0|0|VIC|0|1|0|100|DKK|22303|31482|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín||22303||22303|31482||1|0|L|0|||0
411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól|||||2292||1|0|E|0|||0
411913|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|2695|2448|lyfalmen|V0994|2448|2|2,5|0|25,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||690||690|2448||2|0|G|0|||0
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|SNP|0|0|0|100|XEU|2887|5472|lyfalmen|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2887||2887|5472||1|H|0|0|||0
412395|QM01AE0301|Romefen vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|CES|1|0|0|100|DKK|4159|8061|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||4159||4159|8061||2|0||0|||0
412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|4614|8924|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||4614||4614|8924||2|0||0|||0
412520|M01AB0523|Dimax Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.09.2021||R|1|0|0|G|0|GOV|0|0|1|100|XEU|1404|2779|lyfalmen|V0189|2668|2|100|0|50,0000|Alvogen|Alvogen ehf|Díklófenak||931||931|2779||2|0|G|0|||0
412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|1|G|0|BNB|0|0|0|100|XEU|84415|110042|lyfalmen|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||84415||84415|110042||2|0|G|0|||0
412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|G|0|TEE|0|0|0|100|NOK|44997|60186|lyfalmen|V0711|29328|1|112|0|112,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||44997||44997|60186||1|0|G|0|||0
412566|N03AX1213|Gabapentin Teva|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.08.2019||R|1|0|0|G|0|TVA|0|0|0|100|DKK|7331|11588|lyfalmen|V0254|11588|2|100|0|33,3300|Alvogen|Teva B.V.|Gabapentín||7331||7331|11588||2|0|G|0|||0
412581|N05AX1302|Xeplion|stl|75|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|44835|59981|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||44835||44835|59981||1|0|E|0|||0
412662|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5864|7004|lyfalmen|V0581|5765|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4000||4000|7004||2|0|G|0|||0
412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|3181|5876|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3181||3181|5876||2|0|G|0|||0
413053|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|4084|7119|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||4084||4084|7119||2|0|G|1|30|dagar|0
413116|N02BE0122|Dolorin|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|OVE|0|0|0|100|DKK|31557|43187|lyfalmen|||1|50|0||Pharmanovia A/S|Provepharm S.A.S.|Metýltíónín||31557||31557|43187||2|H|0|0|||0
413289|L01BA0403|Pemetrexed Accord|irþ|500|mg|500|mg|1|hgl|stofn f. innr.þykkni lausn|L01BA04|01.04.2021||R|0|0|0|0|0|CLU|0|1|0|100|XEU|138771|179104|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare S.L.U.|Pemetrexed||138771||138771|179104||1|H|L|0|||0
413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0||0|||0
414424|N06AA0907|Amitriptylin Abcur|filmhtfl|50|mg|100|stk|1|glas||N06AA09|01.10.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|1185|3129|lyfalmen|||2|100|0|66,6666|Icepharma hf|Abcur AB|Amitriptýlín||1185||1185|3129||2|0|G|0|||0
414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|1|G|0|TGM|0|0|0|100|NOK|87515|113963|lyfalmen|||1|12|0|24,0000|Teva Pharma Iceland ehf|TEVA GmbH|Glatíramer acetat||87515||87515|113963||1|0|G|0|||0
414661|L01DC0302|Mitomycin medac|duft|40|mg|1|hgl|1|pakki|+ leysir fyrir þvagblöðrulausn|L01DC03|01.03.2017||R|0|0|0|0|0|WIL|0|0|0|100|XEU|38988|52586|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Mitomycin||38988||38988|52586||2|H|0|0|||0
414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|G|0|LLS|0|0|0|100|DKK|1224|3183|lyfalmen|||1|90|0|54,0000|Icepharma hf|Les Laboratoires Servier|Indapamíð||1224||1224|3183||2|0|G|0|||0
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|G|0|HES|0|0|0|100|DKK|1156|3089|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1156||1156|3089||1|0|G|0|||0
414921|L04AA4201|Mayzent|filmhtfl|2|mg|28|stk|1|þpakki||L04AA42|01.11.2020||R|1|1|1|0|0|NEP|0|1|0|100|DKK|223646|284664|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Limited|Siponimod||223646||223646|284664||1|0|L|0|||0
414991|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.12.2020||R|1|0|0|G|0|BLS|0|0|0|100|IKR|3122|4030|lyfalmen|V0203|4026|2|12|0|84,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Alendrónsýra||1840||1840|4030||1|0|G|0|||0
415202|B05AA0116|Alburex|irl|50|g/líter|500|ml|1|hgl||B05AA01|01.09.2021||R|0|0|0|0|0|CSB|0|0|0|100|SEK|11311|17066|lyfalmen|||1|500|0||Icepharma hf|CSL Behring GmbH|albumin||11311||11311|17066||2|H|0|0|||0
415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|184638|236149|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer AG|Riociguatum||184638||184638|236149||1|0|L|0|||0
415635|N05AX1303|TREVICTA|stl|263|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|151110|194450|lyfalmen|||1|1|0|105,2000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||151110||151110|194450||1|0|G|0|||0
415724|G04CA5202|Dutaprostam|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.10.2019||R|0|0|0|G|0|ALO|0|0|0|100|DKK|2975|4383|lyfalmen|V1010|2979|2|30|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Dútasteríð og tamsúlósínhýdroklóríð||2096||2096|4383||2|0|G|0|||0
415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|G|0|PSA|0|0|0|100|XEU|5384|6501|lyfalmen|V0253|4878|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||3635||3635|6501||2|0|G|0|||0
416072|L01AX0304|Temozolomide Accord|hylki|140|mg|5|stk|1|skpoki||L01AX03|01.06.2021||R|0|0|1|0|0|CLU|0|1|0|100|XEU|24287|33992|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||24287||24287|33992||1|0|L|0|||0
416121|M02AA1505|Voltaren Forte|hlaup|23,2|mg/g|150|g|1|túpa||M02AA15|01.05.2021||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
416330|A10BD2401|Steglujan|filmhtfl|115|mg|98|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|34853|47156|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||34695||34695|47156||1|0|G|0|||0
416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|G|0|MSD|0|0|0|100|DKK|8668|9575|lyfalmen|V0088|3108|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||5868||5868|9575||1|0|G|0|||0
416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|G|0|GOG|0|0|1|100|XEU|2705|5221|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2705||2705|5221||2|0|G|0|||0
417562|N03AX1214|Gabapentin Alvogen|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.07.2021||R|1|0|0|G|0|POF|0|0|0|100|DKK|7331|11588|lyfalmen|V0254|11588|2|100|0|33,3300|Alvogen|Alvogen|Gabapentín||7331||7331|11588||2|0|G|0|||0
417633|A10BJ0601|Ozempic|stl|0,5|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|18409|26836|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||18409||18409|26836||1|0|E|0|||0
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|0|1|0|0|VIC|0|1|0|100|DKK|36505|49445|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Abacavír||36505||36505|49445||1|0|L|0|||0
417880|B02BD0401|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD04|01.07.2012||R|0|0|1|0|0|PEU|0|1|0|100|DKK|93115|121045|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Faktor IX||93115||93115|121045||1|0|L|0|||0
417898|C01CA1703|Hypotron|töflur|5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|G|0|RET|0|0|0|100|IKR|17695|25853|lyfalmen|V0969|20079|2|100|0|16,6666|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||17695||17695|25853||1|0|G|0|||0
418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|G|0|BII|0|0|0|100|DKK|26590|36905|lyfalmen|V0460|36905|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||26590|36905||1|0|G|0|||0
418642|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.02.2019||R|0|1|1|G|0|BIO|0|0|0|100|DKK|27862|38006|lyfalmen|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||27461||27461|38006||3|0|G|0|||0
418667|L01XC0203|Truxima|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|0|CTH|0|1|0|100|DKK|69532|91218|lyfsjukr|||2|20|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||69532||69532|91218||1|H|L|0|||0
418714|C10BA0202|Ezetimib/Simvastatin Krka|töflur|50|mg|100|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.10.2019||R|1|0|0|0|0|KNM|0|0|0|100|IKR|18000|26273|lyfalmen|V0615|26273|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||18000||18000|26273||2|0||0|||0
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|G|0|CHE|0|0|0|100|DKK|2343|4723|lyfalmen|||1|100|0|25,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Alfakalsídól||2343||2343|4723||1|0|G|0|||0
419294|J01DD0403|Rocephalin IV|sts|1|g|1|stk|1|hgl|+ leysir, lausn|J01DD04|01.09.2018||R|0|0|0|0|0|ROA|0|0|1|100|DKK|2783|5328|lyfalmen|||1|1|0|0,5000|Icepharma hf|Roche A.S.|Ceftríaxón||2783||2783|5328||2|0|0|0|||0
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|G|0|CHE|0|0|0|100|DKK|8527|13234|lyfalmen|||1|100|0|100,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Alfakalsídól||8527||8527|13234||1|0|G|0|||0
419311|N03AX1408|Levetiracetam STADA|mixtúra|100|mg/ml|300|ml|1|glas|+ 10 ml munngj.spr.|N03AX14|01.12.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|11000|16638|lyfalmen|V1000|16638|2|300|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||11000||11000|16638||2|0|G|0|||0
419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5426|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5426||2|0|E|1|30|dagar|0
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|1|0|0|OUS|0|0|0|100|XEU|37330|50489|lyfalmen|||1|100|0|7,5000|Recordati AB|Orphan Europe SARL|Mercaptamín||37330||37330|50489||3|0|E|0|||0
419937|A16AA0401|Cystagon|hylki|50|mg|100|stk|1|glas||A16AA04|01.10.2016||R|1|0|1|0|0|OUS|0|0|0|100|XEU|12834|19163|lyfalmen|||1|100|0|2,5000|Recordati AB|Orphan Europe SARL|Mercaptamín||12834||12834|19163||3|0|E|0|||0
419952|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|100|ml|1|glas||D07AD01|01.10.2018||R|0|0|0|G|0|GPH|0|0|1|100|DKK|1711|3853|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||1711||1711|3853||1|0|G|0|||0
419969|S01AD0302|Xorox|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.03.2020||R|0|0|0|G|0|AGE|0|0|1|100|XEU|2107|4398|lyfalmen|||1|4,5|0||Agepha Pharma s.r.o.|Agepha Pharma s.r.o.|Acíklóvír||2107||2107|4398||2|0|G|0|||0
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|G|0|PLS|0|0|1|100|DKK|11299|17050|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||11299||11299|17050||1|0|G|0|||0
420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|1|0|0|GEI|0|1|0|100|DKK|132231|170970|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||132231||132231|170970||2|0|L|0|||0
420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|G|0|RTH|0|0|1|100|IKR|4816|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ómeprazól||500||500|2186||2|0|G|0|||0
420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2.500 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|3507|6325|lyfalmen|||1|2|0|10,0000|Icepharma hf|Pfizer Aps|Dalteparín||3507||3507|6325||1|0|G|0|||0
420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5.000 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|4999|8379|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer Aps|Dalteparín||4999||4999|8379||1|0|G|0|||0
420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|RTH|0|0|1|100|DKK|1455|2950|lyfalmen|V0479|2950|2|60|0|4,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1055||1055|2950||2|0|E|0|||0
420639|L01EL0101|IMBRUVICA|filmhtfl|140|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|232632|295840|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||232632||232632|295840||1|0|L|0|||0
420696|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|60|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0||0|||0
420952|J01CF0204|Cloxacillin Navamedic Nordic|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.08.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|2579|5048|lyfalmen|V1053|5048|1|10|0|5,0000|Icepharma hf|Navamedic ASA|Kloxacillín||2579||2579|5048||2|0|0|0|||0
421120|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2280|4636|lyfalmen|V0214|4604|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2280||2280|4636||2|0|E|0|||0
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1206|3158|lyfalmen|||1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1206||1206|3158||1|0|G|0|||0
421434|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|98|stk|1|þpakki||C10AA05|01.07.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2000|2779|lyfalmen|V0114|2681|2|98|0|196,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0
421673|M04AA0303|Febuxostat Medical Valley|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.10.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|8636|9661|lyfalmen|V1011|9343|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|febuxostat||5931||5931|9661||2|0|E|0|||0
421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|36499|69416|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||36499||36499|69416||1|0||0|||0
421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|G|0|TVA|0|0|1|100|XEU|1658|3284|lyfalmen|V0458|2979|2|100|0|100,0000|Alvogen|Teva B.V.|Deslóratadín||1298||1298|3284||2|0|G|0|||0
421962|A06AB0202|Toilax|sþ-tfl|5|mg|25|stk|1|glas||A06AB02|01.12.2016||L|1|0|0|0|0|ERC|0|0|0|100|IKR|||lyfalmen|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||1925||1|0||0|||0
422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|624|2357|lyfalmen|V0596|2357|2|28|0|1,8600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||624||624|2357||1|0|G|1|30|dagar|0
422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|G|0|RDT|0|0|0|100|DKK|2639|5130|lyfalmen|V0049|2852|1|98|0|62,0667|Vistor hf|Recordati Ireland Limited|Metóprólól||2639||2639|5130||1|0|G|0|||0
422323|L01DB1101|Pixuvri|st/irþ|29|mg|1|hgl|1|pakki||L01DB11|01.02.2020||R|0|0|0|0|0|LLS|0|0|0|100|DKK|91980|119610|lyfalmen|||1|1|0||Icepharma hf|Les Laboratoires Servier|Pixantron||91980||91980|119610||2|H|0|0|||0
422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|G|0|RDT|0|0|0|100|DKK|6722|10750|lyfalmen|V0054|4840|1|98|0|124,1333|Vistor hf|Recordati Ireland Limited|Metóprólól||6722||6722|10750||1|0|G|0|||0
422340|C02AC0201|Intuniv|forðatfl|1|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|9340|14353|lyfalmen|||1|28|0|9,3333|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||9340||9340|14353||1|0|E|0|||0
422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|0|0|CSB|0|1|0|100|SEK|70319|92213|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||70319||70319|92213||2|H|L|0|||0
422545|B02BD0205|Elocta|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|44532|59598|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||44532|59598||3|0|L|0|||0
422591|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.10.2020||R|1|0|0|0|0|ASA|0|0|0|100|SEK|18786|27355|lyfalmen|V0195|9966|1|98|0|392,0000|Vistor hf|Astra Zeneca A/S|Rósuvastatín||18786||18786|27355||1|0|E|0|||0
422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|2794|5344|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2794||2794|5344||3|0|G|0|||0
422860|N03AF0401|Zebinix|töflur|200|mg|60|stk|1|þpakki||N03AF04|01.12.2018||R|1|0|0|G|0|BPC|0|0|0|100|SEK|10613|16106|lyfalmen|||1|60|0|15,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||10613||10613|16106||1|0|G|0|||0
422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|8953|13821|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer AG|Rivaoxaban||8953||8953|13821||2|0|G|0|||0
423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|BAB|0|0|0|100|DKK|2875|4883|lyfalm11|V0993|4411|1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||2875|4883||2|0||0|||1
423414|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0
423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|LEM|0|0|1|100|XEU|18279|26657|lyfalmen|||2|1200|0|15,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||18279||18279|26657||2|0|0|0|||0
423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|5486|9049|lyfalmen|V0373|4834|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5486||5486|9049||2|0|G|0|||0
424199|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|0|SSE|0|0|1|100|DKK|66997|88011|lyfalmen|||1|50|0|33,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||66997||66997|88011||1|0|E|0|||0
424477|N06BA1201|Elvanse Adult|hylki|30|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|10962|16586|lyfalmen|||1|30|0|30,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||10962||10962|16586||1|0|E|1|30|dagar|0
424761|A07AA0204|Nystatin Orifarm|mixtúra|100000|ae/ml|100|ml|1|glas|dreifa|A07AA02|01.03.2020||R|0|0|0|0|0|IRO|0|0|1|100|XEU|5282|8768|lyfalmen|||2|100|0|6,6667|Artasan ehf|Orifarm Generics A/S|Nýstatín||5282||5282|8768||1|0|0|0|||0
424829|N06AX2108|Aritavi|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9638|3963|lyfalmen|V0694|3963|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||1791||1791|3963||1|0|G|0|||0
424973|R03BB0404|Braltus|innönddu|10|mcg|30|stk|3|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|G|0|TVA|0|0|0|100|DKK|12409|17057|lyfalmen|||2|90|0|90,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||11304||11304|17057|31.8.2021|2|0|G|0|||0
424981|J07BX0304|COVID-19 Vaccine Janssen|stl|||2,5|ml|20|hgl|hvert hgl.inniheldur 5x0,5ml|J07BX03|01.05.2021||R|0|0|0|0|0|JCI|0|0|0|100|IKR|||lyfalmen|||1|50|0||Vistor hf|Janssen-Cilag International N.V.|Covid-19 vaccines|||||||1|0||0|||0
425016|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|1|G|0|AZA|0|0|0|100|SEK|21309|24928|lyfalmen|V0183|19375|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||17023||17023|24928||1|0|G|0|||0
425282|L01EA0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01EA01|01.09.2017||R|0|0|1|0|0|ACC|0|1|0|100|XEU|18360|26769|lyfsjukr|||2|60|0||Artasan ehf|Accord Healthcare Limited|Imatinib||18360||18360|26769||1|0|L|0|||0
425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|G|0|GPA|0|0|0|100|XEU|1543|3476|lyfalmen|V0213|3291|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1437||1437|3476||1|0|G|0|||0
425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|G|0|TTT|0|0|0|100|DKK|13469|20037|lyfalmen|||1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||13469||13469|20037||2|0|G|0|||0
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|947|2801|lyfalmen|||1|20|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||947||947|2801||2|0|E|0|||0
427030|J05AR0602|Padviram|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.03.2018|30.06.2021|R|1|0|1|0|0|SHS|0|1|0|100|DKK|104227|121917|lyfsjukr|||2|30|0|30,0000|Artasan ehf|Sandoz A/S|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||93804||93804|121917||1|0|L|0|||0
427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2|0||0|||0
427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|7965|12461|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||7965||7965|12461||1|0||0|||0
427289|B01AC0603|Hjartamagnýl|sþ-tfl|75|mg|100|stk|1|þpakki||B01AC06|01.04.2019||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1|0|0|0|||0
427324|A12BA0103|Kaliumklorid Orifarm (Lyfjaver)|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.06.2021||L|1|0|0|G|0|LVR|0|0|0|100|IKR|||lyfalmen|V1048|4697|3|250|0|62,5000|Lyfjaver ehf|Lyfjaver ehf|Kalíumklóríð|||||4873||3|0|G|0|||0
427556|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|30|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|3004|4893|lyfalmen|V1004|4893|2|30|0|4,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||2467||2467|4893||2|0|E|1|30|dagar|0
427754|B01AF0102|Rivaroxaban WH|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|8560|13280|lyfalmen|V1036|13280|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||8560||8560|13280||2|0|G|0|||0
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Natríum pícósúlfat|||||3268||1|0|E|0|||0
428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2413||1|0|G|0|||0
428489|L02BB0501|Erleada|filmhtfl|60|mg|112|stk|1|þpakki||L02BB05|01.02.2021||R|0|0|0|0|0|JCI|0|1|0|100|SEK|411755|518619|lyfsjukr|||1|112|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Apalutamide||411755||411755|518619||1|0|L|0|||0
428515|N02AA0508|Oxycodone Alvogen|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.01.2021||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3166|5282|lyfalmen|V0598|5282|2|98|0|13,0700|Alvogen|Alvogen ehf|Oxýcódon||2749||2749|5282||2|0|G|1|30|dagar|0
429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|3200|5902|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3200||3200|5902||2|0|0|0|||0
429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|1|0|0|MLD|0|1|0|100|DKK|76543|100085|lyfsjukr|||1|105|0|14,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||76543||76543|100085||1|0|L|0|||0
429584|N06BA0902|Atomoxetin Actavis|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6471|3257|lyfalmen|V0812|3197|2|28|0|3,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1278||1278|3257||1|0|E|0|||0
429759|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|3|glös||S01EE05|01.03.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|7237|11459|lyfalmen|||1|9|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7237||7237|11459||2|0|G|0|||0
429787|D07AA0210|Hydrokortison Evolan|krem|10|mg/g|50|g|1|túpa||D07AA02|01.08.2021||L|0|0|0|0|0|EVO|0|0|1|100|IKR|||lyflausa|||0|50|0||LYFIS ehf|Evolan Pharma AB|Hýdrókortisón|||||||2|0||0|||0
429815|N02AJ0602|Parkodin forte|filmhtfl|530|mg|200|stk|1|tfílát|30+500 mg|N02AJ06|01.02.2018||R|2|0|0|0|0|ATE|0|0|1|100|XEU|4296|7411|lyfalmen|||2|200|0|66,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||4296||4296|7411||1|0|E|1|||0
429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|9231|14203|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||9231||9231|14203||3|0|G|0|||0
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|IBV|0|0|0|100|DKK|5352|10324|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Sulfadiazinum og trimethoprimum||5352||5352|10324||1|0||0|||0
430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|G|0|WEH|0|0|0|100|XEU|17363|13192|lyfalmen|V0184|13192|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||8496||8496|13192||2|0|G|0|||0
430458|M01AH0503|Coxerit|filmhtfl|90|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|5488|7875|lyfalmen|V0831|7403|2|98|0|147,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4633||4633|7875||2|0|G|0|||0
430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|G|0|TTT|0|0|0|100|DKK|5460|9013|lyfalmen|||1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||5460||5460|9013||2|0|G|0|||0
430839|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|50|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|50|0|16,6600|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0
431017|B06AC0501|Takhzyro|stl|300|mg|2|ml|1|hgl|+ein spr og tvær nálar|B06AC05|01.09.2020||R|0|0|1|0|0|HPI|0|1|0|100|DKK|1841351|2296634|lyfsjukr|||1|2|0|14,0187|Vistor hf|Shire Pharmaceuticals Ireland Limited|Lanadelumab||1841349||1841349|2296634||1|0|L|0|||0
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|LEP|0|0|1|100|DKK|1067|2967|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1067||1067|2967||1|0||0|||0
431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0||0|||0
431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|G|0|PLS|0|0|1|100|DKK|1325|3322|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1325||1325|3322||1|0|G|0|||0
431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|G|0|PLS|0|0|1|100|DKK|3440|6233|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3440||3440|6233||1|0|G|0|||0
431922|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|7042|5283|lyfalmen|V0995|5283|2|7,5|0|75,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||2750||2750|5283||2|0|G|0|||0
431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17596|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17596||2|0|E|1|30|dagar|0
431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|0|0|TPA|0|1|0|100|DKK|295745|374335|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||295745||295745|374335||1|H|L|0|||0
431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|2205|4533|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2205||2205|4533||1|0|G|0|||0
432189|L01EM0301|Piqray|filmhtfl|200|mg|28|stk|1|þpakki||L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|488714|614335|lyfsjukr|||1|28|0|18,6667|Vistor hf|Novartis Europharm Limited|Alpelisib||488714||488714|614335||1|0|L|0|||0
432220|QM01AC0603|Rheumocam|stl|20|mg/ml|100|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.06.2018||R|0|0|0|0|0|CHP|1|0|0|100|IKR|6850|13166|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||6850|13166||2|0||0|||0
432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|KNM|0|0|0|100|IKR|3245|5077|lyfalmen|V0693|5077|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||2600||2600|5077||2|0|E|0|||0
432723|A10BJ0602|Rybelsus|töflur|7|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|20843|29636|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||20843||20843|29636||1|0|E|0|||0
432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|BRO|0|0|0|100|XEU|2711|4090|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||2081||2081|4090||2|0|0|0|||0
433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||2176||1|0|E|0|||0
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|G|0|COR|0|0|0|100|DKK|10442|15870|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10442||10442|15870||1|0|G|0|||0
433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|0|G|0|MDI|0|0|0|100|DKK|2352|4735|lyfalmen|||1|28|0|8,4000|Icepharma hf|Mundipharma A/S|Morfín||2352||2352|4735||2|0|G|1|30|dagar|0
433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|0|G|0|MDI|0|0|0|100|DKK|5168|8611|lyfalmen|||1|28|0|25,2000|Icepharma hf|Mundipharma A/S|Morfín||5168||5168|8611||2|0|G|1|30|dagar|0
433345|QI08AA0101|Eravac|stl|||0,5|ml|10|hgl|fleyti|QI08AA01|01.05.2020||R|0|0|0|0|0|LHS|0|0|0|100|IKR|14085|24277|vetbolu|||0|5|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Rabbit haemorrhagic disease virus||14085||14085|24277||2|0||0|||0
433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|1|0|0|MLD|0|1|0|100|DKK|386081|486688|lyfsjukr|||1|96|0|32,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||386081||386081|486688||1|0|L|0|||0
434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|148162|190783|lyfalmen|||1|150|0||Icepharma hf|Bayer AB|Gadóbútról||148162||148162|190783||2|H|0|0|||0
434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|QAS|0|0|0|100|NOK|65529|100287|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||62213||62213|100287||1|0||0|||0
434353|QM01AE9104|Canicaral vet|töflur|160|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|15098|28814|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||15098||15098|28814||2|0||0|||0
434366|G03GA1001|REKOVELLE|stl|12|mcg|0,36|ml|1|áfpen|+ 3 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|13865|20582|lyfalmen|||1|0,36|0|1,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||13865||13865|20582||1|0|G|0|||0
434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|G|0|EIG|0|0|0|100|SEK|7613|11976|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai GmbH|Zonisamíð||7613||7613|11976||1|0|G|0|||0
434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|G|0|KRK|0|0|1|100|IKR|3272|3838|lyfalmen|V0010|3838|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1700||1700|3838||2|0|G|0|||0
434601|N07BC0102|Buvidal|stl|128|mg|0,36|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|56379|74582|lyfsjukr|||1|0,36|0|60,9524|Vistor hf|Camurus AB|Búprenorfín||56379||56379|74582||1|H|L|1|30|dagar|0
434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|MCS|0|0|1|100|SEK|741|2518|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||741||741|2518||1|0|E|0|||0
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|G|0|MEA|0|0|1|100|IKR|6486|10425|lyfalmen|||1|1|0|0,6000|Icepharma hf|Meda AB|Adrenalín tartrat||6486||6486|10425||2|0|G|0|||0
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|G|0|MEA|0|0|1|100|IKR|6471|10405|lyfalmen|||1|1|0|0,3000|Icepharma hf|Meda AB|Adrenalín tartrat||6471||6471|10405||2|0|G|0|||0
434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|DAN|0|0|0|100|XEU|9613|14729|lyfalmen|V0315|6764|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||9613||9613|14729||2|0|E|0|||0
434967|A16AX1401|Galafold|hylki|123|mg|14|stk|1|þpakki|Hart|A16AX14|01.05.2017||R|0|0|1|0|0|AMC|0|1|0|100|XEU|2346256|2924597|lyfsjukr|||1|14|0|28,0000|Vistor hf|Amicus Therapeutics Europe Limited|Migalastat||2346256||2346256|2924597||1|0|L|0|||0
435072|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|0|SDG|0|1|0|100|DKK|12967|19346|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||12967||12967|19346||1|0|L|0|||0
435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|G|0|GRP|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3847||1|0|G|0|||0
435882|N05CD0806|Buccolam|munnh.l|5|mg|1|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12505|18710|lyfalmen|||2|4|0|2,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12505||12505|18710||3|0|E|2|450|mg|0
436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|AST|0|1|0|100|DKK|204105|260361|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||204105||204105|260361||2|H|L|0|||0
436044|N02AJ0601|Parkodin|filmhtfl|510|mg|10|stk|1|þpakki|10+500 mg|N02AJ06|01.07.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|282|1886|lyfalmen|||2|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||282||282|1886||1|0|E|3|||0
436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2|0||0|||0
436308|J05AR2001|Biktarvy|filmhtfl|275|mg|30|stk|1|glas|50+200+25 mg|J05AR20|01.10.2018||R|0|0|1|0|0|GSE|0|1|0|100|DKK|128817|166724|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Emtricitabine, Tenofovir alafenamide og Bictegravir||128817||128817|166724||2|0|L|0|||0
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|LEP|0|0|1|100|DKK|1028|2913|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1028||1028|2913||1|0||0|||0
436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|1|0|0|CFS|0|1|0|100|XEU|68822|90320|lyfsjukr|||1|60|0|0,7500|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||68822||68822|90320||3|0|L|0|||0
436810|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk|Stök áfyllingarpakkning|R03AC19|01.08.2019||R|0|0|0|G|0|BII|0|0|1|100|DKK|3998|7001|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||3998||3998|7001||1|0|G|0|||0
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|G|0|JAS|0|0|0|100|SEK|681|2435|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||681||681|2435||1|0|G|0|||0
437007|N06BA0905|Atomoxetin STADA|hylki|18|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4200|3425|lyfalmen|V0813|3425|2|30|0|6,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||1400||1400|3425||2|0|E|0|||0
437221|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|7717|9624|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||5904||5904|9624||1|0|G|0|||0
437223|V10XX0301|Xofigo|stl|1100|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|0|0|FIN|0|1|0|100|DKK|601792|754972|lyfsjukr|||1|6|0||Icepharma hf|Bayer AG|radium-223 dichloride||601792||601792|754972||2|H|L|0|||0
437581|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|10582|16063|lyfalmen|V0253|4878|3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||10582||10582|16063||3|0|G|0|||0
437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|20535|29246|lyfalmen|V0712|29246|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||20535||20535|29246||1|0|G|0|||0
437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|G|0|DEA|0|0|0|100|XEU|1107|3022|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1107||1107|3022||1|0|G|0|||0
437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|AST|0|1|0|100|DKK|53808|71330|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||53808||53808|71330||2|H|L|0|||0
438084|QM05BA0201|Osphos|stl|51|mg/ml|1|hgl|1|pakki|handa hestum|QM05BA02|01.12.2016||R|0|0|0|0|0|DEH|1|0|0|100|XEU|22224|42334|vetalmen|||0|1|0||Vistor hf|Dechra Regulatory B.V.|Clodronic acid||22224||22224|42334||1|0|0|0|||0
438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|FKA|0|0|1|100|DKK|1949|4181|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1949||1949|4181||1|0|0|0|||0
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002|31.07.2021|R|0|0|0|G|0|HES|0|0|1|100|DKK|2049|4318|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||2049||2049|4318||1|0|G|0|||0
438514|R06AE0708|Cetirizine Alvogen|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.06.2021||L|1|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|Alvogen|Cetirizín|||||||2|0||0|||0
438571|A07EC0204|Asacol|töflur|1600|mg|60|stk|1|þpakki|með breyttan.losunarhraða|A07EC02|01.02.2019||R|1|0|0|G|0|TIL|0|0|0|100|DKK|9978|15232|lyfalmen|||1|60|0|64,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||9978||9978|15232||2|0|G|0|||0
438591|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.06.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|1602|3703|lyfalmen|||1|100|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||1602||1602|3703||1|0|G|0|||0
438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|G|0|WEH|0|0|0|100|XEU|5700|6387|lyfalmen|V0605|2817|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||3552||3552|6387||2|0|G|0|||0
438759|L01EC0101|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01EC01|01.08.2012||R|0|0|1|0|0|RRG|0|1|0|100|DKK|226592|288328|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration GmbH|Vemurafenib||226592||226592|288328||2|0|L|0|||0
438775|R03AK1401|Atectura Breezhaler|innönddu|187,5|mcg/sk|30|stk|1|stsk.þ|125 mcg/62,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|3763|6677|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||3763||3763|6677||1|0|G|0|||0
438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|152253|195871|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||152253||152253|195871||1|0|L|0|||0
438974|D01AE1501|Lamisil|krem|1|%|15|g|1|túpa||D01AE15|01.10.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0||0|||0
439089|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0
439419|B06AC0102|Berinert|sts/irs|2000|ae|1|hgl|1|pakki||B06AC01|01.07.2020||R|0|0|1|0|0|CSB|0|1|0|100|SEK|451168|567638|lyfsjukr|||1|1|0|1,4286|Icepharma hf|CSL Behring GmbH|C1 hemill||451168||451168|567638||2|0|L|0|||0
439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|G|0|RDT|0|0|0|100|DKK|4838|8157|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||4838||4838|8157||1|0|G|0|||0
439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|20038|28618|lyfalmen|V0615|25748|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||20038||20038|28618||1|0||0|||0
439766|N06BA0902|Atomoxetin Actavis|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|15281|11719|lyfalmen|V0818|11719|2|28|0|35,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||7426||7426|11719||1|0|E|0|||0
439822|R03DC0306|Montelukast ratiopharm|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|10719|16252|lyfalmen|||2|98|0|49,0000|Alvogen|Teva Sweden AB|Montelúkast||10719||10719|16252||2|0|G|0|||0
439954|H02AB0901|Solu-Cortef|sts|250|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.02.2021||R|0|0|0|0|0|PLS|0|0|0|100|DKK|863|2686|lyfalmen|||1|1|0|8,3333|Icepharma hf|Pfizer Aps|Hýdrókortisón||863||863|2686||1|H|0|0|||0
440410|N05AX1303|TREVICTA|stl|350|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|170423|218470|lyfalmen|||1|1|0|140,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||170423||170423|218470||1|0|G|0|||0
440431|N02AX0213|Tramadol Krka|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|4500|6591|lyfalmen|V0224|6591|2|100|0|66,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||3700||3700|6591||2|0|G|1|30|dagar|0
440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3115|5785|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5785||2|0|G|0|||0
440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|ATE|0|0|1|100|DKK|1320|3315|lyfalmen|||2|10|0|1,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||1320||1320|3315||1|0|0|0|||0
440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2082|4364|lyfalmen|||2|10|0|3,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||2082||2082|4364||1|0|0|0|||0
441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|KPA|0|0|1|100|SEK|1069|2969|lyfalmen|||1|30|0||Alvogen|Karo Pharma AB|Blöndur||1069||1069|2969||2|0|E|0|||0
441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|G|0|TPA|0|0|0|100|DKK|1074|2976|lyfalmen|V0046|2410|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1074||1074|2976||1|0|G|0|||0
441432|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.07.2021||R|0|0|0|0|0|PBV|0|0|0|100|XEU|793|2589|lyfalmen|V1051|2589|1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||793||793|2589||1|0|0|1|30|dagar|0
441451|N02CC0101|Imigran|nefúði|20|mg/sk|0,1|ml|6|úðaílá||N02CC01|01.04.2020||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5815|9502|lyfalmen|||1|0,6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||5815||5815|9502||1|0|G|0|||0
441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|1|0|0|GEI|0|1|0|100|DKK|101074|132219|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín, rilpívírin og tenófóvír||101074||101074|132219||2|0|L|0|||0
442258|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|2.000 PFU bóluefni|J07BK01|01.01.2020||R|0|0|0|0|0|GPH|0|0|0|100|DKK|5569|9163|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||5569||5569|9163||1|0|0|0|||0
442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2493|4929|lyfalmen|V0283|3750|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2493||2493|4929||2|0|G|0|||0
442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|70073|91902|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||70073||70073|91902||3|0|L|0|||0
442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|G|0|BII|0|0|0|100|DKK|10455|15888|lyfalmen|V0460|12302|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||10455|15888||1|0|G|0|||0
443122|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1586|3681|lyfalmen|V0560|3320|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1586||1586|3681||2|0||0|||0
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|G|0|NAS|0|0|1|100|DKK|3144|5825|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3144||3144|5825||1|0|G|0|||0
443255|N02BE0127|Dolorin Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.04.2021||L|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,8333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|G|0|NAS|0|0|1|100|DKK|24953|34834|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||24953||24953|34834||1|0|G|0|||0
443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|0|G|0|MDI|0|0|0|100|DKK|23031|32403|lyfalmen|||1|90|0|180,0000|Icepharma hf|Mundipharma A/S|Morfín||23031||23031|32403||2|0|G|1|30|dagar|0
443586|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.12.2016||R|0|0|0|0|0|EUS|0|0|0|100|XEU|23713|33266|lyfalmen|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||23713||23713|33266||3|H|0|0|||0
443903|N06AB0311|Fluoxetin Mylan|hylki|20|mg|100|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1771|3006|lyfalmen|V0039|3006|2|100|0|100,0000|Icepharma hf|Mylan AB|Flúoxetín||1096||1096|3006||2|0|G|0|||0
444098|L04AX0306|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2536|4988|lyfalmen|||1|1|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2536||2536|4988||2|0|G|0|||0
444260|L04AC0801|Ilaris|stl|150|mg/ml|1|ml|1|hgl|lausn|L04AC08|01.04.2018||R|0|1|1|0|0|NEP|0|1|0|100|DKK|1580314|1971979|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Limited|Canakinumab||1580314||1580314|1971979||1|0|L|0|||0
444285|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|BLS|0|0|1|100|XEU|2016|3971|lyfalmen|V0337|3971|2|30|0|7,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1797||1797|3971||1|0|E|0|||0
444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|DAN|0|0|0|100|XEU|2925|5524|lyfalmen|||1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2925||2925|5524||2|0|E|0|||0
444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|20475|29170|lyfalmen|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||20475||20475|29170||2|H|0|0|||0
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|G|0|ROA|0|0|0|100|DKK|2106|4397|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2106||2106|4397||2|0|G|0|||0
444511|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.04.2021||R|0|1|0|G|0|NEL|0|0|0|100|DKK|8307|12932|lyfalmen|V0349|12311|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||8307||8307|12932||1|0|G|0|||0
444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|IKR|3537|6366|lyfalmen|||2|100|0|33,3300|Alvogen|ratiopharm Oy|Betahistín||3537||3537|6366||2|0|G|0|||0
444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|G|0|IRO|0|0|0|100|XEU|4934|8289|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||4934||4934|8289||1|0|G|0|||0
444932|B02BD0208|Afstyla|sts|2000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|159153|204453|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||159153||159153|204453||2|0|L|0|||0
445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|G|0|BOE|0|0|0|100|DKK|18217|26572|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||18217||18217|26572||1|0|G|0|||0
445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|4601|7831|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||4601||4601|7831||1|0|G|0|||0
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|G|0|LEO|0|0|1|100|DKK|1873|4076|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1873||1873|4076||1|0|G|0|||0
445169|L01CE0202|Irinotecan Accord|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01CE02|01.06.2020||R|0|0|0|0|0|AEE|0|0|0|100|XEU|39998|53863|lyfalmen|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Irinotecan||39998||39998|53863||1|H|0|0|||0
445240|N05CH0104|Melatonin Vitabalans|töflur|5|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|LYF|0|0|1|100|IKR|7000|5902|lyfalmen|||2|50|0|125,0000|LYFIS ehf|LYFIS ehf|Melatonin||3200||3200|5902||2|0|0|0|||0
445418|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6724|3393|lyfalmen|V0684|3393|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1377||1377|3393||2|0|G|0|||0
445576|L04AC1001|Cosentyx|stl|300|mg|2|ml|1|áfpen||L04AC10|01.08.2021||R|0|0|1|0|0|NEL|0|1|0|100|DKK|158517|203662|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||158517||158517|203662||1|0|L|0|||0
445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|G|0|SDH|0|0|0|100|XEU|5557|9147|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5557||5557|9147||1|0|G|0|||0
445892|QD11AH9102|Cytopoint|stl|40|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|27841|52990|vetalmen|||1|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||27841||27841|52990||2|0||0|||0
446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|1|G|0|EIG|0|0|0|100|SEK|15703|23112|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai GmbH|Rúfínamíð||15703||15703|23112||1|0|G|0|||0
446639|C10BA0202|Ezetimib/Simvastatin Krka|töflur|30|mg|100|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.10.2019||R|1|0|0|0|0|KNM|0|0|0|100|IKR|17377|22144|lyfalmen|||2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||15000||15000|22144||2|0||0|||0
447013|L04AB0402|Imraldi|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.03.2019||R|0|1|1|0|0|SUG|0|1|0|100|XEU|57057|75439|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||57057||57057|75439||2|0|L|0|||0
447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|G|0|KNM|0|0|0|100|IKR|7968|5214|lyfalmen|V0694|3963|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||2700||2700|5214||2|0|G|0|||0
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|10848|16429|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10848||10848|16429||1|0|G|0|||0
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|6072|9855|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6072||6072|9855||1|0|G|0|||0
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|7633|12004|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7633||7633|12004||1|0|G|0|||0
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|7898|12369|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||7898||7898|12369||1|0|G|0|||0
447357|A10AE0407|Toujeo [DoubleStar]|stl|300|ein/ml|3|ml|3|áfpen|áfylltir lyfjapennar|A10AE04|01.09.2019||R|0|1|0|G|0|SDH|0|0|0|100|XEU|11114|16795|lyfalmen|||1|9|0|67,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11114||11114|16795||1|0|G|0|||0
447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|2999|3631|lyfalmen|V0948|3631|2|100|0|66,6700|Alvogen|ratiopharm GmbH|Carvedílól||1550||1550|3631||2|0|G|0|||0
447608|J06BA0104|Cutaquig|stl|165|mg/ml|12|ml|1|hgl||J06BA01|01.04.2020||R|0|0|1|0|0|OCT|0|1|0|100|DKK|22787|32095|lyfsjukr|||1|12|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||22787||22787|32095||1|0|L|0|||0
447939|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|84|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|KNM|0|0|0|100|IKR|28000|38688|lyfalmen|||2|84|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||28000||28000|38688||2|0|E|0|||0
448253|A10AB0505|Fiasp|stl|100|ein/ml|10|ml|1|hgl||A10AB05|01.02.2019||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2806|5360|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2806||2806|5360||1|0|G|0|||0
448379|G03AD0103|Levonorgestrel Apofri|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.12.2019||L|0|0|0|0|0|APO|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|LYFIS ehf|Apofri AB|Levonorgestrel|||||||2|0||0|||1
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|G|0|HES|0|0|1|100|DKK|1950|4182|lyfalmen|V0202|4182|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1950||1950|4182||1|0|G|0|||0
448821|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.02.2017||R|1|0|0|0|0|KRK|0|0|0|100|IKR|4087|4636|lyfalmen|V0214|4604|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2280||2280|4636||2|0|E|0|||0
449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|RAU|0|0|0|100|XEU|1072|2973|lyfalmen|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1072||1072|2973||2|H|0|0|||0
449480|B02BC3002|TISSEEL|vefjalím|||4|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|0|BAM|0|0|0|100|SEK|32622|44534|lyfalmen|||1|4|0||Icepharma hf|Baxter Medical AB|Blöndur||32622||32622|44534||2|H|0|0|||0
449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2271|3474|lyfalmen|V0686|1935|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1436||1436|3474||2|0|E|0|||0
449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1807|3151|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1201||1201|3151||2|0|G|0|||0
449697|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfpen||R03DX10|01.05.2020||R|0|0|1|0|0|ZEN|0|1|0|100|SEK|332676|420267|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||332676||332676|420267||1|0|L|0|||0
449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|ATE|0|0|1|100|DKK|4936|8292|lyfalmen|||2|10|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||4936||4936|8292||1|0|0|0|||0
449842|L01XX2401|Oncaspar|stl/irs|750|ein/ml|5|ml|1|hgl||L01XX24|01.04.2019||R|0|0|0|0|0|LLS|0|1|0|100|DKK|235064|298865|lyfsjukr|||1|5|0||Icepharma hf|Les Laboratoires Servier|Pegaspargase||||235064|298865||2|H|L|0|||0
449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|3241|5959|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer AG|Rivaoxaban||3241||3241|5959||2|0|G|0|||0
450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|0|0|0|LEV|1|0|0|100|XEU|4541|8786|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4541||4541|8786||2|0||1|30|dagar|0
450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|G|0|AEP|0|0|0|100|DKK|1152|3084|lyfalmen|||1|30|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1152||1152|3084||2|0|G|0|||0
450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|0|0|MBV|0|0|0|100|DKK|118712|154156|lyfalmen|||1|20|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||118712||118712|154156||1|H|0|0|||0
450216|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9984|3257|lyfalmen|V0814|3197|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||1278||1278|3257||2|0|E|0|||0
450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|0|BOE|0|0|0|100|DKK|346036|436883|lyfalmen|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||346036||346036|436883||1|H|0|0|||0
450537|N05CD0806|Buccolam|munnh.l|10|mg|2|ml|4|spr|munngjaf.spr|N05CD08|01.11.2019||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12505|18710|lyfalmen|||2|8|0|4,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12505||12505|18710||3|0|E|2|450|mg|0
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992|30.06.2021|R|1|0|0|0|0|SNP|0|0|0|100|XEU|2388|3955|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1785||1785|3955||1|0||2|30|töflur|0
450846|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|4000|ml|1|glas|HDPE plastílát|QN01AX94|01.03.2019||R|0|0|0|0|0|SAS|0|0|0|100|NOK|244131|393539|veteldis|||0|4000|0||Vistor hf|Scan Aqua AS|Isoeugenol||244131||244131|393539||1|0||0|||0
450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|NIL|0|0|0|100|IKR|9072|15636|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||9072||9072|15636||2|0||0|||0
450993|R07AX0101|INOmax|lyfjagas|800|ppm|10|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|0|LIN|0|0|0|100|XEU|20000|28570|lyfalmen|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||20000|28570||5|H|0|0|||0
451009|L01ED0401|Alunbrig|filmhtfl|30|mg|28|stk|1|þpakki||L01ED04|01.02.2021||R|1|1|1|0|0|ASS|0|1|0|100|DKK|166295|213336|lyfsjukr|||1|28|0||Vistor hf|Takeda AS|Brigatinib||166295||166295|213336||1|0|L|0|||0
451135|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|3188|5886|lyfalmen|||3|84|0|7,0000|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||3188||3188|5886||3|0|G|0|||0
451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|OTS|0|0|0|100|DKK|41074|55224|lyfalmen|V0980|55223|1|1|0|30,0800|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||41074||41074|55224||1|0|E|0|||0
451378|H02AB0607|Prednisolon Actavis|töflur|10|mg|25|stk|1|glas||H02AB06|01.12.2016||R|1|0|0|G|0|ATE|0|0|1|100|XEU|631|2366|lyfalmen|||2|25|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Prednisólón||631||631|2366||1|0|G|0|||0
451428|B06AC0102|Berinert|sts/irs|1500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|1|0|0|CSB|0|1|0|100|SEK|295314|373799|lyfsjukr|||1|1|0|1,0714|Icepharma hf|CSL Behring GmbH|C1 hemill||295314||295314|373799||2|0|L|0|||0
451655|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.09.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0||0|||0
451670|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2594|3563|lyfalmen|V0687|3265|2|70|0|35,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E|0|||0
451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|1|G|0|AEP|0|0|0|100|IKR|16132|23702|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma Trading Limited|Búsúlfan||16132||16132|23702||2|0|G|0|||0
452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|TAE|0|0|1|100|IKR|||lyflausa|||0|120|0||Alvogen|Trimb Healthcare AB|Ketókónazól|||||||2|0||0|||0
452215|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.12.2016||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1|0||0|||0
452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|7605|11965|lyfalmen|||1|120|0|60,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||7605||7605|11965||2|0|G|0|||0
452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5813||2|0||0|||0
452499|A10BJ0602|Rybelsus|töflur|3|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|20843|29636|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||20843||20843|29636||1|0|E|0|||0
452500|L01EE0201|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01EE02|01.02.2016||R|1|0|1|0|0|RRG|0|1|0|100|DKK|779846|976421|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration GmbH|Cobimetinib||||779846|976421||2|0|L|0|||0
452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|G|0|KRK|0|0|1|100|IKR|3500|2874|lyfalmen|V0010|2193|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2874||2|0|G|0|||0
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|MEA|0|0|1|100|DKK|8161|12731|lyfalmen|||1|3000|0||Icepharma hf|Meda AB|Imikvímóð||8161||8161|12731||2|0|E|0|||0
452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|11923|17909|lyfalmen|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||11923||11923|17909||2|H|0|0|||0
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|BOA|0|0|0|100|XEU|1379|2377|vetorma|||0|6,4|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||1379||1379|2377||1|0||0|||0
453560|L04AX0501|Esbriet|filmhtfl|267|mg|63|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|98580|127958|lyfalmen|||1|63|0|7,0000|Icepharma hf|Roche Registration GmbH|Pírfenidon||||98580|127958||2|0|E|0|||0
453731|N06AX1613|Venlafaxin Medical Valley|forðatfl|225|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|IKR|3500|6315|lyfalmen|||2|100|0|225,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||3500||3500|6315||2|0|G|0|||0
454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|Bel|1|0|0|100|DKK|4975|9609|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||4975||4975|9609||2|0||0|||0
454650|D05AX5204|Enstilar|húðfroða|||60|g|1|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|G|0|LEP|0|0|0|100|DKK|8283|12899|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8283||8283|12899||1|0|G|0|||0
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|G|0|PLS|0|0|0|100|DKK|33381|41885|lyfalmen|V0342|10683|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||30528||30528|41885||1|0|G|0|||0
454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Alvogen|Karo Pharma AB|Paracetamól|||||||2|0||0|||0
454882|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.05.2017||R|0|0|1|0|0|BIM|0|0|0|100|SEK|378358|477083|lyfalmen|||1|120|0||Icepharma hf|BioMarin International Limited|Saprópterín||378358||378358|477083||2|0||0|||0
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|BID|0|0|0|100|DKK|1076|2115|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín (BAN)||1076||1076|2115||1|0||0|||0
454973|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|ASR|0|0|1|100|IKR|1100|2599|lyfalmen|V0174|2599|2|3|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||800||800|2599||2|0|E|0|||0
455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|7290|11532|lyfalmen|V0713|9844|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||7290||7290|11532||1|0|G|0|||0
455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|CPV|0|1|0|100|DKK|1037963|1297447|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1037963||1037963|1297447||2|0|L|0|||0
455398|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|G|0|LVR|0|0|0|100|DKK|27530|38094|lyfalmen|V0653|38094|3|168|0|42,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban 	||27530||27530|38094||3|0|G|0|||0
455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|762|2547|lyfalmen|||2|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||762||762|2547||1|0|E|0|||0
455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|ATE|0|0|1|100|XEU|860|2682|lyfalmen|||2|15|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||860||860|2682||1|0|E|0|||0
455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1610|3714|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||1610||1610|3714||1|0|E|0|||0
456724|L01EA0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01EA01|01.05.2021||R|0|0|1|0|0|NEL|0|1|0|100|DKK|94270|122506|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatinib||94270||94270|122506||1|0|L|0|||0
456734|C07AB0704|Bisbetol|filmhtfl|10|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|G|0|WEH|0|0|0|100|XEU|4302|7419|lyfalmen|V1040|4102|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||4302||4302|7419||2|0|G|0|||0
456795|L01EB0401|Tagrisso|filmhtfl|80|mg|30|stk|1|stsk.þ||L01EB04|01.06.2019||R|0|0|1|0|0|ZEN|0|1|0|100|SEK|883231|1105003|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||883231||883231|1105003||1|0|L|0|||0
456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|G|0|MED|0|0|0|100|IKR|4926|6315|lyfalmen|V0277|6233|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||3500||3500|6315||2|0|G|0|||0
457112|N06BA0902|Atomoxetin Actavis|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6471|3392|lyfalmen|V0816|3325|2|28|0|21,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1376||1376|3392||1|0|E|0|||0
457185|H05BX0107|Cinacalcet STADA|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|28190|11614|lyfalmen|V0721|11614|2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||7350||7350|11614||2|0||0|||0
457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|1|G|0|ALE|0|0|0|100|SEK|48492|53065|lyfalmen|V0451|53065|2|1|0|83,7200|Alvogen|Alvogen Pharma Trading Europe EOOD|Góserelín||39367||39367|53065||2|0|G|0|||0
457282|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|98|stk|1|þpakki||N06AB10|01.04.2019||R|1|0|0|G|0|BLS|0|0|0|100|XEU|3414|6197|lyfalmen|V0326|5245|2|98|0|147,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Escítalópram||3414||3414|6197||1|0|0|0|||0
457359|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|MYE|0|0|1|100|DKK|1480|3535|lyfalmen|V0561|3535|2|100|0||Icepharma hf|Mylan Ireland Limited|Lídókaín||1480||1480|3535||2|0||0|||0
457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|PEU|0|0|0|100|DKK|6003|9760|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||6003||6003|9760||1|0||0|||0
457692|L04AX0307|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2834|5399|lyfalmen|||1|0,45|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2834||2834|5399||2|0|G|0|||0
457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|ATE|0|0|1|100|XEU|2545|2167|lyfalmen|V0003|2167|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||486||486|2167||1|0|E|0|||0
457755|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|4116|7163|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4116||4116|7163||1|0|G|0|||0
457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|LHS|0|0|0|100|XEU|10441|17996|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||10441||10441|17996||2|0||0|||0
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|CHE|0|0|1|100|DKK|1072|2973|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1072||1072|2973||1|0|E|2|150|hylki|0
458149|L01EX0501|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01EX05|01.06.2014||R|0|0|1|0|0|FIN|0|1|0|100|DKK|369949|466624|lyfsjukr|||1|84|0||Icepharma hf|Bayer AG|Regorafenib||369949||369949|466624||2|0|L|0|||0
458266|L04AB0402|Imraldi|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.03.2019||R|0|1|1|0|0|SUG|0|1|0|100|XEU|57057|75439|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||57057||57057|75439||2|0|L|0|||0
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|KPA|0|0|1|100|DKK|1235|3198|lyfalmen|V0577|2775|1|20|0|6,6667|Alvogen|Karo Pharma AB|Pívmecillínam||1235||1235|3198||2|0|E|0|||0
458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|107202|139841|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||107202||107202|139841||3|0|L|0|||0
458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|9465|13857|lyfalmen|V0653|13605|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||8979||8979|13857||1|0|G|0|||0
458838|M09AX0701|Spinraza|stl|12|mg|5|ml|1|hgl|lausn|M09AX07|01.11.2018||R|0|0|0|0|0|BNB|0|1|0|100|XEU|11254115|14003469|lyfsjukr|||1|5|0|120,0000|Icepharma hf|Biogen Netherlands B.V.|Nusinersen||11254107||11254107|14003469||2|H|L|0|||0
459037|L01EC0201|Tafinlar|hylki|75|mg|120|stk|1|glas||L01EC02|01.11.2013||R|1|0|1|0|0|NEL|0|1|0|100|DKK|821729|1028512|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafenib||821729||821729|1028512||1|0|L|0|||0
459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|80072|104549|lyfalmen|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||80072||80072|104549||2|0|G|0|||0
459324|V08CA0901|Gadovist|stl|1|mmol/ml|5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|BAB|0|0|0|100|DKK|20659|29403|lyfalmen|||1|25|0||Icepharma hf|Bayer AB|Gadóbútról||||20659|29403||2|H|0|0|||0
459342|N05AX1304|Paliperidon Krka|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|G|0|KNM|0|0|0|100|IKR|11123|16808|lyfalmen|V0964|16808|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||11123||11123|16808||2|0|G|0|||0
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|PLS|0|0|1|100|DKK|803|2603|lyfalmen|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||803||803|2603||1|0|0|0|||0
459405|L01EL0101|IMBRUVICA|filmhtfl|560|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|940114|1175750|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||940114||940114|1175750||1|0|L|0|||0
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1471|3523|lyfalmen|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1471||1471|3523||1|0|0|0|||0
459423|N07BC0102|Buvidal|stl|16|mg|0,32|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13183|19643|lyfsjukr|||1|0,32|0|7,6190|Vistor hf|Camurus AB|Búprenorfín||13183||13183|19643||1|H|L|1|30|dagar|0
459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|19885|37896|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|Cefovecinum||19885||19885|37896||2|0||0|||0
459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|2514|2393|lyfalmen|V0284|2329|2|100|0|6,2500|Alvogen|Teva Sweden AB|Quetíapín||650||650|2393||2|0|G|0|||0
459838|N05AH0416|Quetiapin Medical Valley|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|10500|11408|lyfalmen|V0261|11408|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||7200||7200|11408||2|0|0|0|||0
459845|A10BD2301|Segluromet|filmhtfl|1007,5|mg|56|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|5781|9455|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||5781||5781|9455||1|0|G|0|||0
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|G|0|MEA|0|0|1|100|DKK|1920|4141|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Tranexamsýra||1920||1920|4141||2|0|G|0|||0
459926|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.04.2019||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valacíklóvír|||||||1|0|0|0|||0
460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|0|0|AEE|0|1|0|100|XEU|133267|172258|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare B.V.|Bendamústín||133267||133267|172258||1|H|L|0|||0
460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|G|0|HSS|0|0|0|100|DKK|8873|13711|lyfalmen|||1|100|0|25,0000|Artasan ehf|Sandoz GmbH|Rífampicín||8873||8873|13711||1|0|G|0|||0
460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|0|0|RRG|0|1|0|100|DKK|237362|301723|lyfsjukr|||1|5|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||237362||237362|301723||2|H|L|0|||0
460632|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|7052|4109|lyfalmen|V0144|3907|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1897||1897|4109||1|0|E|0|||0
460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|4815|8660|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||4475||4475|8660||2|0|0|0|||0
460889|N02AE0105|Buprenorphine Alvogen|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|DKK|1750|3907|lyfalmen|V0943|3907|2|4|0|2,8000|Alvogen|Alvogen|Búprenorfín||1750||1750|3907||2|0|G|1|30|dagar|0
461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4599|7679|lyfalmen|V0585|7653|2|98|0|26,1300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||4491||4491|7679||1|0|G|1|30|dagar|0
461113|L01EJ0101|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01EJ01|01.02.2014||R|1|0|1|0|0|NEL|0|1|0|100|DKK|428330|539234|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||428330||428330|539234||1|0|L|0|||0
461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Alvogen|ratiopharm GmbH|Flúkónazól|||||1916||2|0|E|0|||0
461405|N02AA0508|Oxycodone Alvogen|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3890|6852|lyfalmen|||2|28|0|14,9300|Alvogen|Alvogen ehf|Oxýcódon||3890||3890|6852||2|0|G|1|30|dagar|0
461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|CPV|0|1|0|100|DKK|1070061|1337368|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1070061||1070061|1337368||2|0|L|0|||0
461563|V03AB1506|Nyxoid|nefúði|1,8|mg|0,1|ml|2|stsk.í||V03AB15|01.03.2020||R|0|1|0|0|0|MIP|0|0|1|100|DKK|6090|9880|lyfalmen|||1|0,2|0||Icepharma hf|Mundipharma Corporation (Ireland) Ltd|Naloxón||6090||6090|9880||2|0|E|0|||0
461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|296779|375621|lyfalmen|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||296779||296779|375621||1|H|0|0|||0
461917|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
462070|A10BK0101|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BK01|01.09.2015||R|1|0|0|G|0|AZE|0|0|0|100|SEK|17932|26180|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||17932||17932|26180||1|0|G|0|||0
462130|N06BA0903|Atomoxetin Medical Valley|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9984|3392|lyfalmen|V0816|3325|2|28|0|21,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1376||1376|3392||2|0|E|0|||0
462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|0|0|IND|0|1|0|100|DKK|3837|6779|lyfsjukr|||1|28|0|7,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||3837||3837|6779||1|0|L|1|30|dagar|0
462429|L01EM0301|Piqray|filmhtfl|150|mg|56|stk|1|þpakki||L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|488714|614335|lyfsjukr|||1|56|0|28,0000|Vistor hf|Novartis Europharm Limited|Alpelisib||488714||488714|614335||1|0|L|0|||0
462849|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4245|7341|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4245||4245|7341||2|0|G|0|||0
463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|5821|2874|lyfalmen|V0605|2874|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Memantín||1000||1000|2874||2|0|G|0|||0
463262|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.04.2020||R|1|0|0|G|0|BLS|0|0|0|100|XEU|2562|5024|lyfalmen|V0325|4435|2|98|0|98,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Escítalópram||2562||2562|5024||1|0|0|0|||0
463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|1|0|0|JCI|0|1|0|100|SEK|49247|65561|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||49247|65561||1|0|L|0|||0
463744|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|tfílát||G02CB03|01.07.1993||R|1|0|0|G|0|PLS|0|0|0|100|DKK|4356|7494|lyfalmen|||1|8|0|8,0000|Icepharma hf|Pfizer Aps|Kabególín||||4356|7494||1|0|G|0|||0
463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.11.2020||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1860|4058|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1860||1860|4058||1|0|G|0|||0
463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratoires Expanscience|Glúkósamín|||||||2|0||0|||0
463956|R02AX0102|Strefen Orange Sukkerfri|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0
464078|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|150 mg/30 mg|QP54AB51|01.04.2018|31.08.2021|R|0|0|0|0|0|BIV|0|0|0|100|XEU|3253|5607|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3253||3253|5607||1|0||0|||0
464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
464170|N02BA5104|Treo Citrus|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.08.2019||L|0|0|0|0|0|MEA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
464201|J07BX0304|COVID-19 Vaccine Janssen|stl|||2,5|ml|10|hgl|hvert hgl.inniheldur 5x0,5ml|J07BX03|01.04.2021||R|0|0|0|0|0|JCI|0|0|0|100|IKR|||lyfalmen|||1|25|0||Vistor hf|Janssen-Cilag International N.V.|Covid-19 vaccines|||||||1|0||0|||0
464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|2130|3356|lyfalmen|V0947|3356|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Carvedílól||1350||1350|3356||2|0|G|0|||0
464327|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|10|hgl||B01AB01|01.07.2019||R|0|0|0|0|0|LEP|0|0|0|100|DKK|7339|11599|lyfalmen|||1|50|0|25,0000|Vistor hf|LEO Pharma A/S|Heparín||7339||7339|11599||1|H|0|0|||0
464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|1|G|0|WIL|0|0|0|100|XEU|6211|10047|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||6211||6211|10047||2|0|G|0|||0
464751|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
464762|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.12.2016|31.07.2021|L|0|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|||2|140|0|35,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mómetasón|||||2991||1|0|G|0|||0
464827|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|505|2193|lyfalmen|V0188|2193|2|30|0|15,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||505||505|2193||2|0|G|0|||0
465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.10.2011||R|0|0|0|G|0|ATE|0|0|0|100|DKK|2547|5004|lyfalmen|V0376|5004|2|7,5|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Latanóprost||2547||2547|5004||1|0|G|0|||0
465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|IBV|0|0|0|100|DKK|1339|2632|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Penicillín í blöndum með öðrum sýklalyfjum||1339||1339|2632||1|0||0|||0
465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|G|0|MDK|0|0|0|100|DKK|1919|4139|lyfalmen|||1|98|0|49,0000|Icepharma hf|Mylan Denmark ApS|Verapamíl||1919||1919|4139||2|0|G|0|||0
465333|L04AX0307|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3140|5820|lyfalmen|||1|0,6|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3140||3140|5820||2|0|G|0|||0
465772|L01XC0302|Kanjinti|st/irþ|150|mg|1|hgl|1|pakki||L01XC03|01.12.2018||R|0|0|0|0|0|AEB|0|1|0|100|DKK|73598|96360|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||73598||73598|96360||1|H|L|0|||0
466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|MDI|0|0|0|100|DKK|587|2306|lyfalmen|||1|25|0|2,5000|Icepharma hf|Mundipharma A/S|Morfín||587||587|2306||2|0|G|1|30|dagar|0
466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|0|G|0|MDI|0|0|0|100|DKK|1827|4013|lyfalmen|||1|100|0|10,0000|Icepharma hf|Mundipharma A/S|Morfín||1827||1827|4013||2|0|G|1|30|dagar|0
466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|1211|2833|lyfalm11|V0545|1872|1|63|0|84,0000|Icepharma hf|Bayer AB|Levónorgestrel og ethinylestradíól||||1211|2833||2|0||0|||1
466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|MDI|0|0|0|100|DKK|1385|3404|lyfalmen|||1|25|0|7,5000|Icepharma hf|Mundipharma A/S|Morfín||1385||1385|3404||2|0|G|1|30|dagar|0
466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|0|G|0|MDI|0|0|0|100|DKK|4801|8106|lyfalmen|||1|100|0|30,0000|Icepharma hf|Mundipharma A/S|Morfín||4801||4801|8106||2|0|G|1|30|dagar|0
466276|J01XD0103|Metronidazol Normon|irl|5|mg/ml|100|ml|50|pokar||J01XD01|01.09.2019||R|0|0|0|0|0|LNA|0|0|1|100|XEU|28351|34588|lyfalmen|||2|5000|0|16,6667|Williams & Halls efh|Laboratorios Normon, S.A.|Metrónídazól||24758||24758|34588||2|0|0|0|||0
466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|RRG|0|1|0|100|DKK|247733|314622|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||247733||247733|314622||2|H|L|0|||0
466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|G|0|EIG|0|0|0|100|SEK|17854|26072|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai GmbH|Zonisamíð||17854||17854|26072||1|0|G|0|||0
466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|0|G|0|MDI|0|0|0|100|DKK|2576|5044|lyfalmen|||1|25|0|15,0000|Icepharma hf|Mundipharma A/S|Morfín||2576||2576|5044||2|0|G|1|30|dagar|0
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|6666|10673|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||6666||6666|10673||1|0|G|0|||0
466571|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|ílát|100+25+200mg|N04BA03|01.05.2021||R|1|0|0|G|0|LVR|0|0|0|100|DKK|9755|14925|lyfalmen|V0829|14925|3|100|0|22,2200|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9755||9755|14925||3|0|G|0|||0
466588|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.02.2017||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1|0||0|||0
466658|V08CA1001|Primovist|stl|0,25|mmol/ml|10|ml|5|áfspr|lausn|V08CA10|01.02.2021||R|0|0|0|0|0|BAB|0|0|0|100|DKK|100006|130891|lyfalmen|||1|50|0||Icepharma hf|Bayer AB|Gadoxetic acid||100006||100006|130891||1|H|0|0|||0
466667|L01AA0501|LEDAGA|hlaup|160|mcg/g|60|g|1|túpa||L01AA05|01.03.2020||R|0|1|0|0|0|HEL|0|1|0|100|XEU|354126|446945|lyfsjukr|||1|60|0||Recordati AB|Helsinn Birex Pharmaceuticals Ltd.|Chlormethine||354126||354126|446945||3|0|L|0|||0
466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|MDI|0|0|0|100|DKK|4238|7331|lyfalmen|||1|25|0|25,0000|Icepharma hf|Mundipharma A/S|Morfín||4238||4238|7331||2|0|G|1|30|dagar|0
466723|V03AN0502|Airapy|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|19907|28898|lyfalmen|V0728|26269|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||19907||19907|28898||1|0|E|0|||0
466902|N02BE0122|Dolorin|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.12.2017||R|1|0|0|0|0|WEH|0|0|1|100|IKR|361|1995|lyfalmen|||2|100|0|16,6666|Williams & Halls efh|Williams & Halls ehf|Paracetamól||361||361|1995||2|0|E|0|||0
467189|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6604|6176|lyfalmen|V0622|6175|2|30|0|54,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||3399||3399|6176||1|0|E|1|30|dagar|0
467437|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|250|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5621|9688|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||5621||5621|9688||2|0||0|||0
467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|5846|9544|lyfalmen|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5846||5846|9544||2|0|0|0|||0
467473|H02AB0912|Alkindi|kyrnhylk|2|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|29059|40027|lyfalmen|||1|50|0|3,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||29059||29059|40027||2|0|G|0|||0
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|11325|17086|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||11325||11325|17086||1|0|G|0|||0
467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|5823|9513|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrogen||5823||5823|9513||2|0||0|||0
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|21255|30157|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||21255||21255|30157||1|0|G|0|||0
467756|A10BJ0301|Lyxumia|stl|20|mcg/sk|3|ml|2|áfpen||A10BJ03|01.10.2013||R|0|0|0|0|0|SGB|0|0|0|100|XEU|10826|16399|lyfalmen|||1|6|0|28,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||10826||10826|16399||1|0|E|0|||0
467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|PIP|0|0|1|100|DKK|75606|98900|lyfalmen|||1|10|0|5,0000|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftarólin||75606||75606|98900||1|0|0|0|||0
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|JAS|0|0|0|100|SEK|389|2033|lyfalmen|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||389||389|2033||1|0|0|0|||0
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|G|0|LBK|0|0|0|100|DKK|5718|6845|lyfalmen|V0317|3700|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3885||3885|6845||1|0|G|0|||0
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|G|0|LBK|0|0|0|100|DKK|7045|6819|lyfalmen|V0318|5077|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3866||3866|6819||1|0|G|0|||0
468374|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|G|0|AZD|0|0|1|100|SEK|933|2782|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||933||933|2782||1|0|G|0|||0
468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|2199|3790|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2199||2199|3790||2|0||0|||0
468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|G|0|ATE|0|0|1|100|XEU|3230|5055|lyfalmen|V0467|4950|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||2584||2584|5055||1|0|G|0|||0
469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|6984|11111|lyfalmen|V0712|9749|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||6984||6984|11111||1|0|G|0|||0
469152|N06BA0408|Methylphenidate Teva|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|6029|5406|lyfalmen|V0960|5406|2|30|0|30,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||2839||2839|5406||1|0|E|1|30|dagar|0
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|PLS|0|0|0|100|DKK|3049|5695|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3049||3049|5695||1|0|E|0|||0
469422|G03AB0501|Gracial|töflur|||66|stk|1|þpakki|Þp 3 * (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|AEP|0|0|0|100|DKK|3309|5418|lyfalm11|||1|66|0|66,0000|Icepharma hf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||3309||3309|5418||2|0||0|||1
469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|6515|10465|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6515||6515|10465||1|0|0|0|||0
469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|2352|3150|lyfalmen|V0037|3150|2|20|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||1200||1200|3150||1|0|G|0|||0
469899|C01CA1703|Hypotron|töflur|2,5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|G|0|RET|0|0|0|100|IKR|14250|21112|lyfalmen|V0968|21112|2|100|0|8,3333|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||14250||14250|21112||1|0|G|0|||0
469912|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|þpakki||C01AA05|01.08.2020||R|1|0|0|G|0|AEP|0|0|0|100|DKK|366|2002|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||366||366|2002||2|0|G|0|||0
469990|L04AB0403|Amgevita|stl|40|mg/penna|0,8|ml|2|áfpen|SureClick penni|L04AB04|01.06.2020||R|0|1|1|0|0|AEB|0|1|0|100|DKK|58652|77457|lyfsjukr|||1|1,6|0|27,5860|Vistor hf|Amgen Europe B.V.|Adalimumab||58652||58652|77457||1|0|L|0|||0
470202|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|14718|18624|lyfalmen|||2|180|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||12443||12443|18624||2|0|G|0|||0
470315|J05AF0703|Virofob|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.01.2017||R|1|1|1|0|0|IPC|0|1|0|100|DKK|46050|55740|lyfsjukr|||2|30|0|30,0000|Alvogen|Alvogen IPco S.á.r.l.|Tenófóvír dísóproxíl||41482||41482|55740||2|0|L|0|||0
470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3872|6827|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3872||3872|6827||1|0|G|0|||0
470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|G|0|MYR|0|0|0|100|DKK|5816|9503|lyfalmen|||1|5|0|10,0000|Icepharma hf|Mylan IRE Healthcare Limited|Fondaparinux||5816||5816|9503||2|0|G|0|||0
470817|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.07.2020||R|0|0|0|0|0|NEL|0|0|0|100|DKK|59720|78807|lyfalmen|V0728|78807|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||59720||59720|78807||1|0|E|0|||0
471066|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|G|0|MEC|0|0|0|100|SEK|481|2160|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck AB|Levótýroxínnatríum||481||481|2160||2|0|G|0|||0
471122|M01AE5102|Parapró|filmhtfl|700|mg|20|stk|1|þpakki|200/500mg|M01AE51|01.03.2021||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||2|20|0||Acare ehf|Acare ehf|Íbúprófen í blöndum|||||||2|0||0|||0
471632|QA05AX9001|Menbutil|stl|100|mg/ml|100|ml|1|hgl|lausn|QA05AX90|01.06.2021||R|0|0|0|0|0|ANI|1|0|0|100|IKR|2753|5393|vetalmen|||0|100|0||Dýraheilsa ehf|aniMedica GmbH|Menbutone||2753||2753|5393||2|0||0|||0
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|COR|1|0|0|100|DKK|5541|10683|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||5541||5541|10683||1|0||0|||0
471970|N05CH0105|Slenyto|forðatfl|5|mg|30|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|RNU|0|0|1|100|XEU|16071|23618|lyfalmen|||2|30|0|75,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||16071||16071|23618||2|0|0|0|||0
472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|G|0|RDT|0|0|0|100|DKK|1626|3736|lyfalmen|V0048|2946|1|98|0|31,0333|Vistor hf|Recordati Ireland Limited|Metóprólól||1626||1626|3736||1|0|G|0|||0
472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|GPH|0|0|0|100|DKK|3595|6446|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3595||3595|6446||1|0||0|||0
472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|0|0|TEA|0|0|0|100|SEK|8118|12672|lyfalmen|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||8118||8118|12672||1|H|0|0|||0
472590|B05BA1024|SmofKabiven extra Nitrogen|irl|||2025|ml|4|pokar|fleyti|B05BA10|01.05.2021||R|0|0|0|0|0|FKA|0|0|0|100|DKK|51036|67824|lyfalmen|||1|8100|0||Vistor hf|Fresenius Kabi AB|Blöndur||51036||51036|67824||1|0|0|0|||0
472610|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|98|stk|1|þpakki||N06AX21|01.12.2018||R|1|0|0|G|0|WEH|0|0|0|100|XEU|4952|5220|lyfalmen|V0811|5192|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2704||2704|5220||2|0|G|0|||0
472741|N03AX1402|Keppra (Lyfjaver)|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|20538|29250|lyfalmen|V0516|12509|3|100|0|66,6700|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||20538||20538|29250||3|0|G|0|||0
472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.12.2019||R|1|0|0|G|0|NVO|0|0|1|100|DKK|3006|5635|lyfalmen|V0458|2979|1|100|0|100,0000|Vistor hf|N.V. Organon|Deslóratadín||3006||3006|5635||1|0|G|0|||0
472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2466|4892|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||2466||2466|4892||1|0|G|0|||0
473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|G|0|ATR|0|0|1|100|DKK|1359|3368|lyfalmen|||1|5|0|5,0000|Atnahs Pharma Nordics A/S|Atnahs Pharma Netherlands B.V.|Ketórólak||1359||1359|3368||2|0|G|0|||0
473879|B01AF0101|Xarelto|filmhtfl|2,5|mg|196|stk|1|þpakki||B01AF01|01.05.2020||R|1|1|0|G|0|FIN|0|0|0|100|DKK|27971|38651|lyfalmen|V0974|38651|1|196|0|24,5000|Icepharma hf|Bayer AG|Rivaoxaban||27971||27971|38651||2|0|G|0|||0
473957|L04AB0102|Benepali|stl|50|mg|4|áf-penni|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|0|SUG|0|1|0|100|XEU|82889|108112|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||82889||82889|108112||2|0|L|0|||0
473968|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.11.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|4315|7437|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||4315||4315|7437||1|0|G|0|||0
474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|PHM|0|0|0|100|DKK|28494|54229|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||28494||28494|54229||2|0||0|||0
475669|N03AX1603|Pregabalin Krka|hylki|50|mg|56|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2904|5495|lyfalmen|||2|56|0|9,3333|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2904||2904|5495||2|0|E|0|||0
475705|QN02AF0104|Torphadine vet.|stl|10|mg/ml|10|ml|1|hgl|lausn|QN02AF01|01.03.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|5789|11153|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Bútorfanóltartrat||||5789|11153||2|0||2|||0
475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0||0|||0
476249|QJ01CA0403|Amoxibactin vet.|töflur|250|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|5695|10975|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||5695||5695|10975||2|0||0|||0
476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|58181|76861|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||58181|76861||1|0|L|0|||0
476818|L01XK0401|Talzenna|hylki|0,25|mg|30|stk|1|glas||L01XK04|01.09.2021||R|0|0|1|0|0|PEU|0|1|0|100|DKK|210676|268533|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Europe MA EEIG|Talazoparib||210676||210676|268533||2|0|L|0|||0
476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|4222|7309|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||4222|7309||2|0|0|0|||0
477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|14833|21914|lyfalmen|V0954|6008|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||14833||14833|21914||1|0|E|0|||0
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|GPH|0|0|0|100|DKK|4270|7375|lyfalmen|V0934|5772|1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||4270||4270|7375||1|0||0|||0
477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|1|0|0|AEB|0|1|0|100|XEU|55398|73341|lyfsjukr|||1|27|0|11,5000|Vistor hf|Amgen Europe B.V.|Apremilast||55398||55398|73341||1|0|L|0|||0
477201|L04AB0102|Benepali|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|0|SUG|0|1|0|100|XEU|82889|108112|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||82889||82889|108112||2|0|L|0|||0
477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|10359|9481|lyfalmen|V0272|8917|2|100|0|75,0000|Alvogen|Teva Pharma B.V.|Quetíapín||5800||5800|9481||2|0|G|0|||0
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||2|0||0|||0
477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|5+2 mg/ml|H02AB01|01.04.2021||R|0|0|0|G|0|MBV|0|0|1|100|DKK|962|2822|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||962||962|2822||1|0|G|0|||0
477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||1|0||0|||0
477864|L01EF0101|Ibrance|filmhtfl|100|mg|21|stk|1|þpakki||L01EF01|01.03.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|306824|388114|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||306824||306824|388114||1|0|L|0|||0
478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|501|2055|lyfalmen|V0500|2054|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metformín||405||405|2055||1|0|G|0|||0
478163|D05AX5204|Enstilar|húðfroða|||60|g|2|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|G|0|LEP|0|0|0|100|DKK|16566|24299|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||16566||16566|24299||1|0|G|0|||0
478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|CHP|1|0|0|100|XEU|7102|13644|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||7102||7102|13644||2|0||0|||0
478386|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.10.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|3532|5232|lyfalm11|V0983|5232|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3158||3158|5232||2|0||0|||1
478808|R03DX0901|Nucala|stl|100|mg|1|pennar|1|pakki||R03DX09|01.07.2020||R|0|0|1|0|0|GSD|0|1|0|100|DKK|164991|211714|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||164991||164991|211714||1|0|L|0|||0
478993|M01AH0502|Coxient|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|2221|3287|lyfalmen|V0825|2811|2|28|0|28,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||1300||1300|3287||2|0|G|0|||0
479127|C10AA0509|Atorvastatin Xiromed|filmhtfl|80|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|0|MVX|0|0|0|100|IKR|4900|7829|lyfalmen|V0115|7808|2|98|0|392,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||4600||4600|7829||2|0|E|0|||0
479703|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|0|0|0|PBV|0|0|0|100|XEU|3217|5926|lyfalmen|V1052|5926|1|50|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||3217||3217|5926||1|0|0|1|30|dagar|0
479904|L01EA0401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01EA04|01.09.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|114690|149153|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|bosutinib||114690||114690|149153||1|0|L|0|||0
479954|L01XC1701|OPDIVO|irþ|10|mg/ml|24|ml|1|hgl||L01XC17|01.10.2019||R|0|1|0|0|0|BMS|0|1|0|100|DKK|387367|488287|lyfsjukr|||1|24|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||387367||387367|488287||1|H|L|0|||0
479991|L01XG0301|Ninlaro|hylki|4|mg|1|stk|3|þpakki|Hvert hylki sérpakkað í þynnu|L01XG03|01.01.2019||R|0|0|1|0|0|TPA|0|1|0|100|DKK|791891|991402|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||791891||791891|991402||1|0|L|0|||0
480454|QN05CM1802|Sileo|munnh.hl|0,1|mg/ml|3|ml|1|spr||QN05CM18|01.01.2017||R|0|0|0|0|0|OCO|0|0|0|100|DKK|3089|6031|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||3089||3089|6031||2|0||0|||0
480519|C09CA0604|Kairasec|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|4126|6117|lyfalmen|V0080|6117|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3356||3356|6117||2|0|G|0|||0
480750|B01AF0101|Xarelto|filmhtfl|10|mg|98|stk|1|þpakki||B01AF01|01.12.2018||R|1|1|0|G|0|FIN|0|0|0|100|DKK|30674|42070|lyfalmen|V0975|42041|1|98|0|49,0000|Icepharma hf|Bayer AG|Rivaoxaban||30674||30674|42070||2|0|G|0|||0
481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|GPH|0|0|0|100|DKK|12288|18411|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||12288||12288|18411||1|0||0|||0
481208|D07AC1302|Ovixan|krem|1|mg/g|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|673|2424|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||673||673|2424||1|0|G|0|||0
481345|N06DA0304|Nimvastid|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|25104|35025|lyfalmen|||2|112|0|37,3300|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||25104||25104|35025||2|0|G|0|||0
481506|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|5608|7377|lyfalmen|V0681|7377|2|30|0|27,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||4271||4271|7377||1|0|E|1|30|dagar|0
481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|0|G|0|GLP|0|0|1|100|DKK|244|1834|lyfalmen|V0055|1832|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||244||244|1834||1|0|G|1|30|dagar|0
482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|G|0|BAB|0|0|0|100|DKK|14734|21778|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer AB|Testósterón||14734||14734|21778||2|0|G|0|||0
482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
482751|QJ01DB0101|Cefabactin vet.|töflur|500|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|BVL|0|0|0|100|IKR|6458|12423|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||6458|12423||2|0||0|||0
483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|0|0|0|0|AEB|0|1|0|100|DKK|55988|74087|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||55988||55988|74087||1|H|L|0|||0
483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|29769|40925|lyfalmen|V0977|40619|1|98|0|98,0000|Icepharma hf|Bayer AG|Rivaoxaban||||29769|40925||2|0|G|0|||0
483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|10053|15335|lyfalmen|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|albumin||10053||10053|15335||2|H|0|0|||0
483485|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|15|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|45714|61093|lyfalmen|||1|150|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||45714||45714|61093||2|H|0|0|||0
483540|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2017||R|0|0|0|G|0|DAN|0|0|0|100|XEU|4774|8069|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4774||4774|8069||2|0|G|0|||0
483556|S01EA0502|Brimonidin Bluefish|augndr|2|mg/ml|5|ml|3|glös|lausn|S01EA05|01.04.2018||R|0|0|0|G|0|BLS|0|0|0|100|XEU|2179|4497|lyfalmen|V0368|4497|2|15|0|75,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Brímónidín||2179||2179|4497||1|0|G|0|||0
483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|G|0|SHS|0|0|1|100|DKK|6366|10260|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||6366||6366|10260||1|0|G|0|||0
483903|N06DX0109|Marbodin|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2486|4920|lyfalmen|||2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2486||2486|4920||2|0|G|0|||0
483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|G|0|MEV|0|0|0|100|DKK|1086|2993|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1086||1086|2993||1|0|G|0|||0
483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|0|G|0|ATE|0|0|1|100|XEU|272|1832|lyfalmen|V0055|1832|2|20|0|3,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||243||243|1832||1|0|G|1|30|dagar|0
484271|L01EX0901|Ofev|hylki|150|mg|60|stk|1|þpakki||L01EX09|01.07.2016||R|0|0|1|0|0|BOE|0|0|0|100|DKK|330166|417145|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||330166||330166|417145||1|0|E|0|||0
484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|1|0|0|AEB|0|1|0|100|DKK|118358|153715|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||118358||118358|153715||1|0|L|0|||0
484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|9723|14881|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer AG|Rivaoxaban||9723||9723|14881||2|0|G|0|||0
484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|44272|59269|lyfalmen|V1045|59266|1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||44272||44272|59269||1|0|G|0|||0
484846|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|G|0|NAS|0|0|0|100|DKK|8249|12852|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||8249||8249|12852||1|0|G|0|||0
485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|G|0|ANS|0|0|1|100|XEU|1324|3320|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1324||1324|3320||2|0|G|0|||0
485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|G|0|ATN|0|0|0|100|DKK|16553|24281|lyfalmen|||1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||||16553|24281|30.6.2021|2|0|G|0|||0
485303|D01AE1604|Amorolfin Alvogen|lakk|5|%|5|ml|1|glas||D01AE16|01.05.2021||L|0|0|0|0|0|POF|0|0|1|100|IKR|||lyfalmen|||2|5|0||Alvogen|Alvogen|Amorolfín|||||5077||2|0|E|0|||0
485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|369276|465787|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer AG|Riociguatum||369276||369276|465787||1|0|L|0|||0
485348|J07BX0305|COVID-19 Vaccine Moderna (Spikevax)|stl|||5|ml|10|hgl|hvert hgl.10x0,5ml sk.|J07BX03|01.02.2021||R|0|0|0|0|0|MOD|0|0|0|100|IKR|||lyfalmen|||1|50|0||MODERNA BIOTECH SPAIN, S.L|MODERNA BIOTECH SPAIN, S.L|Covid-19 vaccines|||||||1|0||0|||0
485398|C02DD0102|Nipruss|irs|60|mg|5|lykjur|1|pakki||C02DD01|01.03.2021||R|0|0|0|0|0|ORE|0|0|0|100|NOK|72053|94406|lyfalmen|||2|5|0|6,0000|Oresund Pharma ApS|Oresund Pharma ApS|Nitroprusside||72053||72053|94406||2|H|0|0|||0
485462|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|30|mg|30|stk|1|þpakki|20+10 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|5917|8538|lyfalmen|V1006|8538|2|30|0|8,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||5115||5115|8538||2|0|E|1|30|dagar|0
485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|13670|20313|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13670||13670|20313||1|0|G|0|||0
485553|L04AX0402|Lenalidomid Alvogen|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|611849|754562|lyfsjukr|||2|21|0|21,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||601462||601462|754562||2|0|L|0|||0
485592|QL04AD0101|Sporimune vet.|mixtúra|50|mg/ml|25|ml|1|glas||QL04AD01|01.06.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|6297|12117|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ciclosporin||6297||6297|12117||2|0||0|||0
485593|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|21|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|4800|4939|lyfalmen|V0116|4939|2|21|0|21,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||2500||2500|4939||2|0||0|||0
485764|J05AJ0301|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AJ03|01.04.2014||R|1|0|1|0|0|VIC|0|1|0|100|DKK|68654|90107|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravír||68654||68654|90107||1|0|L|0|||0
485799|A10BK0401|Steglatro|filmhtfl|5|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|5568|9162|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Ertugliflozin||5568||5568|9162||1|0|G|0|||0
485911|L04AX0402|Lenalidomid Alvogen|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|666591|821489|lyfsjukr|||2|21|0|10,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||655274||655274|821489||2|0|L|0|||0
486750|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|15|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0||0|||0
486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2|0||0|||0
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|G|0|HES|0|0|1|100|DKK|331|1954|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||331||331|1954||1|0|G|0|||0
486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|G|0|HES|0|0|1|100|DKK|519|2212|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||519||519|2212||1|0|G|0|||0
487105|L01ED0201|Zykadia|hylki|150|mg|150|stk|1|þpakki|3 x 50|L01ED02|01.05.2017||R|1|0|1|0|0|NEL|0|1|0|100|DKK|784025|981619|lyfsjukr|||1|150|0||Vistor hf|Novartis Europharm Ltd|Ceritinib||784025||784025|981619||1|0|L|0|||0
487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|G|0|ARN|0|0|1|100|DKK|1742|3896|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||1742||1742|3896||1|0|G|0|||0
487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|24038|33677|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||24038||24038|33677||1|0|L|0|||0
487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|G|0|RTH|0|0|1|100|IKR|2489|4924|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Díklófenak||2489||2489|4924||2|0|G|0|||0
487961|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|9072|17382|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||9072||9072|17382||1|0||0|||0
488024|J07BX0306|COVID-19 Vaccine Pfizer (Comirnaty)|stþ|||1|stk|195|hgl|hvert hgl.6x0,3ml sk.e.þynning|J07BX03|01.01.2021||R|0|0|0|0|0|BNT|0|0|0|100|IKR|||lyfalmen|||1|195|0||Icepharma hf|BioNTech Manufacturing GmbH|Covid-19 vaccines|||||||1|0||0|||0
488468|L01EJ0101|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01EJ01|01.02.2014||R|1|0|1|0|0|NEL|0|1|0|100|DKK|217062|276476|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||217062||217062|276476||1|0|L|0|||0
488730|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|1|G|0|ATE|0|0|0|100|DKK|2651|5147|lyfalmen|||1|50|0|14,2857|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Acitretín||2651||2651|5147||1|0|G|0|||0
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|1|G|0|ATE|0|0|0|100|DKK|7352|11617|lyfalmen|||1|50|0|35,7143|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Acitretín||7352||7352|11617||1|0|G|0|||0
488813|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
489128|A10BD2301|Segluromet|filmhtfl|1007,5|mg|196|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|20061|28647|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||20061||20061|28647||1|0|G|0|||0
489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|6027|9793|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||6027||6027|9793||3|0|G|0|||0
489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|77553|101363|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||77553|101363||1|0|L|0|||0
489264|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|30|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0||0|||0
489274|R03AK0707|Symbicort (Lyfjaver)|innúðal|164,5|mcg/sk|120|skammtar|1|sk-ílá|160+4,5 mcg/sk|R03AK07|01.02.2021||R|0|0|0|G|0|LVR|0|0|0|100|SEK|5626|9242|lyfalmen|||3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||5626||5626|9242||3|0|G|0|||0
489349|N03AX0901|Lamictal|dreifit.|5|mg|60|stk|1|glas||N03AX09|01.10.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1529|3602|lyfalmen|||1|60|0|1,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1529||1529|3602||1|0|G|0|||0
489662|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 33 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|SGB|0|0|0|100|XEU|19467|28292|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og  lixisenatide||19467||19467|28292||1|0|E|0|||0
490174|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.05.2021||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2308|3012|lyfalmen|V0825|3012|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1100||1100|3012||2|0|G|0|||0
490525|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.2020||R|0|0|0|G|0|RDT|0|0|0|100|DKK|2293|4654|lyfalmen|||1|25|0|0,1667|Vistor hf|Recordati Ireland Limited|Metóprólól||2293||2293|4654||1|0|G|0|||0
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|10146|10552|lyfalmen|V0112|2733|1|100|0|50,0000|Icepharma hf|Upjohn EESV|Atorvastatín||6578||6578|10552||1|0|E|0|||0
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|12386|14099|lyfalmen|V0113|2735|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Atorvastatín||9155||9155|14099||1|0|E|0|||0
490823|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|19322|25138|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||17175||17175|25138||1|0|G|0|||0
490827|J01CF0503|Flucloxacillin WH|sts/irs|1000|mg|10|hgl|1|pakki||J01CF05|01.08.2020||R|0|0|0|0|0|WEH|0|0|1|100|XEU|14419|21344|lyfalmen|||2|10|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Flúkloxacillín||14419||14419|21344||2|0|0|0|||0
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|14544|17404|lyfalmen|V0114|2736|1|100|0|200,0000|Icepharma hf|Upjohn EESV|Atorvastatín||11556||11556|17404||1|0|E|0|||0
491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20148|28757|lyfalmen|||1|28|0|21,0000|Eisai AB|Eisai GmbH|Perampanel||20148||20148|28757||1|0|G|0|||0
491230|J05AP5501|Epclusa|filmhtfl|500|mg|28|stk|1|glas|400 mg + 100 mg|J05AP55|01.10.2016||R|0|0|1|0|0|GSE|0|1|0|100|DKK|1340292|1673459|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvír og Velpatasvír||1340292||1340292|1673459||2|0|L|0|||0
491237|L02BX0301|Zytiga|filmhtfl|500|mg|56|stk|1|þpakki||L02BX03|01.12.2017||R|0|0|0|0|0|JCI|0|1|0|100|SEK|349187|440802|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||349187||349187|440802||1|0|L|0|||0
491257|A10BK0401|Steglatro|filmhtfl|5|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|19464|28288|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Ertugliflozin||19464||19464|28288||1|0|G|0|||0
491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|1|0|0|PEU|0|1|0|100|DKK|116029|150819|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||116029||116029|150819||1|0|L|0|||0
491593|M05BX0402|XGEVA|stl|120|mg|1,7|ml|1|hgl|lausn|M05BX04|01.01.2018||R|0|1|0|0|0|AEB|0|0|0|100|DKK|42687|57264|lyfalmen|||1|1,7|0|363,6364|Vistor hf|Amgen Europe B.V.|Denosúmab||42687||42687|57264||1|H|0|0|||0
491660|N05CD0806|Buccolam|munnh.l|7,5|mg|1,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12505|18710|lyfalmen|||2|6|0|3,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12505||12505|18710||3|0|E|2|450|mg|0
491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015|31.07.2021|R|0|0|0|0|0|ASD|0|0|0|100|SEK|2216|3525|lyfalmen|||2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Duloxetín||1473||1473|3525||2|0|E|0|||0
491758|H01CB0203|Octreoanne|sts|10|mg|10|mg|1|hgl|+ leysir|H01CB02|01.05.2020|30.06.2021|R|0|0|0|0|0|TVI|0|1|0|100|NOK|108643|86093|lyfsjukr|||2|10|0|14,2900|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||65480||65480|86093||1|0|L|0|||0
492377|L01EA0401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01EA04|01.09.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|516102|648398|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|bosutinib||516102||516102|648398||1|0|L|0|||0
492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2592|5066|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2592||2592|5066||2|0|G|0|||0
492507|S01BA0201|Softacort|augndr|3,35|mg/ml|0,4|ml|30|sk-ílá|lausn í staksk.íláti|S01BA02|01.05.2018||R|0|0|0|G|0|TEA|0|0|1|100|SEK|1504|3568|lyfalmen|||1|12|0||Vistor hf|Laboratories THEA|Hydrocortisone||1504||1504|3568||1|0|G|0|||0
492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|16350|24002|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||16350||16350|24002||1|0||0|||0
492917|QD07XB0201|Dermanolon|húðúði|19,47|mg/ml|75|ml|1|úðaílá|1,77+17,7 mg/ml|QD07XB02|01.11.2017||R|0|0|0|0|0|VEB|0|0|0|100|IKR|2758|5403|vetalmen|||0|75|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Triamcinolon||||2758|5403||2|0||0|||0
493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
493143|QN02AE0102|Bupredine vet|stl|0,3|mg/ml|10|ml|1|hgl||QN02AE01|01.06.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|3725|7238|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Buprenorphinhýdróklóríð||||3725|7238||2|0||1|30|dagar|0
493173|N06BA0902|Atomoxetin Actavis|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6471|3257|lyfalmen|V0813|3197|2|28|0|6,3000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1278||1278|3257||1|0|E|0|||0
493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|G|0|PAC|0|0|1|100|DKK|22408|31615|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||22408||22408|31615||1|0|G|0|||0
493496|N05AX1303|TREVICTA|stl|175|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|106418|138865|lyfalmen|||1|1|0|70,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||106418||106418|138865||1|0|G|0|||0
493534|L01XC2401|Darzalex|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|JCI|0|1|0|100|SEK|66110|86890|lyfsjukr|||1|5|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||66110||66110|86890||1|H|L|0|||0
493782|L04AD0204|Dailiport|forðahlk|3|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|28103|38818|lyfalmen|||2|50|0|30,0000|Artasan ehf|Sandoz A/S|Tacrolimus||28103||28103|38818||1|0|G|0|||0
493888|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|98|stk|1|þpakki||C09CA01|01.10.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3225|2|98|0|24,5000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G|0|||0
493896|C10AA0509|Atorvastatin Xiromed|filmhtfl|20|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0113|2681|2|98|0|98,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995|30.06.2021|R|1|0|0|G|0|SNP|0|0|0|100|XEU|1109|3024|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1109||1109|3024||1|0|G|0|||0
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|G|0|HES|0|0|0|100|DKK|3228|5941|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||3228||3228|5941||1|0|G|0|||0
494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|RRG|0|1|0|100|DKK|73623|96392|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||73623||73623|96392||2|H|L|0|||0
494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|RRG|0|1|0|100|DKK|184164|235560|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||184164||184164|235560||2|H|L|0|||0
494435|N01BB2001|Emla|krem|50|mg/g|5|g|5|túpa|25mg/g+25mg/g|N01BB20|01.09.2021||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2447|4866|lyfalmen|V1024|4866|1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2447||2447|4866||2|0||0|||0
494533|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|MBP|0|0|0|100|DKK|7169|7167|lyfalmen|V0145|7167|2|8|0|16,0000|BGP Products ApS|Mylan S.A.S|Tadalafíl||4119||4119|7167||2|0|E|0|||0
494534|N01BB2001|Emla|krem|50|mg/g|30|g|1|túpa|25mg/g+25mg/g|N01BB20|01.03.2021||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3554|6390|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Blöndur||3554||3554|6390||2|0||0|||0
494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|PLS|0|0|0|100|DKK|1940|4168|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1940||1940|4168||1|0||0|||0
494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól|||||||1|0||0|||0
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2117|4412|lyfalmen|V0128|2530|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2117||2117|4412||1|0|G|0|||0
494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3076|5732|lyfalmen|V0410|4263|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3076||3076|5732||1|0|G|0|||0
494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|1|0|0|CFS|0|1|0|100|XEU|860282|1076461|lyfsjukr|||1|250|0|9,3700|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||860282||860282|1076461||3|0|L|0|||0
495203|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|406593|512199|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||406593||406593|512199||2|H|L|0|||0
495256|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|G|0|VAL|0|0|1|100|IKR|3000|3838|lyfalmen|V0010|3838|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||1700||1700|3838||2|0|G|0|||0
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|G|0|NAA|0|0|1|100|DKK|20590|7814|lyfalmen|V0384|4878|1|15|0|7,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||4589||4589|7814||1|0|G|0|||0
495637|J02AC0304|Voriconazole Accord|filmhtfl|200|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|G|0|ACC|0|0|1|100|XEU|70522|92470|lyfalmen|||2|30|0|15,0000|Artasan ehf|Accord Healthcare Limited|Voricónazól||70522||70522|92470||1|0|G|0|||0
495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|5123|8549|lyfalmen|||1|28|0|28,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||5123||5123|8549||1|0||0|||0
496076|N06BA0408|Methylphenidate Teva|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|9173|9364|lyfalmen|V0997|9364|2|30|0|60,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||5715||5715|9364||1|0|E|1|30|dagar|0
496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4289|8308|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4289||4289|8308||2|0||0|||0
496614|B03BB0108|Folsyra Evolan|töflur|5|mg|105|stk|1|þpakki||B03BB01|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|2100|4388|lyfalmen|||2|105|0|1312,5000|LYFIS ehf|Evolan Pharma AB|Fólínsýra||2100||2100|4388||2|0|G|0|||0
496912|N02AA0507|OxyContin Depot|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|874|2701|lyfalmen|V0596|2357|1|28|0|1,8600|Icepharma hf|Mundipharma A/S|Oxýcódon||874||874|2701||2|0|G|1|30|dagar|0
496925|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.12.2016||L|1|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klemastín|||||5335||1|0||0|||0
496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|439|2102|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||439||439|2102||1|0|G|1|30|dagar|0
496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|0|G|0|PLS|0|0|0|100|DKK|793|2589|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||793||793|2589||1|0|G|1|30|dagar|0
497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|TPM|0|1|1|100|XEU|211735|269850|lyfsjukr|||1|20|0|10,0000|Vistor hf|Tillotts Pharma GmbH|Fidaxomicin||211735||211735|269850||1|0|L|0|||0
497083|H02AB0912|Alkindi|kyrnhylk|1|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|14530|21497|lyfalmen|||1|50|0|1,6667|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||14530||14530|21497||2|0|G|0|||0
497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|0|G|0|PLS|0|0|0|100|DKK|3024|5660|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3024||3024|5660||1|0|G|1|30|dagar|0
497730|H03BB0212|Thiamazole Uni-Pharma|töflur|5|mg|100|stk|1|þpakki||H03BB02|01.12.2018||R|0|0|0|G|0|UNI|0|0|0|100|XEU|3976|6970|lyfalmen|||2|100|0|50,0000|Artasan ehf|Uni-Pharma Kleon Tsetis|thiamazole||3976||3976|6970||1|0|G|0|||0
497905|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|glas|23,75 mg metoprololsuccinat|C07AB02|01.01.2020||R|1|0|0|G|0|SSA|0|0|0|100|DKK|834|2646|lyfalmen|V0050|2494|2|100|0|16,6667|Artasan ehf|Hexal A/S|Metóprólól||834||834|2646||1|0|G|0|||0
497995|S01EC0304|Dorzolamide Alvogen|augndr|20|mg/ml|5|ml|1|ílát||S01EC03|01.01.2019||R|0|0|0|G|0|POF|0|0|0|100|XEU|1834|4022|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||1834||1834|4022||2|0|G|0|||0
498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2300|4664|lyfalmen|V0472|4664|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4664||2|0|G|0|||0
498481|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6198|3393|lyfalmen|V0683|3393|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1377||1377|3393||2|0|G|0|||0
498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|SAS|0|0|0|100|NOK|64050|103249|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||64050||64050|103249||1|0||0|||0
498656|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2019||R|1|0|0|G|0|BFP|0|0|0|100|XEU|6755|5116|lyfalmen|V0234|5116|2|18|0|36,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||2629||2629|5116||1|0|G|0|||0
498877|N06BA0905|Atomoxetin STADA|hylki|10|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4000|3425|lyfalmen|V0812|3425|2|30|0|3,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||1400||1400|3425||2|0|E|0|||0
498978|G03AC0904|Desirett|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.03.2020||R|0|0|0|0|0|EXH|0|0|0|100|XEU|1445|2930|lyfalm11|V0590|2930|2|84|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Desógestrel||1290||1290|2930||2|0||0|||1
499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20148|28757|lyfalmen|||1|28|0|14,0000|Eisai AB|Eisai GmbH|Perampanel||20148||20148|28757||1|0|G|0|||0
499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|8567|13290|lyfalmen|V1036|13280|1|28|0|28,0000|Icepharma hf|Bayer AG|Rivaoxaban||||8567|13290||2|0|G|0|||0
499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|5878|9588|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||5878||5878|9588||2|0|G|0|||0
499865|J01FA0905|Clarithromycin Alvogen|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.10.2020||R|1|0|0|0|0|POF|0|0|1|100|IKR|2475|3425|lyfalmen|V0116|3293|2|14|0|14,0000|Alvogen|Alvogen|Klaritrómýcín||1400||1400|3425||2|0|E|0|||0
499902|N02BE0127|Dolorin Junior|mixtúra|24|mg/ml|200|ml|1|glas||N02BE01|01.07.2021||L|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|200|0|0,1600|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|9638|14764|lyfalmen|||1|28|0|56,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||9638||9638|14764||1|0||0|||0
500188|S02CA0303|Ciflox|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.05.2021||R|0|0|0|G|0|HES|0|0|1|100|DKK|2060|4333|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||2060||2060|4333||1|0|G|0|||0
500402|C07AB0214|Bloxazoc|forðatfl|25|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|900|2640|lyfalmen|V0050|2494|2|100|0|16,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||830||830|2640||2|0|G|0|||0
500476|L01EX1001|Rydapt|hylki|25|mg|112|stk|1|þpakki|4 x 28|L01EX10|01.04.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|1929674|2406485|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||1929674||1929674|2406485||1|0|L|0|||0
500481|J05AR1701|Descovy|filmhtfl|210|mg|30|stk|1|glas|200+10 mg|J05AR17|01.10.2016||R|0|0|1|0|0|GSE|0|1|0|100|DKK|60584|79900|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||60584||60584|79900||2|0|L|0|||0
501204|R03DX0801|Cinqaero|irþ|10|mg/ml|2,5|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|0|TVB|0|1|0|100|NOK|16482|24184|lyfsjukr|||1|2,5|0|3,5211|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||16482||16482|24184||1|H|L|0|||0
501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|5540|9123|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5540||5540|9123||1|0|G|0|||0
501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2015||R|1|1|0|0|0|HES|0|0|0|100|DKK|13664|14352|lyfalmen|V0997|9364|1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||9339||9339|14352||1|0|E|1|30|dagar|0
501382|C01CA1702|Midodrin Evolan|töflur|5|mg|100|stk|1|þpakki||C01CA17|01.07.2021||R|1|0|0|G|0|EVO|0|0|0|100|IKR|13500|20079|lyfalmen|V0969|20079|2|100|0|16,6666|LYFIS ehf|Evolan Pharma AB|midodrine||13500||13500|20079||2|0|G|0|||0
501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015|31.08.2021|R|1|1|0|G|0|FIN|0|0|0|100|DKK|26204|36416|lyfalmen|||1|168|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||26204||26204|36416||2|0|G|0|||0
501735|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
501880|QA12AX0003|Calmafusion|irl|||500|ml|12|glös|380mg/60mg/50 mg/ml|QA12AX|01.03.2021||R|0|0|0|0|0|INC|1|0|0|100|IKR|10644|20364|vetalmen|||0|6000|0||Dýraheilsa ehf|Interchemie Werken De Adelaar Eesti AS|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||10644||10644|20364||2|0||0|||0
501950|R03DC0306|Montelukast ratiopharm|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.11.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|9732|14893|lyfalmen|V0490|14893|2|98|0|98,0000|Alvogen|Teva Sweden AB|Montelúkast||9732||9732|14893||2|0|G|0|||0
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2273|4626|lyfalmen|V0434|4626|1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2273||2273|4626||2|0|G|0|||0
502157|L01XC2801|Imfinzi|irþ|50|mg/ml|2,4|ml|1|hgl|120 mg/2,4 ml|L01XC28|01.06.2019||R|0|0|0|0|0|AZE|0|1|0|100|SEK|104571|136568|lyfsjukr|||1|2,4|0||Vistor hf|AstraZeneca AB|Durvalumab||||104571|136568||1|H|L|0|||0
502299|M02AA1506|Diclofenac Teva|hlaup|23,2|mg/g|50|g|1|túpa||M02AA15|01.07.2021||L|0|0|0|0|0|TVI|0|0|1|100|IKR|||lyflausa|||0|50|0||Teva Pharma Iceland ehf|Teva B.V|Díklófenak|||||||1|0||0|||0
502341|QP52AF0203|Nematel Vet.|pasta|439|mg/g|30,33|g|1|spr||QP52AF02|01.12.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|1292|2227|vetorma|||0|30,33|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Pyrantelum||||1292|2227||2|0||0|||0
502349|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3475|3817|lyfalmen|V0143|3396|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1685||1685|3817||2|0|E|0|||0
502486|S01LA0501|Eylea|stl|40|mg/ml|1|áf.spr|1|pakki||S01LA05|01.08.2020||R|0|1|0|0|0|FIN|0|1|0|100|DKK|113760|147997|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||113760||113760|147997||2|H|L|0|||0
502647|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|30|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|2098|4386|lyfalmen|V0926|4386|2|30|0|30,0000|Medical ehf|Medical ehf|Tamsúlósín||2098||2098|4386||2|0|G|0|||0
502761|QP51AA0101|Metrobactin vet|töflur|250|mg|100|stk|1|þpakki||QP51AA01|01.04.2018||R|0|0|0|0|0|VEB|0|0|0|100|IKR|3335|5748|vetorma|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metronidazolum||3335||3335|5748||2|0||0|||0
502790|A10BD2401|Steglujan|filmhtfl|105|mg|28|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|10023|15082|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||9869||9869|15082||1|0|G|0|||0
502843|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfpen|m. áfastri nál og nálarhlíf|L04AC16|01.03.2019||R|0|0|1|0|0|JCI|0|1|0|100|SEK|334650|422722|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||334650||334650|422722||1|0|L|0|||0
502851|N06AB0314|Fluoxetine Vitabalans|filmhtfl|20|mg|100|stk|1|þpakki||N06AB03|01.08.2021||R|1|0|0|G|0|VIB|0|0|0|100|IKR|2050|3150|lyfalmen|V0039|3006|2|100|0|100,0000|LYFIS ehf|Vitabalans Oy|Flúoxetín||1200||1200|3150||2|0|G|0|||0
502904|A10BK0101|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BK01|01.11.2015||R|1|0|0|G|0|AZE|0|0|0|100|SEK|5549|9136|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||5549||5549|9136||1|0|G|0|||0
503078|N02BE0115|Paracet|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.04.2019||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Alvogen|Karo Pharma AB|Paracetamól|||||||2|0|0|0|||0
503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|G|0|ZEN|0|0|0|100|SEK|4755|8043|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||4755||4755|8043||1|0|G|0|||0
504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|6283|10146|lyfalmen|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|albumin||6283||6283|10146||2|H|0|0|||0
504026|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.10.2019||L|1|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0||0|||0
504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1433|2854|lyfalmen|V0494|2717|2|90|0|180,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||985||985|2854||1|0|G|0|||0
504120|R03AL0302|Anoro Ellipta|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|6120|9921|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og umeclidinium bromide||6120||6120|9921||1|0|G|0|||0
504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|1|G|0|UPJ|0|0|0|100|DKK|35555|48244|lyfalmen|||1|112|0|22,4000|Icepharma hf|Upjohn EESV|Síldenafíl||35555||35555|48244||1|0|G|0|||0
504231|N02AB0310|Fentanyl Alvogen|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.11.2020||R|0|0|0|G|0|RTH|0|0|0|100|XEU|1941|4101|lyfalmen|V0219|4101|2|5|0|7,5000|Alvogen|ratiopharm GmbH|Fentanýl||1891||1891|4101||2|0|G|1|30|dagar|0
504502|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.09.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|536|2236|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||536||536|2236||1|0|G|0|||0
504763|M05BA0803|Zoledronic acid Actavis|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.09.2020||R|0|1|0|0|0|GRP|0|0|0|100|XEU|10700|5512|lyfalmen|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||2916||2916|5512||1|H|0|0|||0
504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|17206|32814|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||17206||17206|32814||1|0||0|||0
505003|S01ED5122|Fixopost|augndr|||0,2|ml|30|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|G|0|LTH|0|0|0|100|SEK|2435|4849|lyfalmen|||2|6|0|30,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||2435||2435|4849||1|0|G|0|||0
505095|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|XEU|3047|2851|lyfalmen|V0335|2579|2|100|0|150,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||983||983|2851||2|0|G|0|||0
505571|J01MA0207|Ciprofloxacin Navamedic|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.05.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|8473|13160|lyfalmen|||2|2000|0|5,0000|Icepharma hf|Navamedic ASA|Cíprófloxacín||8473||8473|13160||2|0|0|0|||0
505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
505803|N06BA0703|Aspendos|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|1|0|0|MOL|0|0|0|100|IKR|5200|8655|lyfalmen|V0657|8655|2|30|0|10,0000|LYFIS ehf|Medochemie Limited|Modafinil||5200||5200|8655||2|0|E|2|||0
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|PLS|0|0|0|100|DKK|2983|5604|lyfalmen|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||2983||2983|5604||1|H|0|0|||0
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|PLS|0|0|0|100|DKK|7457|11762|lyfalmen|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||7457||7457|11762||1|H|0|0|||0
506553|C01CA1703|Hypotron|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.10.2018|30.06.2021|R|1|0|0|G|0|RET|0|0|0|100|IKR|7114|11290|lyfalmen|||2|50|0|4,1666|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||7114||7114|11290||1|0|G|0|||0
506756|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|5601|7554|lyfalmen|V0831|7554|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4400||4400|7554||2|0|G|0|||0
506788|R03AK1401|Atectura Breezhaler|innönddu|252,5|mcg/sk|90|stk|3|stsk.þ|125 mcg/127,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|13272|19766|lyfalmen|||1|270|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||13272||13272|19766||1|0|G|0|||0
506938|N02AA0507|OxyContin Depot|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|13976|20734|lyfalmen|V0587|13596|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxýcódon||13976||13976|20734||2|0|G|1|30|dagar|0
507822|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9984|3257|lyfalmen|V0812|3197|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1278||1278|3257||2|0|E|0|||0
507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|IKR|4233|7324|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Betahistín||4233||4233|7324||2|0|G|0|||0
507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1828|4014|lyfalmen|V0092|4014|2|100|0|66,6600|Vistor hf|Orion Corporation|Spírónólaktón||1828||1828|4014||1|0|G|0|||0
507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|G|0|AML|0|0|1|100|SEK|847|2664|lyfalmen|||1|5|0||Amdipharm Limited|Amdipharm Limited|Fúsidínsýra||847||847|2664||2|0|G|0|||0
508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3276|3838|lyfalmen|V0687|2612|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3838||2|0|E|0|||0
508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|694|2227|lyfalmen|||2|2|0|1,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||530||530|2227||1|0|E|0|||0
508634|J07BM0301|Gardasil 9|stl|||0,5|ml|1|áf.spr|dreifa + 2 nálar|J07BM03|01.04.2018||R|0|0|0|0|0|MVA|0|0|0|100|DKK|19203|27929|lyfalmen|||1|0,5|0||Vistor hf|MSD VACCINS|Papillomavírus (mannagerð 6, 11, 16, 18, 31, 33, 45, 52, 58)||19203||19203|27929||1|0||0|||0
508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4788|9254|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4788|9254||2|0||0|||0
508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4313|8353|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4313||4313|8353||2|0||0|||0
508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|12779|24415|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12779||12779|24415||2|0||0|||0
508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|0|0|SGB|0|1|0|100|XEU|606841|761252|lyfsjukr|||1|1|0||Vistor hf|Sanofi-aventis groupe|Cabazitaxel||606841||606841|761252||1|H|L|0|||0
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|G|0|LBK|0|0|0|100|DKK|8386|13040|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8386||8386|13040||1|0|G|0|||0
509050|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.06.2020||R|0|1|1|G|0|ATE|0|0|0|100|XEU|6406|7400|lyfalmen|||2|50|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mýcófenólsýra||4288||4288|7400|31.7.2021|1|0|G|0|||0
509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||5425||5425|10463||2|0||0|||0
509259|J07BB0209|VaxigripTetra|stl|15|mcg|0,5|ml|1|áfspr|dreifa í áf. sprautu|J07BB02|01.06.2020||R|0|0|0|0|0|SPU|0|0|0|100|XEU|1359|3368|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Inflúensa, hreinsaðir  mótefnavakar||1359||1359|3368||2|0||0|||0
509296|QA11JA0001|Vitamin AD3E pro injectione|stl|||100|ml|1|hgl|176,47 / 50 / 100 mg/ml|QA11JA|01.01.2021||R|0|0|0|0|0|Bel|0|0|0|100|XEU|1594|3133|vetalmen|||0|100|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Vítamínblöndur||1594||1594|3133||2|0||0|||0
509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2|0||0|||0
509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|BAB|0|0|0|100|DKK|2061|3880|lyfalm11|V0134|3286|1|63|0|84,0000|Icepharma hf|Bayer AB|Cýpróterón og östrógen||2061||2061|3880||2|0||0|||0
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|1|0|0|VIC|0|1|0|100|DKK|42366|56858|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín og lamívúdín||42366||42366|56858||1|0|L|0|||0
509806|L01XC2401|Darzalex|stl|1800|mg|15|ml|1|hgl|120mg/ml|L01XC24|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|791908|991423|lyfsjukr|||1|15|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||791908||791908|991423||1|H|L|0|||0
509895|QD11AH9102|Cytopoint|stl|20|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|15687|29932|vetalmen|||1|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||15687||15687|29932||2|0||0|||0
510462|J01DH0205|Meropenem WH|sts/irs|1|g/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|0|WEH|0|0|1|100|XEU|23343|23366|lyfalmen|||2|10|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Meropenem||15888||15888|23366||2|0|0|0|||0
510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|G|0|TPA|0|0|0|100|DKK|451|2119|lyfalmen|V0601|2093|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||451||451|2119||1|0|G|0|||0
510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|140830|181664|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||140830|181664||1|0|L|0|||0
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3898|3574|lyfalmen|V0445|2884|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fínasteríð||1508||1508|3574||1|0|G|0|||0
510983|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|4149|4664|lyfalmen|V0687|4664|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||2300||2300|4664||2|0|E|0|||0
511263|N02AJ0602|Parkodin forte|filmhtfl|530|mg|30|stk|1|þpakki|30+500 mg|N02AJ06|01.12.2017||R|1|0|0|0|0|ATE|0|0|1|100|XEU|761|2545|lyfalmen|||2|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||761||761|2545||1|0|E|3|||0
511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2522|4969|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2522||2522|4969||1|0|G|0|||0
511418|A10BD2301|Segluromet|filmhtfl|1002,5|mg|196|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|20061|28647|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||20061||20061|28647||1|0|G|0|||0
511506|L01DB0106|Doxorubicin medac|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.08.2017||R|0|0|0|0|0|WIL|0|0|0|100|XEU|2474|4903|lyfalmen|||2|25|0||Williams & Halls efh|medac Gesellschaft|Doxórúbicín||||2474|4903||2|H|0|0|||0
511560|G03GA1001|REKOVELLE|stl|36|mcg|1,08|ml|1|áfpen|+ 6 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|41596|55884|lyfalmen|||1|1,08|0|3,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||41596||41596|55884||1|0|G|0|||0
511688|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
511900|B02BC3002|TISSEEL|vefjalím|||2|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|0|BAM|0|0|0|100|SEK|16310|23947|lyfalmen|||1|2|0||Icepharma hf|Baxter Medical AB|Blöndur||16310||16310|23947||2|H|0|0|||0
511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|BAB|0|0|0|100|DKK|15210|20081|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||15210||15210|20081||2|0|E|0|||1
511988|B05BA1024|SmofKabiven extra Nitrogen|irl|||1012|ml|4|pokar|fleyti|B05BA10|01.05.2021||R|0|0|0|0|0|FKA|0|0|0|100|DKK|34322|46684|lyfalmen|||1|4048|0||Vistor hf|Fresenius Kabi AB|Blöndur||34322||34322|46684||1|0|0|0|||0
512465|J05AR0304|Emtricitabine/Tenofovir disoproxil Mylan|filmhtfl|445|mg|30|stk|1|þpakki|200+245 mg|J05AR03|01.06.2020||R|1|1|1|0|0|ASD|0|1|0|100|DKK|49848|66321|lyfsjukr|||2|30|0|30,0000|Icepharma hf|Mylan S.A.S.|Tenófóvír dísóproxíl og emtrícítabín||49848||49848|66321||2|0|L|0|||0
512477|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.01.2020||R|1|0|0|G|0|SHS|0|0|1|100|DKK|2622|2293|lyfalmen|V0006|2186|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||578||578|2293||1|0|G|0|||0
512532|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammar|N07BA01|01.09.2020||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|FKA|0|0|0|100|DKK|6279|10140|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||6279||6279|10140||1|0|0|0|||0
512646|G04BD1202|Betmiga (Lyfjaver)|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.01.2021||R|1|0|0|G|0|LVR|0|0|0|100|XEU|15009|22156|lyfalmen|V0651|22156|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||15009||15009|22156||3|0|G|0|||0
512821|H02AB0912|Alkindi|kyrnhylk|0,5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|7265|11425|lyfalmen|||1|50|0|0,8333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||7212||7212|11425||2|0|G|0|||0
512918|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|1971|3563|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1500||1500|3563||2|0|G|0|||0
513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|G|0|BLS|0|0|0|100|XEU|999|2357|lyfalmen|V0109|2340|2|100|0|66,6700|Artasan ehf|Bluefish Pharmaceuticals AB|Simvastatín||624||624|2357||1|0|G|0|||0
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|MAR|0|0|1|100|IKR|||lyflausa|||0|35|0||Icepharma hf|Aspen Pharma|Lídókaín|||||||2|0||0|||0
513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|3901|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||1985||1985|3901||2|0|0|0|||0
513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|2521|4953|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2521||2521|4953||2|0||0|||0
513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|1982|3589|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||1826||1826|3589||2|0|0|0|||0
513993|N02BG0901|Penthrox|innö.guf|99,9|%|3|ml|1|glas||N02BG09|01.10.2019||R|0|0|0|0|0|MCL|0|0|0|100|DKK|4813|8123|lyfalmen|||1|3|0||Icepharma hf|Medical Developments NED B.V.|Methoxyflurane||4813||4813|8123||1|H|0|0|||0
514029|C03DA0407|Eplerenon Krka|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|9764|6315|lyfalmen|V0111|6315|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||3500||3500|6315||2|0||0|||0
514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2000|4251|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|4251||2|0|G|0|||0
514105|N05AH0415|Quetiapin Krka|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|6000|7554|lyfalmen|V0910|7540|2|100|0|37,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||4400||4400|7554||2|0|G|0|||0
514280|J07BB0210|Influvactetra|stl|||0,5|ml|10|áf.spr|með nál|J07BB02|01.10.2019||R|0|0|0|0|0|MDK|0|0|0|100|DKK|15187|22401|lyfalmen|||1|5|0||Icepharma hf|Mylan Denmark ApS|Inflúensa, hreinsaðir  mótefnavakar||15187||15187|22401||2|0||0|||0
514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|1|0|0|0|DAN|0|0|0|100|XEU|17090|25021|lyfalmen|V0818|11719|1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||17090|25021||2|0|E|0|||0
514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|KNM|0|0|0|100|IKR|2131|2530|lyfalmen|V0692|2410|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||750||750|2530||2|0|G|0|||0
514949|M04AA0106|Allopurinol Alvogen|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.03.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|842|2657|lyfalmen|||2|100|0|25,0000|Alvogen|Alvogen|Allópúrinol||842||842|2657||2|0|G|0|||0
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|0|PLS|0|0|0|100|DKK|3947|5172|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2669||2669|5172||1|0|G|0|||0
515094|QR06AB0401|Histodine|stl|10|mg/ml|100|ml|1|hgl|lausn|QR06AB04|01.03.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|2756|5399|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Chlorphenamine maleate||||2756|5399||2|0||0|||0
515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|12129|18192|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||12129||12129|18192||3|0|G|0|||0
515699|C08CA0106|Amlodipin Medical Valley|töflur|5|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|1503|2482|lyfalmen|V0056|2482|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||715||715|2482||2|0|G|0|||0
516033|M01AB0523|Dimax Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.07.2021||R|1|0|0|G|0|POF|0|0|1|100|XEU|624|2357|lyfalmen|V0188|2193|2|30|0|15,0000|Alvogen|Alvogen|Díklófenak||624||624|2357||2|0|G|0|||0
516182|L01BC5901|Lonsurf|filmhtfl|28,19|mg|20|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|117664|152852|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||117664|152852||2|0|L|0|||0
516532|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.07.2021||R|0|0|0|0|0|PBV|0|0|0|100|XEU|3217|5926|lyfalmen|V1052|5926|1|50|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||3217||3217|5926||1|0|0|1|30|dagar|0
516694|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.08.2019||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1800|2907|lyfalmen|V0069|2884|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1024||1024|2907||2|0|G|0|||0
516803|L01EA0103|Imatinib ratiopharm|filmhtfl|100|mg|120|stk|1|þpakki||L01EA01|01.01.2019||R|1|0|1|0|0|RTH|0|1|0|100|XEU|97826|65421|lyfsjukr|||2|120|0||Alvogen|ratiopharm GmbH|Imatinib||49136||49136|65421||2|0|L|0|||0
516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6684|10698|lyfalmen|V0384|9756|2|30|0|15,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||6684||6684|10698||1|0|G|0|||0
517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|9000|5077|lyfalmen|V0273|5008|2|100|0|50,0000|Alvogen|Teva Pharma B.V.|Quetíapín||2600||2600|5077||2|0|G|0|||0
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2851|5422|lyfalmen|V0462|3661|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2851||2851|5422||1|0|G|0|||0
517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|29710|40851|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai GmbH|Rúfínamíð||29710||29710|40851||1|0|G|0|||0
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3033|5673|lyfalmen|V0471|3723|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3033||3033|5673||1|0|G|0|||0
517803|H02AB0208|Dexavit|stl/irl|4|mg/ml|1|ml|3|lykjur||H02AB02|01.03.2019||R|0|0|0|0|0|VIT|0|0|1|100|DKK|3472|6277|lyfalmen|||2|3|0|8,0000|Vital Pharma Nordic ApS|Vital Pharma Nordic ApS|Dexametasón||3472||3472|6277||1|0|0|0|||0
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3264|5990|lyfalmen|V0472|3498|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3264||3264|5990||1|0|G|0|||0
517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|28425|39226|lyfalmen|||2|100|0|16,6667|Icepharma hf|Abcur AB|Noradrenalín||28425||28425|39226||2|H|0|0|||0
517914|QI09AL0801|Suvaxyn Circo+MH RTU|stl|||100|ml|1|hgl|fleyti|QI09AL08|01.01.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|9640|16616|vetorma|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||9640||9640|16616||2|0||0|||0
518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|G|0|KNM|0|0|0|100|IKR|23524|29328|lyfalmen|V0711|29328|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||20600||20600|29328||2|0|G|0|||0
518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|G|0|ATE|0|0|1|100|DKK|1047|2939|lyfalmen|||1|20|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||1047||1047|2939||1|0|G|0|||0
518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|G|0|ATE|0|0|1|100|DKK|4323|7448|lyfalmen|||1|100|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||4323||4323|7448||1|0|G|0|||0
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|MBV|0|0|0|100|DKK|1953|3747|lyfalm11|V0590|2930|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel||1953||1953|3747||1|0||0|||1
518341|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
518534|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|rörlyk||A10AE06|01.08.2021||R|0|1|0|G|0|NAS|0|0|0|100|DKK|7847|12299|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||7847||7847|12299||1|0|G|0|||0
518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|G|0|BII|0|0|0|100|DKK|15317|22580|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||15317||15317|22580||1|0|G|0|||0
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|940|2792|lyfalmen|||1|125|0|3,1250|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||940||940|2792||2|0|E|0|||0
519070|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|792|2310|lyfalmen|V0564|2271|2|100|0|50,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||590||590|2310||2|0|G|0|||0
519096|N06AB1008|Escitalopram STADA|filmhtfl|10|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2200|4526|lyfalmen|V0325|4526|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||2200||2200|4526||2|0|0|0|||0
519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|Sulfadiazinum og trimethoprimum||||2463|4841||2|0||0|||0
519162|H02AB0208|Dexavit|stl/irl|4|mg/ml|5|ml|5|lykjur||H02AB02|01.04.2021||R|0|0|0|0|0|VIT|0|0|1|100|DKK|46194|61700|lyfalmen|||2|25|0|66,6670|Vital Pharma Nordic ApS|Vital Pharma Nordic ApS|Dexametasón||46194||46194|61700||1|0|0|0|||0
519172|L01EB0201|Erlotinib WH|filmhtfl|100|mg|30|stk|1|þpakki||L01EB02|01.06.2020||R|0|1|1|0|0|WEH|0|1|0|100|XEU|254381|270376|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlotinib||212158||212158|270376||2|0|L|0|||0
519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|AEP|0|0|1|100|DKK|1024|2907|lyfalmen|||1|100|0|2,5000|Icepharma hf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1024||1024|2907||2|0|E|0|||0
519655|A12BA0103|Kaliumklorid Orifarm (Lyfjaver)|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.06.2021||L|1|0|0|G|0|LVR|0|0|0|100|IKR|||lyfalmen|V1047|2708|3|100|0|25,0000|Lyfjaver ehf|Lyfjaver ehf|Kalíumklóríð|||||2774||3|0|G|0|||0
519722|N07BC0102|Buvidal|stl|64|mg|0,18|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|56379|74582|lyfsjukr|||1|0,18|0|30,4762|Vistor hf|Camurus AB|Búprenorfín||56379||56379|74582||1|H|L|1|30|dagar|0
519755|L01EX1001|Rydapt|hylki|25|mg|56|stk|1|þpakki|2x28|L01EX10|01.03.2020||R|0|0|1|0|0|NEL|0|1|0|100|DKK|932894|1166770|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||932894||932894|1166770||1|0|L|0|||0
520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|2943|5549|lyfalmen|V0515|5198|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2943||2943|5549||1|0|G|0|||0
520082|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|112|stk|1|þpakki||C09CA01|01.07.2020||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1629|3686|lyfalmen|V0213|3686|2|112|0|28,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1590||1590|3686||2|0|G|0|||0
520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|22630|31896|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||22630||22630|31896||1|0|G|0|||0
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|16784|24599|lyfalmen|V0143|3396|1|12|0|12,0000|Icepharma hf|Upjohn EESV|Síldenafíl||16784||16784|24599||1|0|E|0|||0
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|5461|9014|lyfalmen|V0144|1302|1|4|0|8,0000|Icepharma hf|Upjohn EESV|Síldenafíl||5461||5461|9014||1|0|E|0|||0
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|15111|22297|lyfalmen|V0144|3907|1|12|0|24,0000|Icepharma hf|Upjohn EESV|Síldenafíl||15111||15111|22297||1|0|E|0|||0
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1372|2671|lyfalmen|V0056|2216|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Amlódipín||852||852|2671||1|0|G|0|||0
520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|0|0|IND|0|1|0|100|DKK|11446|17252|lyfsjukr|||1|28|0|28,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||11446||11446|17252||1|0|L|1|30|dagar|0
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2219|2671|lyfalmen|V0057|2216|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Amlódipín||852||852|2671||1|0|G|0|||0
520633|N06AB0607|Sertralin Krka|filmhtfl|100|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|9918|8380|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Sertralín||5000||5000|8380||2|0|G|0|||0
520659|G04BD0806|Solifenacin Mylan|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|11421|8958|lyfalmen|V0440|8958|2|90|0|90,0000|Icepharma hf|Mylan AB|Sólífenacín||5420||5420|8958||2|0|G|0|||0
520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|G|0|MEA|0|0|1|100|DKK|627|2361|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Orfenadrín í blöndum||627||627|2361||2|0|G|0|||0
520903|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.2016|30.06.2021|L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0
520936|L01AX0304|Temozolomide Accord|hylki|100|mg|5|stk|1|skpoki|hart|L01AX03|01.06.2021||R|0|0|1|0|0|CLU|0|1|0|100|XEU|8173|12747|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||8173||8173|12747||1|0|L|0|||0
521273|B01AA0303|Warfarin Teva|töflur|3|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1561|3646|lyfalmen|||2|100|0|40,0000|Teva Pharma Iceland ehf|Teva B.V|Warfarín||1561||1561|3646||1|0|G|0|||0
521428|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.09.2020||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
522158|L01XC0302|Kanjinti|st/irþ|420|mg|1|hgl|1|pakki||L01XC03|01.07.2020||R|0|0|0|0|0|AEB|0|1|0|100|DKK|197684|252375|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||197684||197684|252375||1|H|L|0|||0
522175|N02BE0124|Paracaff|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE01|01.04.2019||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,7666|Acare ehf|Acare ehf|Paracetamól|||||||2|0|0|0|||0
522290|C01BD0702|Dronedarone STADA|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2020||R|1|1|1|0|0|ASR|0|0|0|100|IKR|12900|17877|lyfalmen|V1027|17265|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Dronedarón||11900||11900|17877||2|0|E|0|||0
522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|84415|110042|lyfalmen|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||84415||84415|110042||2|0|G|0|||0
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|0|0|NEL|0|1|0|100|DKK|143516|185005|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||143516||143516|185005||1|H|L|0|||0
522985|D01AE1603|Amorolfin Apofri|lakk|5|%|3|ml|1|glas||D01AE16|01.05.2018||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||2|3|0||LYFIS ehf|Apofri AB|Amorolfín|||||||2|0||0|||0
523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4712|3278|lyfalmen|V0285|3278|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||1293||1293|3278||1|0|G|0|||0
523273|H02AB0901|Solu-Cortef|sts|100|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.02.2021||R|0|0|0|G|0|PLS|0|0|1|100|DKK|568|2280|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer Aps|Hýdrókortisón||568||568|2280||1|0|G|0|||0
523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|G|0|HEG|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1916||1|0|G|0|||0
523284|L01EF0101|Ibrance|filmhtfl|75|mg|21|stk|1|þpakki||L01EF01|01.03.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|306824|388114|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||306824||306824|388114||1|0|L|0|||0
523346|L01XC0304|Ontruzant|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.05.2020||R|0|0|0|0|0|SUN|0|1|0|100|DKK|79667|104036|lyfsjukr|||1|150|0||Vistor hf|Samsung Bioepis NL B.V.|Trastuzumab||79667||79667|104036||1|H|L|0|||0
523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|165589|212458|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||165589||165589|212458||1|H|L|0|||0
523355|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.09.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|1597|2583|lyfalmen|V0144|1302|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||788||788|2583||1|0|E|0|||0
523758|L01EA0301|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01EA03|01.03.2013||R|0|1|1|0|0|NEL|0|1|0|100|DKK|338635|427678|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotinib||338635||338635|427678||1|0|L|0|||0
523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2|0||0|||0
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|G|0|SNP|0|0|1|100|XEU|927|2774|lyfalmen|V0903|2518|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||927||927|2774||1|0|G|0|||0
523937|C10AX0903|Ezetimib Krka|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10278|7004|lyfalmen|V0954|6130|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||4000||4000|7004||2|0|E|0|||0
523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1481|3536|lyfalmen|V0584|3536|2|28|0|7,4700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||1481||1481|3536||1|0|G|1|30|dagar|0
524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|G|0|TOG|0|0|0|100|SEK|1978|4220|lyfalmen|V1001|4220|1|98|0|73,5000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||1978||1978|4220||1|0|G|0|||0
524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|EIS|0|0|1|100|IKR|7518|6501|lyfalmen|V0010|3838|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6501||1|0|E|0|||0
524367|N06AB0313|Fluoxetin WH|hylki|20|mg|98|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|G|0|WEH|0|0|0|100|IKR|1122|3042|lyfalmen|V0039|2946|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1122||1122|3042||2|0|G|0|||0
524630|N03AX1610|Pregabalin Medical Valley|hylki|300|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2900|4237|lyfalmen|V0689|4237|2|70|0|70,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1990||1990|4237||2|0|E|0|||0
524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|GAL|0|0|0|100|XEU|6689|10705|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||6689||6689|10705||2|0|E|0|||0
525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|G|0|MEA|0|0|1|100|DKK|1253|3223|lyfalmen|||1|100|0|25,0000|Icepharma hf|Meda AB|Orfenadrín í blöndum||1253||1253|3223||2|0|G|0|||0
525122|R03AK0605|Salmex|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2019||R|0|0|0|G|0|GPN|0|0|0|100|DKK|3858|6391|lyfalmen|V0437|5304|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||3555||3555|6391||2|0|G|0|||0
525418|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||500|ml|20|pokar|lausn|B05BB01|01.07.2018||R|0|0|0|0|0|BAM|0|0|1|100|SEK|4472|7653|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4472||4472|7653||2|0|0|0|||0
525689|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfpen||N02CD03|01.07.2020||R|0|0|1|0|0|TGH|0|0|0|100|XEU|75036|91646|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||69871||69871|91646||1|0|E|0|||0
525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|30182|41448|lyfalmen|V0977|41448|1|100|0|100,0000|Icepharma hf|Bayer AG|Rivaoxaban||||30182|41448||2|0|G|0|||0
525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|5461|9014|lyfalmen|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||5461||5461|9014||2|H|0|0|||0
525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|4994|8372|lyfalmen|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||4994||4994|8372||2|H|0|0|||0
525913|C07AB0706|Bisoprolol Medical Valley|filmhtfl|10|mg|105|stk|1|glas||C07AB07|01.02.2021||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2041|4307|lyfalmen|V1040|4307|2|105|0|105,0000|Acare ehf|Medical Valley Invest AB|bisoprolol||2041||2041|4307||2|0|G|0|||0
525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|VIN|0|0|1|100|DKK|2417|4825|lyfalmen|||2|1000|0|2,5000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2417|4825||2|0|0|0|||0
525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4863||2|0||0|||0
526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4925||2|0||0|||0
526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|G|0|DEA|0|0|0|100|XEU|7279|11517|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||7279||7279|11517||1|0|G|0|||0
526396|N03AX1408|Levetiracetam STADA|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|9168|12509|lyfalmen|V0516|12509|2|100|0|66,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||8000||8000|12509||2|0|G|0|||0
526496|H02AB0207|Dexamethasone Krka|töflur|4|mg|100|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|G|0|KNM|0|0|1|100|IKR|15000|13060|lyfalmen|V0423|13060|2|100|0|266,6666|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||8400||8400|13060||2|0|G|0|||0
526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|WEH|0|0|0|100|XEU|14328|6456|lyfalmen|V0111|6315|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||3602||3602|6456||2|0|E|0|||0
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|G|0|DEA|0|0|0|100|XEU|4056|7081|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4056||4056|7081||1|0|G|0|||0
527132|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|18|stk|1|þpakki||N02CC04|01.06.2019||R|0|0|0|G|0|MSD|0|0|0|100|DKK|6245|10094|lyfalmen|V0621|8802|1|18|0|18,0000|Vistor hf|M.S.D.|Rizatriptan||6245||6245|10094||1|0|G|0|||0
527355|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.01.2021||R|0|0|0|0|0|PBV|0|0|0|100|XEU|18780|25819|lyfalmen|||1|250|0||Williams & Halls efh|Piramal Critical Care B.V.|Sevóflúran||17670||17670|25819||2|H|0|0|||0
527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|10350|12879|lyfalmen|V0516|12509|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||8269||8269|12879||1|0|G|0|||0
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|G|0|NEL|0|0|0|100|DKK|1494|3554|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Emedastín||1494||1494|3554||1|0|G|0|||0
527632|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|áfpen|FlexTouch|A10AB05|01.07.2018||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5065|8469|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5065||5065|8469||1|0|G|0|||0
527685|M01AH0503|Coxerit|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2273|3150|lyfalmen|V0825|2811|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1200||1200|3150||2|0|G|0|||0
527714|N05AX1303|TREVICTA|stl|525|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|248623|315729|lyfalmen|||1|1|0|210,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||248623||248623|315729||1|0|G|0|||0
527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|RPG|0|0|0|100|XEU|1706|3353|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|Prednisolonum og sýkingalyf||1706||1706|3353||2|0||0|||0
528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|939|2410|lyfalmen|V0046|2410|2|100|0|33,3333|Vistor hf|Orion Corporation|Spírónólaktón||663||663|2410||1|0|G|0|||0
528076|D11AX1002|Finasterid STADA|filmhtfl|1|mg|30|stk|1|þpakki||D11AX10|01.07.2018||R|1|0|0|0|0|ASR|0|0|0|100|IKR|3884|6844|lyfalmen|||2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||3884||3884|6844||2|0||0|||0
528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|8816|13632|lyfalmen|||2|100|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||8816||8816|13632||2|0|G|0|||0
528241|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Skópólamín|||||3096||1|0||0|||0
528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|GRH|0|0|1|100|DKK|9149|6168|lyfalmen|V0011|4827|1|100|0|66,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||3393||3393|6168||1|0|G|0|||0
528303|N02AA0507|OxyContin Depot|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|2486|4920|lyfalmen|V0584|3536|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||2486||2486|4920||2|0|G|1|30|dagar|0
528311|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|668|2417|lyfalmen|V0562|2410|2|100|0|33,3300|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||668||668|2417||2|0|G|0|||0
528418|D07AC1302|Ovixan|krem|1|mg/g|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|1934|4160|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1934||1934|4160||1|0|G|0|||0
528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|G|0|LVR|0|0|0|100|SEK|5699|9342|lyfalmen|V0971|9342|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||5699||5699|9342||3|0|G|0|||0
528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|G|0|FEL|0|0|0|100|DKK|6182|10007|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||6182||6182|10007||1|0|G|0|||0
528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.02.2018||R|0|0|0|G|0|RTH|0|0|0|100|XEU|6067|8802|lyfalmen|V0621|8802|2|18|0|18,0000|Alvogen|ratiopharm GmbH|Rizatriptan||5307||5307|8802||2|0|G|0|||0
528948|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|20567|23180|lyfalmen|||2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||15753||15753|23180||1|0|G|0|||0
529142|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|100|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|5193|8394|lyfalmen|V1003|8394|2|100|0|6,6667|Alvogen|Alvogen ehf|Oxycodonum í blöndum||5010||5010|8394||2|0|E|1|30|dagar|0
529352|N05AX1304|Paliperidon Krka|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|0|KNM|0|0|0|100|IKR|9787|14969|lyfalmen|V0963|14969|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||9787||9787|14969||2|0|E|0|||0
529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|PLS|0|0|0|100|DKK|60817|80195|lyfalmen|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||60817||60817|80195||1|H|0|0|||0
529955|J05AE0803|Atazanavir Krka|hylki|300|mg|30|stk|1|glas||J05AE08|01.06.2020||R|0|0|1|0|0|KAN|0|1|0|100|IKR|39565|53315|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Atazanavír||39565||39565|53315||2|0|L|0|||0
530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0||0|||0
530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|||0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||7017||1|0|E|0|||0
530255|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2488|4251|lyfalmen|V0824|4251|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||2000||2000|4251||2|0|G|0|||0
530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|1525|2997|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||1525||1525|2997||2|0||0|||0
530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2673|5177|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2673||2673|5177||1|0|G|0|||0
530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|5952|9690|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5952||5952|9690||1|0|0|0|||0
531360|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|6575|6175|lyfalmen|V0622|6175|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3398||3398|6175||1|0|E|1|30|dagar|0
531382|A10BK0401|Steglatro|filmhtfl|15|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|19485|28317|lyfalmen|||1|98|0|147,0000|Vistor hf|M.S.D.|Ertugliflozin||19485||19485|28317||1|0|G|0|||0
531501|N05CH0105|Slenyto|forðatfl|1|mg|60|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|RNU|0|0|1|100|XEU|6547|10509|lyfalmen|||2|60|0|30,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||6547||6547|10509||2|0|0|0|||0
531894|J01DD0103|Cefotaxim Navamedic|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.05.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|6369|10264|lyfalmen|||2|100|0|2,5000|Icepharma hf|Navamedic ASA|Cefotaximum||6369||6369|10264||2|0|0|0|||0
532257|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2020||R|0|0|0|0|0|VAL|0|0|0|100|XEU|2545|4811|lyfalmen|V0117|4773|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2407||2407|4811||2|0|E|0|||0
532351|C09BA0204|Enalapril HCTZ Medical Valley|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.02.2021||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2165|2566|lyfalmen|V0098|2566|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Enalapríl og þvagræsilyf||776||776|2566||2|0|G|0|||0
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|CNI|0|0|0|100|SEK|803|2603|lyfalmen|||1|30|0|3,0000|Vistor hf|McNeil Sweden AB|Mebendazól||803||803|2603||1|0||0|||0
532526|L04AA4201|Mayzent|filmhtfl|0,25|mg|12|stk|1|þpakki|Skammtastillingarpakkning|L04AA42|01.11.2020||R|1|1|1|0|0|NEP|0|1|0|100|DKK|23962|33581|lyfsjukr|||1|12|0||Vistor hf|Novartis Europharm Limited|Siponimod||23962||23962|33581||1|0|L|0|||0
532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|G|0|WEH|0|0|0|100|XEU|43330|29574|lyfalmen|V0711|26186|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||20794||20794|29574||2|0|G|0|||0
532726|N06AB1008|Escitalopram STADA|filmhtfl|20|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3500|6315|lyfalmen|V0327|6315|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||3500||3500|6315||2|0|0|0|||0
532821|L01XG0101|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XG01|01.02.2016||R|0|1|0|0|0|WEH|0|1|0|100|XEU|110110|143457|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomib||110110||110110|143457||2|H|L|0|||0
532869|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|BAN|0|0|0|100|DKK|24899|42916|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||24899||24899|42916||2|0||0|||0
532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|1871|4073|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||1871||1871|4073||2|0|0|0|||0
532984|N02AJ0601|Parkodin|filmhtfl|510|mg|100|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1265|3239|lyfalmen|||2|100|0|16,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1265||1265|3239||1|0|E|3|||0
533001|A10BA0205|Metformin EQL|filmhtfl|500|mg|105|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|G|0|EQL|0|0|0|100|IKR|500|2186|lyfalmen|V0500|2157|2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Metformín||500||500|2186||2|0|G|0|||0
533147|B02BD0208|Afstyla|sts|3000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|238730|303425|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||238730||238730|303425||2|0|L|0|||0
533363|L04AA3601|Ocrevus|irþ|300|mg|10|ml|1|hgl|lausn|L04AA36|01.04.2018||R|0|0|0|0|0|RRG|0|1|0|100|DKK|757638|948801|lyfsjukr|||1|10|0|91,1854|Icepharma hf|Roche Registration GmbH|Ocrelizumab||||757638|948801||2|H|L|0|||0
533563|R03AK0605|Salmex|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.01.2021||R|0|0|0|G|0|GPN|0|0|0|100|DKK|3364|5527|lyfalmen|V0436|5527|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||2927||2927|5527||2|0|G|0|||0
533979|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|án rotvarnar/án laktósa|H02AB04|01.01.2021||R|0|0|0|G|0|PLS|0|0|1|100|DKK|460|2131|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer Aps|Metýlprednisólón||460||460|2131||1|0|G|0|||0
534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|21177|30058|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||21177||21177|30058||1|0|G|0|||0
534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|1|G|0|PEU|0|0|0|100|DKK|54950|72774|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||54950||54950|72774||1|0|G|0|||0
534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|CES|0|0|0|100|XEU|2808|5498|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Amoxicillinum||2808||2808|5498||2|0||0|||0
534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|KRK|0|0|0|100|IKR|5481|4870|lyfalmen|V0117|4870|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2450||2450|4870||2|0|E|0|||0
534712|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|2313|4682|lyfalmen|||1|100|0|20,0000|Icepharma hf|Abcur AB|Metadón||2313||2313|4682||2|0|G|1|30|dagar|0
534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|5016|8402|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||5016||5016|8402||2|H|0|0|||0
534942|R01AD5801|Dymista|nefúði|187|mcg/sk|120|skammtar|1|glas|137+50mcg|R01AD58|01.10.2019||R|0|0|0|G|0|MEA|0|0|1|100|DKK|2951|5560|lyfalmen|||1|120|0|30,0000|Icepharma hf|Meda AB|Fluticasone í samsetningum||2951||2951|5560||2|0|G|0|||0
535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|G|0|TPA|0|0|0|100|DKK|2102|4391|lyfalmen|V0092|4014|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||2102||2102|4391||1|0|G|0|||0
535453|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|19 mg/4 mg|QP54AB51|01.04.2018|31.08.2021|R|0|0|0|0|0|BIV|0|0|0|100|XEU|2323|4004|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2323||2323|4004||1|0||0|||0
535685|M01AH0503|Coxerit|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2378|3907|lyfalmen|V0826|3647|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1750||1750|3907||2|0|G|0|||0
535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2|0||0|||0
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|G|0|HES|0|0|0|100|DKK|350|1980|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||350||350|1980||1|0|G|0|||0
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|G|0|HES|0|0|0|100|DKK|365|2000|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||365||365|2000||1|0|G|0|||0
536179|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|10|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|0|AEE|0|0|0|100|XEU|5836|9531|lyfalmen|||2|100|0|33,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||5836||5836|9531||1|H|0|2|450|mg|0
536385|C10AA0509|Atorvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0112|2679|2|98|0|49,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0
536460|N05AX1302|Xeplion|stl|150|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|84149|109705|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||84149||84149|109705||1|0|E|0|||0
536682|J02AC0106|Fungyn|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.01.2018||R|1|0|0|0|0|POF|0|0|1|100|IKR|14133|10995|lyfalmen|V0419|9924|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||6900||6900|10995||2|0|E|0|||0
536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|2508|4950|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2508||2508|4950||2|H|0|0|||0
536958|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|2|stk|1|þpakki||N02CC04|01.08.2020||L|0|0|0|0|0|POF|0|0|0|100|XEU|||lyflausa|||2|2|0|2,0000|Alvogen|Alvogen|Rizatriptan|||||||2|0|0|0|||0
537111|J05AR1701|Descovy|filmhtfl|225|mg|30|stk|1|glas|200+25 mg|J05AR17|01.10.2016||R|0|0|1|0|0|GSE|0|1|0|100|DKK|60584|79900|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||60584||60584|79900||2|0|L|0|||0
537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|FKA|0|0|1|100|DKK|5162|8603|lyfalmen|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5162||5162|8603||1|0|0|0|||0
537580|R03DC0306|Montelukast ratiopharm|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.07.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|10565|16040|lyfalmen|V0492|16040|2|98|0|39,2000|Alvogen|Teva Sweden AB|Montelúkast||10565||10565|16040||2|0|G|0|||0
537600|C07AG0207|Carvedilol STADA|töflur|3,125|mg|30|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1500|3563|lyfalmen|||2|30|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1500||1500|3563||2|0|G|0|||0
537772|N02AE0105|Buprenorphine Alvogen|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2021||R|0|0|0|G|0|POF|0|0|0|100|IKR|3504|6321|lyfalmen|V0945|4189|2|4|0|11,2000|Alvogen|Alvogen|Búprenorfín||3504||3504|6321||2|0|G|1|30|dagar|0
537842|N05AH0206|Clozapin Medical|töflur|25|mg|500|stk|1|glas||N05AH02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|14000|13473|lyfalmen|||2|500|0|41,6666|Medical ehf|Medical ehf|Klózapín||8700||8700|13473||2|0|G|0|||0
537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2398||1|0|G|0|||0
537873|N05CM0901|Sefitude|húðuðtfl|445|mg|60|stk|1|þpakki||N05CM09|01.06.2018||L|1|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||1|60|0||Florealis ehf|Florealis ehf|Valerianae radix|||||||2|0||0|||0
538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0
538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0
538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0
538272|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|1062|2960|lyfalmen|||3|12|0|0,5000|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||1062||1062|2960||3|0|G|0|||0
538555|L04AX0306|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2788|5335|lyfalmen|||1|1|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2788||2788|5335||2|0|G|0|||0
538713|R03BB0702|Incruse Ellipta|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|G|0|RGP|0|0|0|100|DKK|4349|7484|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Umeclidiniumbrómið||4349||4349|7484||1|0|G|0|||0
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|1|G|0|SNP|0|0|0|100|XEU|8014|12528|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||8014||8014|12528||1|0|G|0|||0
539310|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|rörlyk|Penfill|A10AB05|01.07.2018||R|0|0|0|G|0|NAS|0|0|0|100|DKK|4801|8106|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4801||4801|8106||1|0|G|0|||0
539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|BMS|0|1|0|100|DKK|63803|83972|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||63803||63803|83972||1|H|L|0|||0
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|736|2511|lyfalmen|||2|25|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||736||736|2511||1|0||2|130|töflur|0
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|0|100|DKK|1115|3033|lyfalmen|||2|100|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1115||1115|3033||1|0||2|130|töflur|0
539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1|0||0|||0
539793|L01EF0201|Kisqali|filmhtfl|200|mg|63|stk|1|þpakki||L01EF02|01.11.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|483148|607412|lyfsjukr|||1|63|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||483148||483148|607412||1|0|L|0|||0
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1681|3812|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1681||1681|3812||1|0|G|0|||0
539990|C10AX0905|Ezetimibe ratiopharm|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.12.2018||R|1|0|0|0|0|RTH|0|0|0|100|DKK|9173|6523|lyfalmen|V0954|6008|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Ezetimíb||3651||3651|6523||2|0||0|||0
540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|FKA|0|0|0|100|DKK|18023|26305|lyfalmen|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||18023||18023|26305||1|0|0|0|||0
540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|40883|11778|lyfalmen|V0721|11614|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||7469||7469|11778||2|0||0|||0
540141|N03AX1213|Gabapentin Teva|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.10.2019|31.07.2021|R|1|0|0|G|0|TVA|0|0|0|100|DKK|12641|18897|lyfalmen|||2|100|0|44,4400|Alvogen|Teva B.V.|Gabapentín||12641||12641|18897||2|0|G|0|||0
540220|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.10.2017||R|0|0|0|0|0|TEA|0|0|0|100|SEK|21420|30366|lyfalmen|V1042|30366|1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||21420||21420|30366||1|H|0|0|||0
540503|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|60|pokar|lausn|B05BB01|01.03.2020||R|0|0|0|0|0|BAM|0|0|1|100|DKK|7246|11471|lyfalmen|||1|6000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7246||7246|11471||2|0|0|0|||0
540752|H01CB0203|Octreoanne|sts|30|mg|30|mg|1|hgl|+ leysir|H01CB02|01.05.2020|30.06.2021|R|0|0|0|0|0|TVI|0|1|0|100|NOK|173559|119500|lyfsjukr|||2|30|0|42,8600|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||91893||91893|119500||1|0|L|0|||0
540857|L01XC3201|Tecentriq|irþ|840|mg|14|ml|1|hgl|lausn|L01XC32|01.02.2020||R|0|1|0|0|0|RRG|0|1|0|100|DKK|473799|595785|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||473799||473799|595785||2|H|L|0|||0
540859|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9984|3257|lyfalmen|V0813|3197|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1278||1278|3257||2|0|E|0|||0
540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|628957|788758|lyfsjukr|||1|21|0|5,2500|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||628957||628957|788758||2|0|L|0|||0
541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
541493|N03AX1602|Lyrica (Lyfjaver)|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|2232|4570|lyfalmen|V0685|2141|3|56|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||2232||2232|4570||3|0|E|0|||0
541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|184638|236149|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer AG|Riociguatum||184638||184638|236149||1|0|L|0|||0
542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|LEM|0|0|1|100|XEU|5066|8471|lyfalmen|||2|800|0|3,3300|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||5066||5066|8471||2|0|0|0|||0
542291|L01BC0603|Ecansya|filmhtfl|150|mg|60|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|1|0|0|KAN|0|0|0|100|IKR|4301|7418|lyfalmen|||2|60|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||4301||4301|7418||2|0|0|0|||0
542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|0|0|G|0|WEH|0|0|0|100|XEU|5180|3393|lyfalmen|V0682|3393|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1377||1377|3393||2|0|G|0|||0
542474|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|túpa|mælipumpa|G03CA03|01.07.2019||R|0|0|0|G|0|BES|0|0|0|100|DKK|1298|3284|lyfalmen|||2|64|0||Vistor hf|Besins Healthcare Ireland Limited|Estradíól||1298||1298|3284||1|0|G|0|||0
542694|G04CA5202|Dutaprostam|hylki|0,9|mg|90|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.02.2021||R|0|0|0|G|0|ALO|0|0|0|100|DKK|9198|8937|lyfalmen|V1010|8937|2|90|0|90,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Dútasteríð og tamsúlósínhýdroklóríð||5405||5405|8937||2|0|G|0|||0
542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|3879|6837|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||3879||3879|6837||2|0|0|0|||0
542893|H05BX0106|Cinacalcet ratiopharm|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.07.2018||R|1|0|0|0|0|RTH|0|0|0|100|XEU|17214|8361|lyfalmen|V0720|8242|2|28|0|14,0000|Alvogen|ratiopharm GmbH|Cinacalcet||4986||4986|8361||2|0||0|||0
543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|17052|24968|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||17052||17052|24968||1|0|G|0|||0
543374|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011|31.07.2021|R|0|0|0|G|0|POF|0|0|0|100|XEU|1535|3611|lyfalmen|||2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1535||1535|3611||2|0|G|0|||0
543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|BAM|0|0|0|100|SEK|87957|114522|lyfalmen|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||87957||87957|114522||2|H|0|0|||0
543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
544374|L01EM0101|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01EM01|01.07.2016||R|1|0|1|0|0|GSE|0|1|0|100|DKK|531886|668028|lyfsjukr|||1|60|0|30,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||531886||531886|668028||2|0|L|0|||0
544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|CSB|0|1|0|100|SEK|353906|446671|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||353906||353906|446671||2|H|L|0|||0
544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|11338|17104|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||11338||11338|17104||1|0|G|0|||0
545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|27126|37583|lyfalmen|||2|100|0|120,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||27126||27126|37583||2|0|G|0|||0
545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|0|0|RRG|0|1|0|100|DKK|259665|329462|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||259665||259665|329462||2|H|L|0|||0
545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|RTH|0|0|0|100|XEU|1579|3286|lyfalm11|V0134|3286|2|63|0|84,0000|Alvogen|ratiopharm GmbH|Cýpróterón og östrógen||1579||1579|3286||2|0||0|||0
545554|M01AE0116|Ibuprofen Bril|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0
545639|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3533|4664|lyfalmen|V0438|4609|2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||2300||2300|4664||2|0|G|0|||0
545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|GPH|0|0|1|100|DKK|863|2686|lyfalmen|||1|15|0||Vistor hf|GlaxoSmithKline Pharma A/S|Múpírócín||863||863|2686||1|0||0|||0
545705|N02AB0310|Fentanyl Alvogen|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.11.2020||R|0|0|0|G|0|RTH|0|0|0|100|XEU|5368|8107|lyfalmen|V0223|8106|2|5|0|30,0000|Alvogen|ratiopharm GmbH|Fentanýl||4802||4802|8107||2|0|G|1|30|dagar|0
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|G|0|LBK|0|0|0|100|DKK|819|2625|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||819||819|2625||1|0|G|0|||0
545827|R06AD0203|Prometazin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||R06AD02|01.07.2017||R|1|0|0|G|0|ATE|0|0|1|100|XEU|1158|2518|lyfalmen|V0903|2518|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Prómetazín||741||741|2518||1|0|G|0|||0
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1884|4091|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1884||1884|4091||1|0|G|0|||0
545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|66736|87681|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||66736||66736|87681||1|0|G|0|||0
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|49839|66310|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||49839||49839|66310||1|0|G|0|||0
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|58196|76880|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||58196||58196|76880||1|0|G|0|||0
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|48202|64239|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||48202||48202|64239||1|0|G|0|||0
546660|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|532|2230|lyfalmen|||1|20|0|4,0000|Icepharma hf|Abcur AB|Metadón||532||532|2230||2|0|G|1|30|dagar|0
546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|G|0|ATE|0|0|1|100|XEU|4052|4084|lyfalmen|V0010|3916|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1879||1879|4084||1|0|G|0|||0
547054|A07EC0203|Pentasa Sachet|forðakyr|4|g|30|pokar|1|pakki||A07EC02|01.04.2017||R|0|0|0|G|0|FER|0|0|0|100|DKK|14926|22042|lyfalmen|||1|30|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14926||14926|22042||1|0|G|0|||0
547094|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|100|ml|20|glös|lausn|B05BB01|01.01.2018||R|0|0|0|0|0|RAU|0|0|1|100|XEU|2967|5582|lyfalmen|||2|2000|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||2967||2967|5582||2|0|0|0|||0
547200|C09DA0312|Valsartan/Hydroklortiazid Jubilant|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|IKR|4100|5765|lyfalmen|V0581|5765|2|98|0|98,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan og þvagræsilyf||3100||3100|5765||2|0|G|0|||0
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|ORC|0|0|1|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||5334||1|0||0|||0
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|0|0|RGP|0|0|0|100|DKK|9047|13950|lyfalmen|||1|100|0|0,3800|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||9047||9047|13950||1|H|0|0|||0
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|0|0|RGP|0|0|0|100|DKK|2909|5502|lyfalmen|||1|10|0|0,1000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||2909||2909|5502||1|H|0|0|||0
547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|6348|10235|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||6348|10235||2|0|0|0|||0
548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|1|G|0|FIN|0|0|0|100|DKK|99935|129671|lyfalmen|||1|15|0|30,0000|Icepharma hf|Bayer AG|Interferón beta-1b||99935||99935|129671||2|0|G|0|||0
548136|C07AB0704|Bisbetol|filmhtfl|5|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|G|0|WEH|0|0|0|100|XEU|2089|4373|lyfalmen|V1038|3068|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||2089||2089|4373||2|0|G|0|||0
548162|M04AA0304|Aburic|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.03.2020||R|1|0|0|0|0|WEH|0|0|0|100|XEU|8636|9626|lyfalmen|V1011|9343|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|febuxostat||5905||5905|9626||2|0|E|0|||0
548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|525|2221|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||525||525|2221||1|0|G|0|||0
548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2152||1|0|G|0|||0
548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|143725|185265|lyfalmen|||1|20|0||Icepharma hf|Baxter Medical AB|Blöndur||143725||143725|185265||2|H|0|0|||0
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|G|0|JAS|0|0|0|100|SEK|6652|10654|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||6652||6652|10654||1|0|G|0|||0
549442|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|4950|5283|lyfalmen|V0117|4870|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2750||2750|5283||2|0|E|0|||0
549476|N06BA0409|Methylphenidate STADA|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|7500|10169|lyfalmen|||2|30|0|60,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||6300||6300|10169|30.6.2021|2|0|E|1|30|dagar|0
549545|QM01AE0301|Romefen vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.2020||R|0|0|0|0|0|CES|1|0|0|100|DKK|4159|8061|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||4159||4159|8061||2|0||0|||0
549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|29769|40925|lyfalmen|V0976|40619|1|98|0|73,5000|Icepharma hf|Bayer AG|Rivaoxaban||||29769|40925||2|0|G|0|||0
550111|S01AA0102|Oftan Chlora|augnsm|10|mg/g|3,5|g|1|túpa||S01AA01|01.02.2018||R|0|0|0|G|0|SAO|0|0|1|100|XEU|882|2712|lyfalmen|||2|3,5|0||Icepharma hf|Santen Oy|Klóramfeníkól||882||882|2712||2|0|G|0|||0
550147|QN01BB0201|Lidor vet.|stl|20|mg/ml|50|ml|1|hgl|lausn|QN01BB02|01.05.2019||R|0|0|0|0|0|RPG|1|0|0|100|XEU|1249|2455|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Lidocaine||1249||1249|2455||2|0||0|||0
550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1457|2101|lyfalmen|V0551|2101|2|7|0|1,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||438||438|2101||1|0|E|0|||0
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.05.2019||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2518|4964|lyfalmen|V0471|4964|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4964||2|0|G|0|||0
551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|G|0|GGM|0|0|0|100|NOK|2785|5331|lyfalmen|||1|100|0|25,0000|Glenwood GmbH P. Erzeugnisse|Glenwood GmbH P. Erzeugnisse|Dípýrídamól||2785||2785|5331||2|0|G|0|||0
551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1|0||0|||0
551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|BAM|0|0|0|100|SEK|7361|11630|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||7361||7361|11630||2|H|0|0|||0
551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|G|0|MEA|0|0|1|100|DKK|1555|3638|lyfalmen|||1|1|0|2,6667|Icepharma hf|Meda AB|Tríamcínólón||1555||1555|3638||2|0|G|0|||0
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|G|0|MEA|0|0|1|100|DKK|4724|8000|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Nabúmeton||4724||4724|8000||2|0|G|0|||0
551683|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.06.2021||R|0|0|0|0|0|PEU|0|0|1|100|DKK|19229|27965|lyfalmen|V1050|27965|1|112|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||19229|27965||1|0||0|||0
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|1812|2276|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E|0|||0
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|2691|3966|lyfalmen|V0467|2772|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E|0|||0
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001|30.06.2021|R|0|0|0|0|0|EIS|0|0|1|100|IKR|1160|1527|lyfalmen|||1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1527||1|0|E|0|||0
551904|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|51710|68676|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||51710||51710|68676||1|H|L|0|||0
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|2821|2276|lyfalmen|V0003|2167|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E|0|||0
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|5587|3966|lyfalmen|V0010|2193|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E|0|||0
552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|1578|3670|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1578||1578|3670||2|0|0|0|||0
552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0
552648|C07AB0215|Metoprolol Alvogen|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.01.2021||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1036|2494|lyfalmen|V0050|2494|2|100|0|15,8333|Alvogen|Alvogen ehf|Metóprólól||724||724|2494||2|0|G|0|||0
552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|QAS|0|0|0|100|GBP|16040|25856|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||16040||16040|25856||1|0||0|||0
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|3012|5644|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3012||3012|5644||1|0|G|0|||0
552913|QJ01GB0301|Genta-Equine|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01GB03|01.01.2019||R|0|0|0|0|0|FRA|1|0|0|100|IKR|3657|7109|vetalmen|||0|100|0||Dýraheilsa ehf|Franklin Pharmaceuticals Ltd.|Gentamicin||3657||3657|7109||2|0||0|||0
553076|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|50|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|162851|209052|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||162851||162851|209052||2|H|0|0|||0
553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|6017|9780|lyfalmen|V0237|9780|1|18|0|18,0000|Icepharma hf|Upjohn EESV|Eletriptan||||6017|9780||1|0|G|0|||0
553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|2272|4625|lyfalmen|V0237|3260|1|6|0|6,0000|Icepharma hf|Upjohn EESV|Eletriptan||2272||2272|4625||1|0|G|0|||0
553382|R06AD0102|Alimemazin Evolan|hylki|20|mg|100|stk|1|glas|hart|R06AD01|01.09.2018||R|1|0|0|G|0|EVO|0|0|1|100|IKR|5684|9321|lyfalmen|||2|100|0|66,6667|LYFIS ehf|Evolan Pharma AB|Alímemazín||5684||5684|9321||2|0|G|0|||0
553387|J01CR0205|Spectracillin|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.12.2018||R|0|0|0|0|0|WEH|0|0|1|100|IKR|1430|2599|lyfalmen|V0169|2599|2|14|0|8,1667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill||800||800|2599||2|0||0|||0
553555|J07BX0307|COVID-19 Vaccine AstraZeneca (Vaxzevria)|stl|||5|ml|10|hgl|hvert hgl.10x0,5ml sk.|J07BX03|01.03.2021||R|0|0|0|0|0|AZE|0|0|0|100|IKR|||lyfalmen|||1|50|0||Vistor hf|AstraZeneca AB|Covid-19 vaccines|||||||1|0||0|||0
553580|QN01BB0202|BelOcain vet.|stl|20|mg/ml|100|ml|12|hgl|lausn|QN01BB02|01.06.2019||R|0|0|0|0|0|Bel|1|0|0|100|IKR|15300|24075|vetalmen|||0|1200|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Lidocaine||12600||12600|24075||2|0||0|||0
553720|L01EJ0101|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01EJ01|01.02.2014||R|1|0|1|0|0|NEL|0|1|0|100|DKK|428330|539234|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||428330||428330|539234||1|0|L|0|||0
554131|L01XC0303|Trazimera|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|0|PEU|0|1|0|100|DKK|82542|107673|lyfsjukr|||1|150|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||82542||82542|107673||1|H|L|0|||0
554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|BID|1|0|0|100|DKK|9296|17807|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||9296||9296|17807||1|0||0|||0
554441|N02AA0508|Oxycodone Alvogen|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|19011|27665|lyfalmen|V0588|27665|2|98|0|104,5300|Alvogen|Alvogen ehf|Oxýcódon||19011||19011|27665||2|0|G|1|30|dagar|0
554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6211|5693|lyfalmen|V0029|5693|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klópídógrel||3048||3048|5693||1|0|G|0|||0
554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|CPV|0|1|0|100|DKK|1212106|1514032|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1212106||1212106|1514032||2|0|L|0|||0
555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|1|0|0|NEL|0|1|0|100|DKK|161376|207218|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||161376||161376|207218||1|0|L|0|||0
555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1562|3648|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1562||1562|3648||1|0|G|0|||0
555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|2173|4489|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2173||2173|4489||1|0|G|0|||0
555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1110|3026|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1110||1110|3026||1|0|G|0|||0
556146|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|21|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|2011|3563|lyfalmen|V0461|3563|2|21|0|5,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||1500||1500|3563||2|0|E|0|||0
556242|QD07XB0202|Recicort|eyrnadr|||20|ml|1|dropaí|1,77+17,7 mg/ml|QD07XB02|01.12.2017||R|0|0|0|0|0|BVL|0|0|0|100|IKR|1328|2610|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet B.V.|Triamcinolon||||1328|2610||2|0||0|||0
556578|N02BE5106|Panodil Extra|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE51|01.12.2019||L|1|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||1|0|0|0|||0
556694|C10AX1401|Praluent|stl|150|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|68630|90077|lyfalmen|||1|2|0|55,5556|Vistor hf|Sanofi-aventis groupe|Alirocumab||68630||68630|90077||1|0|E|0|||0
556903|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.07.2018||R|0|0|0|0|0|VAL|0|0|0|100|DKK|11085|6490|lyfalmen|V0954|6130|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||3627||3627|6490||2|0|E|0|||0
556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|18482|26937|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|Merck AB|Sómatrópín||18482||18482|26937||2|0|L|0|||0
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|4565|7781|lyfalmen|V0972|6837|1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4565||4565|7781||1|0|G|0|||0
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|9549|14641|lyfalmen|V0973|11902|1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||9549||9549|14641||1|0|G|0|||0
557073|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9984|3257|lyfalmen|V0814|3197|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||1278||1278|3257||2|0|E|0|||0
557239|R03AK0606|Salmeterol/Fluticasone Neutec|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2021||R|0|0|0|G|0|NET|0|0|0|100|DKK|3858|5304|lyfalmen|V0437|5304|2|60|0|30,0000|Lyfjaver ehf|Neutec Inhaler Ireland Limited|Salmeteról og fluticason||2765||2765|5304||3|0|G|0|||0
557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|1339|3341|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1339||1339|3341||2|0|G|0|||0
558386|N01BB2001|Emla|plástur|||20|stk|1|pakki|25mg+25mg/plástur|N01BB20|01.07.2020||L|0|0|0|0|0|MAR|0|0|0|100|DKK|||lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Blöndur|||||8732||2|0||0|||0
558417|L01EA0401|Bosulif|filmhtfl|400|mg|28|stk|1|þpakki||L01EA04|01.03.2019||R|1|0|1|0|0|PEU|0|1|0|100|DKK|485765|610667|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bosutinib||485765||485765|610667||1|0|L|0|||0
558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|1|0|0|NEL|0|1|0|100|DKK|216611|275915|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||216611|275915||1|0|L|0|||0
558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
559165|M02AA1505|Voltaren Forte|hlaup|23,2|mg/g|100|g|1|túpa||M02AA15|01.06.2020||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0||0|||0
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0||0|||0
559618|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|4372|7516|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||4372||4372|7516||1|0|G|0|||0
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|G|0|HEG|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1915||1|0|G|0|||0
560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|0|0|BMS|0|1|0|100|DKK|38770|52310|lyfsjukr|||1|100|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Paklítaxel||38770||38770|52310||2|H|L|0|||0
560293|L01XK0101|Lynparza|filmhtfl|100|mg|56|stk|1|þpakki||L01XK01|01.03.2020||R|0|0|1|0|0|AZA|0|1|0|100|SEK|358801|452759|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||358801||358801|452759||1|0|L|0|||0
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Acíklóvír|||||||1|0||0|||0
560435|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2017|30.06.2021|L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0
560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|0|0|COR|0|0|0|100|DKK|103358|135060|lyfalmen|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||103358||103358|135060||1|H|0|0|||0
560682|L01EA0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01EA01|01.09.2017||R|0|0|1|0|0|ACC|0|1|0|100|XEU|160523|114902|lyfsjukr|||2|30|0||Artasan ehf|Accord Healthcare Limited|Imatinib||88258||88258|114902||1|0|L|0|||0
560982|M04AA0305|Febuxostat Krka|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.07.2021||R|1|0|0|0|0|KAN|0|0|0|100|IKR|6000|9343|lyfalmen|V1011|9343|2|28|0|28,0000|Krka Sverige AB|Krka d.d. Novo mesto|febuxostat||5700||5700|9343||2|0|E|0|||0
561022|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
561239|L01EL0101|IMBRUVICA|filmhtfl|420|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|699215|876139|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||699215||699215|876139||1|0|L|0|||0
561745|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|innöndunartæki og 1 áfylling|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|6027|9793|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||6027||6027|9793||1|0|G|0|||0
561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|184638|236149|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer AG|Riociguatum||184638||184638|236149||1|0|L|0|||0
562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1555|2991|lyfalmen|V0098|2566|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||1085||1085|2991||1|0|G|0|||0
562176|B02BD0401|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD04|01.02.2013||R|0|0|1|0|0|PEU|0|1|0|100|DKK|46625|62245|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Faktor IX||46625||46625|62245||1|0|L|0|||0
562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|G|0|TEA|0|0|0|100|SEK|4036|7053|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4036||4036|7053||1|0|G|0|||0
562419|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|891695|1115530|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||891695||891695|1115530||2|H|L|0|||0
562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|RGP|0|1|0|100|DKK|79451|103763|lyfsjukr|||1|1|0|16,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||79451||79451|103763||1|H|L|0|||0
562774|H01CB0203|Octreoanne|sts|20|mg|20|mg|1|hgl|+ leysir|H01CB02|01.05.2020|30.06.2021|R|0|0|0|0|0|TVI|0|1|0|100|NOK|136094|94372|lyfsjukr|||2|20|0|28,5700|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||72026||72026|94372||1|0|L|0|||0
563192|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|10|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|32570|44468|lyfalmen|||1|100|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||32570||32570|44468||2|H|0|0|||0
563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|0|G|0|MDI|0|0|0|100|DKK|1293|3278|lyfalmen|||1|100|0|5,0000|Icepharma hf|Mundipharma A/S|Morfín||1293||1293|3278||2|0|G|1|30|dagar|0
563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|22339|8351|lyfalmen|V0720|8242|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||4979||4979|8351||2|0||0|||0
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3499|6314|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||||3499|6314||2|0|G|0|||0
563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|DIV|0|0|0|100|IKR|1398|2748|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1398|2748||2|0||0|||0
563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|ROD|0|0|0|100|DKK|430619|542081|lyfalmen|||1|60|0|15,0000|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||430619||430619|542081||1|0|E|0|||0
563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|NIL|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||10463||10463|18034||2|0||0|||0
563905|J02AC0106|Fungyn|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.01.2017||L|1|0|0|0|0|GOV|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen ehf|Flúkónazól|||||||2|0||0|||0
564048|J07BA0103|TicoVac|stl|2,4|mcg/sk|0,5|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3469|6273|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3469||3469|6273||1|0||0|||0
564124|N06DA0405|Galantamin STADA|forðahlk|8|mg|30|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3200|5902|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||3200||3200|5902||2|0|G|0|||0
564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|18860|27457|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||18860||18860|27457||3|0|L|0|||0
564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|G|0|NVO|0|0|1|100|DKK|832|2643|lyfalmen|||1|120|0|12,0000|Vistor hf|N.V. Organon|Deslóratadín||832||832|2643||1|0|G|0|||0
564448|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|G|0|BLS|0|0|0|100|XEU|1378|2588|lyfalmen|V0056|2216|2|100|0|100,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Amlódipín||792||792|2588||1|0|G|0|||0
564607|N06BA0409|Methylphenidate STADA|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|3000|4870|lyfalmen|||2|30|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||2450||2450|4870|30.6.2021|2|0|E|1|30|dagar|0
564827|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|9 mg/2 mg|QP54AB51|01.04.2018|31.08.2021|R|0|0|0|0|0|BIV|0|0|0|100|XEU|2216|3819|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2216||2216|3819||1|0||0|||0
565251|A10BJ0602|Rybelsus|töflur|14|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|20843|29636|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||20843||20843|29636||1|0|E|0|||0
565303|C01CA0303|Noradrenalina Normon|irþ|1|mg/ml|10|ml|100|lykjur|lausn|C01CA03|01.04.2019||R|0|0|0|0|0|LNA|0|0|0|100|XEU|260508|330510|lyfalmen|||2|1000|0|166,6667|Williams & Halls efh|Laboratorios Normon, S.A.|Noradrenalín||260508||260508|330510||2|H|0|0|||0
565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|8782|6109|lyfalmen|V0286|5627|2|100|0|50,0000|Alvogen|Teva Sweden AB|Quetíapín||3350||3350|6109||2|0|G|0|||0
565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|8105|15547|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|maropitant||||8105|15547||2|0||0|||0
565921|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|glas|95 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|2136|4127|lyfalmen|V0049|2910|2|100|0|66,6667|Artasan ehf|Hexal A/S|Metóprólól||1910||1910|4127||1|0|G|0|||0
565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|FEL|0|0|0|100|DKK|22399|31604|lyfalmen|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||22399||22399|31604||1|H|0|0|||0
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|G|0|NEL|0|0|0|100|DKK|1433|3470|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||1433||1433|3470||1|0|G|0|||0
566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|13865|20582|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13865||13865|20582||1|0|G|0|||0
567028|L01EH0101|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01EH01|01.02.2012||R|1|0|1|0|0|NEL|0|1|0|100|DKK|175820|225182|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Lapatinib||175820||175820|225182||1|0|L|0|||0
567332|C10AA0508|Lipistad|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3587|2806|lyfalmen|V0114|2736|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0
567371|M05BA0306|Pamidronatdinatrium Pfizer|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|PLS|0|0|0|100|DKK|5795|9474|lyfalmen|||2|10|0|1,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5795||5795|9474||1|H|0|0|||0
567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||3234||2|0|G|0|||0
567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|G|0|ALK|0|0|1|100|DKK|5435|8979|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5435|8979||1|0|G|0|||0
567461|D07AC1702|Flutivate|smyrsli|0,005|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|1941|4170|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1941||1941|4170||1|0|G|0|||0
567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|G|0|JAS|0|0|0|100|SEK|2531|4982|lyfalmen|V0291|2273|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2531||2531|4982||1|0|G|0|||0
567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|G|0|AEP|0|0|0|100|DKK|3325|6074|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||3325||3325|6074||2|0|G|0|||0
567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0||0|||0
567802|L04AX0501|Esbriet|filmhtfl|267|mg|252|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|332090|419538|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration GmbH|Pírfenidon||||332090|419538||2|0|E|0|||0
567805|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0
567980|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
568054|N02CD0101|Aimovig|stl|70|mg|1|ml|1|áfpen||N02CD01|01.12.2018||R|0|0|1|0|0|NEL|0|0|0|100|DKK|64863|85312|lyfalmen|||1|1|0|28,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||64863||64863|85312||1|0|E|0|||0
568324|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|XEU|6057|10440|vetbolu|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6057||6057|10440||2|0|0|0|||0
568413|QN01AX0305|Ketabel vet.|stl|100|mg/ml|10|ml|1|hgl|lausn|QN01AX03|01.04.2021||R|0|0|0|0|0|Bel|1|0|0|100|XEU|1560|3066|vetalmen|||0|10|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Ketaminum||1560||1560|3066||2|0|0|1|30|dagar|0
568478|M01AH0502|Coxient|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|2446|4044|lyfalmen|V0826|3647|2|28|0|42,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||1850||1850|4044||2|0|G|0|||0
568708|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|XEU|2752|2851|lyfalmen|V0334|2579|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||983||983|2851||2|0|G|0|||0
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|GPH|0|0|1|100|DKK|964|2825|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||964||964|2825||1|0||0|||0
568745|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.02.2020||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||2|28|0|18,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól|||||||1|0|0|0|||0
568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2412|2690|lyfalmen|V0058|2690|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Felódipín||866||866|2690||1|0|G|0|||0
568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3659|3302|lyfalmen|V0059|3106|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Felódipín||1311||1311|3302||1|0|G|0|||0
569171|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|25|stk|1|þpakki||H02AB06|01.02.2019||R|1|0|0|G|0|EQL|0|0|1|100|IKR|759|2543|lyfalmen|||2|25|0|12,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||759||759|2543||2|0|G|0|||0
569174|M01AH0503|Coxerit|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2186|2|7|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||500||500|2186||2|0|G|0|||0
569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|0|1|0|0|VIC|0|1|0|100|DKK|122306|158626|lyfsjukr|||1|30|0||Vistor hf|ViiV Healthcare BV|Abacavír, dolutegravír og lamivudín||122306||122306|158626||1|0|L|0|||0
569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|10063|15349|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||10063||10063|15349||2|H|0|0|||0
569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|4800|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1000||1000|2874||2|0|G|0|||0
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|1|0|0|HES|0|0|0|100|DKK|12643|18900|lyfalmen|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||12643||12643|18900||1|0|0|0|||0
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|1|0|0|HES|0|0|0|100|DKK|14538|21508|lyfalmen|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||14538||14538|21508||1|0|0|0|||0
569514|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.02.2017||R|0|0|0|G|0|KNM|0|0|0|100|IKR|4602|5971|lyfalmen|V0811|5298|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3250||3250|5971||2|0|G|0|||0
570106|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|100|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|9871|13493|lyfalmen|V1005|13493|2|100|0|13,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||8715||8715|13493||2|0|E|1|30|dagar|0
570227|QN02BG9102|Librela|stl|15|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|11731|22427|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||11731||11731|22427||2|0||2|||0
570272|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2017||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3582|2585|lyfalmen|V0110|2585|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||790||790|2585||2|0|G|0|||0
570421|L04AX0306|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2385|4781|lyfalmen|||1|1|0|4,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2385||2385|4781||2|0|G|0|||0
570649|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|þpakki|25+100 mg|N04BA02|01.02.2018||R|1|0|0|G|0|MSD|0|0|0|100|DKK|2250|4595|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2250||2250|4595||1|0|G|0|||0
570775|M01AH0108|Celecoxib Medical|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|3584|6431|lyfalmen|V0196|5989|2|100|0|100,0000|LYFIS ehf|Medical ehf|Celekoxíb||3584||3584|6431||2|0|G|0|||0
571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|EST|0|0|0|100|DKK|3175|6194|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||3175||3175|6194||1|0||0|||0
571063|R06AX2707|Dasselta|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|650|2048|lyfalmen|V0908|2048|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||400||400|2048||2|0|G|0|||0
571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|3312|6057|lyfalmen|V0384|4878|2|15|0|7,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||3312||3312|6057||1|0|G|0|||0
571181|R07AA0201|Curosurf|innönddr|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|CHI|0|0|0|100|XEU|67969|89241|lyfalmen|||1|1,5|0|0,7500|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||67969||67969|89241||1|H|0|0|||0
571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|0|0|RRG|0|1|0|100|DKK|511018|642075|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Obinutuzumab||511018||511018|642075||2|H|L|0|||0
571647|QN02BG9102|Librela|stl|20|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|13498|25779|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||13498||13498|25779||2|0||2|||0
571667|N03AX1602|Lyrica (Lyfjaver)|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|15513|22850|lyfalmen|V0687|4664|3|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||15513||15513|22850||3|0|E|0|||0
571872|J01CR0206|Amoxicillin/Clavulanic Acid Normon|sts/irs|1200|mg|100|hgl|1|pakki|1000+200 mg|J01CR02|01.09.2019||R|0|0|0|0|0|LNA|0|0|1|100|XEU|53501|70942|lyfalmen|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Amoxicillín og beta-laktamasa hemill||53501||53501|70942||2|0|0|0|||0
571902|N05AH0416|Quetiapin Medical Valley|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|5400|7540|lyfalmen|V0910|7540|2|100|0|37,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||4390||4390|7540||2|0|0|0|||0
572062|L01AX0304|Temozolomide Accord|hylki|250|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|1|0|0|CLU|0|1|0|100|XEU|35960|48756|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||35960||35960|48756||1|0|L|0|||0
572119|J01DD0206|Ceftazidima Normon|sts|1|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|0|LNA|0|0|1|100|XEU|83919|109414|lyfalmen|||2|50|0|12,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||83919||83919|109414||2|0|0|0|||0
572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|69207|90807|lyfalmen|V1046|90805|1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||69207||69207|90807||1|0|G|0|||0
572697|R06AE0706|Zensitin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.2018||L|1|0|0|G|0|WEH|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||2695||2|0|G|0|||0
572777|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6552|3393|lyfalmen|V0684|3393|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1377||1377|3393||2|0|G|0|||0
573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2985|5606|lyfalmen|V0994|2448|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||2985||2985|5606||1|0|G|0|||0
573382|J05AP5101|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AP51|01.09.2015||R|1|0|1|0|0|GSE|0|1|0|100|DKK|2010455|2506954|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir og ledipasvir||||2010455|2506954||2|0|L|0|||0
573477|L01XC0301|Herceptin|st/irþ|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|0|0|RRG|0|1|0|100|DKK|83127|108413|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||83127||83127|108413||2|H|L|0|||0
573579|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6038|3393|lyfalmen|V0683|3393|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1377||1377|3393||2|0|G|0|||0
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|PLS|0|0|1|100|DKK|13895|14809|lyfalmen|||1|10|0|1,6667|Icepharma hf|Pfizer ApS|Meropenem||9671||9671|14809||1|0|0|0|||0
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|PLS|0|0|1|100|DKK|22623|23365|lyfalmen|||1|10|0|3,3333|Icepharma hf|Pfizer ApS|Meropenem||15887||15887|23365||1|0|0|0|||0
573863|V03AB3403|FOMEPIZOLE SERB|irþ|5|mg/ml|20|ml|5|lykjur||V03AB34|01.06.2020||R|0|0|0|0|0|SER|0|0|0|100|XEU|90379|117585|lyfalmen|||1|100|0||SERB SA|SERB SA|Fómepízól||90379||90379|117585||3|H|0|0|||0
574086|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.09.2016||R|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2|0||0|||0
574395|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.06.2020||R|0|0|0|0|0|AEE|0|0|0|100|XEU|1375|3390|lyfalmen|||2|10|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||1375||1375|3390||1|H|0|2|450|mg|0
574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|0|0|RRG|0|1|0|100|DKK|398097|501632|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Pertuzumab||398097||398097|501632||2|H|L|0|||0
574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|G|0|NAA|0|0|1|100|DKK|8575|13301|lyfalmen|||1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||8575||8575|13301||1|0|G|0|||0
574597|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|7216|7108|lyfalmen|V0322|2912|1|98|0|98,0000|Icepharma hf|Upjohn EESV|Sertralín||4076||4076|7108||1|0|G|0|||0
575356|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|13593|3392|lyfalmen|V0817|3325|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1376||1376|3392||2|0|E|0|||0
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|12303|7108|lyfalmen|V0323|4166|1|98|0|196,0000|Icepharma hf|Upjohn EESV|Sertralín||4076||4076|7108||1|0|G|0|||0
575458|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 50 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|SGB|0|0|0|100|XEU|23370|32832|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og  lixisenatide||23370||23370|32832||1|0|E|0|||0
575484|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|100|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|WIL|0|1|0|100|XEU|37362|50529|lyfsjukr|||2|100|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||37362||37362|50529||2|H|L|0|||0
575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|724268|907298|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||724268||724268|907298||1|H|L|0|||0
575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1286|2310|lyfalmen|V0159|2310|2|20|0|6,6667|Alvogen|ratiopharm GmbH|Amoxicillín||590||590|2310||2|0|E|0|||0
575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1576|2755|lyfalmen|V0160|2755|2|30|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||913||913|2755||2|0|E|0|||0
575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1434|2991|lyfalmen|V0158|2991|2|20|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1085||1085|2991||2|0|E|0|||0
575715|G03GA1001|REKOVELLE|stl|72|mcg|2,16|ml|1|áfpen|+ 9 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|83192|108495|lyfalmen|||1|2,16|0|6,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||83192||83192|108495||1|0|G|0|||0
576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|CPV|0|1|0|100|DKK|1175195|1468125|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1175195||1175195|1468125||2|0|L|0|||0
576253|B01AC2202|Prasugrel Krka|filmhtfl|10|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|G|0|KAN|0|0|0|100|IKR|6577|10445|lyfalmen|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6500||6500|10445|31.7.2021|2|0|G|0|||0
576518|QN05CM1803|Sedadex|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.03.2017||R|0|0|0|0|0|VEB|1|0|0|100|IKR|5680|10947|vetalmen|||2|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Dexmedetomidinum||5680||5680|10947||2|0||0|||0
576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|G|0|AEP|0|0|0|100|IKR|6315|10190|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Merkaptópúrín||6315||6315|10190||2|0|G|0|||0
576797|V03AE0205|Sevelamercarbonat Stada|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.10.2017||R|1|0|0|0|0|ASR|0|0|0|100|IKR|13500|14780|lyfalmen|V0680|14780|2|180|0|22,5000|LYFIS ehf|STADA Arzneimittel AG|Sevelamer||9650||9650|14780||2|0||0|||0
576846|L01AX0304|Temozolomide Accord|hylki|250|mg|5|stk|1|skpoki|hart|L01AX03|01.06.2021||R|0|0|1|0|0|CLU|0|1|0|100|XEU|35960|48756|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||35960||35960|48756||1|0|L|0|||0
577021|N02AJ0601|Parkodin|filmhtfl|510|mg|30|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|445|2110|lyfalmen|||2|30|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||445||445|2110||1|0|E|3|||0
577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|19907|28898|lyfalmen|V0727|26269|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||19907||19907|28898||1|0|E|0|||0
577505|L04AC0701|RoActemra|stl|162|mg|4|áf-penni|1|pakki||L04AC07|01.03.2019||R|0|1|1|0|0|RRG|0|1|0|100|DKK|137250|177212|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||137250||137250|177212||2|0|L|0|||0
577616|N06BA0905|Atomoxetin STADA|hylki|60|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4500|3563|lyfalmen|V0816|3563|2|30|0|22,5000|LYFIS ehf|LYFIS ehf|Atomoxetín||1500||1500|3563||2|0|E|0|||0
577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|10838|16415|lyfalmen|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||10838||10838|16415||2|H|0|0|||0
578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|PLS|0|0|0|100|DKK|4328|7455|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4328||4328|7455||1|0||0|||0
578368|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|100|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|325703|411595|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||325703||325703|411595||2|H|0|0|||0
578537|J05AR2501|DOVATO|filmhtfl|350|mg|30|stk|1|glas|50 mg/300 mg|J05AR25|01.09.2020||R|1|0|1|0|0|VIC|0|1|0|100|DKK|99400|128995|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravir og lamivudin||99400||99400|128995||1|0|L|0|||0
578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|CHP|0|0|0|100|XEU|6553|11295|vetorma|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||6553||6553|11295||2|0||0|||0
578991|R03AK1401|Atectura Breezhaler|innönddu|385|mcg/sk|90|stk|3|stsk.þ|125 mcg/260mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|14659|21675|lyfalmen|||1|270|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||14659||14659|21675||1|0|G|0|||0
579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|G|0|ABC|0|0|1|100|IKR|14658|14436|lyfalmen|V0423|13060|2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||9400||9400|14436||2|0|G|0|||0
579184|L01CD0205|Docetaxel Accord|irþ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.06.2020||R|0|0|0|0|0|CLU|0|0|0|100|XEU|33185|45246|lyfalmen|||2|8|0||Artasan ehf|Accord Healthcare S.L.U.|Docetaxel||33185||33185|45246||1|H|0|0|||0
579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|BMS|0|1|0|100|DKK|159430|204798|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||159430||159430|204798||1|H|L|0|||0
579322|L01BC0503|Gemcitabine W&H|irs|1000|mg|1000|mg|1|hgl|innrennslistofn|L01BC05|01.02.2019||R|0|0|0|0|0|WEH|0|0|0|100|XEU|8809|13623|lyfalmen|||2|1000|0||Williams & Halls efh|Williams & Halls ehf|Gemcitabín||8809||8809|13623||2|H|0|0|||0
579491|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Innöndunartæki og 3 áfyllingar|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|19440|25886|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||17719||17719|25886||1|0|G|0|||0
579796|N02AJ0602|Parkodin forte|filmhtfl|530|mg|100|stk|1|þpakki|30+500 mg|N02AJ06|01.02.2018||R|1|0|0|0|0|ATE|0|0|1|100|IKR|1810|3989|lyfalmen|||2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1810||1810|3989||1|0|E|1|||0
579910|L04AA3701|OLUMIANT|filmhtfl|4|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|1|0|0|NED|0|1|0|100|XEU|117244|152330|lyfsjukr|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||117244||117244|152330||2|0|L|0|||0
579911|B01AF0301|Lixiana|filmhtfl|60|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|9635|14760|lyfalmen|||1|30|0|30,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||9635||9635|14760||1|0|G|0|||0
579932|C03DA0406|Eplerenon Alvogen|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|POF|0|0|0|100|IKR|3302|2544|lyfalmen|V0107|2530|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||760||760|2544||2|0|E|0|||0
579972|C03DA0403|Eplerenon  Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|BLS|0|0|0|100|XEU|13796|9725|lyfalmen|V0111|6315|2|100|0|100,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Eplerenón||5977||5977|9725||1|0|E|0|||0
580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|LBK|0|0|0|100|DKK|8021|12538|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||8021||8021|12538||1|0||0|||0
580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|0|0|FKD|0|0|0|100|DKK|9949|15192|lyfalmen|||1|8|0||Vistor hf|Fresenius Kabi Deutschland GmbH|Docetaxel||9949||9949|15192||1|H|0|0|||0
580699|H01BA0208|NOCDURNA|frþ.tfl|25|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|G|0|FEL|0|0|0|100|DKK|3773|6691|lyfalmen|||1|30|0|1,8750|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3773||3773|6691||1|0|G|0|||0
580713|R03AL1201|Enerzair Breezhaler|innönddu|||30|stk|1|stsk.þ|114 mcg/46 mcg/136mcg|R03AL12|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|8215|12805|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol, glycopyrronium bromide, mometasone||8215||8215|12805||1|0|G|0|||0
580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|1493|3553|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1493||1493|3553||2|0|0|0|||0
581379|C08CA0106|Amlodipin Medical Valley|töflur|10|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2650|2482|lyfalmen|V0057|2482|2|112|0|224,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||715||715|2482||2|0|G|0|||0
581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3042|5685|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3042||3042|5685||2|0|G|0|||0
581474|N02BA5105|Treo Hindbær|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.06.2020||L|0|0|0|0|0|MDK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
581661|N02CC0406|Rizatriptan Alvogen|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|G|0|POF|0|0|0|100|XEU|3335|6088|lyfalmen|||2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||3335||3335|6088||2|0|G|0|||0
581792|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|G|0|GOV|0|0|0|100|IKR|33214|45283|lyfalmen|||2|90|0|270,0000|Alvogen|Alvogen ehf|Bíkalútamíð||33214||33214|45283||2|0|G|0|||0
581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|ANI|1|0|0|100|XEU|13454|25695|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||13454||13454|25695||2|0||2|||0
581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2261|4610|lyfalmen|V0669|3915|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||2261||2261|4610||1|0|G|0|||0
582004|L01EX0801|Lenvima|hylki|4|mg|30|stk|1|þpakki||L01EX08|01.12.2018||R|0|0|1|0|0|SIE|0|1|0|100|SEK|229994|292559|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||229994||229994|292559||1|0|L|0|||0
582034|QM01AC0608|Novaquin|mixtúra|15|mg/ml|125|ml|1|glas|dreifa|QM01AC06|01.03.2018||R|0|0|0|0|0|VEB|0|0|0|100|IKR|4185|8110|vetalmen|||0|125|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||||4185|8110||2|0||0|||0
582096|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|DKK|3989|6837|lyfalmen|V0972|6837|2|100|0|30,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||3879||3879|6837||2|0|G|0|||0
582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|16508|24220|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||16508||16508|24220||3|0|G|0|||0
582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|GEH|0|0|0|100|NOK|21581|30569|lyfalmen|||1|2000|0||Icepharma hf|GE Healthcare AS|Iohexol||21581||21581|30569||2|H|0|0|||0
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|17577|25691|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Iohexol||17577||17577|25691||2|H|0|0|||0
582611|A10BJ0601|Ozempic|stl|1|mg|3|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|18409|26836|lyfalmen|||1|3|0|27,2727|Vistor hf|Novo-Nordisk|Semaglutide||18409||18409|26836||1|0|E|0|||0
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|52730|69967|lyfalmen|||1|3000|0||Icepharma hf|GE Healthcare AS|Iohexol||52730||52730|69967||2|H|0|0|||0
582671|H02AB0912|Alkindi|kyrnhylk|5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|72649|95160|lyfalmen|||1|50|0|8,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||72649||72649|95160||2|0|G|0|||0
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|21945|31030|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||21945||21945|31030||2|H|0|0|||0
582981|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.06.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|3532|5232|lyfalm11|V0983|5232|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3158||3158|5232||2|0||0|||1
582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|31377|42959|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|Merck AB|Sómatrópín||31377||31377|42959||2|0|L|0|||0
583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|G|0|UPJ|0|0|0|100|DKK|1911|4128|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Upjohn EESV|Latanóprost||1911||1911|4128||1|0|G|0|||0
583126|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|44831|59976|lyfalmen|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||44831||44831|59976||2|H|0|0|||0
583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1140|3067|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||1140||1140|3067||2|0|G|0|||0
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|75710|99032|lyfalmen|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||75710||75710|99032||2|H|0|0|||0
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|23986|33611|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||23986||23986|33611||2|H|0|0|||0
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|38377|51813|lyfalmen|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||38377||38377|51813||2|H|0|0|||0
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|71958|94286|lyfalmen|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||71958||71958|94286||2|H|0|0|||0
583888|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|4061|7087|lyfalmen|V0985|7087|2|30|0|60,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||4061||4061|7087||2|0|G|0|||0
583916|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|250|ml|10|pokar|lausn|B05BB01|01.02.2018||R|0|0|0|0|0|RAU|0|0|1|100|XEU|1937|4164|lyfalmen|||2|2500|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1937||1937|4164||2|0|0|0|||0
584306|J01EE0110|Cotrim|töflur|480|mg|30|stk|1|þpakki|80+400 mg|J01EE01|01.01.2021||R|1|0|0|0|0|TVB|0|0|1|100|XEU|1094|3004|lyfalmen|||2|30|0|7,5000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Súlfametoxazól og trímetóprím||||1094|3004||1|0|E|0|||0
584577|A04AD1202|Aprepitant Medical Valley|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.07.2019||R|1|0|0|G|0|VAL|0|0|1|100|XEU|7745|9375|lyfalmen|V0986|9375|2|3|0|1,7273|Acare ehf|Medical Valley Invest AB|Aprepitant||5723||5723|9375||2|0|G|0|||0
584738|N03AX1212|Gabapenstad|hylki|300|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1800|2943|lyfalmen|V0250|2943|2|120|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1050||1050|2943||2|0|G|0|||0
584834|N06AX2701|Spravato|nefúði|28|mg|28|mg|1|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|31589|43227|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||31589||31589|43227||1|H|L|1|30|dagar|0
584851|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.09.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|580|2296|lyfalmen|V0448|2296|2|100|0|50,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||580||580|2296||1|0|G|0|||0
585283|S01ED5122|Fixopost|augndr|||0,2|ml|90|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|G|0|LTH|0|0|0|100|SEK|7181|11382|lyfalmen|||2|18|0|90,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||7181||7181|11382||1|0|G|0|||0
585287|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.07.2020||R|0|0|0|0|0|NEL|0|0|0|100|DKK|59720|78807|lyfalmen|V0727|78807|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||59720||59720|78807||1|0|E|0|||0
585359|L01XC1801|KEYTRUDA|irþ|25|mg/ml|4|ml|1|hgl||L01XC18|01.07.2017||R|0|1|0|0|0|MBV|0|1|0|100|DKK|497638|625434|lyfsjukr|||1|4|0||Vistor hf|Merck Sharp & Dohme B.V.|Pembrolizumab||497638||497638|625434||1|H|L|0|||0
585458|M02AA1502|Voltaren|hlaup|11,6|mg/g|75|g|1|túpa||M02AA15|01.11.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|75|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
585516|A10BK0301|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|17489|25570|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||17489||17489|25570||1|0|G|0|||0
585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|LEP|0|0|1|100|DKK|5764|9431|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5764||5764|9431||1|0||0|||0
585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|2500|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||500||500|2186||2|0|G|0|||0
585754|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.09.2017||R|0|0|0|G|0|MYR|0|0|0|100|DKK|11572|17426|lyfalmen|||1|4|0|20,0000|Icepharma hf|Mylan IRE Healthcare Limited|Fondaparinux||11572||11572|17426||2|0|G|0|||0
585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|GPH|0|0|0|100|DKK|3905|6873|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3905||3905|6873||1|0||0|||0
585905|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|11089|10720|lyfalmen|V0440|9953|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||6700||6700|10720||2|0|G|0|||0
585914|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|129441|167500|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||129441||129441|167500||1|H|L|0|||0
586005|N03AX1212|Gabapenstad|hylki|400|mg|100|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1833|3150|lyfalmen|V0251|3150|2|100|0|22,2200|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1200||1200|3150||2|0|G|0|||0
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|26215|36430|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||26215||26215|36430||1|0|G|0|||0
586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|LEM|0|0|1|100|XEU|12186|18271|lyfalmen|||2|800|0|10,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||12186||12186|18271||2|0|0|0|||0
586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|0|0|MYE|0|1|1|100|DKK|305448|386403|lyfsjukr|||1|224|0|56,0000|Icepharma hf|Mylan Ireland Limited|Tobramýcín||305448||305448|386403||2|0|L|0|||0
586312|C10AX1301|Repatha|stl|140|mg|2|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|65444|86047|lyfalmen|||1|2|0|28,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||65444||65444|86047||1|0|E|0|||0
586579|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|G|0|VAL|0|0|0|100|XEU|3047|2837|lyfalmen|V0335|2837|2|110|0|165,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||973||973|2837||2|0|G|0|||0
586627|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|30|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2358|4743|lyfalmen|||2|30|0|90,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||2358||2358|4743||2|0|0|0|||0
586797|N06BA0902|Atomoxetin Actavis|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6471|3257|lyfalmen|V0815|3197|2|28|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1278||1278|3257||1|0|E|0|||0
586959|L01BC0207|Flúoróúracil Accord|stl/irl|50|mg/ml|100|ml|1|hgl||L01BC02|01.12.2019||R|0|0|0|0|0|AEE|0|0|0|100|XEU|4316|7438|lyfalmen|||2|100|0||Artasan ehf|Accord Healthcare B.V.|Flúóróúracíl||4316||4316|7438||1|H|0|0|||0
586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|27581|38158|lyfalmen|V0652|38156|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||27581|38158||1|0|G|0|||0
587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|4178|5989|lyfalmen|V0196|5989|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||3263||3263|5989||1|0|G|0|||0
587176|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|1|0|0|JAN|0|1|0|100|DKK|151103|194441|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||151103||151103|194441||1|0|L|0|||0
587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|6050|9825|lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||6050||6050|9825||1|0|E|0|||0
587658|M05BA0606|Ibandronic acid WH|stl|3|mg|3|ml|1|áfspr||M05BA06|01.05.2018||R|0|1|0|0|0|WEH|0|0|0|100|IKR|11132|16820|lyfalmen|V0957|16820|2|3|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||11132||11132|16820||2|0|E|0|||0
587958|C09CA0604|Kairasec|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|4030|6308|lyfalmen|V0081|6308|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3495||3495|6308||2|0|G|0|||0
588134|L04AC1201|Kyntheum|stl|210|mg|1,5|ml|2|áf.spr||L04AC12|01.10.2018||R|0|0|1|0|0|OEL|0|1|0|100|DKK|159365|204717|lyfsjukr|||1|3|0|28,0000|Vistor hf|LEO Pharma A/S|Brodalumab||159365||159365|204717||1|0|L|0|||0
588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|0|0|G|0|WEH|0|0|0|100|XEU|6140|3393|lyfalmen|V0683|3393|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1377||1377|3393||2|0|G|0|||0
588227|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|1|0|0|PEU|0|1|0|100|DKK|651308|816556|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||651308||651308|816556||1|0|L|0|||0
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1817|3999|lyfalmen|V0461|3393|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1817||1817|3999||1|0|E|0|||0
588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|16742|12330|lyfalmen|V0282|12098|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||7870||7870|12330||1|0|G|0|||0
589153|L01EC0201|Tafinlar|hylki|50|mg|120|stk|1|glas||L01EC02|01.11.2013||R|1|0|1|0|0|NEL|0|1|0|100|DKK|611209|766684|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafenib||611209||611209|766684||1|0|L|0|||0
589302|N02AX0213|Tramadol Krka|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3500|5214|lyfalmen|V0228|5214|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2700||2700|5214||2|0|G|1|30|dagar|0
589312|N03AX2201|Fycompa|mixtúra|0,5|mg/ml|340|ml|1|glas||N03AX22|01.10.2019||R|0|0|0|G|0|SIE|0|0|0|100|SEK|24727|34548|lyfalmen|||1|340|0|21,2500|Eisai AB|Eisai GmbH|Perampanel||24727||24727|34548||1|0|G|0|||0
589379|C10AA0509|Atorvastatin Xiromed|filmhtfl|10|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2100|2870|lyfalmen|V0112|2870|2|105|0|52,5000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||997||997|2870||2|0|G|0|||0
589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|10237|15588|lyfalmen|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||10237||10237|15588||2|H|0|0|||0
589893|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|4151|5611|lyfalmen|V0691|5611|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2988||2988|5611||1|0|E|1|30|dagar|0
590252|G04BE0312|Granpidam|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|1|G|0|CLU|0|0|0|100|XEU|38929|52511|lyfalmen|V0984|27989|2|90|0|36,0000|Artasan ehf|Accord Healthcare S.L.U.|Síldenafíl||38929||38929|52511||1|0|G|0|||0
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2862|4437|lyfalmen|V0041|3718|2|98|0|147,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísósorbíð mónónítrat||2135||2135|4437||1|0|G|0|||0
590825|L01XG0301|Ninlaro|hylki|2,3|mg|1|stk|3|þpakki|hvert hylki sérpakkað í þynnu|L01XG03|01.01.2019||R|0|0|1|0|0|TPA|0|1|0|100|DKK|791891|991402|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||791891||791891|991402||1|0|L|0|||0
590845|N06AB0406|Citalopram STADA|filmhtfl|10|mg|100|stk|1|þpakki||N06AB04|01.01.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1600|3700|lyfalmen|V0317|3700|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||1600||1600|3700||2|0|G|0|||0
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|BOI|0|0|0|100|DKK|138454|178709|lyfalmen|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||138454||138454|178709||1|H|0|0|||0
591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|G|0|LVR|0|0|0|100|DKK|8872|13709|lyfalmen|V0347|13709|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||8872||8872|13709||3|0|G|0|||0
591405|L04AA2901|Xeljanz|filmhtfl|5|mg|56|stk|1|þpakki||L04AA29|01.12.2017||R|0|1|1|0|0|PEU|0|1|0|100|DKK|114058|148367|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||114058||114058|148367||1|0|L|0|||0
591418|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1935|4161|lyfalmen|V0561|3535|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1935||1935|4161||2|0||0|||0
591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1087|2994|lyfalmen|V0168|2994|1|21|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1087||1087|2994||1|0|E|0|||0
591812|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|129441|167500|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||129441||129441|167500||1|H|L|0|||0
592068|J01DD0402|Ceftriaxona Normon|sts|1000|mg|1|stk|1|hgl|+ 1 lykja með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|2261|4610|lyfalmen|||2|1|0|0,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||2261||2261|4610|31.7.2021|2|0|0|0|||0
592418|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2308|3012|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1100||1100|3012|31.8.2021|2|0|G|0|||0
592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|3755|7294|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||3755||3755|7294||1|0||0|||0
592961|H05BX0107|Cinacalcet STADA|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|41798|43747|lyfalmen|V0722|43747|2|28|0|42,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||32000||32000|43747||2|0||0|||0
592977|L01EX0401|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01EX04|01.07.2012||R|1|1|1|0|0|GEB|0|1|0|100|XEU|676375|845242|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetanib||674373||674373|845242||1|0|L|0|||0
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|G|0|ROA|0|0|0|100|DKK|891|2724|lyfalmen|||1|150|0|9,3750|Icepharma hf|Roche A.S.|Klónazepam||891||891|2724||2|0|G|2|450|töflur|0
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|G|0|ROA|0|0|0|100|DKK|1141|3068|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche A.S.|Klónazepam||1141||1141|3068||2|0|G|2|100|töflur|0
593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|G|0|WEH|0|0|0|100|XEU|7219|4493|lyfalmen|V0694|3884|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2176||2176|4493||2|0|G|0|||0
593527|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.05.2021||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2548|3907|lyfalmen|V0826|3907|2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1750||1750|3907||2|0|G|0|||0
593555|N03AX1610|Pregabalin Medical Valley|hylki|75|mg|70|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|1556|3474|lyfalmen|V0686|2419|2|70|0|17,5000|Acare ehf|Medical Valley Invest AB|Pregabalín||1436||1436|3474||2|0|E|0|||0
594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|G|0|MEA|0|0|1|100|DKK|17541|25641|lyfalmen|||1|12|0|32,0000|Icepharma hf|Meda AB|Tríamcínólón||17541||17541|25641||2|0|G|0|||0
594343|N02AE0104|Buprenorphine ratiopharm|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018|31.07.2021|R|0|0|0|G|0|RTH|0|0|0|100|IKR|3504|6321|lyfalmen|||2|4|0|11,2000|Alvogen|ratiopharm GmbH|Búprenorfín||2500||3504|6321||2|0|G|1|30|dagar|0
594709|C01CA1702|Midodrin Evolan|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|G|0|EVO|0|0|0|100|IKR|10293|15665|lyfalmen|V0969|10040|2|50|0|8,3333|LYFIS ehf|Evolan Pharma AB|midodrine||10293||10293|15665||2|0|G|0|||0
595176|C10AA0509|Atorvastatin Xiromed|filmhtfl|80|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|0|0|MVX|0|0|0|100|IKR|5142|8575|lyfalmen|V0115|8365|2|105|0|420,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||5142||5142|8575||2|0|E|0|||0
595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|15348|22623|lyfalmen|V1031|22622|1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||15348||15348|22623||1|0|G|0|||0
595364|N06BA0409|Methylphenidate STADA|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|3000|4870|lyfalmen|V0959|4558|2|30|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||2450||2450|4870||2|0|E|1|30|dagar|0
595455|A10BA0205|Metformin EQL|filmhtfl|500|mg|330|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|G|0|EQL|0|0|0|100|IKR|2000|4251|lyfalmen|||2|330|0|82,5000|LYFIS ehf|EQL Pharma AB|Metformín||2000||2000|4251||2|0|G|0|||0
595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|19166|27878|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||19166||19166|27878||1|0|L|0|||0
596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|48551|64681|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||48551|64681||1|0|L|0|||0
596223|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|40|skammtar|1|glas||N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|40|0|1,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
596523|QP52AC5501|Drontaste|töflur|344|mg|2|stk|1|þpakki|150+144+50 mg|QP52AC55|01.10.2017||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1239|2136|vetorma|||0|2|0||Icepharma hf|Vetoquinol S.A.|Febantel, Pyrantelembonat,Prazikvantel||1239||1239|2136||2|0||0|||0
597167|J01DD0206|Ceftazidima Normon|sts|2|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|0|LNA|0|0|1|100|XEU|91089|102557|lyfalmen|||2|50|0|25,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||78497||78497|102557||2|0|0|0|||0
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1653|3773|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1653||1653|3773||1|0|E|0|||0
597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|BMS|0|1|0|100|DKK|531360|667374|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||531360||531360|667374||1|H|L|0|||0
597488|M03BX0107|Baclofen Sintetica í mænuvökva|irl|2|mg/ml|5|ml|1|lykja||M03BX01|01.06.2021||R|1|0|1|0|0|SIN|0|0|1|100|XEU|13926|17412|lyfalmen|||2|5|0|18,1800|Williams & Halls efh|Sintetica GmbH|Baklófen||11562||11562|17412||2|0|0|0|||0
597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|97077|126057|lyfalmen|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||97077||97077|126057||2|0|G|0|||0
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|TAE|0|0|1|100|IKR|||lyflausa|||0|30|0||Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|G|0|ADI|0|0|0|100|SEK|2268|4620|lyfalmen|||1|100|0|33,3333|Abcur AB|Amdipharm Limited|Acetazólamíð||2268||2268|4620||2|0|G|0|||0
598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0||0|||0
598859|M05BA0306|Pamidronatdinatrium Pfizer|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|PLS|0|0|0|100|DKK|5128|8556|lyfalmen|||2|10|0|1,0000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5128||5128|8556||1|H|0|0|||0
598908|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|EKI|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Íbúprófen|||||2215||1|0||0|||0
599010|L01EK0101|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01EK01|01.05.2013||R|1|0|1|0|0|PEU|0|1|0|100|DKK|495843|623201|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||495843||495843|623201||1|0|L|0|||0
599176|L01XA0303|Oxaliplatin Actavis|irþ|5|mg/ml|20|ml|1|hgl|lausn|L01XA03|01.03.2018||R|0|0|0|0|0|ATE|0|0|0|100|XEU|7430|11725|lyfalmen|||2|20|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxalíplatín||7430||7430|11725||1|H|0|0|||0
599248|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|3550|6906|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||3550||3550|6906||1|0||0|||0
599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|4224|8184|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4224||4224|8184||2|0||0|||0
599460|S01XA2024|Oculac án rotvarnar|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2507||1|0|G|0|||0
599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|27531|38095|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||27531|38095||1|0|G|0|||0
599632|B01AA0303|Warfarin Teva|töflur|1|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1236|3199|lyfalmen|||2|100|0|13,3333|Teva Pharma Iceland ehf|Teva B.V|Warfarín||1236||1236|3199||1|0|G|0|||0
599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|G|0|BLS|0|0|0|100|XEU|3418|3638|lyfalmen|V0334|2579|2|100|0|75,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1555||1555|3638||1|0|G|0|||0
954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|0|0|EAG|0|0|0|100|NOK|108227|141115|lyfalmen|||1|5|0||Icepharma hf|GE Healthcare B.V.|Lofendýlat||108227||108227|141115||2|H|0|0|||0
957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|22309|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|22309||2|0||0|||0
957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3296|6035|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||3296||3296|6035||2|0||0|||0
968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|PAR|0|0|1|100|IKR|1918|4138|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1918||1918|4138||2|0||0|||0
968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27471|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27471||2|0||0|||0
968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5529|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5529||2|0||0|||0
968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6522|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6522||2|0||0|||0
970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|PAR|0|0|1|100|IKR|4187|7261|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||4187||4187|7261||2|0||0|||0
970039|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||C09AA01|01.02.2017||R|0|0|0|0|0|PAR|0|0|0|100|IKR|15995|23513|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||15995||15995|23513||2|0||0|||0
970063|N07BB0401|Naltrexone Hydrochloride-forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||N07BB04|01.03.2017||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2095|4381|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naltrexone||2095||2095|4381||2|0|E|0|||0
974784|A01AC0001|Clobetasol propionate - forskriftarlyf|munnskol|0,5|mg/ml|300|ml|1|fl||A01AC|01.02.2018||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3375|6143|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3375|6143||2|0||0|||0
974792|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|2,5|mg/ml|100|ml|1|fl||C09AA01|01.07.2018||R|0|0|0|0|0|PAR|0|0|0|100|IKR|23568|33082|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||23568||23568|33082||2|0||0|||0
974809|A01AC0002|Fluticasone propionate - forskriftarlyf|munnskol|0,1|mg/ml|300|ml|1|fl||A01AC|01.12.2018||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3962|6951|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3962|6951||2|0||0|||0
974825|D07XA0103|HTH krem - forskriftarlyf|krem|||30|g|1|túpa|4%/0,025%/1%|D07XA01|01.06.2019||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3475|6281|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Hydrocortisone||3475||3475|6281||2|0|0|0|||0
974841|D10AD0104|Tretinoin - forskriftarlyf|krem|0,05|%|30|g|1|túpa||D10AD01|01.01.2020||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2979|5598|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tretínóín||2979||2979|5598||2|0|0|0|||0
980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|5245|8717|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||5245||5245|8717||2|0||0|||0
980071|D07AD0102|Clobetazol in Dermazink - forskriftarlyf|lausn|50|mg|120|ml|1|fl||D07AD01|01.02.2017||R|0|0|0|0|0|PAR|0|0|1|100|IKR|16998|24894|lyfalmen|||0|120|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Klóbetasól||16998||16998|24894||2|0||0|||0
985145|A07EA0102|Prednisolon - forskriftarlyf|eþ-stíll|10|mg|10|stk|1|pakki||A07EA01|01.01.2021||R|0|0|0|0|0|PAR|0|0|0|100|IKR|9369|14393|lyfalmen|||0|10|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Prednisolone||9369||9369|14393||2|0|0|0|||0
985153|A07EA0102|Prednisolon - forskriftarlyf|eþ-stíll|20|mg|10|stk|1|pakki||A07EA01|01.01.2021||R|0|0|0|0|0|PAR|0|0|0|100|IKR|10090|15386|lyfalmen|||0|10|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Prednisolone||10090||10090|15386||2|0|0|0|||0
985161|D10AD0104|Tretinoin - forskriftarlyf|krem|0,1|%|30|g|1|túpa||D10AD01|01.07.2021||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3292|6029|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tretínóín||3292||3292|6029||2|0|0|0|||0